<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ecam.oxfordjournals.org">
<title>Evidence-based Complementary and Alternative Medicine - Advance Access</title>
<link>http://ecam.oxfordjournals.org</link>
<description>Evidence-based Complementary and Alternative Medicine - RSS feed of articles</description>
<prism:eIssn>1741-4288</prism:eIssn>
<prism:publicationName>Evidence-based Complementary and Alternative Medicine</prism:publicationName>
<prism:issn>1741-427X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep183v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep185v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep184v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep034v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep174v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep166v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep165v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep180v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep158v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep170v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep164v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep159v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep178v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep177v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep175v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep172v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep169v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep168v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep156v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep155v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep146v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep176v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep173v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep151v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep076v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep145v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep163v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep160v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep162v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep144v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep161v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep157v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep131v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep154v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep141v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep150v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep149v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep142v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep138v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep152v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep153v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep147v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep148v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep143v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep127v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep137v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep140v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep139v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep135v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep096v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep120v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep136v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep124v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep126v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep119v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep109v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep133v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep130v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep134v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep132v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep125v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep128v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep111v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep095v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep122v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep123v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep121v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep107v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep104v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep116v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep102v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep117v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep112v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep115v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep114v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep113v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep110v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep108v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep106v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep105v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep103v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep094v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep088v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep091v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep089v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep083v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep090v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep064v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep063v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep062v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep051v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep093v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep084v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep075v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep074v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep078v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep077v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep069v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep072v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep067v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep082v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep081v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep071v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep070v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep068v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep066v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep080v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep073v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep060v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep059v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep061v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep055v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep039v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep056v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep057v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep050v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep053v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep049v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep052v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep048v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep047v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep042v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep045v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep043v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep036v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep038v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep016v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep044v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep040v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep041v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep035v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep037v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep028v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep033v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep030v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep032v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep031v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep029v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep024v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep022v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep027v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep025v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep023v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep018v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep026v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep021v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep020v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep019v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep014v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep015v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep010v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen090v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep006v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep011v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep005v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep004v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep007v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep009v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep012v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep013v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen089v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep003v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep002v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep001v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen091v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen074v3?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen088v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen086v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen087v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen085v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen084v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen081v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen083v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen082v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen080v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen079v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen066v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen078v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen077v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen075v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen070v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen068v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen072v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen069v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen034v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen071v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen067v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen062v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen063v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen065v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen064v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen061v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen060v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen058v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen056v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen059v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen057v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen052v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen055v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen051v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen053v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen050v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen047v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen037v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem182v3?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen045v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen049v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen044v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem179v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen048v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen040v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen036v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen042v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen043v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen039v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen038v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen032v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen033v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen031v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen029v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen027v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen026v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen030v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen028v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen025v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen024v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen021v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen019v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen023v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen022v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen011v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen018v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen017v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen007v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen010v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen009v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen001v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem155v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen006v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen003v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem177v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen004v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem188v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem187v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem186v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem185v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem183v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem184v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem181v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem180v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem176v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem178v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem140v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem172v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem170v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem159v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem171v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem162v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem150v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem129v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem168v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem165v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem153v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem118v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem166v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem161v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem146v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem143v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem163v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem160v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem151v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem156v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem144v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem142v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem141v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem158v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem152v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem148v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem147v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem076v1?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep183v1?rss=1">
<title><![CDATA[Analgesic and Anti-Inflammatory Activities of the Methanol Extract from Pogostemon cablin]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep183v1?rss=1</link>
<description><![CDATA[
<p><I>Pogostemon cablin</I> (PC) is a herbal medicine traditionally applied to treat not only common cold, nausea and diarrhea but also headache and fever. The aim of this study was to investigate the analgesic and anti-inflammatory properties of standardized PC methanol extract (PCMeOH) in vivo. Investigations were performed in mice with two analgesic models. One was acetic acid-induced writhing response and the other formalin-induced paw licking. The anti-inflammatory effect was tested by -carrageenan (Carr)-induced mice paw edema. These analgesic experimental results indicated that PCMeOH (1.0 g/kg) decreased the acetic acid-induced writhing responses and PCMeOH (0.5 and 1.0 g/kg) decreased the licking time in the second phase of the formalin test. Moreover, Carr-induced paw edema inflammation was significantly reduced in a dose-dependent manner when PCMeOH (0.5 and 1.0 g/kg) was administered 3 and 4 h after the Carr injection. Mechanistic studies showed that PCMeOH decreased the levels of malondialdehyde in the edema paw by increasing the activities of anti-oxidant enzymes, such as superoxide dismutase, glutathione peroxidase and glutathione reductase, in the liver and decreasing the cyclooxygenase 2 and tumor necrosis factor- activities in the edema paw. This study has demonstrated the analgesic and anti-inflammatory effects of PCMeOH, thus verifying its popular use in traditional medicine.</p>
]]></description>
<dc:creator><![CDATA[Lu, T.-C., Liao, J.-C., Huang, T.-H., Lin, Y.-C., Liu, C.-Y., Chiu, Y.-j., Peng, W.-H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 07:28:01 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep183</dc:identifier>
<dc:title><![CDATA[Analgesic and Anti-Inflammatory Activities of the Methanol Extract from Pogostemon cablin]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep185v1?rss=1">
<title><![CDATA[Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep185v1?rss=1</link>
<description><![CDATA[
<p>While traditional Chinese medicine (TCM) is widely used among Chinese patients with cancer, studies evaluating the effectiveness of TCM using objective indicators are rare. We examined the effectiveness of TCM for liver protection and completion of chemotherapy among patients with cancer receiving chemotherapy. We used a case&ndash;control design to examine the medical records of patients with cancer who received chemotherapy in a teaching hospital in Taipei in 2004. A total of 184 courses of chemotherapy among 89 patients were studied. Of the 184 courses, 42 used TCM jointly with chemotherapy served as cases, while the remaining 142 courses served as controls. Outcome variables included counts of cancelled or delayed chemotherapies and liver function (aspartate aminotransferase, AST and alanine aminotransferase, ALT) 1 week before, during and 2 weeks after chemotherapy. Generalized estimating equations were used to analyze the data. Patients who had concomitant TCM with chemotherapy had lower serum ALT and AST during chemotherapy than the controls given that the age, sex, cancer stage, radiotherapy sites, cancer diagnosis and potential hepatotoxicity of the chemotherapeutic drugs were controlled for in the model [<I>&beta;</I> = &ndash;3.48, 95% confidence interval (CI) &ndash;10.08 to 3.11 for AST; <I>&beta;</I> = &ndash;5.95, 95% CI: &ndash;11.47 to &ndash;0.44 for ALT]. There was no significant difference between the case and control groups for odds of completing one course of chemotherapy. Use of TCM with chemotherapy resulted in protection of the liver during chemotherapy, as manifested by lower serum AST and ALT levels.</p>
]]></description>
<dc:creator><![CDATA[Liu, M.-L., Chien, L.-Y., Tai, C.-J., Lin, K.-C., Tai, C.-J.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 07:24:02 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep185</dc:identifier>
<dc:title><![CDATA[Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep184v1?rss=1">
<title><![CDATA[The RCCM 2009 Survey: Mapping Doctoral and Postdoctoral CAM Research in the United Kingdom]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep184v1?rss=1</link>
<description><![CDATA[
<p>Complementary and Alternative Medicine (CAM) is widely available in the UK and used frequently by the public, but there is little high quality research to sustain its continued use and potential integration into the NHS. There is, therefore, a need to develop rigorous research in this area. One essential way forward is to train and develop more CAM researchers so that we can enhance academic capacity and provide the evidence upon which to base strategic healthcare decisions. This UK survey identified 80 research active postgraduates registered for MPhils/PhDs in 21 universities and were either current students or had completed their postgraduate degree during the recent UK Research Assessment Exercise (RAE) 2001&ndash;2008. The single largest postgraduate degree funder was the university where the students registered (26/80). Thirty-two projects involved randomized controlled trials and 33 used qualitative research methods. The UK RAE also indicates a significant growth of postdoctoral and tenured research activity over this period (in 2001 there were three full time equivalents; in 2008 there were 15.5) with a considerable improvement in research quality. This mapping exercise suggests that considerable effort is currently being invested in developing UK CAM research capacity and thus inform decision making in this area. However, in comparative international terms UK funding is very limited. As in the USA and Australia, a centralized and strategic approach by the National Institute of Health Research to this currently uncoordinated and underfunded activity may benefit CAM research in the UK.</p>
]]></description>
<dc:creator><![CDATA[Robinson, N., Lewith, G.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 07:24:01 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep184</dc:identifier>
<dc:title><![CDATA[The RCCM 2009 Survey: Mapping Doctoral and Postdoctoral CAM Research in the United Kingdom]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep034v2?rss=1">
<title><![CDATA[Temperament and Character Profiles of Sasang Typology in an Adult Clinical Sample]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep034v2?rss=1</link>
<description><![CDATA[
<p>The purpose of this study was to examine the biopsychological personality profiles of traditional Korean <I>Sasang</I> typology based on the Temperament and Character Inventory (TCI) in a Korean adult clinical sample. A total of 97 adults completed the Korean version of the TCI. The participants were classified as one of three traditional Korean <I>Sasang</I> types (31 So-Yang, 41 Tae-Eum, 25 So-Eum) by three specialists in <I>Sasang</I> typology. The seven dimensions of TCI were compared between the different <I>Sasang</I> types using analysis of variance (ANOVA) and profile analysis. There were no significant differences in age, gender and education across the <I>Sasang</I> types. The TCI profile for each of the <I>Sasang</I> types was significantly different (profile analysis, df = 5.038, <I>F</I> = 3.546, <I>P</I> = 0.004). There were significant differences in the temperament dimensions of Novelty Seeking (<I>F</I> = 3.43, <I>P</I> = 0.036) and Harm Avoidance (<I>F</I> = 5.43, <I>P</I> = 0.006) among the <I>Sasang</I> types. The Novelty Seeking score of the So-Yang type (31.90 &plusmn; 9.87) was higher than that of the So-Eum type (25.24 &plusmn; 9.21; <I>P</I> = 0.019) while the So-Eum type (44.64 &plusmn; 8.47) scored higher on the Harm Avoidance score compared to the So-Yang type (35.16 &plusmn; 11.50; <I>P</I> = 0.003). There were no significant differences in the temperament dimension of Reward Dependence and Persistence, and the three character dimensions of Self-Directedness, Cooperativeness and Self-Transcendence. Results demonstrated distinct temperament traits associated with traditional Korean <I>Sasang</I> types using an objective biopsychological personality inventory. With further study, the <I>Sasang</I> typology may lead to enhanced clinical safety and efficacy as part of personalized medicine with traditional medicine.</p>
]]></description>
<dc:creator><![CDATA[Park, S. H., Kim, M.-g., Lee, S. J., Kim, J. Y., Chae, H.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 21:47:04 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep034</dc:identifier>
<dc:title><![CDATA[Temperament and Character Profiles of Sasang Typology in an Adult Clinical Sample]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep174v1?rss=1">
<title><![CDATA[Safety of Herbal Medicinal Products: Echinacea and Selected Alkylamides do not Induce CYP3A4 mRNA Expression]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep174v1?rss=1</link>
<description><![CDATA[
<p>A major safety concern with the use of herbal medicinal products (HMP) is their interactions with conventional medicines, which are often mediated via the cytochrome P450 (CYP) system. Echinacea is a widely used over-the-counter HMP, with proven immunomodulatory properties. Its increasing use makes research into its safety an urgent concern. Previously, we showed that Echinacea extracts and its alkylamides (thought to be important for Echinacea's immunomodulatory activity) mildly inhibit the enzymatic activity of the main drug metabolising CYP isoforms, but to this date, there is insufficient work on its ability to alter CYP expression levels. We now report for the first time the effect of a commercial Echinacea extract (Echinaforce&reg;) and four Echinacea alkylamides on the transcription of the major drug metabolizing enzyme CYP3A4. HepG2 cells were exposed for 96 h to clinically relevant concentrations of Echinaforce (22, 11.6 and 1.16 &micro;g ml<sup>&ndash;1</sup>) or the alkylamides (1.62 and 44 nM). CYP3A4 mRNA levels were quantified using real-time reverse transcription polymerase chain reaction (RT-PCR). Neither Echinaforce&reg; nor the alkylamides produced any significant changes in the steady-state CYP3A4 mRNA levels, under these conditions. In contrast, treatment with 50 &micro;M rifampicin resulted in a 3.8-fold up-regulation over the vehicle control. We conclude that Echinaforce&reg; is unlikely to affect CYP3A4 transcriptional levels, even at concentrations which can inhibit the enzymatic activity of CYP3A4. Overall, our data provides further evidence for the lack of interactions between Echinacea and conventional drugs.</p>
]]></description>
<dc:creator><![CDATA[Modarai, M., Silva, E., Suter, A., Heinrich, M., Kortenkamp, A.]]></dc:creator>
<dc:date>Wed, 11 Nov 2009 07:18:13 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep174</dc:identifier>
<dc:title><![CDATA[Safety of Herbal Medicinal Products: Echinacea and Selected Alkylamides do not Induce CYP3A4 mRNA Expression]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-11</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep166v1?rss=1">
<title><![CDATA[A Parametric Study on the Immunomodulatory Effects of Electroacupuncture in DNP-KLH Immunized Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep166v1?rss=1</link>
<description><![CDATA[
<p>This study was conducted to compare the effects of low frequency electroacupuncture (EA) and high frequency EA at acupoint ST36 on the production of IgE and Th1/Th2 cytokines in BALB/c mice that had been immunized with 2,4-dinitrophenylated keyhole limpet protein (DNP-KLH), as well as to investigate the difference in the immunomodulatory effects exerted by EA stimulations at acupoint ST36 and at a non-acupoint (tail). Female BALB/c mice were divided into seven groups: normal (no treatments), IM (immunization only), ST36-PA (IM + plain acupuncture at ST36), ST36-LEA [IM + low frequency (1 Hz) EA at ST36], ST36-HEA [IM + high frequency (120 Hz) EA at ST36], NA-LEA [IM + low frequency (1 Hz) EA at non-acupoint] and NA-HEA [IM + high frequency (120 Hz) EA at non-acupoint]. EA stimulation was performed daily for two weeks, and total IgE, DNP-KLH specific IgE, IL-4 and IFN- levels were measured at the end of the experiment. The results of this study showed that the IgE and IL-4 levels were significantly suppressed in the ST36-LEA and ST36-HEA groups, but not in the NA-LEA and NA-HEA groups. However, there was little difference in the immunomodulatory effects observed in the ST36-LEA and ST36-HEA groups. Taken together, these results suggest that EA stimulation-induced immunomodulation is not frequency dependent, but that it is acupoint specific.</p>
]]></description>
<dc:creator><![CDATA[Kim, S. K., Lee, Y., Cho, H., Koo, S., Choi, S. M., Shin, M.-K., Hong, M.-C., Min, B.-I., Bae, H.]]></dc:creator>
<dc:date>Mon, 09 Nov 2009 01:54:55 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep166</dc:identifier>
<dc:title><![CDATA[A Parametric Study on the Immunomodulatory Effects of Electroacupuncture in DNP-KLH Immunized Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-09</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep165v1?rss=1">
<title><![CDATA[Targeting PML-RAR{alpha} and Oncogenic Signaling Pathways by Chinese Herbal Mixture Tien-Hsien Liquid in Acute Promyelocytic Leukemia NB4 Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep165v1?rss=1</link>
<description><![CDATA[
<p><I>Tien-Hsien</I> Liquid (THL) is a Chinese herbal mixture that has been used worldwide as complementary treatment for cancer patients in the past decade. Recently, THL has been shown to induce apoptosis in various types of solid tumor cells <I>in vitro</I>. However, the underlying molecular mechanisms have not yet been well elucidated. In this study, we explored the effects of THL on acute promyelocytic leukemia (APL) NB4 cells, which could be effectively treated by some traditional Chinese remedies containing arsenic trioxide. The results showed THL could induce G2/M arrest and apoptosis in NB4 cells. Accordingly, the decrease of cyclin A and B1 were observed in THL-treated cells. The THL-induced apoptosis was accompanied with caspase-3 activation and decrease of PML-RAR fusion protein. Moreover, DNA methyltransferase 1 and oncogenic signaling pathways such as Akt/mTOR, Stat3 and ERK were also down-regulated by THL. By using ethyl acetate extraction and silica gel chromatography, an active fraction of THL named as EAS5 was isolated. At about 0.5&ndash;1% of the dose of THL, EAS5 appeared to have most of THL-induced multiple molecular targeting effects in NB4 cells. Based on the findings of these multi-targeting effects, THL might be regarding as a complementary and alternative therapeutic agent for refractory APL.</p>
]]></description>
<dc:creator><![CDATA[Yao, C.-J., Yang, C.-M., Chuang, S.-E., Yan, J.-L., Liu, C.-Y., Chen, S.-W., Yan, K.-H., Lai, T.-Y., Lai, G.-M.]]></dc:creator>
<dc:date>Fri, 06 Nov 2009 05:31:56 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep165</dc:identifier>
<dc:title><![CDATA[Targeting PML-RAR{alpha} and Oncogenic Signaling Pathways by Chinese Herbal Mixture Tien-Hsien Liquid in Acute Promyelocytic Leukemia NB4 Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-06</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep180v1?rss=1">
<title><![CDATA[Ethanolic Extract of Propolis Augments TRAIL-Induced Apoptotic Death in Prostate Cancer Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep180v1?rss=1</link>
<description><![CDATA[
<p>Prostate cancer is a commonly diagnosed cancer in men. The ethanolic extract of propolis (EEP) and its phenolic compounds possess immunomodulatory, chemopreventive and antitumor effects. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/APO2L) is a naturally occurring anticancer agent that preferentially induces apoptosis in cancer cells and is not toxic to normal cells. We examined the cytotoxic and apoptotic effects of EEP and phenolic compounds isolated from propolis in combination with TRAIL on two prostate cancer cell lines, hormone-sensitivity LNCaP and hormone-refractory DU145. The cytotoxicity was evaluated by MTT and LDH assays. The apoptosis was determined using flow cytometry with annexin V-FITC/propidium iodide. The prostate cancer cell lines were proved to be resistant to TRAIL-induced apoptosis. Our study demonstrated that EEP and its components significantly sensitize to TRAIL-induced death in prostate cancer cells. The percentage of the apoptotic cells after cotreatment with 50 &micro;g ml<sup>&ndash;1</sup> EEP and 100 ng ml<sup>&ndash;1</sup> TRAIL increased to 74.9 &plusmn; 0.7% for LNCaP and 57.4 &plusmn; 0.7% for DU145 cells. The strongest cytotoxic effect on LNCaP cells was exhibited by apigenin, kaempferid, galangin and caffeic acid phenylethyl ester (CAPE) in combination with TRAIL (53.51 &plusmn; 0.68 &ndash; 66.06 &plusmn; 0.62% death cells). In this work, we showed that EEP markedly augmented TRAIL-mediated apoptosis in prostate cancer cells and suggested the significant role of propolis in chemoprevention of prostate cancer.</p>
]]></description>
<dc:creator><![CDATA[Szliszka, E., Czuba, Z. P., Bronikowska, J., Mertas, A., Paradysz, A., Krol, W.]]></dc:creator>
<dc:date>Thu, 05 Nov 2009 06:21:41 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep180</dc:identifier>
<dc:title><![CDATA[Ethanolic Extract of Propolis Augments TRAIL-Induced Apoptotic Death in Prostate Cancer Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-05</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep158v1?rss=1">
<title><![CDATA[In Vivo Anti-Diabetic Activity of the Ethanolic Crude Extract of Sorbus decora C.K.Schneid. (Rosacea): A Medicinal Plant Used by Canadian James Bay Cree Nations to Treat Symptoms Related to Diabetes]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep158v1?rss=1</link>
<description><![CDATA[
<p>A number of potential anti-diabetic plants were identified through an ethnobotanical survey of the traditional pharmacopeia of the Cree of Eeyou Istchee (CEI&mdash;Northeastern Canada) used against symptoms of diabetes and their biological activity assessed by <I>in vitro</I> bioassays. Among these, <I>Sorbus decora</I> C.K.Schneid. (Rosacea) ranked highly and increased the transport of glucose in skeletal muscle cells in culture. The present study thus aimed at confirming the antidiabetic potential of <I>S. decora</I> in <I>in vivo</I> models of insulin resistance and diabetes, notably the streptozotocin Type 1 diabetic rat (STZ), the genetic KK-A<sup>y</sup> Type 2 diabetic mouse and the rat rendered insulin resistant with 10% glucose water consumption for 6 weeks. <I>Sorbus decora</I> ethanol extract (SDEE) was administered orally (200 mg kg<sup>&ndash;1</sup>) and compared to metformin (150 or 500 mg kg<sup>&ndash;1</sup>). The intragastric (i.g.) gavage of SDEE transiently decreased glycemia in STZ rats in a bi-phasic manner but the effect was cumulative over several days. In KK-Ay mice, SDEE incorporated in food (0.12%) decreased glycemia by 15% within 1 week as compared to vehicle controls. In pre-diabetic insulin-resistant rats, SDEE fed daily by i.g. gavage for 2 weeks significantly decreased the slight hyperglycemia and hyperinsulinemia, without affecting sugar water intake. Using the HOMA insulin resistance parameter, the effect of SDEE was equivalent to that of metformin. In conclusion, the ethanol extract of <I>S. decora</I> demonstrates both anti-hyperglycemic and insulin-sensitizing activity <I>in vivo</I>, thereby confirming anti-diabetic potential and validating CEI traditional medicine.</p>
]]></description>
<dc:creator><![CDATA[Vianna, R., Brault, A., Martineau, L. C., Couture, R., Arnason, J. T., Haddad, P. S.]]></dc:creator>
<dc:date>Tue, 03 Nov 2009 04:47:57 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep158</dc:identifier>
<dc:title><![CDATA[In Vivo Anti-Diabetic Activity of the Ethanolic Crude Extract of Sorbus decora C.K.Schneid. (Rosacea): A Medicinal Plant Used by Canadian James Bay Cree Nations to Treat Symptoms Related to Diabetes]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-03</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep170v1?rss=1">
<title><![CDATA[Reporting Experiments in Homeopathic Basic Research--Description of the Checklist Development]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep170v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study was to develop a criteria catalogue serving as a guideline for authors to improve quality of reporting experiments in basic research in homeopathy. A Delphi Process was initiated including three rounds of adjusting and phrasing plus two consensus conferences. European researchers who published experimental work within the last 5 years were involved. A checklist for authors provide a catalogue with 23 criteria. The &lsquo;Introduction&rsquo; should focus on underlying hypotheses, the homeopathic principle investigated and state if experiments are exploratory or confirmatory. &lsquo;Materials and methods&rsquo; should comprise information on object of investigation, experimental setup, parameters, intervention and statistical methods. A more detailed description on the homeopathic substances e.g. manufacture, dilution method, starting point of dilution is required. A further result of the Delphi process is to raise scientists&rsquo; awareness of reporting blinding, allocation, replication, quality control and system performance controls. The part &lsquo;Results&rsquo; should provide the exact number of treated units per setting which were included in each analysis and state missing samples and drop outs. Results presented in tables and figures are as important as appropriate measures of effect size, uncertainty and probability. &lsquo;Discussion&rsquo; in a report should depict more than a general interpretation of results in the context of current evidence but also limitations and an appraisal of aptitude for the chosen experimental model. Authors of homeopathic basic research publications are encouraged to apply our checklist when preparing their manuscripts. Feedback is encouraged on applicability, strength and limitations of the list to enable future revisions.</p>
]]></description>
<dc:creator><![CDATA[Stock-Schroer, B., Albrecht, H., Betti, L., Dobos, G., Endler, C., Linde, K., Ludtke, R., Musial, F., van Wijk, R., Witt, C., Baumgartner, S.]]></dc:creator>
<dc:date>Sun, 01 Nov 2009 21:33:07 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep170</dc:identifier>
<dc:title><![CDATA[Reporting Experiments in Homeopathic Basic Research--Description of the Checklist Development]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep164v1?rss=1">
<title><![CDATA[Antioxidant and Hepatoprotective Effects of Silibinin in a Rat Model of Nonalcoholic Steatohepatitis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep164v1?rss=1</link>
<description><![CDATA[
<p>Nonalcoholic steatohepatitis (NASH) is a progressive liver disease related to the metabolic syndrome, obesity and diabetes. The rising prevalence of NASH and the lack of efficient treatments have led to the exploration of different therapeutic approaches. Milk thistle (<I>Silibum marianum</I>) is a medicinal plant used for its hepatoprotective properties in chronic liver disease since the 4th century BC. We explored the therapeutic effect of silibinin, the plant's most biologically active extract, in an experimental rat NASH model. A control group was fed a standard liquid diet for 12 weeks. The other groups were fed a high-fat liquid diet for 12 weeks without (NASH) or with simultaneous daily supplement with silibinin&ndash;phosphatidylcholine complex (Silibinin 200 mg kg<sup>&ndash;1</sup>) for the last 5 weeks. NASH rats developed all key hallmarks of the pathology. Treatment with silibinin improved liver steatosis and inflammation and decreased NASH-induced lipid peroxidation, plasma insulin and TNF-. Silibinin also decreased O<SUB>2</SUB><sup>&bull;&ndash;</sup> release and returned the relative liver weight as well as GSH back to normal. Our results suggest that milk thistle's extract, silibinin, possesses antioxidant, hypoinsulinemic and hepatoprotective properties that act against NASH-induced liver damage. This medicinal herb thus shows promising therapeutic potential for the treatment of NASH.</p>
]]></description>
<dc:creator><![CDATA[Haddad, Y., Vallerand, D., Brault, A., Haddad, P. S.]]></dc:creator>
<dc:date>Sun, 01 Nov 2009 21:33:06 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep164</dc:identifier>
<dc:title><![CDATA[Antioxidant and Hepatoprotective Effects of Silibinin in a Rat Model of Nonalcoholic Steatohepatitis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep159v1?rss=1">
<title><![CDATA[Experimental Adjustment on Drug Interactions through Intestinal CYP3A Activity in Rat: Impacts of Kampo Medicines Repeat Administered]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep159v1?rss=1</link>
<description><![CDATA[
<p>To provide the information that is necessary for making the proper use of kampo medicines, we have proposed the adequate methodology focused on the following issues: (i) kampo medicines emphasize the effects produced by the combination of herbal drugs rather than the individual effect of any single herb and (ii) Intestinal CYP3A has become a key factor for the bioavailability of orally administrated drugs. In the present study, we investigated both the <I>in vivo</I> and <I>in vitro</I> effects of Saireito and Hochuekkito (kampo formulas) on CYP3A activities. From our study, oral pre-treatment with Saireito or Hochuekkito did not affect the pharmacokinetics of nifedipine after intravenous administration to rats. When nifedipine was administered to rat intrajejunum, a significant decrease of AUC was showed by pre-treatment with both kampo formulas. Saireito pre-treatment led to 80% decrease in <I>C</I><SUB>max</SUB> of nifedipine. Saireito caused significant increases in both protein expression and metabolic activity of CYP3A in intestinal microsome, whereas it had no effect on CYP3A in hepatic microsome. Our result also showed that this affect of Saireito can be gone by wash-out with 1 week. These findings demonstrated that Saireito may induce CYP3A activity of intestine but not of liver in rats. When resources for research are limited, well-designed scientific studies except clinical trials also have many advantages.</p>
]]></description>
<dc:creator><![CDATA[Kinoshita, N., Yamaguchi, Y., Hou, X.-L., Takahashi, K., Takahashi, K.]]></dc:creator>
<dc:date>Sun, 01 Nov 2009 21:33:05 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep159</dc:identifier>
<dc:title><![CDATA[Experimental Adjustment on Drug Interactions through Intestinal CYP3A Activity in Rat: Impacts of Kampo Medicines Repeat Administered]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep178v1?rss=1">
<title><![CDATA[Hypolipidemic Effects of Three Purgative Decoctions]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep178v1?rss=1</link>
<description><![CDATA[
<p>In traditional Chinese medicine (TCM), purgation is indicated when a person suffers an illness due to the accumulation of evil internal heat. Obese individuals with a large belly, red face, thick and yellow tongue fur, constipation, and avoidance of heat are thought accumulates of evil internal heat, and they are also treated with purgatives such as <I>Ta-Cheng-Chi-Tang</I> (TCCT), <I>Xiao-Chen-Chi-Tang</I> (XCCT), and <I>Tiao-Wei-Chen-Chi-Tang</I> (TWCCT) by TCM doctors. In previous studies, our group found that TCCT has potent anti-inflammatory activity, and that XCCT is an effective antioxidant. Since rhubarb is the principle herb in these three prescriptions, we will first present a thorough review of the literature on the demonstrated effect (or lack of effect) of rhubarb and rhubarb-containing polyherbal preparations on lipid and weight control. We will then continue our research with an investigation of the anti-obesity and lipid-lowering effect of TCCT, XCCT, TWCCT, and rhubarb extracts using two animal models. TWCCT lowered the serum triglyceride concentration as much as fenofibrate in Triton WR-1339-treated mice. Daily supplementation with XCCT and TWCCT significantly attenuated the high-fat-diet-induced hypercholesterolemia in rats. In addition, TWCCT also significantly lowered the high-fat-diet-induced hypertriglycemia. Although feeding high-fat diet rats with these extracts did not cause loose stools or diarrhea or other deleterious effects on renal or hepatic function. None of these extracts lowered the body weight of rats fed on high-fat diet. In conclusion, the results suggest that XCCT and TWCCT might exert beneficial effects in the treatment of hyperlipidemia.</p>
]]></description>
<dc:creator><![CDATA[Tseng, S.-H., Chien, T.-Y., Chen, J.-R., Lin, I-H., Wang, C.-C.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 04:42:45 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep178</dc:identifier>
<dc:title><![CDATA[Hypolipidemic Effects of Three Purgative Decoctions]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-30</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep177v1?rss=1">
<title><![CDATA[Centella asiatica Improves Physical Performance and Health-related Quality of Life in Healthy Elderly Volunteer]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep177v1?rss=1</link>
<description><![CDATA[
<p>Recently, oxidative stress has been reported to contribute an important role in the decline of physical function as age advances. Numerous antioxidants can improve both physical and psychological performances resulting in the increase of health-related quality of life (HQOL). Therefore, we hypothesized that <I>Centella asiatica</I>, a medicinal plant reputed for nerve tonic, strength improvement and antioxidant activity, could improve the physical performance and HQOL especially in the physical satisfaction aspect, of the healthy elderly volunteer. To test this hypothesis, a double-blind, placebo-controlled, randomized trial was performed. Eighty healthy elderly were randomly assigned to receive placebo or standardized extract of <I>C. asiatica</I> at doses of 250, 500 and 750 mg once daily for 90 days. The subjects were evaluated to establish baseline data of physical performance using 30-s chair stand test, hand grip test and 6-min walk test. The health-related quality of life was assessed using SF-36. These assessments were repeated every month throughout the 3-month experimental period using the aforementioned parameters. Moreover, 1 month after the cessation of <I>C. asiatica</I> treatment, all subjects were also evaluated using these parameters again. The results showed that after 2 months of treatment, <I>C. asiatica</I> at doses of 500 and 750 mg per day increased lower extremity strength assessed via the 30-s chair stand test. In addition, the higher doses of <I>C. asiatica</I> could improve the life satisfaction subscale within the physical function subscale. Therefore, the results from this study appear to support the traditional reputation of <I>C. asiatica</I> on strength improvement, especially in the lower extremities of the elderly. <I>C. asiatica</I> also possesses the potential to be a natural resource for vigor and strength increase, in healthy elderly persons. However, further research is essential.</p>
]]></description>
<dc:creator><![CDATA[Mato, L., Wattanathorn, J., Muchimapura, S., Tongun, T., Piyawatkul, N., Yimtae, K., Thanawirattananit, P., Sripanidkulchai, B.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 04:42:43 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep177</dc:identifier>
<dc:title><![CDATA[Centella asiatica Improves Physical Performance and Health-related Quality of Life in Healthy Elderly Volunteer]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-30</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep175v1?rss=1">
<title><![CDATA[The Herb Medicine Formula 'Chong Lou Fu Fang' Increases the Cytotoxicity of Chemotherapeutic Agents and Down-regulates the Expression of Chemotherapeutic Agent Resistance-related Genes in Human Gastric Cancer Cells In Vitro]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep175v1?rss=1</link>
<description><![CDATA[
<p>The herb medicine formula &lsquo;Chong Lou Fu Fang&rsquo; (CLFF) has efficacy in inhibiting the proliferation of human gastric cancer <I>in vitro</I> and <I>in vivo</I>. To explore the potentially useful combination of CLFF with chemotherapeutic agents commonly used in gastric cancer therapy, we assess the interaction between CLFF and these chemotherapeutic agents in both SGC-7901cell lines and BGC-823 cell lines using a median effect analysis and apoptosis analysis, and we also investigate the influence of CLFF on chemotherapeutic agent-associated gene expression. The synergistic analysis indicated that CLFF had a synergistic effect on the cytotoxicity of 5-fluorouracil (5-FU) in a relative broad dose inhibition range (20&ndash;95% fraction affected in SGC-7901cell lines and 5&ndash;65% fraction affected in BGC-823 cell lines), while the synergistic interaction between CLFF and oxaliplatin or docetaxel only existed in a low dose inhibition range (&le;50% fraction affected in both cell lines). Combination of CLFF and chemotherapeutic agents could also induce apoptosis in a synergistic manner. After 24 h, CLFF alone or CLFF combination with chemotherapeutic agents could significantly suppress the levels of expression of chemotherapeutic agent resistance related genes in gastric cancer cells. Our findings indicate that there are useful synergistic interactions between CLFF and chemotherapeutic agents in gastric cancer cells, and the possible mechanisms might be partially due to the down-regulation of chemotherapeutic agent resistance related genes and the synergistic apoptotic effect.</p>
]]></description>
<dc:creator><![CDATA[Liu, Y., Ling, Y., Hu, W., Xie, L., Yu, L., Qian, X., Zhang, B., Liu, B.]]></dc:creator>
<dc:date>Thu, 29 Oct 2009 04:59:43 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep175</dc:identifier>
<dc:title><![CDATA[The Herb Medicine Formula 'Chong Lou Fu Fang' Increases the Cytotoxicity of Chemotherapeutic Agents and Down-regulates the Expression of Chemotherapeutic Agent Resistance-related Genes in Human Gastric Cancer Cells In Vitro]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep172v1?rss=1">
<title><![CDATA[Auricular Acupunctures are Effective for the Prevention of Postoperative Agitation in Old Patients]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep172v1?rss=1</link>
<description><![CDATA[
<p>Postoperative cognitive problems and delirium are not uncommon in the elderly. We reported four cases in which auricular acupunctures on the &lsquo;Shenmen&rsquo; and &lsquo;Point Zero&rsquo; points successfully managed postoperative problematic behaviors of the three patients with dementia and the one patient postoperatively demonstrating an agitated behavior.</p>
]]></description>
<dc:creator><![CDATA[Arai, Y.-C. P., Ito, A., Hibino, S., Niwa, S., Ueda, W.]]></dc:creator>
<dc:date>Thu, 29 Oct 2009 04:59:42 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep172</dc:identifier>
<dc:title><![CDATA[Auricular Acupunctures are Effective for the Prevention of Postoperative Agitation in Old Patients]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-29</prism:publicationDate>
<prism:section>Case Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep169v1?rss=1">
<title><![CDATA[Diaphragmatic Breathing Reduces Exercise-induced Oxidative Stress]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep169v1?rss=1</link>
<description><![CDATA[
<p>Diaphragmatic breathing is relaxing and therapeutic, reduces stress, and is a fundamental procedure of Pranayama Yoga, Zen, transcendental meditation and other meditation practices. Analysis of oxidative stress levels in people who meditate indicated that meditation correlates with lower oxidative stress levels, lower cortisol levels and higher melatonin levels. It is known that cortisol inhibits enzymes responsible for the antioxidant activity of cells and that melatonin is a strong antioxidant; therefore, in this study, we investigated the effects of diaphragmatic breathing on exercise-induced oxidative stress and the putative role of cortisol and melatonin hormones in this stress pathway. We monitored 16 athletes during an exhaustive training session. After the exercise, athletes were divided in two equivalent groups of eight subjects. Subjects of the studied group spent 1 h relaxing performing diaphragmatic breathing and concentrating on their breath in a quiet place. The other eight subjects, representing the control group, spent the same time sitting in an equivalent quite place. Results demonstrate that relaxation induced by diaphragmatic breathing increases the antioxidant defense status in athletes after exhaustive exercise. These effects correlate with the concomitant decrease in cortisol and the increase in melatonin. The consequence is a lower level of oxidative stress, which suggests that an appropriate diaphragmatic breathing could protect athletes from long-term adverse effects of free radicals.</p>
]]></description>
<dc:creator><![CDATA[Martarelli, D., Cocchioni, M., Scuri, S., Pompei, P.]]></dc:creator>
<dc:date>Thu, 29 Oct 2009 04:59:44 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep169</dc:identifier>
<dc:title><![CDATA[Diaphragmatic Breathing Reduces Exercise-induced Oxidative Stress]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep168v1?rss=1">
<title><![CDATA[The Curious Case of Charles Darwin and Homeopathy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep168v1?rss=1</link>
<description><![CDATA[
<p>In 1849, Charles Darwin was so ill that he was unable to work one out of every 3 days, and after having various troubling symptoms for 2&ndash;12 years, he wrote to a friend that he was &lsquo;going the way of all flesh&rsquo;. He sought treatment from Dr James Manby Gully, a medical doctor who used water cure and homeopathic medicines. Despite being highly skeptical of these treatments, he experienced a dramatic improvement in his health, though some of his digestive and skin symptoms returned various times in his life. He grew to appreciate water cure, but remained skeptical of homeopathy, even though his own experiments on insectivore plants using what can be described as homeopathic doses of ammonia salts surprised and shocked him with their significant biological effect. Darwin even expressed concern that he should publish these results. Two of Darwin's sons were as incredulous as he was, but their observations confirmed the results of his experiments. Darwin was also known to have read a book on evolution written by a homeopathic physician that Darwin described as similar to his own but &lsquo;goes much deeper.&rsquo;</p>
]]></description>
<dc:creator><![CDATA[Ullman, D.]]></dc:creator>
<dc:date>Thu, 29 Oct 2009 04:59:42 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep168</dc:identifier>
<dc:title><![CDATA[The Curious Case of Charles Darwin and Homeopathy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-29</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep156v1?rss=1">
<title><![CDATA[An Overture for eCAM: Science, Technology and Innovation Initiation for Prosperous, Healthy Nepal]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep156v1?rss=1</link>
<description><![CDATA[
<p>Nepal the &lsquo;Shangri-La&rsquo; in the lap of the Himalayas is gearing up for modern times as it starts rebuilding after a decade of senseless violence and destruction. The nation one of the poorest in the global development index is rich in natural resources and biodiversity. Reports of medicinal plants far exceeding those recorded and reported so far are encouraging and at the same time concerns for medicinal plants under threat as a result of overexploitation are emerging from Nepal. The harsh mountain terrains, lack of industrialization and harnessing potentiality of its areas of strength; water; natural resources and tourism make it poor in per capita income which averages ~300 US$, with half the population living under &gt;1$ a day. Nepal is beginning to realize that the way ahead is only possible through the path of Science and Technology (ST). Nepal Academy of Science and Technology formerly known as Royal Academy of Science and Technology organized the fifth national conference held every 4 years that took place in the capital Kathmandu during November 10&ndash;12, 2008. The ST initiation event saw the participation of ~1400 people representing over 150 organizations from the country and experts from abroad. The theme for the fifth national meet was &lsquo;Science, Technology and Innovation for Prosperous Nepal&rsquo;. Complementary and Alternative Medicine (CAM) was an important theme in the event as the realization for the need of ST research focused in CAM for harnessing the chemo diversity potential was univocally approved.</p>
]]></description>
<dc:creator><![CDATA[Kaphle, K., Bhuju, D. R., Jha, P. K., Bhattarai, H. N.]]></dc:creator>
<dc:date>Thu, 29 Oct 2009 04:59:41 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep156</dc:identifier>
<dc:title><![CDATA[An Overture for eCAM: Science, Technology and Innovation Initiation for Prosperous, Healthy Nepal]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-29</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep155v1?rss=1">
<title><![CDATA[Therapeutic Potential of Polar and Non-polar Extracts of Cyanthillium cinereum In vitro]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep155v1?rss=1</link>
<description><![CDATA[
<p><I>Cyanthillium cinereum</I> (Less.) H. Rob. (Asteraceae) has been traditionally known for its medicinal properties, all aspects of which are yet to be exploited. This study was aimed at investigating the therapeutic potential of polar (methanolic and aqueous) and nonpolar (hexane and chloroform) crude extracts of the whole plant. Several parameters including free-radical (DPPH<sup>&bull;</sup>, ABTS<sup>&bull;+</sup>, H<SUB>2</SUB>O<SUB>2</SUB> and <sup>&bull;</sup>OH) scavenging, reducing power, protection of DNA against oxidative damage, cytotoxicity, inhibition of oxidative hemolysis in erythrocytes, total phenolic content and inhibition of lipid peroxidation were examined. All the free-radical generating assay models demonstrated positive scavenging efficiency with differential but considerable magnitudes for the four extracts. However, only the hexane extract showed significant H<SUB>2</SUB>O<SUB>2</SUB> scavenging effect. Lipid peroxidation was estimated by thiobarbituric acid&ndash;malondialdehyde (MDA) reaction, and a high degree of inhibition was shown by all the extracts. Reducing power of the polar extracts was higher than the non-polar ones. All extracts showed a concentration-dependent increase in phenolic contents. Oxidative damage to erythrocytes was hindered by all extracts in diverse degrees. XTT assay showed that all extracts have mild cytotoxic property. The aqueous extract evidently demonstrated protective effect on pBR322 plasmid DNA against oxidative breakdown. These results suggested the potential of <I>C. cinereum</I> as medicine against free-radical-associated oxidative damage and related degenerative diseases involving metabolic stress, genotoxicity and cytotoxicity.</p>
]]></description>
<dc:creator><![CDATA[Guha, G., Rajkumar, V., Ashok Kumar, R., Mathew, L.]]></dc:creator>
<dc:date>Thu, 29 Oct 2009 04:59:41 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep155</dc:identifier>
<dc:title><![CDATA[Therapeutic Potential of Polar and Non-polar Extracts of Cyanthillium cinereum In vitro]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep146v1?rss=1">
<title><![CDATA[Integration of Herbal Medicine in Primary Care in Israel: A Jewish-Arab Cross-cultural Perspective]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep146v1?rss=1</link>
<description><![CDATA[
<p>Herbal medicine is a prominent complementary and alternative medicine (CAM) modality in Israel based on the country's natural diversity and impressive cultural mosaic. In this study, we compared cross-cultural perspectives of patients attending primary care clinics in northern Israel on herbal medicine specifically and CAM generally, and the possibility of integrating them within primary care. Research assistants administered a questionnaire to consecutive patients attending seven primary care clinics. About 2184 of 3713 respondents (59%) defined themselves as Muslims, Christians or Druze (henceforth Arabs) and 1529 (41%) as Jews. Arab respondents reported more use of herbs during the previous year (35 versus 27.8% <I>P</I> = 0.004) and of more consultations with herbal practitioners (<I>P</I> &lt; 0.0001). Druze reported the highest rate of herbal consultations (67.9%) and Ashkenazi Jews the lowest rate (45.2%). About 27.5% of respondents supported adding a herbal practitioner to their clinic's medical team if CAM were to be integrated within primary care. Both Arabs and Jews report considerable usage of herbal medicine, with Arabs using it significantly more. Cross-cultural perspectives are warranted in the study of herbal medicine use in the Arab and Jewish societies.</p>
]]></description>
<dc:creator><![CDATA[Ben-Arye, E., Lev, E., Keshet, Y., Schiff, E.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 04:48:24 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep146</dc:identifier>
<dc:title><![CDATA[Integration of Herbal Medicine in Primary Care in Israel: A Jewish-Arab Cross-cultural Perspective]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-28</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep176v1?rss=1">
<title><![CDATA[Agaricus blazei Extract Induces Apoptosis through ROS-dependent JNK Activation Involving the Mitochondrial Pathway and Suppression of Constitutive NF-{kappa}B in THP-1 Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep176v1?rss=1</link>
<description><![CDATA[
<p><I>Agaricus blazei</I> is widely accepted as a traditional medicinal mushroom, and it has been known to exhibit immunostimulatory and anti-cancer activity. However, the apoptotic mechanism in cancer cells is poorly understood. In this study, we have investigated whether <I>A. blazei</I> extract (ABE) exerts antiproliferative and apoptotic effects in human leukemic THP-1 cells. We observed that ABE-induced apoptosis is associated with the mitochondrial pathway, which is mediated by reactive oxygen species (ROS) generation and prolonged c-Jun N-terminal kinase (JNK) activation. In addition, the ABE treatment resulted in the accumulation of cytochrome <I>c</I> in the cytoplasm, an increase in caspase activity, and an upregulation of Bax and Bad. With those results in mind, we found that ABE decreases constitutive NF-B activation and NF-B-regulated gene products such as IAP-1 and -2. We concluded that ABE induces apoptosis with ROS-dependent JNK activation and constitutive activated NF-B inhibition in THP-1 cells.</p>
]]></description>
<dc:creator><![CDATA[Kim, M.-O., Moon, D.-O., Jung, J. M., Lee, W. S., Choi, Y. H., Kim, G.-Y.]]></dc:creator>
<dc:date>Tue, 27 Oct 2009 09:27:35 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep176</dc:identifier>
<dc:title><![CDATA[Agaricus blazei Extract Induces Apoptosis through ROS-dependent JNK Activation Involving the Mitochondrial Pathway and Suppression of Constitutive NF-{kappa}B in THP-1 Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep173v1?rss=1">
<title><![CDATA[The Traditional Japanese Medicine Rikkunshito Promotes Gastric Emptying via the Antagonistic Action of the 5-HT3 Receptor Pathway in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep173v1?rss=1</link>
<description><![CDATA[
<p>The traditional Japanese medicine rikkunshito ameliorates the nitric oxide-associated delay in gastric emptying. Whether rikkunshito affects gastric motility associated with 5-hydroxytryptamine (serotonin: 5-HT) receptors or dopamine receptors is unknown. We examined the effects of rikkunshito on the delay in gastric emptying induced by 5-HT or dopamine using the phenol red method in male Wistar rats. 5-HT (0.01&ndash;1.0 mg kg<sup>&ndash;1</sup>, i.p.) dose dependently delayed gastric emptying, similar to the effect of the 5-HT<SUB>3</SUB> receptor agonist 1-(3-chlorophenyl) biguanide (0.01&ndash;1.0 mg kg<sup>&ndash;1</sup>, i.p.). Dopamine also dose dependently delayed gastric emptying. The 5-HT<SUB>3</SUB> receptor antagonist ondansetron (0.04&ndash;4.0 mg kg<sup>&ndash;1</sup>) and rikkunshito (125&ndash;500 mg kg<sup>&ndash;1</sup>) significantly suppressed the delay in gastric emptying caused by 5-HT or 1-(3-chlorophenyl) biguanide. Hesperidin (the most active ingredient in rikkunshito) suppressed the 5-HT-induced delayed gastric emptying in a dose-dependent manner, the maximum effect of which was similar to that of ondansetron (0.4 mg kg<sup>&ndash;1</sup>). The improvement obtained by rikkunshito or ondansetron in delaying gastric emptying was completely blocked by pretreatment with atropine. Rikkunshito appears to improve delay in gastric emptying via the antagonistic action of the 5-HT<SUB>3</SUB> receptor pathway.</p>
]]></description>
<dc:creator><![CDATA[Tominaga, K., Kido, T., Ochi, M., Sadakane, C., Mase, A., Okazaki, H., Yamagami, H., Tanigawa, T., Watanabe, K., Watanabe, T., Fujiwara, Y., Oshitani, N., Arakawa, T.]]></dc:creator>
<dc:date>Tue, 27 Oct 2009 09:27:32 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep173</dc:identifier>
<dc:title><![CDATA[The Traditional Japanese Medicine Rikkunshito Promotes Gastric Emptying via the Antagonistic Action of the 5-HT3 Receptor Pathway in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep151v1?rss=1">
<title><![CDATA[Proteomic Analysis of Anti-inflammatory Effects of a Kampo (Japanese Herbal) Medicine 'Shoseiryuto (Xiao-Qing-Long-Tang)' on Airway Inflammation in a Mouse Model]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep151v1?rss=1</link>
<description><![CDATA[
<p>Effects of a Kampo (Japanese herbal) medicine &lsquo;shoseiryuto (SST, xiao-qing-long-tang in Chinese)&rsquo;, which has been used for the treatment of allergic bronchial asthma clinically, were examined on ovalbumin (OVA)-sensitized allergic airway inflammation model (i.e. bronchial asthma) in a mouse. When SST was orally administered at 0.5 g kg<sup>&ndash;1</sup> day<sup>&ndash;1</sup> from day 1 to 6 after OVA inhalation, SST reduced the inflammation in lung tissue, the number of eosinophils and the OVA-specific immunoglobulin E (IgE) antibody titer in bronchoalveolar lavage (BAL) fluids at 7 days after the OVA inhalation. SST also reduced the airway hyperreactivity at 6 days after the OVA inhalation. Proteomic analysis with the agarose two-dimensional electrophoresis showed that the expression of spectrin 2 was reduced in the lung tissue of OVA-sensitized mice and SST recovered the expression. Western blot and immunohistochemical analyses of lung tissue also confirmed this result. When prednisolone was orally administered at 3 mg kg<sup>&ndash;1</sup> day<sup>&ndash;1</sup> from day 1 to 6 after OVA inhalation, the inflammation in lung tissue, the number of eosinophils in BAL fluids and airway hyperreactivity were reduced in the OVA-sensitized mice. However, prednisolone did not reduce the OVA-specific IgE antibody titer in BAL fluids and did not recover the expression of spectrin 2 in lung tissue. These results suggest that at least a part of action mechanism of SST against OVA-sensitized allergic airway inflammation in a mouse model is different from that of prednisolone.</p>
]]></description>
<dc:creator><![CDATA[Nagai, T., Nakao, M., Shimizu, Y., Kodera, Y., Oh-Ishi, M., Maeda, T., Yamada, H.]]></dc:creator>
<dc:date>Tue, 27 Oct 2009 09:27:31 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep151</dc:identifier>
<dc:title><![CDATA[Proteomic Analysis of Anti-inflammatory Effects of a Kampo (Japanese Herbal) Medicine 'Shoseiryuto (Xiao-Qing-Long-Tang)' on Airway Inflammation in a Mouse Model]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep076v1?rss=1">
<title><![CDATA[Nordihydroguaiaretic Acid from Creosote Bush (Larrea tridentata) Mitigates 12-O-Tetradecanoylphorbol-13-Acetate-induced Inflammatory and Oxidative Stress Responses of Tumor Promotion Cascade in Mouse Skin]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep076v1?rss=1</link>
<description><![CDATA[
<p>Nordihydroguaiaretic acid (NDGA) is a phenolic antioxidant found in the leaves and twigs of the evergreen desert shrub, <I>Larrea tridentata</I> (Sesse and Moc. ex DC) Coville (creosote bush). It has a long history of traditional medicinal use by the Native Americans and Mexicans. The modulatory effects of topically applied NDGA was studied on acute inflammatory and oxidative stress responses in mouse skin induced by stage I tumor promoting agent, 12-<I>O</I>-tetradecanoylphorbol-13-acetate (TPA). Double TPA treatment adversely altered many of the marker responses of stage I skin tumor promotion cascade. Pretreatment of NDGA in TPA-treated mice mitigated cutaneous lipid peroxidation and inhibited production of hydrogen peroxide. NDGA treatment also restored reduced glutathione level and activities of antioxidant enzymes. Elevated activities of myeloperoxidase, xanthine oxidase and skin edema formation in TPA-treated mice were also lowered by NDGA indicating a restrained inflammatory response. Furthermore, results of histological study demonstrated inhibitory effect of NDGA on cellular inflammatory responses. This study provides a direct evidence of antioxidative and anti-inflammatory properties of NDGA against TPA-induced cutaneous inflammation and oxidative stress corroborating its chemopreventive potential against skin cancer.</p>
]]></description>
<dc:creator><![CDATA[Rahman, S., Ansari, R. A., Rehman, H., Parvez, S., Raisuddin, S.]]></dc:creator>
<dc:date>Tue, 27 Oct 2009 09:27:38 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep076</dc:identifier>
<dc:title><![CDATA[Nordihydroguaiaretic Acid from Creosote Bush (Larrea tridentata) Mitigates 12-O-Tetradecanoylphorbol-13-Acetate-induced Inflammatory and Oxidative Stress Responses of Tumor Promotion Cascade in Mouse Skin]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep145v2?rss=1">
<title><![CDATA[Transcutaneous Electrical Stimulation of Acupoints Changes Body Composition and Heart Rate Variability in Postmenopausal Women with Obesity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep145v2?rss=1</link>
<description><![CDATA[
<p>This study aimed to evaluate the effect of transcutaneous electric acupoint stimulations (TEAS) on body composition and heart rate variability (HRV) in postmenopausal women with obesity. In this prospective study, 49 postmenopausal women were recruited in Taiwan. Body composition was used as a screening test for obesity (percentage body fat &gt;30%, waist circumference &gt;80 cm). The experimental group (<I>n</I> = 24) received TEAS treatment 30 min twice per week for 12 weeks at the Zusanli (ST 36) and Sanyinjiao (SP 6) acupoints. The control group (<I>n</I> = 25) did not receive any intervention. The study of HRV was analyzed by time [standard deviation of the normal-to-normal (NN) intervals (SDNN) and square root of the mean squared differences of successive NN intervals (RMSSD) indices] and frequency domain methods. Power spectral components were obtained at low (LF) and high (HF) frequencies. Body composition and HRV values were measured at the 4th, 8th and 12th weeks. A total of 40 subjects completed this study. Waist circumference and percentage body fat in the experimental group (<I>n</I> = 20) were significantly less than those of the control group (<I>n</I> = 20) at the 8th and 12th weeks (all <I>P</I> &lt; 0.05). Additionally, at the same time points, percentage lean body mass in the experimental group was significantly greater than that in the control group (<I>P</I> &lt; 0.05). SDNN values increased significantly at the 4th and 8th weeks when compared with the control group (all <I>P</I> &lt; 0.05). At 12 weeks, SDNN value was not significantly different from that of the control group (<I>P</I> = 0.105). TEAS treatment improves body composition, and has a transient effect on the HRV in postmenopausal women with obesity.</p>
]]></description>
<dc:creator><![CDATA[Chien, L.-W., Lin, M.-H., Chung, H.-Y., Liu, C.-F.]]></dc:creator>
<dc:date>Wed, 21 Oct 2009 06:41:20 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep145</dc:identifier>
<dc:title><![CDATA[Transcutaneous Electrical Stimulation of Acupoints Changes Body Composition and Heart Rate Variability in Postmenopausal Women with Obesity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-21</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep163v1?rss=1">
<title><![CDATA[The Effectiveness of Moxibustion: An Overview During 10 Years]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep163v1?rss=1</link>
<description><![CDATA[
<p>Moxibustion has been used to treat various types of disease. However, there is still insufficient evidence regarding its effectiveness. This study was performed to summarize and evaluate the effectiveness of moxibustion. A search was performed for all randomized controlled trials in PubMed between January 1998 and July 2008 with no language restriction. The results yielded 47 trials in which six moxibustion types were applied to 36 diseases ranging from breech presentation to digestive disorders. Moxibustion was compared to three types of control group: general care, Oriental medical therapies or waiting list. Moxibustion was superior to the control in 14 out of 54 control groups in 46 studies. There were no significant differences among groups in 7 studies, and the outcome direction was not determined in 33 studies. Seven studies were included in a meta-analysis. Moxibustion was more effective than medication in two ulcerative colitis studies [relative risk (95% CI), 2.20 (1.37, 3.52), <I>P</I> = 0.001, <I>I</I><sup>2</sup> = 0%]. Overall, our results did not support the effectiveness of moxibustion in specific diseases due to the limited number and low quality of the studies and inadequate use of controls. In order to provide appropriate evidence regarding the effectiveness of moxibustion, more rigorous clinical trials using appropriate controls are warranted.</p>
]]></description>
<dc:creator><![CDATA[Kim, S.-Y., Chae, Y., Lee, S. M., Lee, H., Park, H.-J.]]></dc:creator>
<dc:date>Tue, 13 Oct 2009 03:42:44 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep163</dc:identifier>
<dc:title><![CDATA[The Effectiveness of Moxibustion: An Overview During 10 Years]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-13</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep160v1?rss=1">
<title><![CDATA[Experimental Evaluation of Ethanolic Extract of Carapa guianensis L. Leaf for Its Wound Healing Activity Using Three Wound Models]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep160v1?rss=1</link>
<description><![CDATA[
<p>The leaves of <I>Carapa guianensis</I> have been used to treat ulcers, skin parasites, and skin problems. The ethanolic extract of <I>C. guianensis</I> leaf was evaluated for its antibacterial and wound healing activity using excision, incision and dead space wound models in rats. The animals were randomly divided into two groups (<I>n</I> = 6) in all the models. In the excision wound model test group animals were treated topically with the leaf extract (250 mg kg<sup>&ndash;1</sup> body weight) whereas, control animals were treated with petroleum jelly. In the incision and dead space wound models, the test group animals were treated with extract (250 mg kg<sup>&ndash;1</sup> day<sup>&ndash;1</sup>) orally by mixing in drinking water and the control group animals were maintained with plain drinking water. Healing was assessed by the rate of wound contraction, period of epithelialization, skin breaking strength, granulation tissue weight and hydoxyproline content. On Day 15 extract-treated animals exhibited 100% reduction in the wound area when compared to controls (95%) with significant decrease in the epithelialization period. The extract failed to demonstrate antibacterial activity. Skin breaking strength (<I>P</I> &lt; 0.001), wet (<I>P</I> &lt; 0.002) and dry (<I>P</I> &lt; 0.02) granulation tissue and hydroxyproline content (<I>P</I> &lt; 0.03) were significantly higher in extract treated animals. The increased rate of wound contraction, skin breaking strength and hydroxyproline content supports potential application of <I>C. guianensis</I> in wound healing.</p>
]]></description>
<dc:creator><![CDATA[Nayak, B. S., Kanhai, J., Milne, D. M., Pereira, L. P., Swanston, W. H.]]></dc:creator>
<dc:date>Tue, 13 Oct 2009 03:42:44 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep160</dc:identifier>
<dc:title><![CDATA[Experimental Evaluation of Ethanolic Extract of Carapa guianensis L. Leaf for Its Wound Healing Activity Using Three Wound Models]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-13</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep162v1?rss=1">
<title><![CDATA[Genetic Effects of FTO and MC4R Polymorphisms on Body Mass in Constitutional Types]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep162v1?rss=1</link>
<description><![CDATA[
<p>Sasang constitutional medicine (SCM), a Korean tailored medicine, categorizes human beings into four types through states of physiological imbalances and responsiveness to herbal medicine. One SCM type susceptible to obesity seems sensitive to energy intake due to an imbalance toward preserving energy. Common variants of fat mass and obesity associated (<I>FTO</I>) and melanocortin 4 receptor (<I>MC4R</I>) genes have been associated with increased body mass index (BMI) by affecting energy intake. Here, we statistically examined the association of <I>FTO</I> and <I>MC4R</I> polymorphisms with BMI in two populations with 1370 Koreans before and after SCM typing, and with the lowering of BMI in 538 individuals who underwent a 1-month lifestyle intervention. The increased BMI replicated the association with <I>FTO</I> haplotypes (effect size ~=1.1 kg/m<sup>2</sup>) and <I>MC4R</I> variants (effect size ~=0.64 kg/m<sup>2</sup>). After the lifestyle intervention, the carriers of the haplotype represented by the minor allele of rs1075440 had a tendency to lose more waist-to-hip ratio (0.76%) than non-carriers. The constitutional discrepancy for the accumulation of body mass by the effects of <I>FTO</I> and/or <I>MC4R</I> variants seemed to reflect the physique differences shown in each group of SCM constitutional types. In conclusion, <I>FTO</I> and <I>MC4R</I> polymorphisms appear to play an important role in weight gain, while only <I>FTO</I> variants play a role in weight loss after lifestyle intervention. Different trends were observed among individuals of SCM types, especially for weight gain. Therefore, classification of individuals based on physiological imbalance would offer a good genetic stratification system in assessing the effects of obesity genes.</p>
]]></description>
<dc:creator><![CDATA[Cha, S., Koo, I., Park, B. L., Jeong, S., Choi, S. M., Kim, K. S., Shin, H. D., Kim, J. Y.]]></dc:creator>
<dc:date>Sun, 11 Oct 2009 23:49:38 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep162</dc:identifier>
<dc:title><![CDATA[Genetic Effects of FTO and MC4R Polymorphisms on Body Mass in Constitutional Types]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-11</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep144v1?rss=1">
<title><![CDATA[Antinociceptive Activity of Trichilia catigua Hydroalcoholic Extract: New Evidence on its Dopaminergic Effects]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep144v1?rss=1</link>
<description><![CDATA[
<p><I>Trichilia catigua</I> is a native plant of Brazil; its barks are used by some local pharmaceutical companies to prepare tonic drinks, such as Catuama&reg;. The present study was addressed to evaluate the effects of <I>T. catigua</I> hydroalcoholic extract in mouse nociception behavioral models, and to evaluate the possible mechanisms involved in its actions. Male Swiss mice were submitted to hot-plate, writhing and von Frey tests, after oral treatment with <I>T</I>. <I>catigua</I> extract (200 mg kg<sup>&ndash;1</sup>, p.o.). The extract displayed antinociceptive effect in all three models. For characterization of the mechanisms involved in the antinociceptive action of the extract, the following pharmacological treatments were done: naloxone (2.5 mg kg<sup>&ndash;1</sup>, s.c.), SR141716A (10 mg kg<sup>&ndash;1</sup>, i.p.), SCH23390 (15 &micro;g kg<sup>&ndash;1</sup>, i.p.), sulpiride (50 mg kg<sup>&ndash;1</sup>, i.p.), prazosin (1 mg kg<sup>&ndash;1</sup>, i.p.), bicuculline (1 mg kg<sup>&ndash;1</sup>, i.p.) or <scp>dl</scp>-<I>p</I>-chlorophenylalanine methyl ester (PCPA, 100 mg kg<sup>&ndash;1</sup>, i.p.). In these experiments, the action of <I>T. catigua</I> extract was evaluated in the hot-plate test. The treatment with SCH23390 completely prevented the antinociceptive effect, while naloxone partially prevented it. The possible involvement of the dopaminergic system in the actions of <I>T. catigua</I> extract was substantiated by data showing the potentiation of apomorphine-induced hypothermia and by the prevention of haloperidol-induced catalepsy. In conclusion, the antinociceptive effects of <I>T. catigua</I> extract seem to be mainly associated with the activation of dopaminergic system and, to a lesser extent, through interaction with opioid pathway.</p>
]]></description>
<dc:creator><![CDATA[Viana, A. F., Maciel, I. S., Motta, E. M., Leal, P. C., Pianowski, L., Campos, M. M., Calixto, J. B.]]></dc:creator>
<dc:date>Thu, 08 Oct 2009 07:48:57 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep144</dc:identifier>
<dc:title><![CDATA[Antinociceptive Activity of Trichilia catigua Hydroalcoholic Extract: New Evidence on its Dopaminergic Effects]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep161v1?rss=1">
<title><![CDATA[Efficacy and Safety Assessment of T. Angelica Herbal Tonic(R), a Phytomedicinal Product Popularly Used in Nigeria]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep161v1?rss=1</link>
<description><![CDATA[
<p>T. Angelica Herbal Tonic&reg; (TAHT) is a herbal product indicated for indigestion and constipation and highly patronized in Nigeria. In this study, the efficacy and safety of the herbal tonic in relation to the label claims were assessed. The effect on peristalsis in mice was evaluated by the charcoal meal model and <I>in vitro</I> using guinea pig ileum. The effects of TAHT on behavior, fertility, birth and organ weights were also determined. Teratogenic potential and reproductive toxicity were studied in pregnant rats. Acute toxicity studies showed that at doses above 5000 mg kg<sup>&ndash;1</sup>, the herbal tonic did not cause lethality and produced no signs of intoxication in mice. The study did not show any gross behavioral changes in mice treated with 1000 mg kg<sup>&ndash;1</sup> of TAHT as compared with the negative control treatment. TAHT (400 mg kg<sup>&ndash;1</sup>) exhibited a dose-dependent enhancement in the gastrointestinal tract motility in mice when compared with the negative control. At concentrations up to 300 &micro;g ml<sup>&ndash;1</sup>, TAHT did not cause any significant effect on acetylcholine, histamine and nicotine-evoked contractions of guinea pig ileum preparation. It took an average of 31.25 &plusmn; 4.52 days for the TAHT-treated animals to litter, which is significantly (<I>P</I> &lt; 0.05) different from the 55 &plusmn; 4.51 days recorded for the control treatment group. TAHT exhibited a modest fertility-promoting effect and showed lack of abortifacient and teratogenic properties in the study. Generally, the results of this study showed some favorable pharmacological effects of TAHT in animals which may authenticate some of the label claims.</p>
]]></description>
<dc:creator><![CDATA[Esimone, C. O., Akah, P. A., Nworu, C. S.]]></dc:creator>
<dc:date>Wed, 07 Oct 2009 05:52:50 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep161</dc:identifier>
<dc:title><![CDATA[Efficacy and Safety Assessment of T. Angelica Herbal Tonic(R), a Phytomedicinal Product Popularly Used in Nigeria]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep157v1?rss=1">
<title><![CDATA[Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep157v1?rss=1</link>
<description><![CDATA[
<p><I>Phyllanthus urinaria</I> Linnea (Euphorbiaceae) is one of the traditional medicinal plants widely used by oriental people to treat various diseases. We have previously demonstrated that the acetone extract of <I>P. urinaria</I> inhibits herpes simplex virus type 2 (HSV-2) but not HSV-1 infection. In a continuing effort to clarify the antiviral mechanisms of <I>P. urinaria</I>, we isolated the pure compound excoecarianin from the whole plant of <I>P. urinaria</I> through acetone extraction, and investigated its anti-HSV-1 and HSV-2 activities. Our results indicated that excoecarianin protected Vero cells from HSV-2 but not HSV-1 infection, and its 50% inhibitory concentration (IC<SUB>50</SUB>) was 1.4 &plusmn; 0.1 &micro;M. The antiviral effective concentration of excoecarianin did not affect the viability or the morphology of Vero cells. Although excoecarianin inhibited HSV-2 infection, the inhibitory effect, however, was most prominent when excoecarianin was concurrently added with the virus. Pretreatment of Vero cells with excoecarianin with removal of the drug prior to infection did not yield any antiviral effects, and the same observation was made for post viral entry treatment. Subsequent studies revealed that excoecarianin inactivated HSV-2 virus particles to prevent viral infection. A synergistic antiviral effect against HSV-2 was also observed when Vero cells were treated with a combination of acyclovir (ACV) and excoecarianin. These results suggested that excoecarianin merits to be further explored as an entry inhibitor against HSV-2 and could potentially be investigated for combinatorial drug treatment with nucleoside analogues such as ACV in therapeutic management of HSV-2 infection.</p>
]]></description>
<dc:creator><![CDATA[Cheng, H.-Y., Yang, C.-M., Lin, T.-C., Lin, L.-T., Chiang, L.-C., Lin, C.-C.]]></dc:creator>
<dc:date>Tue, 06 Oct 2009 06:39:02 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep157</dc:identifier>
<dc:title><![CDATA[Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-06</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep131v1?rss=1">
<title><![CDATA[Schwann Cell Migration Induced by Earthworm Extract via Activation of PAs and MMP2/9 Mediated through ERK1/2 and p38]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep131v1?rss=1</link>
<description><![CDATA[
<p>The earthworm, which has stasis removal and wound-healing functions, is a widely used Chinese herbal medicine in China. Schwann cell migration is critical for the regeneration of injured nerves. Schwann cells provide an essentially supportive activity for neuron regeneration. However, the molecular migration mechanisms induced by earthworms in Schwann cells remain unclear. Here, we investigate the roles of MAPK (ERK1/2, JNK and p38) pathways for earthworm-induced matrix-degrading proteolytic enzyme (PAs and MMP2/9) production in Schwann cells. Moreover, earthworm induced phosphorylation of ERK1/2 and p38, but not JNK, activate the downstream signaling expression of PAs and MMPs in a time-dependent manner. Earthworm-stimulated ERK1/2 and p38 phosphorylation was attenuated by pretreatment with U0126 and SB203580, resulting in migration and uPA-related signal pathway inhibition. The results were confirmed using small interfering ERK1/2 and p38 RNA. These results demonstrated that earthworms can stimulate Schwann cell migration and up-regulate PAs and MMP2/9 expression mediated through the MAPK pathways, ERK1/2 and p38. Taken together, our data suggests the MAPKs (ERK1/2, p38)-, PAs (uPA, tPA)-, MMP (MMP2, MMP9) signaling pathway of Schwann cells regulated by earthworms might play a major role in Schwann cell migration and nerve regeneration.</p>
]]></description>
<dc:creator><![CDATA[Chang, Y.-M., Shih, Y.-T., Chen, Y.-S., Liu, C.-L., Fang, W.-K., Tsai, C.-H., Tsai, F.-J., Kuo, W.-W., Lai, T.-Y., Huang, C.-Y.]]></dc:creator>
<dc:date>Tue, 06 Oct 2009 06:39:00 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep131</dc:identifier>
<dc:title><![CDATA[Schwann Cell Migration Induced by Earthworm Extract via Activation of PAs and MMP2/9 Mediated through ERK1/2 and p38]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-10-06</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep154v1?rss=1">
<title><![CDATA[Methodological Problems in fMRI Studies on Acupuncture: A Critical Review With Special Emphasis on Visual and Auditory Cortex Activations]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep154v1?rss=1</link>
<description><![CDATA[
<p>Functional magnetic resonance imaging (fMRI) has been used for more than a decade to investigate possible supraspinal mechanisms of acupuncture stimulation. More than 60 studies and several review articles have been published on the topic. However, till now some acupuncture-fMRI studies have not adopted all methodological standards applied to most other fMRI studies. In this critical review, we comment on some of the problems including the choice of baseline, interpretation of deactivations, attention control and implications of different group statistics. We illustrate the possible impact of these problems by focussing on some early findings, namely activations of visual and auditory cortical areas, when acupoints were stimulated that are believed to have a therapeutic effect on vision or hearing in traditional Chinese medicine. While we are far from questioning the validity of using fMRI for the study of acupuncture effects, we think that activations reported by some of these studies were probably not a direct result of acupuncture stimulation but rather attributable to one or more of the methodological problems covered here. Finally, we try to offer solutions for these problems where possible.</p>
]]></description>
<dc:creator><![CDATA[Beissner, F., Henke, C.]]></dc:creator>
<dc:date>Wed, 30 Sep 2009 06:25:02 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep154</dc:identifier>
<dc:title><![CDATA[Methodological Problems in fMRI Studies on Acupuncture: A Critical Review With Special Emphasis on Visual and Auditory Cortex Activations]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-30</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep141v1?rss=1">
<title><![CDATA[Construct Validity of the Holistic Complementary and Alternative Medicines Questionnaire (HCAMQ)--An Investigation Using Modern Psychometric Approaches]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep141v1?rss=1</link>
<description><![CDATA[
<p>The scientific basis of efficacy studies of complementary medicine requires the availability of validated measures. The Holistic Complementary and Alternative Medicine Questionnaire (HCAMQ) is one such measure. This article aimed to examine its construct validity, using a modern psychometric approach. The HCAMQ was completed by 221 patients (mean age 66.8, SD 8.29, 58% females) with chronic stable pain predominantly from a single joint (hip or knee) of mechanical origin, waiting for a hip (40%) or knee (60%) joint replacement, on enrolment in a study investigating the effects of acupuncture and placebo controls. The HCAMQ contains a Holistic Health (HH) Subscale (five items) and a CAM subscale (six items). Validity of the subscales was tested using Cronbach alpha's, factor analysis, Mokken scaling and Rasch analysis, which did not support the original two-factor structure of the scale. A five-item HH subscale and a four-item CAM subscale (worded in a negative direction) fitted the Rasch model and were unidimensional (2 = 8.44, <I>P</I> = 0.39, PSI = 0.69 versus 2 = 17.33, <I>P</I> = 0.03, PSI = 0.77). Two CAM items (worded in the positive direction) had significant misfit. In conclusion, we have shown that the original two-factor structure of the HCAMQ could not be supported but that two valid shortened subscales can be used, one for HH Beliefs (four-item HH), and the other for CAM Beliefs (four-item CAM). It is recommended that consideration is given to rewording the two discarded positively worded CAM questions to enhance construct validity.</p>
]]></description>
<dc:creator><![CDATA[Kersten, P., White, P. J., Tennant, A.]]></dc:creator>
<dc:date>Wed, 30 Sep 2009 06:25:02 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep141</dc:identifier>
<dc:title><![CDATA[Construct Validity of the Holistic Complementary and Alternative Medicines Questionnaire (HCAMQ)--An Investigation Using Modern Psychometric Approaches]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-30</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep150v1?rss=1">
<title><![CDATA[A Clinical Study of the Pulse Wave Characteristics at the Three Pulse Diagnosis Positions of Chon, Gwan and Cheok]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep150v1?rss=1</link>
<description><![CDATA[
<p>In this work, we analyze the baseline, signal strength, aortic augmentation index (AIx), radial AIx, time to reflection and P_T2 at Chon, Gwan and Cheok, which are the three pulse diagnosis positions in Oriental medicine. For the pulse measurement, we used the SphygmoCor apparatus, which has been widely used for the evaluation of the arterial stiffness at the aorta. By two-way repeated measures analysis of variance, we tested two independent measurements for repeatability and investigated their mean differences among Chon, Gwan and Cheok. To characterize further the parameters that were shown to be different between each palpation position, we carried out Duncan's test for the multiple comparisons. The baseline and signal strength were statistically different (<I>P</I> &lt; 0.05) among Chon, Gwan and Cheok, respectively, which supports the major hypothesis of Oriental medicine that all of the three palpation positions contain different clinical information. On the other hand, aortic AIx and time to reflection were found to be statistically different between Chon and the others, and radial AIx and P_T2 did not show any difference between pulse positions. In the clinical sense, however, the aortic AIx at each palpation position was found to fall within the 90% confidence interval of normal arterial compliance. The results of the multiple comparisons indicate that the parameters of arterial stiffness were independent of the palpation positions. This work is the first attempt to characterize quantitatively the pulse signals at Chon, Gwan and Cheok with some relevant parameters extracted from the SphygmoCor apparatus.</p>
]]></description>
<dc:creator><![CDATA[Jeon, Y. J., Kim, J. U., Lee, H. J., Lee, J., Ryu, H. H., Lee, Y. J., Kim, J. Y.]]></dc:creator>
<dc:date>Tue, 29 Sep 2009 07:03:57 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep150</dc:identifier>
<dc:title><![CDATA[A Clinical Study of the Pulse Wave Characteristics at the Three Pulse Diagnosis Positions of Chon, Gwan and Cheok]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep149v1?rss=1">
<title><![CDATA[Protective Effects of Rosa damascena and its Active Constituent on A{beta}(25-35)-induced Neuritic Atrophy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep149v1?rss=1</link>
<description><![CDATA[
<p>Dementia is a clinical syndrome characterized by multiple cognitive deficits and causes progressive neurodegeneration leading eventually to death. The incidence of dementia is increasing worldwide with the increase in ageing population. However, no effective treatment is available yet. It has been hypothesized that drugs activating neurite outgrowth might induce neuronal reconstruction and help in the recovery of brain function. Working on this hypothesis, we recently observed that the chloroform extract of the <I>Rosa damascena</I> significantly induced the neurite outgrowth activity and inhibited the A&beta;(25&ndash;35)-induced atrophy and cell death. Further workup led the isolation of a very long polyunsaturated fatty acid having molecular formula C<SUB>37</SUB>H<SUB>64</SUB>O<SUB>2</SUB> as an active constituent. The structure of this compound was established by extensive analysis of fragmentations observed in EI-MS mode. The isolated compound protected A&beta;(25&ndash;35)-induced atrophy and displayed strong neurite outgrowth activity. The length of dendrite in the cells treated with this compound were comparable to those of nerve growth factor (NGF) treated cells.</p>
]]></description>
<dc:creator><![CDATA[Awale, S., Tohda, C., Tezuka, Y., Miyazaki, M., Kadota, S.]]></dc:creator>
<dc:date>Tue, 29 Sep 2009 07:03:55 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep149</dc:identifier>
<dc:title><![CDATA[Protective Effects of Rosa damascena and its Active Constituent on A{beta}(25-35)-induced Neuritic Atrophy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep142v1?rss=1">
<title><![CDATA[Alpinia pricei Rhizome Extracts Induce Cell Cycle Arrest in Human Squamous Carcinoma KB Cells and Suppress Tumor Growth in Nude Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep142v1?rss=1</link>
<description><![CDATA[
<p><I>Alpinia pricei</I> has been shown to induce apoptosis in human squamous carcinoma (KB) cells. In this study, we report the effectiveness of the ethanol (70%) extracts of <I>A. pricei</I> rhizome (AP extracts) in terms of tumor regression as determined using both <I>in vitro</I> cell culture and <I>in vivo</I> athymic nude mice models of KB cells. We found that the AP extract (25&ndash;200 &micro;g/ml) treatment decreased the proliferation of KB cells by arresting progression through the G2/M phase of the cell cycle. This cell cycle blockade was associated with reductions in cyclin A and B1, Cdc2, and Cdc25C, and increased p21/WAF1, Wee1, p53 and phospho-p53 (p-p53) in a dose- and time-dependent manner. Moreover, we found that AP extract treatment decreased metalloproteinase-9 (MMP-9) and urokinase plasminogen activator (u-PA) expression, while expression of their endogenous inhibitors, tissue inhibitor of MMP-1 (TIMP-1) and plasminogen activator inhibitor-1 (PAI-1), were increased in KB cells. Furthermore, AP extract treatment effectively delayed tumor incidence in nude mice inoculated with KB cells and reduced the tumor burden. AP extract treatment also induced apoptotic DNA fragmentation, as detected by <I>in situ</I> TUNEL staining. Thus, <I>A. pricei</I> may possess antitumor activity in human squamous carcinoma (KB) cells.</p>
]]></description>
<dc:creator><![CDATA[Hseu, Y.-C., Chen, C.-S., Wang, S.-Y.]]></dc:creator>
<dc:date>Tue, 29 Sep 2009 07:03:54 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep142</dc:identifier>
<dc:title><![CDATA[Alpinia pricei Rhizome Extracts Induce Cell Cycle Arrest in Human Squamous Carcinoma KB Cells and Suppress Tumor Growth in Nude Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep138v1?rss=1">
<title><![CDATA[Withania somnifera Improves Semen Quality in Stress-Related Male Fertility]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep138v1?rss=1</link>
<description><![CDATA[
<p>Stress has been reported to be a causative factor for male infertility. <I>Withania somnifera</I> has been documented in Ayurveda and Unani medicine system for its stress-combating properties. However, limited scientific literature is available on this aspect of <I>W. somnifera</I>. We undertook the present study to understand the role of stress in male infertility, and to test the ability of <I>W. somnifera</I> to combat stress and treat male infertility. We selected normozoospermic but infertile individuals (<I>N</I> = 60), further categorized in three groups: normozoospermic heavy smokers (<I>N</I> = 20), normozoospermics under psychological stress (<I>N</I> = 20) and normozoospermics with infertility of unknown etiology (<I>N</I> = 20). Normozoospermic fertile men (<I>N</I> = 60) were recruited as controls. The subjects were given root powder of <I>W. somnifera</I> at a rate of 5 g/day for 3 months. Measuring various biochemical and stress parameters before and after treatment, suggested a definite role of stress in male infertility and the ability of <I>W. somnifera</I> to treat stress-related infertility. Treatment resulted in a decrease in stress, improved the level of anti-oxidants and improved overall semen quality in a significant number of individuals. The treatment resulted in pregnancy in the partners of 14% of the patients.</p>
]]></description>
<dc:creator><![CDATA[Mahdi, A. A., Shukla, K. K., Ahmad, M. K., Rajender, S., Shankhwar, S. N., Singh, V., Dalela, D.]]></dc:creator>
<dc:date>Tue, 29 Sep 2009 07:03:51 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep138</dc:identifier>
<dc:title><![CDATA[Withania somnifera Improves Semen Quality in Stress-Related Male Fertility]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep152v1?rss=1">
<title><![CDATA[Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep152v1?rss=1</link>
<description><![CDATA[
<p>It is now accepted that an overwhelming inflammatory response is the cause of human deaths from avian H5N1 influenza infection. With this in mind we sought to examine the literature for examples of complementary and alternative medicines that reduce inflammation, and to place the results of this search in the context of our own work in a mouse model of influenza disease, using a pharmaceutical agent with anti-inflammatory properties. Two Chinese herbs, <I>Angelica sinensis</I> (Dang Gui) and <I>Salvia miltiorrhiza</I> (Danshen), have been recently shown to protect mice during lethal experimental sepsis via inhibition of the novel inflammatory cytokine High Mobility Group Box 1 protein (HMGB1). Biochanin A, a ligand of the peroxisome proliferator activated receptors (PPAR) alpha and gamma and the active isoflavone in <I>Trifolium pratense</I> (red clover), has anti-inflammatory properties, and thus could be used as an influenza treatment. This is of great interest since we have recently shown that gemfibrozil, a drug used to treat hyperlipidemia in humans and a synthetic ligand of PPAR alpha, significantly reduces the mortality associated with influenza infections in mice. The inflammation-modulating abilities of these natural agents should be considered in light of what is now known about the mechanisms of fatal influenza, and tested as potential candidates for influenza treatments in their own right, or as adjunct treatments to antivirals.</p>
]]></description>
<dc:creator><![CDATA[Alleva, L. M., Cai, C., Clark, I. A.]]></dc:creator>
<dc:date>Thu, 24 Sep 2009 06:43:59 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep152</dc:identifier>
<dc:title><![CDATA[Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-24</prism:publicationDate>
<prism:section>Hypothesis</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep153v1?rss=1">
<title><![CDATA[The Use of Intuition in Homeopathic Clinical Decision Making: An Interpretative Phenomenological Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep153v1?rss=1</link>
<description><![CDATA[
<p>While intuition plays a role in clinical decision making within conventional medicine, little is understood about its use in complementary and alternative medicine (CAM). The aim of this qualitative study was to investigate intuition from the perspective of homeopathic practitioners; its&rsquo; manifestation, how it was recognized, its origins and when it was used within daily clinical practice. Semi-structured interviews were carried out with clinically experienced non-National Health Service (NHS) UK homeopathic practitioners. Interpretative phenomenological analysis was used to analyze the data. Homeopaths reported many similarities with conventional medical practitioner regarding the nature, perceived origin and manifestation of their intuitions in clinical practice. Intuition was used in two key aspects of the consultation: (i) to enhance the practitioner&ndash;patient relationship, these were generally trusted; and (ii) intuitions relating to the prescribing decision. Homeopaths were cautious about these latter intuitions, testing any intuitive thoughts through deductive reasoning before accepting them. Their reluctance is not surprising given the consequences for patient care, but we propose this also reflects homeopaths&rsquo; sensitivity to the academic and medical mistrust of both homeopathy and intuition. This study is the first to explore the use of intuition in decision making in any form of complementary medicine. The similarities with conventional practitioners may provide confidence in validating intuition as a legitimate part of the decision making process for these specific practitioners. Further work is needed to elucidate if these findings reflect intuitive use in clinical practice of other CAM practitioners in both private and NHS (i.e. time limited) settings.</p>
]]></description>
<dc:creator><![CDATA[Brien, S., Dibb, B., Burch, A.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 08:13:23 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep153</dc:identifier>
<dc:title><![CDATA[The Use of Intuition in Homeopathic Clinical Decision Making: An Interpretative Phenomenological Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-22</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep147v1?rss=1">
<title><![CDATA[In vitro activity of 2-methoxy-1,4-naphthoquinone and stigmasta-7,22-diene-3{beta}-ol from Impatiens balsamina L. against multiple antibiotic-resistant Helicobacter pylori]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep147v1?rss=1</link>
<description><![CDATA[
<p>Infection with <I>Helicobacter pylori</I> is strongly associated with gastric cancer and gastric adenocarcinoma. WHO classified <I>H. pylori</I> as a group 1 carcinogen in 1994. <I>Impatiens balsamina</I> L. has been used as indigenous medicine in Asia for the treatment of rheumatism, fractures and fingernail inflammation. In this study, we isolated anti-<I>H. pylori</I> compounds from this plant and investigated their anti- and bactericidal activity. Compounds of 2-methoxy-1,4-naphthoquinone (MeONQ) and stigmasta-7,22-diene-3&beta;-ol (spinasterol) were isolated from the pods and roots/stems/leaves of <I>I. balsamina</I> L., respectively. The minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) for MeONQ were in the ranges of 0.156&ndash;0.625 and 0.313&ndash;0.625 &micro;g ml<sup>&ndash;1</sup>, respectively, and in the ranges of 20&ndash;80 &micro;g ml<sup>&ndash;1</sup> both of MICs and MBCs for spinasterol against antibiotic (clarithromycin, metronidazole and levofloxacin) resistant <I>H. pylori</I>. Notably, the activity of MeONQ was equivalent to that of amoxicillin (AMX). The bactericidal <I>H. pylori</I> action of MeONQ was dose-dependent. Furthermore, the activity of MeONQ was not influenced by the environmental pH values (4&ndash;8) and demonstrated good thermal (121&deg;C for 15 min) stability. MeONQ abounds in the <I>I. balsamina</I> L. pod at the level of 4.39% (w/w db). In conclusion, MeONQ exhibits strong potential to be developed as a candidate agent for the eradication of <I>H. pylori</I> infection.</p>
]]></description>
<dc:creator><![CDATA[Wang, Y.-C., Li, W.-Y., Wu, D.-C., Wang, J.-J., Wu, C.-H., Liao, J.-J., Lin, C.-K.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 08:13:22 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep147</dc:identifier>
<dc:title><![CDATA[In vitro activity of 2-methoxy-1,4-naphthoquinone and stigmasta-7,22-diene-3{beta}-ol from Impatiens balsamina L. against multiple antibiotic-resistant Helicobacter pylori]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-22</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep148v1?rss=1">
<title><![CDATA[Anti-arthritic Activity of Bartogenic Acid Isolated from Fruits of Barringtonia racemosa Roxb. (Lecythidaceae)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep148v1?rss=1</link>
<description><![CDATA[
<p>The fruits of <I>Barringtonia racemosa</I> are prescribed in the ayurvedic literature for the treatment of pain, inflammation and rheumatic conditions. In present investigation, activity guided isolation of bartogenic acid (BA) and its evaluation in the Complete Freund's Adjuvant (CFA)-induced arthritis in rats is reported. Among the various extracts and fractions investigated preliminarily for carrageenan-induced acute inflammation in rats, the ethyl acetate fraction displayed potent anti-inflammatory activity. Large-scale isolation and characterization using chromatography and spectral study confirmed that the constituent responsible for the observed pharmacological effects was BA. Subsequently the BA was evaluated for effectiveness against CFA-induced arthritis in rats. The results indicate that at doses of 2, 5 and 10 mg kg<sup>&ndash;1</sup> day<sup>&ndash;1</sup>, p.o., BA protects rats against the primary and secondary arthritic lesions, body weight changes and haematological perturbations induced by CFA. The serum markers of inflammation and arthritis, such as C-reactive protein and rheumatoid factor, were also reduced in the BA-treated arthritic rats. The overall severity of arthritis as determined by radiological analysis and pain scores indicated that BA exerts a potent protective effect against adjuvant-induced arthritis in rats. In conclusion, the present study validates the ethnomedicinal use of fruits of <I>B. racemosa</I> in the treatment of pain and inflammatory conditions. It further establishes the potent anti-arthritic effects of BA. However, additional clinical investigations are needed to prove the efficacy of BA in the treatment of various immuno-inflammatory disorders.</p>
]]></description>
<dc:creator><![CDATA[Patil, K. R., Patil, C. R., Jadhav, R. B., Mahajan, V. K., Patil, P. R., Gaikwad, P. S.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 08:39:23 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep148</dc:identifier>
<dc:title><![CDATA[Anti-arthritic Activity of Bartogenic Acid Isolated from Fruits of Barringtonia racemosa Roxb. (Lecythidaceae)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-21</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep143v1?rss=1">
<title><![CDATA[Bioactive Markers Based Pharmacokinetic Evaluation of Extracts of a Traditional Medicinal Plant, Piper sarmentosum]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep143v1?rss=1</link>
<description><![CDATA[
<p><I>In vitro</I> assays are economical and easy to perform but to establish relevance of their results to real clinical outcome in animals or human, pharmacokinetics is prerequisite. Despite various <I>in vitro</I> pharmacological activities of extracts of <I>Piper sarmentosum</I>, there is no report of pharmacokinetics. Therefore, present study aimed to evaluate ethanol extract of fruit of the plant in dose of 500 mg kg<sup>&ndash;1</sup> orally for pharmacokinetics. Sprague&ndash;Dawley rats were randomly divided into groups 1, 2 and 3 (each <I>n</I> = 6) to study absorption, distribution and excretion, respectively. High performance liquid chromatography (HPLC) with ultraviolet detection was applied to quantify pellitorine, sarmentine and sarmentosine in plasma, tissues, feces and urine to calculate pharmacokinetic parameters. Pellitorine exhibited maximum plasma concentration (<I>C</I><SUB>max</SUB>) 34.77 ng ml<sup>&ndash;1</sup> &plusmn; 1.040, time to achieve <I>C</I><SUB>max</SUB> (<I>T</I><SUB>max</SUB>) 8 h, mean resident time (MRT) 26.00 &plusmn; 0.149 h and half life (<I>t</I><SUB>1/2</SUB>) 18.64 &plusmn; 1.65 h. Sarmentine showed <I>C</I><SUB>max</SUB> 191.50 &plusmn; 12.69 ng ml<sup>&ndash;1</sup>, <I>T</I><SUB>max</SUB> 6 h, MRT 11.12 &plusmn; 0.44 h and <I>t</I><SUB>1/2</SUB> 10.30 &plusmn; 1.98 h. Sarmentosine exhibited zero oral bioavailability because it was neither detected in plasma nor in tissues, feces and urine. Pellitorine was found to be distributed in intestinal wall, liver, lungs, kidney and heart, whereas sarmentine was found only in intestinal wall and heart. The cumulative excretion of pellitorine, sarmentine and sarmentosine in feces in 72 h was 0.0773, 0.976 and 0.438 &micro;g, respectively. This study shows that pellitorine and sarmentine have good oral bioavailability while sarmentosine is not absorbed from the gastrointestinal tract.</p>
]]></description>
<dc:creator><![CDATA[Hussain, K., Ismail, Z., Sadikun, A., Ibrahim, P.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 08:39:22 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep143</dc:identifier>
<dc:title><![CDATA[Bioactive Markers Based Pharmacokinetic Evaluation of Extracts of a Traditional Medicinal Plant, Piper sarmentosum]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-21</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep127v1?rss=1">
<title><![CDATA[Antimicrobial and Antioxidant Activities of Plants from Northeast of Mexico]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep127v1?rss=1</link>
<description><![CDATA[
<p>Traditional medicine has a key role in health care worldwide. Obtaining scientific information about the efficacy and safety of the plants from our region is one of the goals of our research group. In this report, 17 plants were selected and collected in different localities from northeast Mexico. The dried plants were separated into leaves, flowers, fruit, stems, roots and bark. Each part was extracted with methanol, and 39 crude extracts were prepared. The extracts were tested for their antimicrobial activity using three Gram-negative bacterial strains (<I>Pseudomonas aeruginosa</I>, <I>Klebsiella pneumoniae</I> and <I>Acinetobacter baumannii</I>), three Gram-positive bacterial strains (<I>Enterococcus faecalis</I> and two <I>Staphylococcus aureus</I> strains), and seven clinically isolated yeasts (<I>Candida albicans</I>, <I>C. krusei</I>, <I>C. tropicalis</I>, <I>C. parapsilosis</I> and <I>C. glabrata</I>); their antioxidant activity was tested using a DPPH free radical assay. No activity against Gram-negative bacteria was observed with any extract up to the maximum concentration tested, 1000 &micro;g ml<sup>&ndash;1</sup>. We report here for the first time activity of <I>Ceanothus coeruleus</I> against <I>S. aureus</I> [flowers, minimal inhibitory concentration (MIC) 125 &micro;g ml<sup>&ndash;1</sup>], <I>C. glabrata</I> (MICs 31.25 &micro;g ml<sup>&ndash;1</sup>) and <I>C. parapsilosis</I> (MICs between 31.25 and 125 &micro;g ml<sup>&ndash;1</sup>); <I>Chrysanctinia mexicana</I> against <I>C. glabrata</I> (MICs 31.25 &micro;g ml<sup>&ndash;1</sup>); <I>Colubrina greggii</I> against <I>E. faecalis</I> (MICs 250 &micro;g ml<sup>&ndash;1</sup>) and <I>Cordia boissieri</I> against <I>C. glabrata</I> (MIC 125 &micro;g ml<sup>&ndash;1</sup>). Furthermore, this is the first report about antioxidant activity of extracts from <I>Ceanothus coeruleus</I>, <I>Chrysanctinia mexicana</I>, <I>Colubrina greggii</I> and <I>Cyperus alternifolius</I>. Some correlation could exist between antioxidant activity and antiyeast activity against yeasts in the species <I>Ceanothus coeruleus</I>, <I>Schinus molle</I>, <I>Colubrina greggii</I> and <I>Cordia boissieri</I>.</p>
]]></description>
<dc:creator><![CDATA[Salazar-Aranda, R., Perez-Lopez, L. A., Lopez-Arroyo, J., Alanis-Garza, B. A., Waksman de Torres, N.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 08:39:21 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep127</dc:identifier>
<dc:title><![CDATA[Antimicrobial and Antioxidant Activities of Plants from Northeast of Mexico]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-21</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep137v1?rss=1">
<title><![CDATA[Wound Healing Activity of Rubus sanctus Schreber (Rosaceae): Preclinical Study in Animal Models]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep137v1?rss=1</link>
<description><![CDATA[
<p>Young shoots of <I>Rubus</I> species have been used for healing of wounds, infected insect bites and pimples in folk medicine for ages. In order to evaluate the wound healing activity of <I>Rubus sanctus</I>, four different extracts were prepared from the whole aerial parts of the plant by using <I>n</I>-hexane, chloroform, ethyl acetate and methanol, respectively. Incision wound healing model by using tensiometer on rats and excision model on mice were employed to assess the activity. Remarkable wound healing activity was observed with the ointment formulation of the methanol extract at 1% concentration on the mentioned models. The results of histopathological examination also supported the outcome of both incision and excision wound models. The wound healing effect was comparatively evaluated with a reference ointment Madecassol&reg;. The experimental data confirmed the ethnobotanical usage of <I>R. sanctus</I>.</p>
]]></description>
<dc:creator><![CDATA[Pesin, I., Koca, U., Keles, H., Akkol, E. K.]]></dc:creator>
<dc:date>Tue, 15 Sep 2009 06:30:50 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep137</dc:identifier>
<dc:title><![CDATA[Wound Healing Activity of Rubus sanctus Schreber (Rosaceae): Preclinical Study in Animal Models]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-15</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep140v1?rss=1">
<title><![CDATA[3,4-Di-O-Caffeoylquinic Acid Inhibits Angiotensin-II-induced Vascular Smooth Muscle Cell Proliferation and Migration by Downregulating the JNK and PI3K/Akt Signaling Pathways]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep140v1?rss=1</link>
<description><![CDATA[
<p>We previously reported 3,4-di-<I>O</I>-caffeoylquinic acid (CQC) protected vascular endothelial cells against oxidative stress and restored impaired endothelium-dependent vasodilatation. Here, we further investigated its anti-atherosclerotic effect against angiotensin II (Ang II) evoked proliferation and migration of cultured rat vascular smooth muscle cells (rVSMC). The results showed CQC (1&ndash;20 &micro;M) clearly inhibited Ang-II-stimulated BrdU incorporation and cell migration of rVSMC in a concentration-dependent manner but without significant cytotoxicity. Western blot analysis revealed Ang II increased the phosphorylation levels of Akt and mitogen-activated protein kinases (MAPKs;p38, ERK1/2 and JNK) in rVSMC. In the presence of phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin and three individual MAPK inhibitors SB203580, PD98059 and SP600125, both Ang-II-induced cell proliferation and migration were significantly attenuated, although to differing extents, suggesting the PI3K and MAPK signal pathways all participated in regulating rVSMC proliferation and migration. Also, the CQC pretreatment markedly suppressed Ang-II-induced phosphorylation of Akt and JNK rather than ERK1/2, although it failed to affect p38 phosphorylation. In conclusion, our data demonstrate CQC may act by down-regulating Akt, JNK and part of the ERK1/2 pathways to inhibit Ang-II-induced rVSMC proliferation and migration. The anti-atherosclerotic effect of CQC is achieved either by endothelial cells protection or by VSMC proliferation/migration inhibition, suggesting this compound may be useful in preventing vascular diseases.</p>
]]></description>
<dc:creator><![CDATA[Chiou, W.-F., Chen, C.-C., Wei, B.-L.]]></dc:creator>
<dc:date>Mon, 14 Sep 2009 08:04:49 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep140</dc:identifier>
<dc:title><![CDATA[3,4-Di-O-Caffeoylquinic Acid Inhibits Angiotensin-II-induced Vascular Smooth Muscle Cell Proliferation and Migration by Downregulating the JNK and PI3K/Akt Signaling Pathways]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-14</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep139v1?rss=1">
<title><![CDATA[Homeopathic Doses of Gelsemium sempervirens Improve the Behavior of Mice in Response to Novel Environments]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep139v1?rss=1</link>
<description><![CDATA[
<p><I>Gelsemium sempervirens</I> is used in homeopathy for treating patients with anxiety related symptoms, however there have been few experimental studies evaluating its pharmacological activity. We have investigated the effects of homeopathic doses of <I>G. sempervirens</I> on mice, using validated behavioral models. Centesimal (CH) dilutions/dynamizations of <I>G. sempervirens</I>, the reference drug diazepam (1 mg/kg body weight) or a placebo (solvent vehicle) were intraperitoneally delivered to groups of mice of CD1 strain during 8 days, then the effects were assessed by the Light&ndash;Dark (LD) choice test and by the Open-Field (OF) exploration test, in a fully blind manner. In the LD test, the mean time spent in the illuminated area by control and placebo-treated animals was 15.98%, for mice treated with diazepam it increased to 19.91% (<I>P</I> = 0.047), while with <I>G</I>. <I>sempervirens</I> 5 CH it was 18.11% (<I>P</I> = 0.341, non-significant). The number of transitions between the two compartments increased with diazepam from 6.19 to 9.64 (<I>P</I> &lt; 0.001) but not with <I>G</I>. <I>Sempervirens</I>. In the OF test, <I>G</I>. <I>sempervirens</I> 5 CH significantly increased the time spent and the distance traveled in the central zone (<I>P</I> = 0.009 and <I>P</I> = 0.003, respectively), while diazepam had no effect on these OF test parameters. In a subsequent series of experiments, <I>G</I>. <I>sempervirens</I> 7 and 30 CH also significantly improved the behavioral responses of mice in the OF test (<I>P</I> &lt; 0.01 for all tested variables). Neither dilutions of <I>G</I>. <I>sempervirens</I> affected the total distance traveled, indicating that the behavioral effect was not due to unspecific changes in locomotor activity. In conclusion, homeopathic doses of <I>G</I>. <I>sempervirens</I> influence the emotional responses of mice to novel environments, suggesting an improvement in exploratory behavior and a diminution of thigmotaxis or neophobia.</p>
]]></description>
<dc:creator><![CDATA[Bellavite, P., Magnani, P., Zanolin, E., Conforti, A.]]></dc:creator>
<dc:date>Mon, 14 Sep 2009 08:04:49 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep139</dc:identifier>
<dc:title><![CDATA[Homeopathic Doses of Gelsemium sempervirens Improve the Behavior of Mice in Response to Novel Environments]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-14</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep135v1?rss=1">
<title><![CDATA[Andrographolide: A New Plant-Derived Antineoplastic Entity on Horizon]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep135v1?rss=1</link>
<description><![CDATA[
<p>Plant-derived natural products occupy an important position in the area of cancer chemotherapy. Molecules such as vincristine, vinblastine, paclitaxel, camptothecin derivatives, epipodophyllotoxin, etc. are invaluable contributions of nature to modern medicine. However, the quest to find out novel therapeutic compounds for cancer treatment and management is a never-ending venture; and diverse plant species are persistently being studied for identification of prospective anticancer agents. In this regard, <I>Andrographis paniculata</I> Nees, a well-known plant of Indian and Chinese traditional system of medicines, has drawn attention of researchers in recent times. Andrographolide, the principal bioactive chemical constituent of the plant has shown credible anticancer potential in various investigations around the globe. <I>In vitro</I> studies demonstrate the capability of the compound of inducing cell-cycle arrest and apoptosis in a variety of cancer cells at different concentrations. Andrographolide also shows potent immunomodulatory and anti-angiogenic activities in tumorous tissues. Synthetic analogues of the compound have also been created and analyzed, which have also shown similar activities. Although it is too early to predict its future in cancer chemotherapy, the prologue strongly recommends further research on this molecule to assess its potential as a prospective anticancer agent.</p>
]]></description>
<dc:creator><![CDATA[Varma, A., Padh, H., Shrivastava, N.]]></dc:creator>
<dc:date>Mon, 14 Sep 2009 08:04:48 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep135</dc:identifier>
<dc:title><![CDATA[Andrographolide: A New Plant-Derived Antineoplastic Entity on Horizon]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-14</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep096v1?rss=1">
<title><![CDATA[Predictive Analyses of Biological Effects of Natural Products: From Plant Extracts to Biomolecular Laboratory and Computer Modeling]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep096v1?rss=1</link>
<description><![CDATA[
<p>Year by year, the characterization of the biological activity of natural products is becoming more competitive and complex, with the involvement in this research area of experts belonging to different scientific fields, including chemistry, biochemistry, molecular biology, immunology and bioinformatics. These fields are becoming of great interest for several high-impact scientific journals, including <I>eCAM</I>. The available literature in general, and a survey of reviews and original articles recently published, establishes that natural products, including extracts from medicinal plants and essential oils, retain interesting therapeutic activities, including antitumor (1&ndash;7), antiviral (8), anti-inflammatory (9), pro-apoptotic (10,11) and differentiating (12) properties. In this commentary, we focus attention on interest in networks based on complementary activation and comparative evaluation of different experimental strategies applied to the discovery and characterization of bioactive natural products. A representative flow chart is shown in Fig. 1.</p>
]]></description>
<dc:creator><![CDATA[Gambari, R.]]></dc:creator>
<dc:date>Mon, 14 Sep 2009 08:04:47 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep096</dc:identifier>
<dc:title><![CDATA[Predictive Analyses of Biological Effects of Natural Products: From Plant Extracts to Biomolecular Laboratory and Computer Modeling]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-14</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep120v1?rss=1">
<title><![CDATA[Inhibitory effects of ethyl acetate extract of Andrographis paniculata on NF-{kappa}B trans-activation activity and LPS-induced acute inflammation in mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep120v1?rss=1</link>
<description><![CDATA[
<p>This study was to investigate anti-inflammatory effect of <I>Andrographis paniculata</I> (Burm. f.) Nees (Acanthaceae) (AP). The effects of ethyl acetate (EtOAc) extract from AP on the level of inflammatory mediators were examined first using nuclear factor kappa B (NF-B) driven luciferase assay. The results showed that AP significantly inhibited NF-B luciferase activity and tumor necrosis factor  (TNF-), interleukin 6 (IL-6), macrophage inflammatory protein-2 (MIP-2) and nitric oxide (NO) secretions from lipopolysaccharide (LPS)/interferon- stimulated Raw264.7 cells. To further evaluate the anti-inflammatory effects of AP <I>in vivo</I>, BALB/c mice were tube-fed with 0.78 (AP1), 1.56 (AP2), 3.12 (AP3) and 6.25 (AP4) mg kg<sup>&ndash;1</sup> body weight (BW)/day in soybean oil, while the control and PDTC (pyrrolidine dithiocarbamate, an anti-inflammatory agent) groups were tube-fed with soybean oil only. After 1 week of tube-feeding, the PDTC group was injected with 50 mg kg<sup>&ndash;1</sup> BW PDTC and 1 h later, all of the mice were injected with 15 mg kg<sup>&ndash;1</sup> BW LPS. The results showed that the AP1, AP2, AP3 and PDTC groups, but not AP4, had significantly higher survival rate than the control group. Thus, the control, AP1, AP2, AP3 and PDTC groups were repeated for <I>in vivo</I> parameters. The results showed that the AP and PDTC groups had significantly lower TNF-, IL-12p40, MIP-2 or NO in serum or peritoneal macrophages and infiltration of inflammatory cells into the lung of mice. The AP1 group also had significantly lower MIP-2 mRNA expression in brain. This study suggests that AP can inhibit the production of inflammatory mediators and alleviate acute hazards at its optimal dosages.</p>
]]></description>
<dc:creator><![CDATA[Chao, W.-W., Kuo, Y.-H., Hsieh, S.-L., Lin, B.-F.]]></dc:creator>
<dc:date>Thu, 10 Sep 2009 06:29:00 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep120</dc:identifier>
<dc:title><![CDATA[Inhibitory effects of ethyl acetate extract of Andrographis paniculata on NF-{kappa}B trans-activation activity and LPS-induced acute inflammation in mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep136v1?rss=1">
<title><![CDATA[A systematic review of single Chinese herbs for Alzheimer's disease treatment]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep136v1?rss=1</link>
<description><![CDATA[
<p>The objectives here are to provide a systematic review of the current evidence concerning the use of Chinese herbs in the treatment of Alzheimer's disease (AD) and to understand their mechanisms of action with respect to the pathophysiology of the disease. AD, characterized microscopically by deposition of amyloid plaques and formation of neurofibrillary tangles in the brain, has become the most common cause of senile dementia. The limitations of western medications have led us to explore herbal medicine. In particular, many Chinese herbs have demonstrated some interesting therapeutic properties. The following databases were searched from their inception: MEDLINE (PUBMED), ALT HEALTH WATCH (EBSCO), CINAH and Cochrane Central. Only single Chinese herbs are included. Two reviewers independently extracted the data and performed quality assessment. The quality assessment of a clinical trial is based on the <I>Jadad</I> criteria. Seven Chinese herbs and six randomized controlled clinical trials were identified under the predefined criteria. <I>Ginkgo biloba</I>, Huperzine A (<I>Lycopodium serratum</I>) and Ginseng have been assessed for their clinical efficacy with limited favorable evidence. No serious adverse events were reported. Chinese herbs show promise in the treatment of AD in terms of their cognitive benefits and more importantly, their mechanisms of action that deal with the fundamental pathophysiology of the disease. However, the current evidence in support of their use is inconclusive or inadequate. Future research should place emphasis on herbs that can treat the root of the disease.</p>
]]></description>
<dc:creator><![CDATA[Fu, L.-M., Li, J.-T.]]></dc:creator>
<dc:date>Tue, 08 Sep 2009 01:51:26 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep136</dc:identifier>
<dc:title><![CDATA[A systematic review of single Chinese herbs for Alzheimer's disease treatment]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-08</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep124v1?rss=1">
<title><![CDATA[Metabolism and Pharmacokinetics of San-Huang-Xie-Xin-Tang, a Polyphenol-rich Chinese Medicine Formula, in Rats and Ex-vivo Antioxidant Activity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep124v1?rss=1</link>
<description><![CDATA[
<p>San-Huang-Xie-Xin-Tang (SHXXT), a widely used Chinese herbal formula, consists of rhizomes of <I>Rheum officinale</I>, roots of <I>Scutellaria baicalensis</I> and rhizomes of <I>Coptis chinesis</I>. This study investigated the metabolism and pharmacokinetics of polyphenols in SHXXT, including baicalin, baicalein, wogonin, emodin, aloe-emodin, rhein and chrysophanol. The quantitation methods of SHXXT decoction and rat serum using high performance liquid chromatography were developed and validated in this study. After oral administration of SHXXT decoction to rats, the parent forms of various constituents and their conjugated metabolites in serum were determined before and after hydrolysis with &beta;-glucuronidase and sulfatase. The results showed that only free form of rhein can be quantitated, whereas the parent forms of coptisine, palmatine, berberine, baicalein, wogonin, emodin, aloe-emodin and chrysophanol were not detected in serum. The glucuronides of baicalein, wogonin, emodin, aloe-emodin, rhein and chrysophanol were the predominant forms in bloodstream. In order to evaluate the <I>in vivo</I> antioxidant activity of SHXXT, the serum metabolite of SHXXT was prepared, characterized and followed by evaluation of the effect on AAPH-induced hemolysis. The results indicated that metabolites of SHXXT exhibited significant free radical scavenging activity. We suggest that biologists redirect their focus to the bioactivity of the conjugated metabolites of these polyphenols.</p>
]]></description>
<dc:creator><![CDATA[Shia, C.-S., Hou, Y.-C., Juang, S.-H., Tsai, S.-Y., Hsieh, P.-H., Ho, L.-C., Chao, P.-D. L.]]></dc:creator>
<dc:date>Tue, 08 Sep 2009 01:51:25 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep124</dc:identifier>
<dc:title><![CDATA[Metabolism and Pharmacokinetics of San-Huang-Xie-Xin-Tang, a Polyphenol-rich Chinese Medicine Formula, in Rats and Ex-vivo Antioxidant Activity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep126v1?rss=1">
<title><![CDATA[HMC05, Herbal Formula, Inhibits TNF-{alpha}-induced Inflammatory Response in Human Umbilical Vein Endothelial Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep126v1?rss=1</link>
<description><![CDATA[
<p>Vascular inflammation has been implicated in the progression of cardiovascular diseases such as atherosclerosis. In the present study, we found that HMC05, an extract from eight different herbal mixtures, dose-dependently inhibited tumor necrosis factor- (TNF-)-induced adhesion of monocytes to endothelial cells. Such inhibitory effect of HMC05 correlated with suppressed expression of monocyte chemoattractant protein-1, CC chemokine receptor 2, vascular cell adhesion molecule-1 and intercellular cell adhesion molecule-1. In addition, HMC05 significantly inhibited production of reactive oxygen species (ROS) and nuclear factor (NF)-B activation by TNF-. Those inhibitory effects of HMC05 (1&ndash;10 &micro;g ml<sup>&ndash;1</sup>) on the TNF--induced inflammatory event was similar to those of berberine (1&ndash;10 &micro;M), which is a major component of HMC05 and one of herbal compounds known to have vasorelaxing and lipid-lowering activities. However, berberine significantly reduced the viability of HUVECs in a time- and concentration-dependent manner. In contrast, HMC05 (1&ndash;10 &micro;g ml<sup>&ndash;1</sup>) did not affect the cell viability for up to 48 h treatment. In conclusion, we propose that HMC05 may be a safe and potent herbal formula against vascular inflammation, and its action may be attributable to the inhibition of ROS- and NF-B-dependent expression of adhesion molecules and chemokines.</p>
]]></description>
<dc:creator><![CDATA[Lee, J. S., Park, S.-Y., Thapa, D., Kim, A. R., Shin, H.-M., Kim, J.-A.]]></dc:creator>
<dc:date>Mon, 07 Sep 2009 00:27:30 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep126</dc:identifier>
<dc:title><![CDATA[HMC05, Herbal Formula, Inhibits TNF-{alpha}-induced Inflammatory Response in Human Umbilical Vein Endothelial Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep119v1?rss=1">
<title><![CDATA[Treatment with at Homeopathic Complex Medication Modulates Mononuclear Bone Marrow Cell Differentiation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep119v1?rss=1</link>
<description><![CDATA[
<p>A homeopathic complex medication (HCM), with immunomodulatory properties, is recommended for patients with depressed immune systems. Previous studies demonstrated that the medication induces an increase in leukocyte number. The bone marrow microenvironment is composed of growth factors, stromal cells, an extracellular matrix and progenitor cells that differentiate into mature blood cells. Mice were our biological model used in this research. We now report <I>in vivo</I> immunophenotyping of total bone marrow cells and <I>ex vivo</I> effects of the medication on mononuclear cell differentiation at different times. Cells were examined by light microscopy and cytokine levels were measured <I>in vitro</I>. After <I>in vivo</I> treatment with HCM, a pool of cells from the new marrow microenvironment was analyzed by flow cytometry to detect any trend in cell alteration. The results showed decreases, mainly, in CD11b and TER-119 markers compared with controls. Mononuclear cells were used to analyze the effects of <I>ex vivo</I> HCM treatment and the number of cells showing ring nuclei, niche cells and activated macrophages increased in culture, even in the absence of macrophage colony-stimulating factor. Cytokines favoring stromal cell survival and differentiation in culture were induced <I>in vitro</I>. Thus, we observe that HCM is immunomodulatory, either alone or in association with other products.</p>
]]></description>
<dc:creator><![CDATA[Cesar, B., Abud, A. P. R., de Oliveira, C. C., Cardoso, F., Bernardi, R. P. D., Guimaraes, F. S.F., Gabardo, J., de Freitas Buchi, D.]]></dc:creator>
<dc:date>Mon, 07 Sep 2009 00:27:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep119</dc:identifier>
<dc:title><![CDATA[Treatment with at Homeopathic Complex Medication Modulates Mononuclear Bone Marrow Cell Differentiation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep109v1?rss=1">
<title><![CDATA[Phytochemical Composition and Antioxidant Capacity of Three Malian Medicinal Plant Parts]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep109v1?rss=1</link>
<description><![CDATA[
<p>This study evaluates the levels of total polyphenolic compounds in three Malian medicinal plants and determines their antioxidant potential. Quantitative and qualitative analysis of polyphenolics contained in plants extracts were carried out by RP-C18 RP&ndash;HPLC using UV detector. The antioxidant activity was determined by three tests. They are phosphomolybdenum, DPPH (2,2-diphenyl-1 picrylhydrazyl) and ABTS [<cross-ref type="bib" refid="B2">2</cross-ref>,2'-azino-<I>bis</I>(3-ethylbenzothiazoline-6-sulfonic)] tests. The total phenolic and the total flavonoid contents varied from 200 to 7600 mg 100 g<sup>&ndash;1</sup> dry weight (dw), expressed as gallic acid equivalents and from 680 to 12 300 mg 100 g<sup>&ndash;1</sup> dw expressed as catechin equivalents, respectively. The total anthocyanin concentrations expressed as cyanin-3-glycoside equivalent varied from 1670 to 28 388 mg 100 g<sup>&ndash;1</sup> dw. The antioxidant capacity was measured by determining concentration of a polyphenolic (in mg ml<sup>&ndash;1</sup>) required to quench the free radicals by 50% (IC<SUB>50</SUB>) and expressed as vitamin C equivalent antioxidant capacity. The IC<SUB>50</SUB> values were ranked between 2.68 and 8.80 &micro;g ml<sup>&ndash;1</sup> of a solution of 50% (v/v) methanol in water. The uses of plants are rationalized on the basis of their antioxidant capacity.</p>
]]></description>
<dc:creator><![CDATA[Muanda, F., Kone, D., Dicko, A., Soulimani, R., Younos, C.]]></dc:creator>
<dc:date>Mon, 07 Sep 2009 00:27:27 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep109</dc:identifier>
<dc:title><![CDATA[Phytochemical Composition and Antioxidant Capacity of Three Malian Medicinal Plant Parts]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep133v1?rss=1">
<title><![CDATA[Electroacupuncture Treatment Normalized Sleep Disturbance in Morphine Withdrawal Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep133v1?rss=1</link>
<description><![CDATA[
<p>Sleep disturbance is considered as an important symptom of acute and protracted opiate withdrawal. Current results suggest that sleep disturbance may be taken as a predictor of relapse. Appropriate sleep enhancement therapy will be in favor of the retention in treatment for opiate addicts. Our previous studies have shown that electroacupuncture (EA) is effective in suppressing morphine withdrawal syndrome. The aim of the present study is to investigate the effect of 2 and 100 Hz EA on the sleep disturbance during morphine withdrawal. Rats were made dependent on morphine by repeated morphine injections (escalating doses of 5&ndash;80 mg kg<sup>&ndash;1</sup>, subcutaneously, twice a day) for 5 days. EA of 2 or 100 Hz was given twice a day for 3 days, starting at 48 h after the last morphine injection. Electroencephalogram and electromyogram were monitored at the end of the first and the last EA treatments, respectively. Results showed that non-rapid eye movement (NREM) sleep, REM sleep and total sleep time decreased dramatically, while the sleep latency prolonged significantly during acute morphine withdrawal. Both 2 and 100 Hz EA produced a significant increase in NREM sleep, REM sleep and total sleep time. It was suggested that EA could be a potential treatment for sleep disturbance during morphine withdrawal.</p>
]]></description>
<dc:creator><![CDATA[Li, Y.-J., Zhong, F., Yu, P., Han, J.-S., Cui, C.-L., Wu, L.-Z.]]></dc:creator>
<dc:date>Fri, 04 Sep 2009 07:02:32 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep133</dc:identifier>
<dc:title><![CDATA[Electroacupuncture Treatment Normalized Sleep Disturbance in Morphine Withdrawal Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-04</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep130v1?rss=1">
<title><![CDATA[Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep130v1?rss=1</link>
<description><![CDATA[
<p>The prevalence of prehypertension and Stage 1 hypertension continues to increase despite being amenable to non-pharmacologic interventions. Iyengar yoga (IY) has been purported to reduce blood pressure (BP) though evidence from randomized trials is lacking. We conducted a randomized controlled trial to assess the effects of 12 weeks of IY versus enhanced usual care (EUC) (based on individual dietary adjustment) on 24-h ambulatory BP in yoga-na&iuml;ve adults with untreated prehypertension or Stage 1 hypertension. In total, 26 and 31 subjects in the IY and EUC arms, respectively, completed the study. There were no differences in BP between the groups at 6 and 12 weeks. In the EUC group, 24-h systolic BP (SBP), diastolic BP (DBP) and mean arterial pressure (MAP) significantly decreased by 5, 3 and 3 mmHg, respectively, from baseline at 6 weeks (<I>P</I> &lt; 0.05), but were no longer significant at 12 weeks. In the IY group, 24 h SBP was reduced by 6 mmHg at 12 weeks compared to baseline (<I>P</I> = 0.05). 24 h DBP (<I>P</I> &lt; 0.01) and MAP (<I>P</I> &lt; 0.05) decreased significantly each by 5 mmHg. No differences were observed in catecholamine or cortisol metabolism to explain the decrease in BP in the IY group at 12 weeks. Twelve weeks of IY produces clinically meaningful improvements in 24 h SBP and DBP. Larger studies are needed to establish the long term efficacy, acceptability, utility and potential mechanisms of IY to control BP.</p>
]]></description>
<dc:creator><![CDATA[Cohen, D. L., Bloedon, L. T., Rothman, R. L., Farrar, J. T., Galantino, M. L., Volger, S., Mayor, C., Szapary, P. O., Townsend, R. R.]]></dc:creator>
<dc:date>Fri, 04 Sep 2009 07:02:31 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep130</dc:identifier>
<dc:title><![CDATA[Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-04</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep134v1?rss=1">
<title><![CDATA[Animal-based Remedies as Complementary Medicines in the Semi-arid Region of Northeastern Brazil]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep134v1?rss=1</link>
<description><![CDATA[
<p>Animals (and their derived products) are essential ingredients in the preparation of many traditional remedies. Despite its prevalence in traditional medical practices worldwide, research on medicinal animals has often been neglected in comparison to medicinal plant research. This work documents the medicinal animals used by a rural community in the semi-arid region, inserted in Caatinga Biome, where 66 respondents provided information on animal species used as medicine, body parts used to prepare the remedies and illnesses to which the remedies were prescribed. We calculated the informant consensus factor to determine the consensus over which species are effective for particular ailments, as well as the species use value to determine the extent of utilization of each species. We recorded the use of 51 animal species as medicines, whose products were recommended for the treatment of 68 illnesses. The informant consensus in the use of many specific remedies is fairly high, giving an additional validity to this folk medicine. Eight species not previously reported as having medicinal use were recorded. The local medicinal fauna is largely based on wild animals, including some endangered species. Given a high proportion of medicinal animals observed in the study area, it is logical to conclude that any conservation strategy should include access to modern health care.</p>
]]></description>
<dc:creator><![CDATA[Alves, R. R. N., Barbosa, J. A. A., Santos, S. L. D. X., Souto, W. M. S., Barboza, R. R. D.]]></dc:creator>
<dc:date>Thu, 03 Sep 2009 08:33:28 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep134</dc:identifier>
<dc:title><![CDATA[Animal-based Remedies as Complementary Medicines in the Semi-arid Region of Northeastern Brazil]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-03</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep132v1?rss=1">
<title><![CDATA[Endogenous Opiates in the Nucleus Tractus Solitarius Mediate Electroacupuncture-induced Sleep Activities in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep132v1?rss=1</link>
<description><![CDATA[
<p>Electroacupuncture (EA) possesses various therapeutic effects, including alleviation of pain, reduction of inflammation and improvement of sleep disturbance. The mechanisms of EA on sleep improvement, however, remain to be determined. It has been stated in ancient Chinese literature that the Anmian (EX17) acupoint is one of the trigger points that alleviates insomnia. We previously demonstrated that EA stimulation of Anmian acupoints in rats during the dark period enhances non-rapid eye movement (NREM) sleep, which involves the induction of cholinergic activity in the nucleus tractus solitarius (NTS). In addition to cholinergic activation of the NTS, activation of the endogenous opioidergic system may also be a mechanism by which acupuncture affects sleep. Therefore, this study was designed to investigate the involvement of the NTS opioidergic system in EA-induced alterations in sleep. Our present results indicate that EA of Anmian acupoints increased NREM sleep, but not rapid eye movement sleep, during the dark period in rats. This enhancement in NREM sleep was dose-dependently blocked by microinjection of opioid receptor antagonist, naloxone, and the &micro;-opioid receptor antagonist, naloxonazine, into the NTS; administrations of -receptor antagonist, natrindole, and the -receptor antagonist, <I>nor</I>-binaltrophimine, however, did not affect EA-induced alterations in sleep. Furthermore, &beta;-endorphin was significantly increased in both the brainstem and hippocampus after the EA stimuli, an effect blocked by administration of the muscarinic antagonist scopolamine into the NTS. Our findings suggest that mechanisms of EA-induced NREM sleep enhancement may be mediated, in part, by cholinergic activation, stimulation of the opiodergic neurons to increase the concentrations of &beta;-endorphin and the involvement of the &micro;-opioid receptors.</p>
]]></description>
<dc:creator><![CDATA[Cheng, C.-H., Yi, P.-L., Lin, J.-G., Chang, F.-C.]]></dc:creator>
<dc:date>Thu, 03 Sep 2009 08:33:28 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep132</dc:identifier>
<dc:title><![CDATA[Endogenous Opiates in the Nucleus Tractus Solitarius Mediate Electroacupuncture-induced Sleep Activities in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-03</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep125v1?rss=1">
<title><![CDATA[Influence of Craniosacral Therapy on Anxiety, Depression and Quality of Life in Patients with Fibromyalgia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep125v1?rss=1</link>
<description><![CDATA[
<p>Fibromyalgia is considered as a combination of physical, psychological and social disabilities. The causes of pathologic mechanism underlying fibromyalgia are unknown, but fibromyalgia may lead to reduced quality of life. The objective of this study was to analyze the repercussions of craniosacral therapy on depression, anxiety and quality of life in fibromyalgia patients with painful symptoms. An experimental, double-blind longitudinal clinical trial design was undertaken. Eighty-four patients diagnosed with fibromyalgia were randomly assigned to an intervention group (craniosacral therapy) or placebo group (simulated treatment with disconnected ultrasound). The treatment period was 25 weeks. Anxiety, pain, sleep quality, depression and quality of life were determined at baseline and at 10 min, 6 months and 1-year post-treatment. State anxiety and trait anxiety, pain, quality of life and Pittsburgh sleep quality index were significantly higher in the intervention versus placebo group after the treatment period and at the 6-month follow-up. However, at the 1-year follow-up, the groups only differed in the Pittsburgh sleep quality index. Approaching fibromyalgia by means of craniosacral therapy contributes to improving anxiety and quality of life levels in these patients.</p>
]]></description>
<dc:creator><![CDATA[Mataran-Penarrocha, G. A., Castro-Sanchez, A. M., Garcia, G. C., Moreno-Lorenzo, C., Carreno, T. P., Zafra, M. D. O.]]></dc:creator>
<dc:date>Thu, 03 Sep 2009 08:33:26 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep125</dc:identifier>
<dc:title><![CDATA[Influence of Craniosacral Therapy on Anxiety, Depression and Quality of Life in Patients with Fibromyalgia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-09-03</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep128v1?rss=1">
<title><![CDATA[A Review of a Historical Summit on Integrative Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep128v1?rss=1</link>
<description><![CDATA[
<p>The US Institute of Medical sponsors a "Summit on Integrative Medicine and the Health of the Public" on February 25&ndash;27, 2009. A prestigious body of speakers and attendees created a dynamic conference in which the content and discussions provided vital information for transforming the US health care system. Topics included: patient-centered care, the scientific basis of integrative medicine, health care financing reform and value-driven care, and mind-body relationships and health.</p>
]]></description>
<dc:creator><![CDATA[Ullman, D.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 05:15:59 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep128</dc:identifier>
<dc:title><![CDATA[A Review of a Historical Summit on Integrative Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep111v1?rss=1">
<title><![CDATA[Cytotoxic Effects of Bangladeshi Medicinal Plant Extracts]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep111v1?rss=1</link>
<description><![CDATA[
<p>To investigate the cytotoxic effect of some Bangladeshi medicinal plant extracts, 16 Bangladeshi medicinal plants were successively extracted with <I>n</I>-hexane, dichloromethane, methanol and water. The methanolic and aqueous extracts were screened for cytotoxic activity against healthy mouse fibroblasts (NIH3T3) and three human cancer-cell lines (gastric: AGS; colon: HT-29; and breast: MDA-MB-435S) using the MTT assay. Two methanolic extracts (<I>Hygrophila auriculata</I> and <I>Hibiscus tiliaceous</I>) and one aqueous extract (<I>Limnophila indica</I>) showed no toxicity against healthy mouse fibroblasts, but selective cytotoxicity against breast cancer cells (IC<SUB>50</SUB> 1.1&ndash;1.6 mg mL<sup>&ndash;1</sup>). Seven methanolic extracts from <I>L. indica</I>, <I>Clerodendron inerme</I>, <I>Cynometra ramiflora</I>, <I>Xylocarpus moluccensis</I>, <I>Argemone mexicana</I>, <I>Ammannia baccifera</I> and <I>Acrostichum aureum</I> and four aqueous extracts from <I>Hygrophila auriculata</I>, <I>Bruguiera gymnorrhiza</I>, <I>X. moluccensis</I> and <I>Aegiceras corniculatum</I> showed low toxicity (IC<SUB>50</SUB> &gt; 2.5 mg mL<sup>&ndash;1</sup>) against mouse fibroblasts but selective cytotoxicity (IC<SUB>50</SUB> 0.2&ndash;2.3 mg mL<sup>&ndash;1</sup>) against different cancer cell lines. The methanolic extract of <I>Blumea lacera</I> showed the highest cytotoxicity (IC<SUB>50</SUB> 0.01&ndash;0.08 mg mL<sup>&ndash;1</sup>) against all tested cell lines among all extracts tested in this study. For some of the plants their traditional use as anticancer treatments correlates with the cytotoxic results, whereas for others so far unknown cytotoxic activities were identified.</p>
]]></description>
<dc:creator><![CDATA[Uddin, S. J., Grice, I. D., Tiralongo, E.]]></dc:creator>
<dc:date>Tue, 25 Aug 2009 05:52:26 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep111</dc:identifier>
<dc:title><![CDATA[Cytotoxic Effects of Bangladeshi Medicinal Plant Extracts]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep095v1?rss=1">
<title><![CDATA[The Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: suppression of angiotensin II/AT1 signaling]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep095v1?rss=1</link>
<description><![CDATA[
<p>In human diabetic nephropathy, the extent of tubulointerstitial fibrosis is the leading cause of end-stage renal disease; fibrosis is closely correlated with renal dysfunction. Although a wide array of medicinal plants play a role in the prevention and treatment of diabetes, there are few reports of the application of herbal medicines in amelioration of renal fibrosis, or the underlying mechanisms by which such benefits are mediated. The efficacy of the Ayurvedic antidiabetic medicine <I>Salacia oblonga</I> (SO) root on rat renal fibrosis was investigated. An aqueous extract from SO (100 mg/kg, p.o., 6 weeks) diminished renal glomerulosclerosis and interstitial fibrosis in Zucker diabetic fatty (ZDF) rats, as revealed by van Giesen-staining. SO also reduced renal salt-soluble, acid-soluble and salt-insoluble collagen contents. These changes were accompanied by normalization of hypoalbuminemia and BUN. Gene profiling revealed that the increase in transcripts encoding the glomerulosclerotic mediators collagen I, collagen IV, fibronectin, angiotensin II type 1 receptor (AT1), transforming growth factor (TGF)-&beta;1, plasminogen activator inhibitor (PAI)-1 observed in ZDF rat kidney was suppressed by SO. In rat-derived mesangial cells, similar to the effect of the AT1 antagonist telmisartan, SO and its major component mangiferin suppressed the stimulatory effect of angiotensin II on proliferation and increased mRNA expression and/or activities of collagen I, collagen IV, fibronectin, AT1, TGF-&beta;1 and PAI-1. Considered together the present findings demonstrate that SO attenuates diabetic renal fibrosis, at least in part by suppressing anigiotensin II/AT1 signaling. Further, it now emerges that mangiferin is an effective antifibrogenic agent.</p>
]]></description>
<dc:creator><![CDATA[He, L., Qi, Y., Rong, X., Jiang, J., Yang, Q., Yamahara, J., Murray, M., Li, Y.]]></dc:creator>
<dc:date>Tue, 25 Aug 2009 05:52:25 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep095</dc:identifier>
<dc:title><![CDATA[The Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: suppression of angiotensin II/AT1 signaling]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep122v1?rss=1">
<title><![CDATA[A Follow-up Study on the Efficacy of the Homeopathic Remedy Arsenicum Album in Volunteers Living in High Risk Arsenic Contaminated Areas]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep122v1?rss=1</link>
<description><![CDATA[
<p>In continuation of our short-term pilot studies reported earlier, results on certain toxicity biomarkers in volunteers who continued to take the potentized Arsenicum Album 200C till 2 years are presented. Out of some 130 &lsquo;verum&rsquo;-fed volunteers of pilot study, 96 continued to take the remedy till 6 months, 65 till 1 year and 15 among them continued till 2 years. They provided samples of their urine and blood at 6 months, 1 year and finally at 2 years. None out of 17 who received &lsquo;placebo&rsquo; turned up for providing blood or urine at these longer intervals. Standard methodologies were used for determination of arsenic content in blood and urine, and for measurement of toxicity biomarkers like acid and alkaline phosphatases, alanine and aspartate amino transferases, lipid peroxidation and reduced glutathione and anti-nuclear antibody titers. Most of the volunteers reported status quo maintained after the improvement they achieved within the first 3 months of homeopathic treatment, in respect of their general health and spirit, and appetite and sleep. A few with skin symptoms and burning sensation, however, improved further. This was supported by the data of toxicity biomarkers, levels of all of which remained fairly within normal range. Therefore, administration of Arsenicum Album 200C considerably ameliorates symptoms of arsenic toxicity on a long-term basis, and can be recommended for interim use, particularly in high risk remote villages lacking modern medical and arsenic free drinking water facilities. Similar studies by others are encouraged.</p>
]]></description>
<dc:creator><![CDATA[Khuda-Bukhsh, A. R., Roy-Karmakar, S., Banerjee, A., Banerjee, P., Pathak, S., Biswas, S. J., Haque, S., Das, D., Boujedaini, N., Belon, P.]]></dc:creator>
<dc:date>Mon, 24 Aug 2009 04:46:48 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep122</dc:identifier>
<dc:title><![CDATA[A Follow-up Study on the Efficacy of the Homeopathic Remedy Arsenicum Album in Volunteers Living in High Risk Arsenic Contaminated Areas]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep123v1?rss=1">
<title><![CDATA[Mutagenic Activity of Indigofera truxillensis and I. suffruticosa Aerial Parts]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep123v1?rss=1</link>
<description><![CDATA[
<p><I>Indigofera truxillensis</I> and <I>I. suffruticosa</I>, are used as a source of indigo dye and to treat several diseases. The mutagenic activity of the methanolic extracts from aerial parts, glycerolipid, flavonoid and alkaloid fractions of the extract were evaluated by means of <I>Salmonella/</I>microsome assays using TA100, TA98, TA102 and TA97a strains. The methanolic extract of <I>I. truxillensis</I> showed mutagenic activity in the TA98 strain without S9 while glycerolipid fraction was devoid of activity. The flavonoid and alkaloid fractions of both plants showed mutagenicity. Chemical analysis of flavonoid fractions of <I>I. truxillensis</I> and <I>I. suffruticosa</I> resulted in the identification of kaempferol, quercetin and their derivatives. The alkaloid fraction of both the species contained indigo and indirubin and indigo was found mainly responsible for the mutagenic activity.</p>
]]></description>
<dc:creator><![CDATA[Calvo, T. R., Cardoso, C. R. P., da Silva Moura, A. C., dos Santos, L. C., Colus, I. M. S., Vilegas, W., Varanda, E. A.]]></dc:creator>
<dc:date>Thu, 20 Aug 2009 09:03:18 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep123</dc:identifier>
<dc:title><![CDATA[Mutagenic Activity of Indigofera truxillensis and I. suffruticosa Aerial Parts]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep121v1?rss=1">
<title><![CDATA[Full-length Sequence of Mouse Acupuncture-induced 1-L (Aig1l) Gene Including its Transcriptional Start Site]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep121v1?rss=1</link>
<description><![CDATA[
<p>We have been investigating the molecular efficacy of electroacupuncture (EA), which is one type of acupuncture therapy. In our previous molecular biological study of acupuncture, we found an EA-induced gene, named acupuncture-induced 1-L (<I>Aig1l</I>), in mouse skeletal muscle. The aims of this study consisted of identification of the full-length cDNA sequence of <I>Aig1l</I> including the transcriptional start site, determination of the tissue distribution of <I>Aig1l</I> and analysis of the effect of EA on <I>Aig1l</I> gene expression. We determined the complete cDNA sequence including the transcriptional start site via cDNA cloning with the cap site hunting method. We then analyzed the tissue distribution of <I>Aig1l</I> by means of northern blot analysis and real-time quantitative polymerase chain reaction. We used the semiquantitative reverse transcriptase-polymerase chain reaction to examine the effect of EA on <I>Aig1l</I> gene expression. Our results showed that the complete cDNA sequence of <I>Aig1l</I> was 6073 bp long, and the putative protein consisted of 962 amino acids. All seven tissues that we analyzed expressed the <I>Aig1l</I> gene. In skeletal muscle, EA induced expression of the <I>Aig1l</I> gene, with high expression observed after 3 h of EA. Our findings thus suggest that the <I>Aig1l</I> gene may play a key role in the molecular mechanisms of EA efficacy.</p>
]]></description>
<dc:creator><![CDATA[Ohta, M., Sugano, A., Goto, S., Yusoff, S., Hirota, Y., Funakoshi, K., Miura, K., Maeda, E., Takaoka, N., Sato, N., Ishizuka, H., Arizono, N., Nishio, H., Takaoka, Y.]]></dc:creator>
<dc:date>Thu, 20 Aug 2009 09:03:17 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep121</dc:identifier>
<dc:title><![CDATA[Full-length Sequence of Mouse Acupuncture-induced 1-L (Aig1l) Gene Including its Transcriptional Start Site]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep107v1?rss=1">
<title><![CDATA[Ganoderma lucidum Polysaccharides Induce Macrophage-like Differentiation in Human Leukemia THP-1 Cells via Caspase and p53 Activation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep107v1?rss=1</link>
<description><![CDATA[
<p>Differentiation therapy by induction of tumor cells is an important method in the treatment of hematological cancers such as leukemia. Tumor cell differentiation ends cancer cells&rsquo; immortality, thus stopping cell growth and proliferation. In our previous study, we found that fucose-containing polysaccharide fraction F3 extracted from <I>Ganoderma lucidum</I> can bring about cytokine secretion and cell death in human leukemia THP-1 cells. This prompted us to further investigate on how F3 induces the differentiation in human leukemia cells. We integrated time-course microarray analysis and network modeling to study the F3-induced effects on THP-1 cells. In addition, we determined the differentiation effect using Liu's staining, nitroblue tetrazolium (NBT) reduction assay, flow cytometer, western blotting and Q-PCR. We also examined the modulation and regulation by F3 during the differentiation process. Dynamic gene expression profiles showed that cell differentiation was induced in F3-treated THP-1 cells. Furthermore, F3-treated THP-1 cells exhibited enhanced macrophage differentiation, as demonstrated by changes in cell adherence, cell cycle arrest, NBT reduction and expression of differentiation markers including CD11b, CD14, CD68, matrix metalloproteinase-9 and myeloperoxidase. In addition, caspase cleavage and p53 activation were found to be significantly enhanced in F3-treated THP-1 cells. We unraveled the role of caspases and p53 in F3-induced THP-1 cells differentiation into macrophages. Our results provide a molecular explanation for the differentiation effect of F3 on human leukemia THP-1 cells and offer a prospect for a potential leukemia differentiation therapy.</p>
]]></description>
<dc:creator><![CDATA[Hsu, J.-W., Huang, H.-C., Chen, S.-T., Wong, C.-H., Juan, H.-F.]]></dc:creator>
<dc:date>Thu, 20 Aug 2009 09:03:16 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep107</dc:identifier>
<dc:title><![CDATA[Ganoderma lucidum Polysaccharides Induce Macrophage-like Differentiation in Human Leukemia THP-1 Cells via Caspase and p53 Activation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep104v1?rss=1">
<title><![CDATA[A Novel Uni-acupoint Electroacupuncture Stimulation Method for Pain Relief]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep104v1?rss=1</link>
<description><![CDATA[
<p>Electroacupuncture stimulation (EAS) has been demonstrated effective for pain relief and treating other various diseases. However, the conventional way of EAS, the bi-acupoint method, is not suitable for basis study of acupoint specificity. Moreover, its operations are inconvenient and difficult to be persevered, especially for long-term, continuous and even imperative treatments. These disadvantages motivate designs of new EAS methods. We present a novel uni-acupoint electrical stimulation method, which is applied at a single acupoint and quite meets the needs of basis study and simpler clinical application. Its pain relief effect has been evaluated by animal tests of Wistar rats. During the experiments, rats were given 30 min 2/100 Hz uni- and bi-acupoint EAS and their nociceptive thresholds before and after EAS were attained by hot-plate test. The analgesic effect was defined as the change of nociceptive threshold and used to evaluate the effectiveness of uni-acupoint EAS for pain relief. The hot-plate test results indicated that analgesic effect of uni-acupoint group was significantly higher than that of the control group and there was no significant difference of analgesic effects between uni- and bi- acupoint EAS. The results suggested that uni-acupoint method was an effective EAS method and had comparable pain relief effect with bi-acupoint method.</p>
]]></description>
<dc:creator><![CDATA[Niu, C., Hao, H., Lu, J., Li, L., Han, Z., Tu, Y.]]></dc:creator>
<dc:date>Thu, 20 Aug 2009 09:03:15 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep104</dc:identifier>
<dc:title><![CDATA[A Novel Uni-acupoint Electroacupuncture Stimulation Method for Pain Relief]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep116v1?rss=1">
<title><![CDATA[Treatment of Idiopathic Parkinson's Disease with Traditional Chinese Herbal Medicine: A Randomized Placebo-Controlled Pilot Clinical Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep116v1?rss=1</link>
<description><![CDATA[
<p>The objective of this clinical study is to examine the effects of a Chinese herbal medicine formula (<I>Jia Wei Liu Jun Zi Tang: JWLJZT</I>) on motor and non-motor symptoms, and on complications of conventional therapy in idiopathic Parkinson's disease (PD), using an add-on design. Fifty-five patients with PD were randomly allocated to receive either Chinese herbal medicine or placebo for 24 weeks. Primary outcome measure was the 39-item Parkinson's Disease Questionnaire (PDQ-39). Secondary outcome measures included the Unified Parkinson's Disease Rating Scale (UPDRS), Short-Form-36 Health Survey (SF-36), Geriatric Depression Scale (GDS), home diaries, and a range of category rating scales. <I>JWLJZT</I> resulted in a significant improvement in the UPDRS IVC when compared with placebo at 12 weeks (<I>P</I> = 0.039) and 24 weeks (<I>P</I> = 0.034). In addition, patients in the Chinese herbal medicine group also showed significant improvement in PDQ-39 communication scores at 12 weeks (<I>P</I> = 0.024) and 24 weeks (<I>P</I> = 0.047) when compared with the placebo group. There were no significant differences between treatment and control groups for SF-36 variables, GDS score or the mean daily &lsquo;on-off&rsquo; time. One case of mild diarrhea was noted in the treatment group. The findings suggest that <I>JWLJZT</I> can relieve some non-motor complications of conventional therapy and improve the communication ability in patients with PD. The results of this pilot study warrant larger multi-center clinical studies to assess long-term efficacy and tolerability of <I>JWLJZT</I>, and to elucidate the mechanisms by which it affects PD function.</p>
]]></description>
<dc:creator><![CDATA[Kum, W. F., Durairajan, S. S. K., Bian, Z. X., Man, S. C., Lam, Y. C., Xie, L. X., Lu, J. H., Wang, Y., Huang, X. Z., Li, M.]]></dc:creator>
<dc:date>Wed, 19 Aug 2009 05:09:50 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep116</dc:identifier>
<dc:title><![CDATA[Treatment of Idiopathic Parkinson's Disease with Traditional Chinese Herbal Medicine: A Randomized Placebo-Controlled Pilot Clinical Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-19</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep102v1?rss=1">
<title><![CDATA[Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep102v1?rss=1</link>
<description><![CDATA[
<p>Chronic inflammation of the hair follicle (HF) is considered a contributing factor in the pathogenesis of androgenetic alopecia (AGA). Previously, we clinically tested liposterolic extract of <I>Serenoa repens</I> (LSESr) and its glycoside, &beta;-sitosterol, in subjects with AGA and showed a highly positive response to treatment. In this study, we sought to determine whether blockade of inflammation using a composition containing LSESr as well as two anti-inflammatory agents (carnitine and thioctic acid) could alter the expression of molecular markers of inflammation in a well-established <I>in vitro</I> system. Using a well-validated assay representative of HF keratinocytes, specifically, stimulation of cultured human keratinocyte cells <I>in vitro</I>, we measured changes in gene expression of a spectrum of well-known inflammatory markers. Lipopolysaccharide (LPS) provided an inflammatory stimulus. In particular, we found that the composition effectively suppressed LPS-activated gene expression of chemokines, including <I>CCL17</I>, <I>CXCL6</I> and <I>LTB(4)</I> associated with pathways involved in inflammation and apoptosis. Our data support the hypothesis that the test compound exhibits anti-inflammatory characteristics in a well-established <I>in vitro</I> assay representing HF keratinocyte gene expression. These findings suggest that 5-alpha reductase inhibitors combined with blockade of inflammatory processes could represent a novel two-pronged approach in the treatment of AGA with improved efficacy over current modalities.</p>
]]></description>
<dc:creator><![CDATA[Chittur, S., Parr, B., Marcovici, G.]]></dc:creator>
<dc:date>Wed, 19 Aug 2009 05:09:50 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep102</dc:identifier>
<dc:title><![CDATA[Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-19</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep117v1?rss=1">
<title><![CDATA[Utilization of 3-month Yoga Program for Adults at High Risk for Type 2 Diabetes: A Pilot Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep117v1?rss=1</link>
<description><![CDATA[
<p>Various modes of physical activity, combined with dieting, have been widely recommended to prevent or delay type 2 diabetes. Among these, yoga holds promise for reducing risk factors for type 2 diabetes by promoting weight loss, improving glucose levels and reducing blood pressure and lipid levels. This pilot study aimed to assess the feasibility of implementing a 12-week yoga program among adults at high risk for type 2 diabetes. Twenty-three adults (19 Whites and 4 non-Whites) were randomly assigned to the yoga intervention group or the educational group. The yoga group participated in a 3-month yoga intervention with sessions twice per week and the educational group received general health educational materials every 2 weeks. All participants completed questionnaires and had blood tests at baseline and at the end of 3 months. Effect sizes were reported to summarize the efficacy of the intervention. All participants assigned to the yoga intervention completed the yoga program without complication and expressed high satisfaction with the program (99.2%). Their yoga session attendance ranged from 58.3 to 100%. Compared with the education group, the yoga group experienced improvements in weight, blood pressure, insulin, triglycerides and exercise self-efficacy indicated by small to large effect sizes. This preliminary study indicates that a yoga program would be a possible risk reduction option for adults at high risk for type 2 diabetes. In addition, yoga holds promise as an approach to reducing cardiometabolic risk factors and increasing exercise self-efficacy for this group.</p>
]]></description>
<dc:creator><![CDATA[Yang, K., Bernardo, L. M., Sereika, S. M., Conroy, M. B., Balk, J., Burke, L. E.]]></dc:creator>
<dc:date>Tue, 18 Aug 2009 05:51:32 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep117</dc:identifier>
<dc:title><![CDATA[Utilization of 3-month Yoga Program for Adults at High Risk for Type 2 Diabetes: A Pilot Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-18</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep112v1?rss=1">
<title><![CDATA[Aqueous Extract of Brazilian Green Propolis: Primary Components, Evaluation of Inflammation and Wound Healing by Using Subcutaneous Implanted Sponges]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep112v1?rss=1</link>
<description><![CDATA[
<p>Propolis is a chemically complex resinous bee product which has gained worldwide popularity as a means to improve health condition and prevent diseases. The main constituents of an aqueous extract of a sample of green propolis from Southeast Brazil were shown by high performance liquid chromatography/mass spectroscopy/mass spectroscopy to be mono- and di-<I>O</I>-caffeoylquinic acids; phenylpropanoids known as important constituents of alcohol extracts of green propolis, such as artepillin C and drupanin were also detected in low amounts in the aqueous extract. The anti-inflammatory activity of this extract was evaluated by determination of wound healing parameters. Female Swiss mice were implanted subcutaneously with polyesther-polyurethane sponge discs to induce wound healing responses, and administered orally with green propolis (500 mg kg<sup>&ndash;1</sup>). At 4, 7 and 14 days post-implantation, the fibrovascular stroma and deposition of extracellular matrix were evaluated by histopathologic and morphometric analyses. In the propolis-treated group at Days 4 and 7 the inflammatory process in the sponge was reduced in comparison with control. A progressive increase in cell influx and collagen deposition was observed in control and propolis-treated groups during the whole period. However, these effects were attenuated in the propolis-treated group at Days 4 and 7, indicating that key factors of the wound healing process are modulated by propolis constituents.</p>
]]></description>
<dc:creator><![CDATA[Moura, S. A. L. d., Negri, G., Salatino, A., Lima, L. D. d. C., Dourado, L. P. A., Mendes, J. B., Andrade, S. P., Ferreira, M. A. N. D., Cara, D. C.]]></dc:creator>
<dc:date>Tue, 18 Aug 2009 05:51:32 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep112</dc:identifier>
<dc:title><![CDATA[Aqueous Extract of Brazilian Green Propolis: Primary Components, Evaluation of Inflammation and Wound Healing by Using Subcutaneous Implanted Sponges]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-18</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep115v1?rss=1">
<title><![CDATA[Paeoniae alba Radix Promotes Peripheral Nerve Regeneration]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep115v1?rss=1</link>
<description><![CDATA[
<p>The present study provides <I>in vitro</I> and <I>in vivo</I> evaluation of <I>Paeoniae alba</I> Radix (PR) on peripheral nerve regeneration. In the <I>in vitro</I> study, we found the PR caused a marked enhancement of the nerve growth factor-mediated neurite outgrowth from PC12 cells as well as their expression of growth associated protein 43 and synapsin I. In the <I>in vivo</I> study, silicone rubber chambers filled with the PR water extract were used to bridge a 10-mm sciatic nerve defect in rats. At the conclusion of 8 weeks, regenerated nerves in the PR groups, especially at 1.25 mg ml<sup>&ndash;1</sup> had a higher rate of successful regeneration across the wide gap, relatively larger mean values of total nerve area, myelinated axon count and blood vessel number, and a significantly larger nerve conductive velocity compared to the control group (<I>P</I> &lt; 0.05). These results suggest that the PR extract can be a potential nerve growth-promoting factor, being salutary in aiding the growth of injured peripheral nerve.</p>
]]></description>
<dc:creator><![CDATA[Huang, K.-S., Lin, J.-G., Lee, H.-C., Tsai, F.-J., Bau, D.-T., Huang, C.-Y., Yao, C.-H., Chen, Y.-S.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 08:48:44 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep115</dc:identifier>
<dc:title><![CDATA[Paeoniae alba Radix Promotes Peripheral Nerve Regeneration]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep114v1?rss=1">
<title><![CDATA[Homeopathic Individualized Q-potencies versus Fluoxetine for Moderate to Severe Depression: Double-blind, Randomized Non-inferiority Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep114v1?rss=1</link>
<description><![CDATA[
<p>Homeopathy is a complementary and integrative medicine used in depression, The aim of this study is to investigate the non-inferiority and tolerability of individualized homeopathic medicines [Quinquagintamillesmial (Q-potencies)] in acute depression, using fluoxetine as active control. Ninety-one outpatients with moderate to severe depression were assigned to receive an individualized homeopathic medicine or fluoxetine 20 mg day<sup>&ndash;1</sup> (up to 40 mg day<sup>&ndash;1</sup>) in a prospective, randomized, double-blind double-dummy 8-week, single-center trial. Primary efficacy measure was the analysis of the mean change in the Montgomery &amp; &Aring;sberg Depression Rating Scale (MADRS) depression scores, using a non-inferiority test with margin of 1.45. Secondary efficacy outcomes were response and remission rates. Tolerability was assessed with the side effect rating scale of the Scandinavian Society of Psychopharmacology. Mean MADRS scores differences were not significant at the 4th (<I>P</I> = 0.654) and 8th weeks (<I>P</I> = 0.965) of treatment. Non-inferiority of homeopathy was indicated because the upper limit of the confidence interval (CI) for mean difference in MADRS change was less than the non-inferiority margin: mean differences (homeopathy&ndash;fluoxetine) were &ndash;3.04 (95% CI &ndash;6.95, 0.86) and &ndash;2.4 (95% CI &ndash;6.05, 0.77) at 4th and 8th week, respectively. There were no significant differences between the percentages of response or remission rates in both groups. Tolerability: there were no significant differences between the side effects rates, although a higher percentage of patients treated with fluoxetine reported troublesome side effects and there was a trend toward greater treatment interruption for adverse effects in the fluoxetine group. This study illustrates the feasibility of randomized controlled double-blind trials of homeopathy in depression and indicates the non-inferiority of individualized homeopathic Q-potencies as compared to fluoxetine in acute treatment of outpatients with moderate to severe depression.</p>
]]></description>
<dc:creator><![CDATA[Adler, U. C., Paiva, N. M. P., Cesar, A. T., Adler, M. S., Molina, A., Padula, A. E., Calil, H. M.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 08:48:43 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep114</dc:identifier>
<dc:title><![CDATA[Homeopathic Individualized Q-potencies versus Fluoxetine for Moderate to Severe Depression: Double-blind, Randomized Non-inferiority Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep113v1?rss=1">
<title><![CDATA[The Ayurveda Education in India: How Well are the Graduates Exposed to Basic Clinical Skills?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep113v1?rss=1</link>
<description><![CDATA[
<p>&lsquo;Ayurveda&rsquo; is an ancient system of healthcare that is native to India. At present, in India, there are more than 240 colleges that offer a graduate-level degree (Bachelor of Ayurvedic Medicine and Surgery&mdash;BAMS) in Ayurveda. Even though the Central Council of Indian Medicine, the governing body that monitors the matters related to Ayurveda education, has imposed various educational norms and regulations, the standard of education has been a cause of concern in recent years. The mushrooming of substandard Ayurvedic colleges is the most important factor that is being held responsible for this kind of erosion in the standards. The present study is a mailed survey, which was carried out to evaluate the &lsquo;Extent of exposure to basic clinical skills during BAMS course&rsquo; as perceived by the sample groups of students and teachers drawn from 32 Ayurvedic educational institutions spread all over India. A methodically validated questionnaire was used as the tool in the study, to which 1022 participants responded. The study indicates that there are some serious flaws in the existing system of the graduate-level Ayurveda education. Since the Ayurvedic graduates play an important role in the primary healthcare delivery system of the country, governing bodies are required to take necessary steps to ensure the adequate exposure of the students to basic clinical skills. Along with the strict implementation of all the regulatory norms during the process of recognition of the colleges, introducing some changes in the policy model may also be required to tackle the situation.</p>
]]></description>
<dc:creator><![CDATA[Patwardhan, K., Gehlot, S., Singh, G., Rathore, H. C. S.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 08:48:43 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep113</dc:identifier>
<dc:title><![CDATA[The Ayurveda Education in India: How Well are the Graduates Exposed to Basic Clinical Skills?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep110v1?rss=1">
<title><![CDATA[Changes of Blood Flow Volume in the Superior Mesenteric Artery and Brachial Artery with Abdominal Thermal Stimulation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep110v1?rss=1</link>
<description><![CDATA[
<p>In traditional Chinese medicine, moxibustion is a local thermal therapy that is used for several conditions. Quantifying the effects of moxibustion therapy has been difficult because the treatment temperature depends on the physician's experience, and the temperature distribution in the target area is not uniform. This prospective observational study aims to quantify the effect of local thermal stimulation to the abdomen. We developed a heat transfer control device (HTCD) for local thermal stimulation. Twenty-four healthy subjects were enrolled and they underwent abdominal thermal stimulation to the para-umbilical region with the device for 20 min. Blood flow volume in the superior mesenteric artery (SMA) and brachial artery (BA), the heart rate and the blood pressure were measured at rest, 15 min after starting thermal stimulation and 10, 20, 30 and 40 min after completing thermal stimulation. Blood flow parameters were measured by high-resolution ultrasound. In the SMA, blood flow volume was significantly increased during thermal stimulation (<I>P</I> &lt; 0.01), as well as at 10 min (<I>P</I> &lt; 0.01) and 20 min (<I>P</I> &lt; 0.05) after stimulation. In the BA, blood flow volume decreased at 40 min after stimulation (<I>P</I> &lt; 0.01). In conclusion we could quantify the effect of local thermal stimulation with an HTCD and high-resolution ultrasound. Thermal stimulation of the para-umbilical region increased blood flow in the SMA 20 min after stimulation in healthy subjects.</p>
]]></description>
<dc:creator><![CDATA[Takayama, S., Seki, T., Watanabe, M., Takashima, S., Sugita, N., Konno, S., Takeda, T., Arai, H., Yambe, T., Yaegashi, N., Yoshizawa, M., Maruyama, S., Nitta, S.-I.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 08:48:42 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep110</dc:identifier>
<dc:title><![CDATA[Changes of Blood Flow Volume in the Superior Mesenteric Artery and Brachial Artery with Abdominal Thermal Stimulation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep108v1?rss=1">
<title><![CDATA[Review of Pharmacological Effects of Antrodia camphorata and its Bioactive Compounds]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep108v1?rss=1</link>
<description><![CDATA[
<p><I>Antrodia camphorata</I> is a unique mushroom of Taiwan, which has been used as a traditional medicine for protection of diverse health-related conditions. In an effort to translate this Eastern medicine into Western-accepted therapy, a great deal of work has been carried out on <I>A. camphorata</I>. This review discusses the biological activities of the crude extracts and the main bioactive compounds of <I>A. camphorata</I>. The list of bioactivities of crude extracts is huge, ranging from anti-cancer to vasorelaxation and others. Over 78 compounds consisting of terpenoids, benzenoids, lignans, benzoquinone derivatives, succinic and maleic derivatives, in addition to polysaccharides have been identified. Many of these compounds were evaluated for biological activity. Many activities of crude extracts and pure compounds of <I>A. camphorata</I> against some major diseases of our time, and thus, a current review is of great importance. It is concluded that <I>A. camphorata</I> can be considered as an efficient alternative phytotherapeutic agent or a synergizer in the treatment of cancer and other immune-related diseases. However, clinical trails of human on <I>A. camphorata</I> extracts are limited and those of pure compounds are absent. The next step is to produce some medicines from <I>A. camphorata</I>, however, the production may be hampered by problems related to mass production.</p>
]]></description>
<dc:creator><![CDATA[Geethangili, M., Tzeng, Y.-M.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 08:48:41 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep108</dc:identifier>
<dc:title><![CDATA[Review of Pharmacological Effects of Antrodia camphorata and its Bioactive Compounds]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-17</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep106v1?rss=1">
<title><![CDATA[The Use of Humor in Serious Mental Illness: A Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep106v1?rss=1</link>
<description><![CDATA[
<p>There is now a relatively good understanding of the broad range of direct and indirect effects of humor and laughter on perceptions, attitudes, judgments and emotions, which can potentially benefit the physical and psychological state. This article presents a review and discussion of the use of humor and laughter in treating people with serious mental illness, distinguishing between clinical papers on individual and group psychotherapy, and empirical research reports describing humor and laughter interventions. In spite of the exponential growth of the field over the last 30 years, I conclude that empirical studies are still lacking, the studies that do exist have major methodological shortcomings, and the field is in dire need of further investigation.</p>
]]></description>
<dc:creator><![CDATA[Gelkopf, M.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 08:48:40 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep106</dc:identifier>
<dc:title><![CDATA[The Use of Humor in Serious Mental Illness: A Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-17</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep105v1?rss=1">
<title><![CDATA[In vitro and In vivo Antibacterial Activity of Punica granatum Peel Ethanol Extract Against Salmonella]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep105v1?rss=1</link>
<description><![CDATA[
<p><I>Punica granatum</I> is commonly used in Korea as a traditional medicine for the treatment of pathogenic bacteria. In this study, we investigated the <I>in vitro</I> and <I>in vivo</I> antimicrobial activity of <I>P. granatum</I> peel EtOH extract (PGPE) against 16 strains of <I>Salmonella</I>. The minimal inhibitory concentrations of PGPE were in the range of 62.5&ndash;1000 &micro;g ml<sup>&ndash;1</sup>. In addition, the <I>in vivo</I> antibacterial activity of the PGPE extract was examined in a <I>S. typhimurium</I> infection mouse model. Mice were initially infected with <I>S. typhimurium</I> and then with PGPE. The extract was found to have significant effects on mortality and the numbers of viable <I>S. typhimurium</I> recovered from feces. Although clinical signs and histological damage were rarely observed in the treated mice, the untreated controls showed signs of lethargy and histological damage in the liver and spleen. Taken together, the results of this study indicate that PGPE has the potential to provide an effective treatment for salmonellosis.</p>
]]></description>
<dc:creator><![CDATA[Choi, J.-G., Kang, O.-H., Lee, Y.-S., Chae, H.-S., Oh, Y.-C., Brice, O.-O., Kim, M.-S., Sohn, D.-H., Kim, H.-S., Park, H., Shin, D.-W., Rho, J.-R., Kwon, D.-Y.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 08:48:40 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep105</dc:identifier>
<dc:title><![CDATA[In vitro and In vivo Antibacterial Activity of Punica granatum Peel Ethanol Extract Against Salmonella]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep103v1?rss=1">
<title><![CDATA[Electroacupuncture Zusanli (ST36) on Release of Nitric Oxide in the Gracile Nucleus and Improvement of Sensory Neuropathies in Zucker Diabetic Fatty Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep103v1?rss=1</link>
<description><![CDATA[
<p>The purpose of these studies was to examine the effects of electroacupuncture (EA) Zusanli (ST36) on release of nitric oxide (NO) in the gracile nucleus (GN) and determine if functional neuropathic changes were modified by EA ST36-induced NO in the nucleus in Zucker diabetic fatty (ZDF) rats. The foot withdrawal responses to mechanical, thermal and cold stimuli were measured before and after EA stimulation. A microdialysis probe was implanted in the GN and dialysate samples were collected 20 min before, during and after EA ST36. Total nitrate and nitrite (NO<f><SUB><I>x</I></SUB><sup>&ndash;</sup></f>) concentrations in the samples were quantified by using chemiluminescence. The baseline dialysate NO<f><SUB><I>x</I></SUB><sup>&ndash;</sup></f> concentrations in the GN were decreased in ZDF rats compared to lean control (LC) rats (<I>P</I> &lt; 0.05). In ZDF rats, dialysate NO<f><SUB><I>x</I></SUB><sup>&ndash;</sup></f> releases in the GN were markedly increased during EA ST36, whereas in LC rats, the releases were moderately enhanced at 20&ndash;40 min after EA ST36. The withdrawal latencies to mechanical, cold and thermal stimuli were significantly improved 20 min after EA ST36 both in LC and ZDF rats, but not altered by non-acupoint stimulation. The withdrawal latencies to EA ST36 were further potentiated by 3-morpholinyl-sydnoneimine and inhibited by N<sup>G</sup>-Propyl-<scp>l</scp>-arginine infused into the GN in ZDF rats (<I>P</I> &lt; 0.05). These results show that EA ST36 increases NO release in the GN, and NO in the nucleus modifies withdrawal latencies to mechanical, cold, and thermal nociception stimuli. Data suggest that EA ST36 induces NO release in the GN, which contributes to improvement of sensory neuropathies in rats.</p>
]]></description>
<dc:creator><![CDATA[Rong, P.-J., Ma, S.-X.]]></dc:creator>
<dc:date>Thu, 13 Aug 2009 06:50:33 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep103</dc:identifier>
<dc:title><![CDATA[Electroacupuncture Zusanli (ST36) on Release of Nitric Oxide in the Gracile Nucleus and Improvement of Sensory Neuropathies in Zucker Diabetic Fatty Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-08-13</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep094v1?rss=1">
<title><![CDATA[Utilization of Western Medicine and Traditional Chinese Medicine Services by Physicians and Their Relatives: The Role of Training Background]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep094v1?rss=1</link>
<description><![CDATA[
<p>Despite extensive efforts to improve the attitude and practice of physicians with respect to complementary and alternative medicine (CAM), the role of training background on physician's own utilization of mainstream Western medicine (WM) and CAM remains unclear. We aimed to compare personal utilizations of WM and traditional Chinese medicine (TCM) among doctors trained in WM only, TCM only or both. A retrospective population-based study was conducted using the 2004 Taiwan's National Health Insurance data. A total of 103 879 doctors and their relatives and 2 623 658 other adults with equivalent socioeconomic status were analyzed. Ambulatory care utilization of WM and TCM services was compared using the following three measures: probability of any use, number of visits and total annual expenditure. Doctors who were trained in Western medicine only (WMDs) had the highest WM use, followed by doctors who were trained in both (WMD-CMDs), while Chinese medicine-trained doctors (CMDs) had the lowest use. For TCM use, a reverse pattern was observed. Similar patterns were found among doctors&rsquo; relatives. Compared with other adults with equivalent socioeconomic status, both the CMDs and WMD-CMDs had a greater use of TCM services. For WM, although the WMDs&rsquo; probability and frequency of usage were similar to other adults, they incurred considerably higher expenditure. The use of WM and TCM by doctors and their relatives was significantly associated with the training background of the doctors. This highlights the importance of how increasing knowledge and understanding of other medical discipline may influence a practitioner's care-providing behaviors.</p>
]]></description>
<dc:creator><![CDATA[Huang, N., Chou, Y.-J., Chen, L.-S., Lee, C.-H., Wang, P.-J., Tsay, J.-H.]]></dc:creator>
<dc:date>Wed, 29 Jul 2009 09:26:26 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep094</dc:identifier>
<dc:title><![CDATA[Utilization of Western Medicine and Traditional Chinese Medicine Services by Physicians and Their Relatives: The Role of Training Background]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep088v1?rss=1">
<title><![CDATA[S-Petasin, the Main Sesquiterpene of Petasites formosanus, Inhibits Phosphodiesterase Activity and Suppresses Ovalbumin-induced Airway Hyperresponsiveness]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep088v1?rss=1</link>
<description><![CDATA[
<p><I>S</I>-Petasin is the main sesquiterpene of <I>Petasites formosanus</I>, a traditional folk medicine used to treat hypertension, tumors and asthma in Taiwan. The aim of the present study was to investigate its inhibitory effects on phosphodiesterase (PDE) 1&ndash;5, and on ovalbumin (OVA)-induced airway hyperresponsiveness (AHR) in a murine model of allergic asthma. S-Petasin concentration-dependently inhibited PDE3 and PDE4 activities with 50% inhibitory concentrations (IC<SUB>50</SUB>) of 25.5, and 17.5 &micro;M, respectively. According to the Lineweaver&ndash;Burk analysis, <I>S</I>-petasin competitively inhibited PDE3 and PDE4 activities with respective dissociation constants for inhibitor binding (<I>K</I><SUB>i</SUB>) of 25.3 and 18.1 &micro;M, respectively. Both IC<SUB>50</SUB> and <I>K</I><SUB>i</SUB> values for PDE3 were significantly greater than those for PDE4. <I>S</I>-Petasin [10&ndash;30 &micro;mol/kg, administered subcutaneously (s.c.)] dose-dependently and significantly attenuated the enhanced pause (<I>P</I><SUB>enh</SUB>) value induced by methacholine (MCh) in sensitized and challenged mice. It also significantly suppressed the increases in total inflammatory cells, lymphocytes, neutrophils, eosinophils and levels of cytokines, including interleukin (IL)-2, IL-4 and IL-5, tumor necrosis factor (TNF)- and interferon (IFN)- in bronchoalveolar lavage fluid (BALF) of these mice. In addition, <I>S</I>-petasin (10&ndash;30 &micro;mol/kg, s.c.) dose-dependently and significantly attenuated total and OVA-specific immunoglobulin E (IgE) levels in the serum and BALF, and enhanced the IgG<SUB>2a</SUB> level in serum of these mice. The PDE4<SUB>H</SUB> value of <I>S</I>-petasin was &gt;300 &micro;M; therefore, its PDE4<SUB>H</SUB>/PDE4<SUB>L</SUB> value was calculated to be &gt;17. In conclusion, the present results for <I>S</I>-petasin at least partially explain why <I>Petasites formosanus</I> is used as a folk medicine to treat asthma in Taiwan.</p>
]]></description>
<dc:creator><![CDATA[Shih, C.-H., Huang, T.-J., Chen, C.-M., Lin, Y.-L., Ko, W.-C.]]></dc:creator>
<dc:date>Wed, 29 Jul 2009 09:26:25 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep088</dc:identifier>
<dc:title><![CDATA[S-Petasin, the Main Sesquiterpene of Petasites formosanus, Inhibits Phosphodiesterase Activity and Suppresses Ovalbumin-induced Airway Hyperresponsiveness]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep091v2?rss=1">
<title><![CDATA[Eleucine indica Possesses Antioxidant, Antibacterial and Cytotoxic Properties]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep091v2?rss=1</link>
<description><![CDATA[
<p>The use of evidence-based complementary and alternative medicine is increasing rapidly. <I>Eleucine indica</I> (EI) is traditionally used in ailments associated with liver and kidneys. The therapeutic benefit of the medicinal plants is often attributed to their antioxidant properties. Therefore, the aim of this study was to screen the hexane, dicholoromethane, ethyl acetate (EA) and methanol extracts (MeTH) of EI for their antioxidant, antibacterial and anti-cancer effects using total phenolic contents (TPCs) and DPPH, disc diffusion method and MTT cytotoxicity assays, respectively. The MeTH was showed to have the highest TPC and scavenging activity (77.7%) on DPPH assay, followed by EA (64.5%), hexane (47.19%) and DCM (40.83%) extracts, whereas the MeTH showed no inhibitory effect on all tested bacteria strains. However, the EA extract exhibited a broad spectrum antibacterial activity against all tested bacteria except <I>Bacillus subtilis</I>, in which this bacterium was found to be resistant to all EI extracts. Meanwhile, hexane extract was demonstrated to have a remarkable antibacterial activity against methicillin resistant <I>Staphylococcus aureus</I> (MRSA) and <I>Pseudomonas aeruginosa</I>, while the dicholoromethane extract did not exhibit significant activity against <I>P. aeruginosa</I>. None of the extracts showed significant cytotoxic activity towards MCF-7, HT-29 and CEM-SS human cancer cell lines after 72 h incubation time (IC<SUB>50</SUB> &gt; 30 &micro;g/ml). These results demonstrate that the extract prepared from the EI possesses antioxidant activity <I>in vitro</I> in addition to antibacterial properties. Further investigations are needed to verify the antioxidant effects <I>in vitro</I> and <I>in vivo</I>.</p>
]]></description>
<dc:creator><![CDATA[Al-Zubairi, A. S., Abdul, A. B., Abdelwahab, S. I., Peng, C. Y., Mohan, S., Elhassan, M. M.]]></dc:creator>
<dc:date>Fri, 24 Jul 2009 04:12:38 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep091</dc:identifier>
<dc:title><![CDATA[Eleucine indica Possesses Antioxidant, Antibacterial and Cytotoxic Properties]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep089v1?rss=1">
<title><![CDATA[Keishibukuryogan Reduces Renal Injury in the Early Stage of Renal Failure in the Remnant Kidney Model]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep089v1?rss=1</link>
<description><![CDATA[
<p>The effects of keishibukuryogan on the early stage of progressive renal failure were examined in rats subjected to 5/6 nephrectomy. Keishibukuryogan, one of the traditional herbal formulations, was given orally at a dose of 1% (w/w) and 3% (w/w) in chow. Administration of keishibukuryogan was started at 1 week after 5/6 nephrectomy and was continued for 4 weeks. At the end of the experiment, Azan staining did not reveal any severe histological changes in the kidneys of the nephrectomized rats. On the other hand, significant increases in mRNA expressions of transforming growth factor-&beta;<SUB>1</SUB> and fibronectin related to tissue fibrosis, as examined by Reverse Transcriptase-Polymerase Chain Reaction, were observed in nephrectomized rats, and they were significantly suppressed by 3% keishibukuryogan treatment. Against gene expressions related to macrophage infiltration, 3% keishibukuryogan treatment significantly suppressed osteopontin mRNA levels, and monocyte chemoattractant protein-1 and vascular cell adhesion molecule-1 mRNA levels showed a tendency to decrease, but without statistical significance. It was also observed that 3% keishibukuryogan attenuated serum urea nitrogen and urinary protein excretion levels. From these results, it was suggested that keishibukuryogan exerts beneficial effects that result in slowing the progression of chronic renal failure.</p>
]]></description>
<dc:creator><![CDATA[Nakagawa, T., Tashiro, I., Fujimoto, M., Jo, M., Sakai, S., Oka, H., Goto, H., Shimada, Y., Shibahara, N.]]></dc:creator>
<dc:date>Fri, 24 Jul 2009 04:12:38 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep089</dc:identifier>
<dc:title><![CDATA[Keishibukuryogan Reduces Renal Injury in the Early Stage of Renal Failure in the Remnant Kidney Model]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep083v1?rss=1">
<title><![CDATA[Comparative Analysis of Gelsemine and Gelsemium sempervirens Activity on Neurosteroid Allopregnanolone Formation in the Spinal Cord and Limbic System]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep083v1?rss=1</link>
<description><![CDATA[
<p>Centesimal dilutions (5, 9 and 15 cH) of <I>Gelsemium sempervirens</I> are claimed to be capable of exerting anxiolytic and analgesic effects. However, basic results supporting this assertion are rare, and the mechanism of action of <I>G. sempervirens</I> is completely unknown. To clarify the point, we performed a comparative analysis of the effects of dilutions 5, 9 and 15 cH of <I>G. sempervirens</I> or gelsemine (the major active principle of <I>G. sempervirens</I>) on allopregnanolone (3,5-THP) production in the rat limbic system (hippocampus and amygdala or H-A) and spinal cord (SC). Indeed, H-A and SC are two pivotal structures controlling, respectively, anxiety and pain that are also modulated by the neurosteroid 3,5-THP. At the dilution 5 cH, both <I>G. sempervirens</I> and gelsemine stimulated [<sup>3</sup>H]progesterone conversion into [<sup>3</sup>H]3,5-THP by H-A and SC slices, and the stimulatory effect was fully (100%) reproducible in all assays. The dilution 9 cH of <I>G. sempervirens</I> or gelsemine also stimulated 3,5-THP formation in H-A and SC but the reproducibility rate decreased to 75%. At 15 cH of <I>G. sempervirens</I> or gelsemine, no effect was observed on 3,5-THP neosynthesis in H-A and SC slices. The stimulatory action of <I>G</I>. s<I>empervirens</I> and gelsemine (5 cH) on 3,5-THP production was blocked by strychnine, the selective antagonist of glycine receptors. Altogether, these results, which constitute the first basic demonstration of cellular effects of <I>G. sempervirens</I>, also offer interesting possibilities for the improvement of <I>G. sempervirens</I>-based therapeutic strategies.</p>
]]></description>
<dc:creator><![CDATA[Venard, C., Boujedaini, N., Mensah-Nyagan, A. G., Patte-Mensah, C.]]></dc:creator>
<dc:date>Thu, 23 Jul 2009 08:24:36 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep083</dc:identifier>
<dc:title><![CDATA[Comparative Analysis of Gelsemine and Gelsemium sempervirens Activity on Neurosteroid Allopregnanolone Formation in the Spinal Cord and Limbic System]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-23</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep090v1?rss=1">
<title><![CDATA[Fermented Wheat Germ Extract (Avemar) in the Treatment of Cardiac Remodeling and Metabolic Symptoms in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep090v1?rss=1</link>
<description><![CDATA[
<p>Avemar, a product of industrial fermentation of wheat germ with a standardized content of benzoquinone and plant flavonoids, has been tested as an anti-cancer and immunomodulatory dietary supplement. Proposed mechanisms include anti-oxidant and anti-inflammatory actions. This study has determined whether these actions of Avemar may also be useful in the treatment of cardiovascular diseases. Two experimental rat models of cardiovascular remodeling were used in this project: the deoxycorticosterone acetate (DOCA)-salt-induced model of chronic hypertension (study I) and a high-carbohydrate/high-fat diet-induced model producing chronic symptoms of the metabolic syndrome and its associated cardiovascular complications (study II). Our results in these rat models of hypertension and diet-induced obesity show that treatment with Avemar improved cardiac function, decreased macrophage infiltration resulting in decreased collagen deposition in the ventricular myocardium, reversed an increased stiffness of the left ventricle in the diseased hearts and attenuated increased plasma malondialdehyde concentrations. In addition to the changes in the heart, Avemar reversed glucose intolerance, normalized systolic blood pressure and decreased visceral fat deposition in rats fed a high-fat/high-carbohydrate diet. In conclusion, the fermented wheat germ extract Avemar has a potential role in attenuating chronic hypertension, diabetes or metabolic syndrome-induced cardiovascular symptoms along with metabolic abnormalities such as glucose tolerance and obesity.</p>
]]></description>
<dc:creator><![CDATA[Iyer, A., Brown, L.]]></dc:creator>
<dc:date>Tue, 21 Jul 2009 06:23:56 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep090</dc:identifier>
<dc:title><![CDATA[Fermented Wheat Germ Extract (Avemar) in the Treatment of Cardiac Remodeling and Metabolic Symptoms in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-21</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep064v1?rss=1">
<title><![CDATA[The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep064v1?rss=1</link>
<description><![CDATA[
<p>Abundant research has mapped the inflammatory pathways leading to autoimmunity and neuroinflammatory disorders. The latest T helper to be identified, Th17, through its proinflammatory cytokine IL-17, plays a pathogenic role in many inflammatory conditions. Today, healthcare providers have a wealth of anti-inflammatory agents from which to choose. On one hand, pharmaceutical companies market brand-name drugs direct to the public and physicians. Medical botanical knowledge, on the other hand, has been passed down from generation to generation. The demands for natural healing therapies have brought corresponding clinical and laboratory research studies to elucidate the medicinal properties of alternative practices. With a variety of options, it can be difficult to pinpoint the proper anti-inflammatory agent for each case presented. In this review, the authors highlight a vast array of anti-inflammatory medicaments ranging from drugs to vitamins and from botanicals to innate molecules. This compilation may serve as a guide for complimentary and alternative healthcare providers who need to target neuroinflammation driven by Th17 and its inflammatory cytokine IL-17. By understanding the mechanisms of anti-inflammatory agents, CAM practitioners can tailor therapeutic interventions to fit the needs of the patient, thereby providing faster relief from inflammatory complaints.</p>
]]></description>
<dc:creator><![CDATA[Vojdani, A., Lambert, J., Kellermann, G.]]></dc:creator>
<dc:date>Tue, 21 Jul 2009 06:23:54 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep064</dc:identifier>
<dc:title><![CDATA[The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-21</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep063v1?rss=1">
<title><![CDATA[The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep063v1?rss=1</link>
<description><![CDATA[
<p>Decades of research went into understanding the role that Th1 autoreactive T-cells play in neuroinflammation. Here we describe another effector population, the IL-17-producing T-helper lineage (Th17), which drives the inflammatory process. Through the recruitment of inflammatory infiltration neutrophils and the activation of matrix metalloproteinases, IL-17, a cytokine secreted by Th17 cells, contributes to blood&ndash;brain barrier breakdown and the subsequent attraction of macrophages and monocytes into the nervous system. The entry of cells along with the local production of inflammatory cytokines leads to myelin and axonal damage. This activation of the inflammatory response system is induced by different pathogenic factors, such as gut bacterial endotoxins resulting in progressive neurodegeneration by Th17 cells. Through the understanding of the role of bacterial endotoxins and other pathogenic factors in the induction of autoimmune diseases by Th17 cells, CAM practitioners will be able to design CAM therapies targeting IL-17 activity. Targeted therapy can restore the integrity of the intestinal and blood&ndash;brain barriers using probiotics, <I>N</I>-acetyl-cysteine, -lipoic acid, resveratrol and others for their patients with autoimmunities, in particular those with neuroinflammation and neurodegeneration.</p>
]]></description>
<dc:creator><![CDATA[Vojdani, A., Lambert, J.]]></dc:creator>
<dc:date>Tue, 21 Jul 2009 06:23:53 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep063</dc:identifier>
<dc:title><![CDATA[The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-21</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep062v1?rss=1">
<title><![CDATA[The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep062v1?rss=1</link>
<description><![CDATA[
<p>CD4<sup>+</sup> effector cells, based on cytokine production, nuclear receptors and signaling pathways, have been categorized into four subsets. T-helper-1 cells produce IFN-, TNF-&beta;, lymphotoxin and IL-10; T-helper-2 cells produce IL-4, IL-5, IL-10, IL-13, IL-21 and IL-31; T-helper-3, or regulatory T-cells, produce IL-10, TGF-&beta; and IL-35; and the recently discovered T-helper-17 cell produces IL-17, IL-17A, IL-17F, IL-21, IL-26 and CCL20. By producing IL-17 and other signaling molecules, Th17 contributes to the pathogenesis of multiple autoimmune diseases including allergic inflammation, rheumatoid arthritis, autoimmune gastritis, inflammatory bowel disease, psoriasis and multiple sclerosis. In this article, we review the differential regulation of inflammation in different tissues with a major emphasis on enhancement of neuroinflammation by local production of IL-17 in the brain. By understanding the role of pathogenic factors in the induction of autoimmune diseases by Th17 cells, CAM practitioners will be able to design CAM therapies targeting Th17 and associated cytokine activities and signaling pathways to repair the intestinal and blood&ndash;brain barriers for their patients with autoimmunities, in particular, those with neuroinflammation and neurodegeneration.</p>
]]></description>
<dc:creator><![CDATA[Vojdani, A., Lambert, J.]]></dc:creator>
<dc:date>Tue, 21 Jul 2009 06:23:53 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep062</dc:identifier>
<dc:title><![CDATA[The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-21</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep051v1?rss=1">
<title><![CDATA[Recruitment and Early Retention of Women with Advanced Breast Cancer in a Complementary and Alternative Medicine Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep051v1?rss=1</link>
<description><![CDATA[
<p>More than 80% of women with breast cancer are now reported to be using complementary and alternative medicine (CAM) therapies during conventional treatment. A randomized clinical trial (RCT) of reflexology with late stage breast cancer patients serves as the data source for this article. The purposes were to investigate: (i) reasons for refusal to participate in a RCT of reflexology; (ii) the differences between those who completed the baseline interview and those who dropped out before baseline; and (iii) the utility of the Palliative Prognostic Score (PPS) as a prognostic screening tool in minimizing early attrition (before baseline) from the trial. Eligible women (<I>N</I> = 400) approached at 12 cancer centers in the Midwest had advanced breast cancer, were on chemotherapy or hormonal therapy, and had a PPS of 11 or less. Comparisons of those who dropped out early (<I>N</I> = 33) to those who stayed in the trial (<I>N</I> = 240) were carried out using Wilcoxon rank, <I>t</I>-, chi-squared and Fisher's exact tests. The reasons of being &lsquo;too sick&rsquo; or &lsquo;overwhelmed&rsquo; were given by less than 12% of the women who refused to participate. There was a higher early dropout rate among black women compared to other (primarily white) women (<I>P</I> = 0.01). Cancer recurrence and metastasis, age, and the PPS were not predictive of early retention of women. Specialized techniques may be needed to ensure black women remain in the trial once consented. Women with advanced disease were likely to enter and remain in the trial despite deterioration in health.</p>
]]></description>
<dc:creator><![CDATA[Sikorskii, A., Wyatt, G. K., Siddiqi, A.-e-A., Tamkus, D.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 02:22:21 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep051</dc:identifier>
<dc:title><![CDATA[Recruitment and Early Retention of Women with Advanced Breast Cancer in a Complementary and Alternative Medicine Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep093v1?rss=1">
<title><![CDATA[Suppression of Heregulin-{beta}1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep093v1?rss=1</link>
<description><![CDATA[
<p>Invasive breast cancer is the major cause of death among females and its incidence is closely linked to HER2 (human epidermal growth factor receptor 2) overexpression. Pterostilbene, a natural analog of resveratrol, exerts its cancer chemopreventive activity similar to resveratrol by inhibiting cancer cell proliferation and inducing apoptosis. However, the anti-invasive effect of pterostilbene on HER2-bearing breast cancer has not been evaluated. Here, we used heregulin-&beta;1 (HRG-&beta;1), a ligand for HER3, to transactivate HER2 signaling. We found that pterostilbene was able to suppress HRG-&beta;1-mediated cell invasion, motility and cell transformation of MCF-7 human breast carcinoma through down-regulation of matrix metalloproteinase-9 (MMP-9) activity and growth inhibition. In parallel, pterostilbene also inhibited protein and mRNA expression of MMP-9 driven by HRG-&beta;1, suggesting that pterostilbene decreased HRG-&beta;1-mediated MMP-9 induction via transcriptional regulation. Examining the signaling pathways responsible for HRG-&beta;1-associated MMP-9 induction and growth inhibition, we observed that pterostilbene, as well as SB203580 (p38 kinase inhibitor), can abolish the phosphorylation of p38 mitogen-activated protein kinase (p38 kinase), a downstream HRG-&beta;1-responsive kinase responsible for MMP-9 induction. In addition, HRG-&beta;1-driven Akt phosphorylation required for cell proliferation was also suppressed by pterostilbene. Taken together, our present results suggest that pterostilbene may serve as a chemopreventive agent to inhibit HRG-&beta;1/HER2-mediated aggressive and invasive phenotype of breast carcinoma through down-regulation of MMP-9, p38 kinase and Akt activation.</p>
]]></description>
<dc:creator><![CDATA[Pan, M.-H., Lin, Y.-T., Lin, C.-L., Wei, C.-S., Ho, C.-T., Chen, W.-J.]]></dc:creator>
<dc:date>Thu, 16 Jul 2009 21:51:18 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep093</dc:identifier>
<dc:title><![CDATA[Suppression of Heregulin-{beta}1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep084v1?rss=1">
<title><![CDATA[Modulation of Signal Proteins: A Plausible Mechanism to Explain How a Potentized Drug Secale Cor 30C Diluted beyond Avogadro's Limit Combats Skin Papilloma in Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep084v1?rss=1</link>
<description><![CDATA[
<p>In homeopathy, ability of ultra-high diluted drugs at or above potency 12C (diluted beyond Avogadro's limit) in ameliorating/curing various diseases is often questioned, particularly because the mechanism of action is not precisely known. We tested the hypothesis if suitable modulations of signal proteins could be one of the possible pathways of action of a highly diluted homeopathic drug, Secale cornutum 30C (diluted 10<sup>60</sup> times; Sec cor 30). It could successfully combat DMBA + croton oil-induced skin papilloma in mice as evidenced by histological, cytogenetical, immunofluorescence, ELISA and immunoblot findings. Critical analysis of several signal proteins like AhR, PCNA, Akt, Bcl-2, Bcl-xL, NF-kB and IL-6 and of pro-apoptotic proteins like cytochrome <I>c</I>, Bax, Bad, Apaf, caspase-3 and -9 revealed that Sec cor 30 suitably modulated their expression levels along with amelioration of skin papilloma. FACS data also suggested an increase of cell population at S and G2 phases and decrease in sub-G1 and G1 phages in carcinogen-treated drug-unfed mice, but these were found to be near normal in the Sec cor 30-fed mice. There was reduction in genotoxic and DNA damages in bone marrow cells of Sec Cor 30-fed mice, as revealed from cytogenetic and Comet assays. Changes in histological features of skin papilloma were noted. Immunofluorescence studies of AhR and PCNA also suggested reduced expression of these proteins in Sec cor 30-fed mice, thereby showing its anti-cancer potentials against skin papilloma. Furthermore, this study also supports the hypothesis that potentized homeopathic drugs act at gene regulatory level.</p>
]]></description>
<dc:creator><![CDATA[Khuda-Bukhsh, A. R., Bhattacharyya, S. S., Paul, S., Dutta, S., Boujedaini, N., Belon, P.]]></dc:creator>
<dc:date>Thu, 16 Jul 2009 21:51:16 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep084</dc:identifier>
<dc:title><![CDATA[Modulation of Signal Proteins: A Plausible Mechanism to Explain How a Potentized Drug Secale Cor 30C Diluted beyond Avogadro's Limit Combats Skin Papilloma in Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep075v1?rss=1">
<title><![CDATA[Ganoderma lucidum Protects Dopaminergic Neuron Degeneration Through Inhibition of Microglial Activation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep075v1?rss=1</link>
<description><![CDATA[
<p>Abundant evidence has suggested that neuroinflammation participates in the pathogenesis of Parkinson's disease (PD). The emerging evidence has supported that microglia may play key roles in the progressive neurodegeneration in PD and might be a promising therapeutic target. <I>Ganoderma lucidum</I> (GL), a traditional Chinese medicinal herb, has been shown potential neuroprotective effects in our clinical trials that make us to speculate that it might possess potent anti-inflammatory and immunomodulating properties. To test this hypothesis, we investigated the potential neuroprotective effect of GL and possible underlying mechanism of action through protecting microglial activation using co-cultures of dopaminergic neurons and microglia. The microglia is activated by LPS and MPP<sup>+</sup>-treated MES 23.5 cell membranes. Meanwhile, GL extracts significantly prevent the production of microglia-derived proinflammatory and cytotoxic factors [nitric oxide, tumor necrosis factor- (TNF-), interlukin 1&beta; (IL-1&beta;)] in a dose-dependent manner and down-regulate the TNF- and IL-1&beta; expressions on mRNA level as well. In conclusion, our results support that GL may be a promising agent for the treatment of PD through anti-inflammation.</p>
]]></description>
<dc:creator><![CDATA[Zhang, R., Xu, S., Cai, Y., Zhou, M., Zuo, X., Chan, P.]]></dc:creator>
<dc:date>Thu, 16 Jul 2009 21:51:14 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep075</dc:identifier>
<dc:title><![CDATA[Ganoderma lucidum Protects Dopaminergic Neuron Degeneration Through Inhibition of Microglial Activation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep074v1?rss=1">
<title><![CDATA[Ginseng (Panax quinquefolius) and Licorice (Glycyrrhiza uralensis) Root Extract Combinations Increase Hepatocarcinoma Cell (Hep-G2) Viability]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep074v1?rss=1</link>
<description><![CDATA[
<p>The combined cytoactive effects of American ginseng (<I>Panax quinquefolius</I>) and licorice (<I>Glycyrrhiza uralensis</I>) root extracts were investigated in a hepatocarcinoma cell line (Hep-G2). An isobolographic analysis was utilized to express the possibility of synergistic, additive or antagonistic interaction between the two extracts. Both ginseng and licorice roots are widely utilized in traditional Chinese medicine preparations to treat a variety of ailments. However, the effect of the herbs in combination is currently unknown in cultured Hep-G2 cells. Ginseng (GE) and licorice (LE) extracts were both able to reduce cell viability. The LC50 values, after 72 h, were found to be 0.64 &plusmn; 0.02 mg/ml (GE) and 0.53 &plusmn; 0.02 mg/ml (LE). An isobologram was plotted, which included five theoretical LC50s calculated, based on the fixed fraction method of combination ginseng to licorice extracts to establish a line of additivity. All combinations of GE to LE (1/5, 1/3, 1/2, 2/3, 4/5) produced an effect on Hep-G2 cell viability but they were all found to be antagonistic. The LC50 of fractions 1/3, 1/2, 2/3 were 23%, 21% and 18% above the theoretical LC50. Lactate dehydrogenase release indicated that as the proportion of GE to LE increased beyond 50%, the influence on membrane permeability increased. Cell-cycle analysis showed a slight but significant arrest at the G1 phase of cell cycle for LE. Both GE and LE reduced Hep-G2 viability independently; however, the combinations of both extracts were found to have an antagonistic effect on cell viability and increased cultured Hep-G2 survival.</p>
]]></description>
<dc:creator><![CDATA[Popovich, D. G., Yeo, S. Y., Zhang, W.]]></dc:creator>
<dc:date>Thu, 16 Jul 2009 21:51:12 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep074</dc:identifier>
<dc:title><![CDATA[Ginseng (Panax quinquefolius) and Licorice (Glycyrrhiza uralensis) Root Extract Combinations Increase Hepatocarcinoma Cell (Hep-G2) Viability]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep078v1?rss=1">
<title><![CDATA[KIOM-79, an Inhibitor of AGEs-Protein Cross-linking, Prevents Progression of Nephropathy in Zucker Diabetic Fatty Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep078v1?rss=1</link>
<description><![CDATA[
<p>Advanced glycation end products (AGEs) have been implicated in the development of diabetic complications, including diabetic nephropathy. KIOM-79, an 80% ethanolic extract obtained from parched Puerariae Radix, gingered Magnolia Cortex, Glycyrrhiza Radix and Euphorbia Radix, was investigated for its effects on the development of renal disease in Zucker diabetic fatty rats, an animal model of type 2 diabetes. <I>In vitro</I> inhibitory effect of KIOM-79 on AGEs cross-linking was examined by enzyme-linked immunosorbent assay (ELISA). KIOM-79 (50 mg/kg/day) was given to Zucker diabetic fatty rats for 13 weeks. Body and kidney weight, blood glucose, glycated hemoglobin, urinary albumin and creatinine excretions were monitored. Kidney histopathology, collagen accumulation, fibrinogen and transforming growth factor-beta 1 (TGF-&beta;1) expression were also examined. KIOM-79 reduced blood glucose, kidney weight, histologic renal damage and albuminuria in Zucker diabetic fatty rats. KIOM-79 prevented glomerulosclerosis, tubular degeneration, collagen deposition and podocyte apoptosis. In the renal cortex, TGF-&beta;1, fibronectin mRNA and protein were significantly reduced by KIOM-79 treatment. KIOM-79 reduces AGEs accumulation <I>in vivo</I>, AGE&ndash;protein cross-linking and protein oxidation. KIOM-79 could be beneficial in preventing the progression of diabetic glomerularsclerosis in type 2 diabetic rats by attenuating AGEs deposition in the glomeruli.</p>
]]></description>
<dc:creator><![CDATA[Kim, Y. S., Kim, J., Kim, C.-S., Sohn, E. J., Lee, Y. M., Jeong, I.-H., Kim, H., Jang, D. S., Kim, J. S.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 08:13:02 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep078</dc:identifier>
<dc:title><![CDATA[KIOM-79, an Inhibitor of AGEs-Protein Cross-linking, Prevents Progression of Nephropathy in Zucker Diabetic Fatty Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-15</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep077v1?rss=1">
<title><![CDATA[Seasonality Role on the Phenolics from Cultivated Baccharis dracunculifolia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep077v1?rss=1</link>
<description><![CDATA[
<p><I>Baccharis dracunculifolia</I> is the source of Brazilian green propolis (BGP). Considering the broad spectrum of biological activities attributed to green proplis, <I>B. dracunculifolia</I> has a great potential for the development of new cosmetic and pharmaceutical products. In this work, the cultivation of 10 different populations of native <I>B. dracunculifolia</I> had been undertaken aiming to determine the role of seasonality on its phenolic compounds. For this purpose, fruits of this plant were collected from populations of 10 different regions, and 100 individuals of each population were cultivated in an experimental area of 1800 m<sup>2</sup>. With respect to cultivation, the yields of dry plant, essential oil and crude extract were measured monthly resulting in mean values of 399 &plusmn; 80 g, 0.6 &plusmn; 0.1% and 20 &plusmn; 4%, respectively. The HPLC analysis allowed detecting seven phenolic compounds: caffeic acid, ferulic acid, aromadendrin-4'-methyl ether (AME), isosakuranetin, artepillin C, baccharin and 2-dimethyl-6-carboxyethenyl-2H-1-benzopyran acid, which were the major ones throughout the 1-year monthly analysis. Caffeic acid was detected in all cultivated populations with mean of 4.0%. AME displayed the wide variation in relation to other compounds showing means values of 0.65 &plusmn; 0.13% at last quarter. Isosakuranetin and artepillin C showed increasing concentrations with values between 0% and 1.4% and 0% and 1.09%, respectively. The obtained results allow suggesting that the best time for harvesting this plant, in order to obtain good qualitative and quantitative results for these phenolic compounds, is between December and April.</p>
]]></description>
<dc:creator><![CDATA[de Sousa, J. P. B., Leite, M. F., Jorge, R. F., Resende, D. O., da Silva Filho, A. A., Furtado, N. A. J. C., Soares, A. E. E., Spadaro, A. C. C., de Magalhaes, P. M., Bastos, J. K.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 08:13:01 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep077</dc:identifier>
<dc:title><![CDATA[Seasonality Role on the Phenolics from Cultivated Baccharis dracunculifolia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-15</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep069v2?rss=1">
<title><![CDATA[The Budding Yeast 'Saccharomyces cerevisiae' as a Drug Discovery Tool to Identify Plant-Derived Natural Products with Anti-Proliferative Properties]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep069v2?rss=1</link>
<description><![CDATA[
<p>The budding yeast <I>Saccharomyces cerevisiae</I> is a valuable system to study cell-cycle regulation, which is defective in cancer cells. Due to the highly conserved nature of the cell-cycle machinery between yeast and humans, yeast studies are directly relevant to anticancer-drug discovery. The budding yeast is also an excellent model system for identifying and studying antifungal compounds because of the functional conservation of fungal genes. Moreover, yeast studies have also contributed greatly to our understanding of the biological targets and modes of action of bioactive compounds. Understanding the mechanism of action of clinically relevant compounds is essential for the design of improved second-generation molecules. Here we describe our methodology for screening a library of plant-derived natural products in yeast in order to identify and characterize new compounds with anti-proliferative properties.</p>
]]></description>
<dc:creator><![CDATA[Qaddouri, B., Guaadaoui, A., Bellirou, A., Hamal, A., Melhaoui, A., Brown, G. W., Bellaoui, M.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 08:33:50 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep069</dc:identifier>
<dc:title><![CDATA[The Budding Yeast 'Saccharomyces cerevisiae' as a Drug Discovery Tool to Identify Plant-Derived Natural Products with Anti-Proliferative Properties]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-15</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep072v1?rss=1">
<title><![CDATA[Assessment of the Antioxidant and Reactive Oxygen Species Scavenging Activity of Methanolic Extract of Caesalpinia crista Leaf]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep072v1?rss=1</link>
<description><![CDATA[
<p>&lsquo;Oxidative stress&rsquo; is initiated by reactive oxygen species (ROS), which are responsible for majority of the diseases. However, antioxidants with ROS scavenging ability may have great relevance in the prevention of oxidative stress. The present study was undertaken, using a 70% methanolic extract of <I>Caesalpinia crista</I> leaves, to examine different <I>in vitro</I> tests in diversified fields including total antioxidant activity, scavenging activities for various ROS, iron chelating activity and phenolic and flavonoid contents. Total antioxidant activity was evaluated as trolox equivalent antioxidant capacity value of 0.546 &plusmn; 0.014. The extract was investigated for different ROS scavenging activities and IC<SUB>50</SUB> values were found to be 0.44 &plusmn; 0.1 mg/ml, 24.9 &plusmn; 0.98 &micro;g/ml, 33.72 &plusmn; 0.85 &micro;g/ml, 61.13 &plusmn; 3.24 &micro;g/ml and 170.51 &plusmn; 4.68 &micro;g/ml for hydroxyl, superoxide, nitric oxide, singlet oxygen and hypochlorous acid, respectively; however, no significant results were obtained in scavenging of hydrogen peroxide and peroxynitrite anion. The extract was found to be a potent iron chelator with IC<SUB>50</SUB> = 279.85 &plusmn; 4.72 &micro;g/ml. The plant extract (100 mg) yielded 50.23 &plusmn; 0.003 mg/ml gallic acid equivalent phenolic content and 106.83 &plusmn; 0.0003 mg/ml quercetin equivalent flavonoid content. In the <I>in vivo</I> experiments, the extract treatment showed significant increase in the level of superoxide dismutase, catalase, glutathione-<I>S</I>-transferase and reduced glutathione. In a word, it may be concluded that 70% methanol extract of <I>C. crista</I> leaves acts as an antioxidant and ROS scavenger; which may be due to the presence of phenolic and flavonoid compounds.</p>
]]></description>
<dc:creator><![CDATA[Mandal, S., Hazra, B., Sarkar, R., Biswas, S., Mandal, N.]]></dc:creator>
<dc:date>Mon, 13 Jul 2009 07:49:23 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep072</dc:identifier>
<dc:title><![CDATA[Assessment of the Antioxidant and Reactive Oxygen Species Scavenging Activity of Methanolic Extract of Caesalpinia crista Leaf]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-13</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep067v1?rss=1">
<title><![CDATA[Traditional Medicinal Plant Extracts and Natural Products with Activity Against Oral Bacteria: Potential Application in the Prevention and Treatment of Oral Diseases]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep067v1?rss=1</link>
<description><![CDATA[
<p>Oral diseases are major health problems with dental caries and periodontal diseases among the most important preventable global infectious diseases. Oral health influences the general quality of life and poor oral health is linked to chronic conditions and systemic diseases. The association between oral diseases and the oral microbiota is well established. Of the more than 750 species of bacteria that inhabit the oral cavity, a number are implicated in oral diseases. The development of dental caries involves acidogenic and aciduric Gram-positive bacteria (mutans streptococci, lactobacilli and actinomycetes). Periodontal diseases have been linked to anaerobic Gram-negative bacteria (<I>Porphyromonas gingivalis</I>, <I>Actinobacillus</I>, <I>Prevotella</I> and <I>Fusobacterium</I>). Given the incidence of oral disease, increased resistance by bacteria to antibiotics, adverse affects of some antibacterial agents currently used in dentistry and financial considerations in developing countries, there is a need for alternative prevention and treatment options that are safe, effective and economical. While several agents are commercially available, these chemicals can alter oral microbiota and have undesirable side-effects such as vomiting, diarrhea and tooth staining. Hence, the search for alternative products continues and natural phytochemicals isolated from plants used as traditional medicines are considered as good alternatives. In this review, plant extracts or phytochemicals that inhibit the growth of oral pathogens, reduce the development of biofilms and dental plaque, influence the adhesion of bacteria to surfaces and reduce the symptoms of oral diseases will be discussed further. Clinical studies that have investigated the safety and efficacy of such plant-derived medicines will also be described.</p>
]]></description>
<dc:creator><![CDATA[Palombo, E. A.]]></dc:creator>
<dc:date>Mon, 13 Jul 2009 07:49:21 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep067</dc:identifier>
<dc:title><![CDATA[Traditional Medicinal Plant Extracts and Natural Products with Activity Against Oral Bacteria: Potential Application in the Prevention and Treatment of Oral Diseases]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-13</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep082v1?rss=1">
<title><![CDATA[Bufalin Induces Reactive Oxygen Species Dependent Bax Translocation and Apoptosis in ASTC-a-1 Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep082v1?rss=1</link>
<description><![CDATA[
<p>Bufalin has been shown to induce cancer cell death through apoptotic pathways. However, the molecular mechanisms are not well understood. In this study, we used the confocal fluorescence microscopy (CFM) to monitor the spatio-temporal dynamics of reactive oxygen species (ROS) production, Bax translocation and caspase-3 activation during bufalin-induced apoptosis in living human lung adenocarcinoma (ASTC-a-1) cells. Bufalin induced ROS production and apoptotic cell death, demonstrated by Hoechst 33258 staining as well as flow cytometry analysis. Bax redistributed from cytosol to mitochondria from 12 to 48 h after bufalin treatment in living cells expressed with green fluorescent protein Bax. Treatment with the antioxidant <I>N</I>-acetyl-cysteine (NAC), a ROS scavenger, inhibited ROS generation and Bax translocation and led to a significant protection against bufalin-induced apoptosis. Our results also revealed that bufalin induced a prominent increase of caspase-3 activation blocked potently by NAC. Taken together, bufalin induced ROS-mediated Bax translocation, mitochondrial permeability transition and caspase-3 activation, implying that bufalin induced apoptosis via ROS-dependent mitochondrial death pathway in ASTC-a-1 cells.</p>
]]></description>
<dc:creator><![CDATA[Sun, L., Chen, T., Wang, X., Chen, Y., Wei, X.]]></dc:creator>
<dc:date>Fri, 10 Jul 2009 07:10:50 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep082</dc:identifier>
<dc:title><![CDATA[Bufalin Induces Reactive Oxygen Species Dependent Bax Translocation and Apoptosis in ASTC-a-1 Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep081v1?rss=1">
<title><![CDATA[Intestinal Anti-inflammatory Activity of Baccharis dracunculifolia in the Trinitrobenzenesulphonic Acid Model of Rat Colitis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep081v1?rss=1</link>
<description><![CDATA[
<p><I>Baccharis dracunculifolia</I> DC (Asteraceae) is a Brazilian medicinal plant popularly used for its antiulcer and anti-inflammatory properties. This plant is the main botanical source of Brazilian green propolis, a natural product incorporated into food and beverages to improve health. The present study aimed to investigate the chemical profile and intestinal anti-inflammatory activity of <I>B. dracunculifolia</I> extract on experimental ulcerative colitis induced by trinitrobenzenosulfonic acid (TNBS). Colonic damage was evaluated macroscopically and biochemically through its evaluation of glutathione content and its myeloperoxidase (MPO) and alkaline phosphatase activities. Additional <I>in vitro</I> experiments were performed in order to test the antioxidant activity by inhibition of induced lipid peroxidation in the rat brain membrane. Phytochemical analysis was performed by HPLC using authentic standards. The administration of plant extract (5 and 50 mg kg<sup>&ndash;1</sup>) significantly attenuated the colonic damage induced by TNBS as evidenced both macroscopically and biochemically. This beneficial effect can be associated with an improvement in the colonic oxidative status, since plant extract prevented glutathione depletion, inhibited lipid peroxidation and reduced MPO activity. Caffeic acid, <I>p</I>-coumaric acid, aromadendrin-4-<I>O</I>-methyl ether, 3-prenyl-<I>p</I>-coumaric acid, 3,5-diprenyl-<I>p</I>-coumaric acid and baccharin were detected in the plant extract.</p>
]]></description>
<dc:creator><![CDATA[Cestari, S. H., Bastos, J. K., Di Stasi, L. C.]]></dc:creator>
<dc:date>Fri, 10 Jul 2009 07:10:50 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep081</dc:identifier>
<dc:title><![CDATA[Intestinal Anti-inflammatory Activity of Baccharis dracunculifolia in the Trinitrobenzenesulphonic Acid Model of Rat Colitis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep071v1?rss=1">
<title><![CDATA[Investigation of Electroacupuncture and Manual Acupuncture on Carnitine and Glutathione in Muscle]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep071v1?rss=1</link>
<description><![CDATA[
<p>Electroacupuncture (EA) and manual acupuncture (MA) have therapeutic effects on muscle fatigue in muscle disease. The deficiencies of carnitine and glutathione induce muscle fatigue. This report investigated the effects of EA and MA on carnitine and glutathione in muscle. After the mice of EA group were fixed in the animal cage, right Zusanli (ST36) and Jiexi (ST41) were acupunctured and stimulated with uniform reinforcing and reducing method by twirling the acupuncture needle for 15 min. And then, the needle handles were connected to an electric stimulator for stimulating the acupoint with dense-sparse waves. After the mice of MA group were fixed in an animal cage, right ST36 and ST41 were acupunctured and allowed for 15 min. The mice of normal control group were not acupunctured and stimulated for 15 min. The mice of all groups were killed for collecting muscle tissue 1 h after the final treatment. Carnitine and glutathione in homogenate of muscle tissue were determined with carnitine (Kainos Laboratories Co., Tokyo, Japan) and glutathione assay kit (Dojin Chemicals Co., Kumamoto, Japan). Carnitine level in muscle tissue of MA group was significantly higher than those of EA group and normal control group. Carnitine level in muscle tissue of EA group was not significantly different from that of normal control group. Glutathione levels in muscle tissue of EA group and MA group were significantly higher than that of normal control group. This report presented that carnitine in muscle is increased by MA, and not increased by EA, and that glutathione in muscle is increased by EA and MA.</p>
]]></description>
<dc:creator><![CDATA[Toda, S.]]></dc:creator>
<dc:date>Fri, 10 Jul 2009 07:10:49 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep071</dc:identifier>
<dc:title><![CDATA[Investigation of Electroacupuncture and Manual Acupuncture on Carnitine and Glutathione in Muscle]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep070v1?rss=1">
<title><![CDATA[Ethanol Extract of Fructus Schisandrae Decreases Hepatic Triglyceride Level in Mice Fed with a High Fat/Cholesterol Diet, with Attention to Acute Toxicity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep070v1?rss=1</link>
<description><![CDATA[
<p>Effects of the ethanol extract of Fructus Schisandrae (EtFSC) on serum and liver lipid contents were investigated in mice fed with high fat/cholesterol (HFC) diet for 8 or 15 days. The induction of hypercholesterolemia by HFC diet caused significant increases in serum and hepatic total cholesterol (TC) levels (up to 62% and 165%, respectively) and hepatic triglyceride (TG) levels (up to 528%) in mice. EtFSC treatment (1 or 5 g/kg/day for 7 days; from Day 1 to 7 or from Day 8 to 14, i.g.) significantly decreased the hepatic TG level (down to 35%) and slightly increased the hepatic index (by 8%) in hypercholesterolemic mice. Whereas fenofibrate treatment (0.1 g/kg/day for 7 days, i.g.) significantly lowered the hepatic TG level (by 61%), it elevated the hepatic index (by 77%) in hypercholesterolemic mice. Acute toxicity test showed that EtFSC was relatively non-toxic, with an LD<SUB>50</SUB> value of 35.63 &plusmn; 6.46 g/kg in mice. The results indicate that EtFSC treatment can invariably decrease hepatic TG in hypercholesterolemic mice, as assessed by both preventive and therapeutic protocols, suggesting its potential use for fatty liver treatment.</p>
]]></description>
<dc:creator><![CDATA[Pan, S.-Y., Yu, Z.-L., Dong, H., Xiang, C.-J., Fong, W.-F., Ko, K.-M.]]></dc:creator>
<dc:date>Fri, 10 Jul 2009 07:10:48 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep070</dc:identifier>
<dc:title><![CDATA[Ethanol Extract of Fructus Schisandrae Decreases Hepatic Triglyceride Level in Mice Fed with a High Fat/Cholesterol Diet, with Attention to Acute Toxicity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep068v1?rss=1">
<title><![CDATA[North American (Panax quinquefolius) and Asian Ginseng (Panax ginseng) Preparations for Prevention of the Common Cold in Healthy Adults: A Systematic Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep068v1?rss=1</link>
<description><![CDATA[
<p>Background: Standardized ginseng extract has become the best-selling cold and flu remedy in Canada, yet much controversy regarding the efficacy of ginseng in preventing common colds remains. Objective: To assess the efficacy of ginseng preparations for the prevention of common colds in healthy adults. Methods: Comprehensive bibliographic database, trial registry and grey literature searches were conducted up to December 2007. Randomized controlled trials or controlled clinical trials comparing North American (<I>Panax quinquefolius</I>) or Asian ginseng (<I>Panax ginseng</I>) root extract to placebo or no treatment in healthy adults were included. Two reviewers independently applied the study selection criteria and assessed methodological quality. Results: Five trials involving 747 participants were included. All five trials examined North American ginseng. The methodological quality of the trials varied widely. Ginseng preparations significantly reduced the total number of common colds by 25% compared to placebo (one trial; 95% CI: 5&ndash;45). There was a tendency toward a lower incidence of having at least one common cold or other acute respiratory infection (ARI) in the ginseng group compared to the placebo group (five trials; relative risk: 0.70; 95% CI: 0.48&ndash;1.02). Compared to placebo, ginseng significantly shortened the duration of colds or ARIs by 6.2 days (two trials; 95% CI: 3.4&ndash;9.0). Conclusions: There is insufficient evidence to conclude that ginseng reduces the incidence or severity of common colds. North American ginseng appears to be effective in shortening the duration of colds or ARIs in healthy adults when taken preventatively for durations of 8&ndash;16 weeks.</p>
]]></description>
<dc:creator><![CDATA[Seida, J. K., Durec, T., Kuhle, S.]]></dc:creator>
<dc:date>Fri, 10 Jul 2009 07:10:48 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep068</dc:identifier>
<dc:title><![CDATA[North American (Panax quinquefolius) and Asian Ginseng (Panax ginseng) Preparations for Prevention of the Common Cold in Healthy Adults: A Systematic Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep066v1?rss=1">
<title><![CDATA[8-Prenylkaempferol Suppresses Influenza A Virus-Induced RANTES Production in A549 Cells via Blocking PI3K-Mediated Transcriptional Activation of NF-{kappa}B and IRF3]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep066v1?rss=1</link>
<description><![CDATA[
<p>8-Prenylkaempferol (8-PK) is a prenylflavonoid isolated from <I>Sophora flavescens</I>, a Chinese herb with antiviral and anti-inflammatory properties. In this study, we investigated its effect on regulated activation, normal T cell expressed and secreted (RANTES) secretion by influenza A virus (H1N1)-infected A549 alveolar epithelial cells. Cell inoculation with H1N1 evoked a significant induction in RANTES accumulation accompanied with time-related increase in nuclear translocation of nuclear factor-B (NF-B) and interferon regulatory factor 3 (IRF-3), but showed no effect on c-Jun phosphorylation. 8-PK could significantly inhibit not only RANTES production but also NF-B and IRF-3 nuclear translocation. We had proved that both NF-B and IRF-3 participated in H1N1-induced RANTES production since NF-B inhibitor pyrrolidinedithio carbamate (PDTC) and IRF-3 siRNA attenuated significantly RANTES accumulation. H1N1 inoculation also increased PI3K activity as well as Akt phosphorylation and such responsiveness were attenuated by 8-PK. In the presence of wortmannin, nuclear translocation of NF-B and IRF3 as well as RANTES production by H1N1 infection were all reversed, demonstrating that PI3K&ndash;Akt pathway is essential for NF-B- and IRF-3-mediated RANTES production in A549 cells. Furthermore, 8-PK but not wortmannin, prevented effectively H1N1-evoked IB degradation. In conclusion, 8-PK might be an anti-inflammatory agent for suppressing influenza A virus-induced RANTES production acts by blocking PI3K-mediated transcriptional activation of NF-B and IRF-3 and in part by interfering with IB degradation which subsequently decreases NF-B translocation.</p>
]]></description>
<dc:creator><![CDATA[Chiou, W.-F., Chen, C.-C., Wei, B.-L.]]></dc:creator>
<dc:date>Fri, 10 Jul 2009 07:10:47 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep066</dc:identifier>
<dc:title><![CDATA[8-Prenylkaempferol Suppresses Influenza A Virus-Induced RANTES Production in A549 Cells via Blocking PI3K-Mediated Transcriptional Activation of NF-{kappa}B and IRF3]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep080v1?rss=1">
<title><![CDATA[Effective Control of Type 2 Diabetes through Antioxidant Defense by Edible Fruits of Diospyros peregrina]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep080v1?rss=1</link>
<description><![CDATA[
<p>The matured fruits of <I>Diospyros peregrina</I> are successfully employed by the traditional healers and local people of costal West Bengal, India for the treatment of diabetes. Present investigation was undertaken to evaluate the role of hydroalcoholic extract of <I>D. peregrina</I> (HDP) on type 2 diabetes as well as the augmented oxidative stresses associated with it. Oral administration of HDP at 25, 50 and 100 mg kg<sup>&ndash;1</sup> body weight per day to diabetic rats was found to possess significant dose-dependent hypoglycemic and hypolipidemic activity. The diabetic rats showed lower activities of superoxide dismutase (SOD), catalase (CAT) and reduced glutathione (GSH) content in hepatic and renal tissues as compared to normal rats. The activities of SOD, CAT and GSH were found to be increased in extract-treated diabetic rats in selected tissues. The increased level of lipid peroxidation (thiobarbituric acid reactive substances) in diabetic rats was also found to be reverted back to near normal status in extract-treated groups. Thus it may be concluded that the HDP may produce its hypoglycemic effect through antioxidant defense mechanism.</p>
]]></description>
<dc:creator><![CDATA[Dewanjee, S., Maiti, A., Sahu, R., Dua, T. K., Mandal, V.]]></dc:creator>
<dc:date>Tue, 07 Jul 2009 00:28:44 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep080</dc:identifier>
<dc:title><![CDATA[Effective Control of Type 2 Diabetes through Antioxidant Defense by Edible Fruits of Diospyros peregrina]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep073v1?rss=1">
<title><![CDATA[Maternal Baicalin Treatment Increases Fetal Lung Surfactant Phospholipids in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep073v1?rss=1</link>
<description><![CDATA[
<p>Baicalin is a flavonoid compound purified from the medicinal plant <I>Scutellaria baicalensis</I> Georgi and has been reported to stimulate surfactant protein (SP)-A gene expression in human lung epithelial cell lines (H441). The aims of this study were to determine whether maternal baicalin treatment could increase lung surfactant production and induce lung maturation in fetal rats. This study was performed with timed pregnant Sprague&ndash;Dawley rats. One-day baicalin group mothers were injected intraperitoneally with baicalin (5 mg/kg/day) on Day 18 of gestation. Two-day baicalin group mothers were injected intraperitoneally with baicalin (5 mg/kg/day) on Days 17 and 18 of gestation. Control group mothers were injected with vehicle alone on Day 18 of gestation. On Day 19 of gestation, fetuses were delivered by cesarean section. Maternal treatment with 2-day baicalin significantly increased saturated phospholipid when compared with control group and total phospholipid in fetal lung tissue when compared with control and 1-day baicalin groups. Antenatal treatment with 2-day baicalin significantly increased maternal growth hormone when compared with control group. Fetal lung SP-A mRNA expression and maternal serum corticosterone levels were comparable among the three experimental groups. Maternal baicalin treatment increases pulmonary surfactant phospholipids of fetal rat lungs and the improvement was associated with increased maternal serum growth hormone. These results suggest that antenatal baicalin treatment might accelerate fetal rat lung maturation.</p>
]]></description>
<dc:creator><![CDATA[Chen, C.-M., Wang, L.-F., Cheng, K.-T.]]></dc:creator>
<dc:date>Tue, 07 Jul 2009 00:28:43 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep073</dc:identifier>
<dc:title><![CDATA[Maternal Baicalin Treatment Increases Fetal Lung Surfactant Phospholipids in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep060v1?rss=1">
<title><![CDATA[Gastroprotective Effect of Ginger Rhizome (Zingiber officinale) Extract: Role of Gallic Acid and Cinnamic Acid in H+, K+-ATPase/H. pylori Inhibition and Anti-oxidative Mechanism]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep060v1?rss=1</link>
<description><![CDATA[
<p><I>Zinger officinale</I> has been used as a traditional source against gastric disturbances from time immemorial. The ulcer-preventive properties of aqueous extract of ginger rhizome (GRAE) belonging to the family Zingiberceae is reported in the present study. GRAE at 200 mg kg<sup>&ndash;1</sup> b.w. protected up to 86% and 77% for the swim stress-/ethanol stress-induced ulcers with an ulcer index (UI) of 50 &plusmn; 4.0/46 &plusmn; 4.0 respectively, similar to that of lansoprazole (80%) at 30 mg kg<sup>&ndash;1</sup> b.w. Increased H<sup>+</sup>, K<sup>+</sup>-ATPase activity and thiobarbituric acid reactive substances (TBARS) were observed in ulcer-induced rats, while GRAE fed rats showed normalized levels and GRAE also normalized depleted/amplified anti-oxidant enzymes in swim stress and ethanol stress-induced animals. Gastric mucin damage was recovered up to 77% and 74% in swim stress and ethanol stress, respectively after GRAE treatment. GRAE also inhibited the growth of <I>H. pylori</I> with MIC of 300 &plusmn; 38 &micro;g and also possessed reducing power, free radical scavenging ability with an IC<SUB>50</SUB> of 6.8 &plusmn; 0.4 &micro;g ml<sup>&ndash;1</sup> gallic acid equivalent (GAE). DNA protection up to 90% at 0.4 &micro;g was also observed. Toxicity studies indicated no lethal effects in rats fed up to 5 g kg<sup>&ndash;1</sup> b.w. Compositional analysis favored by determination of the efficacy of individual phenolic acids towards their potential ulcer-preventive ability revealed that between cinnamic (50%) and gallic (46%) phenolic acids, cinnamic acid appear to contribute to better H<sup>+</sup>, K<sup>+</sup>-ATPase and <I>Helicobacter pylori</I> inhibitory activity, while gallic acid contributes significantly to anti-oxidant activity.</p>
]]></description>
<dc:creator><![CDATA[Nanjundaiah, S. M., Annaiah, H. N. M., M.Dharmesh, S.]]></dc:creator>
<dc:date>Wed, 01 Jul 2009 09:25:47 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep060</dc:identifier>
<dc:title><![CDATA[Gastroprotective Effect of Ginger Rhizome (Zingiber officinale) Extract: Role of Gallic Acid and Cinnamic Acid in H+, K+-ATPase/H. pylori Inhibition and Anti-oxidative Mechanism]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep059v1?rss=1">
<title><![CDATA[Abnormal Savda Munziq, an Herbal Preparation of Traditional Uighur Medicine, may Prevent 1,2-dimethylhydrazine-induced Rat Colon Carcinogenesis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep059v1?rss=1</link>
<description><![CDATA[
<p>The study tried to assess the chemoprotective effect of abnormal Savda Munziq (ASMq) on 1,2-dimethylhydrazine (DMH)-induced rat colon carcinogenesis. Male F344 rats were randomized into eight groups: Group 1 was served as control, no DMH injection was given and treated daily with normal saline. Rats in Groups 2&ndash;8 were given a single intraperitoneal injection of DMH (20 mg/kg body weight) at the beginning of the study. Group 2 was served as negative control, administered with normal saline until the end of the experiment after the single DMH injection. Groups 3&ndash;5 were served as pretreatment group, administered with ASMq ethanol extract at 400, 800 and 1600 mg/kg body weight, respectively, until the 45th day, continued by normal saline administration for another 45 days. Groups 6&ndash;8 were served as the treatment group, administered with normal saline for the first 45 days from the day of DMH injection, ASMq ethanol extract at three different doses to be administered until the end of the second 45th day. All rats were sacrificed at 91st day and the colons were analyzed for aberrant crypt foci (ACF) formation and crypt multiplicity. Results showed that ASMq ethanol extract reduced the number of ACF, AC and crypt multiplicity significantly (<I>P</I> &lt; 0.05). It suggested that ASMq ethanol extract had chemoprotective effects on DMH-induced colon carcinogenesis, by suppressing the development of preneoplastic lesions, and probably exerted protection against the initiation and promotion steps of colon carcinogenesis.</p>
]]></description>
<dc:creator><![CDATA[Yusup, A., Upur, H., Umar, A., Berke, B., Yimit, D., Lapham, J. C., Moore, N., Cassand, P.]]></dc:creator>
<dc:date>Fri, 26 Jun 2009 08:53:19 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep059</dc:identifier>
<dc:title><![CDATA[Abnormal Savda Munziq, an Herbal Preparation of Traditional Uighur Medicine, may Prevent 1,2-dimethylhydrazine-induced Rat Colon Carcinogenesis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-26</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep061v1?rss=1">
<title><![CDATA[Podophyllum hexandrum-Mediated Survival Protection and Restoration of Other Cellular Injuries in Lethally Irradiated Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep061v1?rss=1</link>
<description><![CDATA[
<p>This study aims at the development of a safe and effective formulation to counter the effects of lethal irradiation. The sub-fraction (G-001M), prepared from <I>Podophyllum hexandrum</I> has rendered high degree of survival (&gt;90%) at a dose of 6 mg kg<sup>&ndash;1</sup> body weight (intramuscular) in lethally irradiated mice. Therapeutic dose of G-001M, at about 20 times lower concentration than its LD<SUB>100</SUB>, has revealed a DRF of 1.62. Comet assay studies in peripheral blood leukocytes have reflected that, treatment of G-001M before irradiation has significantly reduced DNA tail length (<I>P</I> &lt; 0.001) and DNA damage score (<I>P</I> &lt; 0.001), as compared to radiation-only group. Spleen cell counts in irradiated animals had declined drastically at the very first day of exposure, and the fall continued till the 5th day (<I>P</I> &lt; 0.001). In the treated irradiated groups, there was a steep reduction in the counts initially, but this phase did not prolong. More than 60% decline in thymocytes of irradiated group animals was registered at 5 h of irradiation when compared with controls, and the fall progressed further downwards with the similar pace till 5th day of exposure (<I>P</I> &lt; 0.001). At later intervals, thymus was found fully regressed. In G-001M pre-treated irradiated groups also, thymocytes decreased till the 5th day but thereafter rejuvenated and within 30 days of treatment the values were close to normal. Current studies have explicitly indicated that, G-001M in very small doses has not only rendered high survivability in lethally irradiated mice, but also protected their cellular DNA, besides supporting fast replenishment of the immune system.</p>
]]></description>
<dc:creator><![CDATA[Sankhwar, S., Gupta, M. L., Gupta, V., Verma, S., Suri, K. A., Devi, M., Sharma, P., Khan, E. A., Alam, M. S.]]></dc:creator>
<dc:date>Wed, 24 Jun 2009 08:11:13 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep061</dc:identifier>
<dc:title><![CDATA[Podophyllum hexandrum-Mediated Survival Protection and Restoration of Other Cellular Injuries in Lethally Irradiated Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep055v1?rss=1">
<title><![CDATA[Feldenkrais Method Balance Classes Improve Balance in Older Adults: A Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep055v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study was to investigate the effects of Feldenkrais Method balance classes on balance and mobility in older adults. This was a prospective non-randomized controlled study with pre/post measures. The setting for this study was the general community. A convenience sample of 26 community-dwelling older adults (median age 75 years) attending Feldenkrais Method balance classes formed the Intervention group. Thirty-seven volunteers were recruited for the Control group (median age 76.5 years). A series of Feldenkrais Method balance classes (the &lsquo;Getting Grounded Gracefully&rsquo; series), two classes per week for 10 weeks, were conducted. Main outcome measures were Activities-Specific Balance Confidence (ABC) questionnaire, Four Square Step Test (FSST), self- selected gait speed (using GAITRite<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> instrumented gait mat). At re-testing, the Intervention group showed significant improvement on all of the measures (ABC, <I>P</I> = 0.016, FSST, <I>P</I> = 0.001, gait speed, <I>P</I> &lt; 0.001). The Control group improved significantly on one measure (FSST, <I>P</I> &lt; 0.001). Compared to the Control group, the Intervention group made a significant improvement in their ABC score (<I>P</I> = 0.005), gait speed (<I>P</I> = 0.017) and FSST time (<I>P</I> = 0.022). These findings suggest that Feldenkrais Method balance classes may improve mobility and balance in older adults.</p>
]]></description>
<dc:creator><![CDATA[Connors, K. A., Galea, M. P., Said, C. M.]]></dc:creator>
<dc:date>Wed, 24 Jun 2009 08:11:11 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep055</dc:identifier>
<dc:title><![CDATA[Feldenkrais Method Balance Classes Improve Balance in Older Adults: A Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep039v1?rss=1">
<title><![CDATA[Evaluation of the Wound Healing Potential of Achillea biebersteinii Afan. (Asteraceae) by in vivo Excision and Incision Models]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep039v1?rss=1</link>
<description><![CDATA[
<p><I>Achillea</I> species are widely used for diarrhea, abdominal pain, stomachache and healing of wounds in folk medicine. To evaluate the wound healing activity of the plant, extracts were prepared with different solvents; hexane, chloroform, ethyl acetate and methanol, respectively from the roots of <I>Achillea biebersteinii</I>. Linear incision by using tensiometer and circular excision wound models were employed on mice and rats. The wound healing effect was comparatively evaluated with the standard skin ointment Madecassol&reg;. The n-hexane extract treated groups of animals showed 84.2% contraction, which was close to contraction value of the reference drug Madecassol&reg; (100%). On the other hand the same extract on incision wound model demonstrated a significant increase (40.1%) in wound tensile strength as compared to other groups. The results of histoptological examination supported the outcome of linear incision and circular excision wound models as well. The experimental data demonstrated that <I>A. biebersteinii</I> displayed remarkable wound healing activity.</p>
]]></description>
<dc:creator><![CDATA[Akkol, E. K., Koca, U., Pesin, I., Yilmazer, D.]]></dc:creator>
<dc:date>Mon, 22 Jun 2009 04:29:04 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep039</dc:identifier>
<dc:title><![CDATA[Evaluation of the Wound Healing Potential of Achillea biebersteinii Afan. (Asteraceae) by in vivo Excision and Incision Models]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-22</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep056v1?rss=1">
<title><![CDATA[Antihypertension Induced by Tanshinone IIA Isolated from the Roots of Salvia Miltiorrhiza]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep056v1?rss=1</link>
<description><![CDATA[
<p>Tanshinone IIA is one of the active principles in danshen (<I>Salvia miltiorrhiza</I> Bge) widely used in treatment of cardiovascular disorders. We investigated the effect of danshen or tanshinone IIA on blood pressure and its possible mechanisms. An i.p. injection of danshen at 10 mg kg<sup>&ndash;1</sup> significantly lowered systolic blood pressure (SBP) of spontaneously hypertensive rats (SHRs) but failed to modify the SBP in normotensive Wistar&ndash;Kyoto rats (WKY). Oral administration of tanshinone IIA also decreased SBP in SHR but not in WKY. Tanshinone IIA produced a concentration-dependent relaxation in isolated SHR aortic rings precontracted with phenylephrine (10 nmol l<sup>&ndash;1</sup>) or potassium chloride (KCl) (40 mmol l<sup>&ndash;1</sup>). The relaxing effect of tanshinone IIA on tonic contraction of phenylephrine in isolated aortic rings without endothelium remained produced. Glibenclamide at concentration sufficient to block adenosine triphosphatase (ATP)-sensitive potassium (K<sup>+</sup>) channel attenuated this tanshinone IIA-induced relaxation that was not influenced by other inhibitors. We further investigated the effect of tanshinone IIA on the changes of intracellular calcium concentration ([Ca<sup>2+</sup>]i) in cultured aortic smooth muscle (A7r5) cells using fura-2 as indicator. Tanshinone IIA decreased [Ca<sup>2+</sup>]i elicited by phenylephrine (10 nmol l<sup>&ndash;1</sup>) or KCl (40 mmol l<sup>&ndash;1</sup>) in a concentration-dependent manner; glibenclamide, but not other inhibitors for K<sup>+</sup> channel, abated this effect. Our results suggest that tanshinone IIA acts as an active principle of danshen showing vasodilation through ATP-sensitive K<sup>+</sup> channel to lower [Ca<sup>2+</sup>]i.</p>
]]></description>
<dc:creator><![CDATA[Chan, P., Liu, I-M., Li, Y.-X., Yu, W.-J., Cheng, J.-T.]]></dc:creator>
<dc:date>Fri, 19 Jun 2009 05:20:53 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep056</dc:identifier>
<dc:title><![CDATA[Antihypertension Induced by Tanshinone IIA Isolated from the Roots of Salvia Miltiorrhiza]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-19</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep057v1?rss=1">
<title><![CDATA[Cytotoxic Activities of Physalis minima L. Chloroform Extract on Human Lung Adenocarcinoma NCI-H23 Cell Lines by Induction of Apoptosis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep057v1?rss=1</link>
<description><![CDATA[
<p><I>Physalis minima</I> L. is reputed for having anticancer property. In this study, the chloroform extract of this plant exhibited remarkable cytotoxic activities on NCI-H23 (human lung adenocarcinoma) cell line at dose- and time-dependent manners (after 24, 48 and 72 h of incubation). Analysis of cell-death mechanism demonstrated that the extract exerted apoptotic programed cell death in NCI-H23 cells with typical DNA fragmentation, which is a biochemical hallmark of apoptosis. Morphological observation using transmission electron microscope (TEM) also displayed apoptotic characteristics in the treated cells, including clumping and margination of chromatins, followed by convolution of the nuclear and budding of the cells to produce membrane-bound apoptotic bodies. Different stages of apoptotic programed cell death as well as phosphatidylserine externalization were confirmed using annexin V and propidium iodide staining. Furthermore, acute exposure to the extract produced a significant regulation of c-myc, caspase-3 and p53 mRNA expression in this cell line. Due to its apoptotic effect on NCI-H23 cells, it is strongly suggested that the extract could be further developed as an anticancer drug.</p>
]]></description>
<dc:creator><![CDATA[Leong, O. K., Muhammad, T. S. T., Sulaiman, S. F.]]></dc:creator>
<dc:date>Thu, 18 Jun 2009 05:15:51 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep057</dc:identifier>
<dc:title><![CDATA[Cytotoxic Activities of Physalis minima L. Chloroform Extract on Human Lung Adenocarcinoma NCI-H23 Cell Lines by Induction of Apoptosis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-18</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep050v1?rss=1">
<title><![CDATA[Evaluation of influence of Acupuncture and Electro-acupuncture for Blood Perfusion of Stomach by Laser Doppler Blood Perfusion Imaging]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep050v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study is to observe effects of acupuncture and electro-acupuncture (EA) on blood perfusion in the stomach, and probe into the application of laser Doppler blood perfusion imaging technique in the study of the effect of acupuncture and moxibustion on the entrails. In the acupuncture group of 20 rats, acupuncture was given at &lsquo;Zusanli&rsquo; (ST 36) and in EA group of 18 rats, EA was applied at &lsquo;Zusanli&rsquo; (ST 36), with 18 rats without acupuncture used as control group. Changes of blood perfusion and microcirculation distribution in the stomach were investigated with laser Doppler blood perfusion imager (LDPI). The laser Doppler blood perfusion image could clearly display changes of blood flow distribution in the stomach before and after acupuncture. After acupuncture or EA was given at &lsquo;Zusanli&rsquo; (ST 36), the blood perfusion in the stomach increased significantly, the blood perfusion in the blood vessels and microcirculation of other parts significantly increased, and the maximum increase of the blood perfusion was found at 10 min after acupuncture or EA, with increases of 0.50 &plusmn; 0.11 (PU) and 0.66 &plusmn; 0.16 (PU), respectively, and the blood perfusion still kept at a higher degree within 10 min after ceasing of the acupuncture or EA. While the blood perfusion in the stomach in the rat of the control group tended to gradual decrease. It has been concluded that both acupuncture and EA can increase blood perfusion in the stomach, the EA having stronger action, and LDPI can display the regulative action of acupuncture on the blood vessel of the stomach by using an image.</p>
]]></description>
<dc:creator><![CDATA[Dong, Z., Shun-Yue, L., Shu-You, W., Hui-Min, M.]]></dc:creator>
<dc:date>Tue, 16 Jun 2009 09:27:49 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep050</dc:identifier>
<dc:title><![CDATA[Evaluation of influence of Acupuncture and Electro-acupuncture for Blood Perfusion of Stomach by Laser Doppler Blood Perfusion Imaging]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep053v1?rss=1">
<title><![CDATA[An Angiotensin I Converting Enzyme Polymorphism is Associated With Clinical Phenotype When Using Differentiation-Syndrome to Categorize Korean Bronchial Asthma Patients]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep053v1?rss=1</link>
<description><![CDATA[
<p>In this study, genetic analysis was conducted to investigate the association of angiotensin I converting enzyme (ACE) gene polymorphism with clinical phenotype based on differentiation-syndrome of bronchial asthma patients. Differentiation-syndrome is a traditional Korean medicine (TKM) theory in which patients are classified into a Deficiency Syndrome Group (DSG) and an Excess Syndrome Group (ESG) according to their symptomatic classification. For this study, 110 participants were evaluated by pulmonary function test. Among them, 39 patients were excluded because they refused genotyping. Of the remaining patients, 52 with DSG of asthma (DSGA) and 29 with ESG of asthma (ESGA), as determined by the differentiation-syndrome techniques were assessed by genetic analysis. ACE insertion/deletion (I/D) polymorphism analysis was conducted using polymerase chain reaction (PCR). Student's <I>t</I>, chi-square, Fisher and Hardy&ndash;Weinberg equilibrium tests were used to compare groups. No significant differences in pulmonary function were observed between DSGA and ESGA. The genotypic frequency of ACE I/D polymorphism was found to differ slightly between DSGA and ESGA (<I>P</I> = 0.0495). However, there were no significant differences in allelic frequency observed between DSGA and ESGA (<I>P</I> = 0.7006, <I>OR</I> = 1.1223). Interestingly, the allelic (<I>P</I> = 0.0043, <I>OR</I> = 3.4545) and genotypic (<I>P</I> = 0.0126) frequencies of the ACE I/D polymorphism in female patients differed significantly between DSGA and ESGA. Taken together, the results presented here indicate that the symptomatic classification of DSGA and ESGA by differentiation-syndrome in Korean asthma patients could be useful in evaluation of the pathogenesis of bronchial asthma.</p>
]]></description>
<dc:creator><![CDATA[Jung, S.-k., Ra, J., Seo, J., Jung, H.-J., Choi, J.-Y., Cho, Y.-J., Hong, M.-S., Chung, J.-H., Kim, J.]]></dc:creator>
<dc:date>Fri, 12 Jun 2009 06:31:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep053</dc:identifier>
<dc:title><![CDATA[An Angiotensin I Converting Enzyme Polymorphism is Associated With Clinical Phenotype When Using Differentiation-Syndrome to Categorize Korean Bronchial Asthma Patients]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-12</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep049v1?rss=1">
<title><![CDATA[Is Placebo Acupuncture What It is Intended to Be?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep049v1?rss=1</link>
<description><![CDATA[
<p>Randomized, placebo-controlled clinical trials are recommended for evaluation of a treatment's efficacy with the goal of separating the specific effects (verum) from the non-specific ones (placebo). In order to be able to carry out placebo-controlled acupuncture trials, minimal/sham acupuncture procedures and a sham acupuncture needle has been used with the intention of being inert. However, clinical and experimental results suggest that sham/minimal acupuncture is not inert since it is reported that both verum acupuncture and sham/minimal acupuncture induce a significant alleviation of pain. This alleviation is as pronounced as the alleviation obtained with standard treatment and more obvious than the one obtained with placebo medication or by the use of waiting list controls. These results also suggest that sham acupuncture needles evoke a physiological response. In healthy individuals sham acupuncture results in activation of limbic structures, whereas a deactivation is seen in patients with pain, i.e. results from healthy individuals do not reflect what is seen in clinical conditions. Also, depending on the etiology of pain (or any under clinical condition under investigation), the response to sham acupuncture is varying. The acupuncture ritual may also be seen as an emotional focused therapy allowing for psychological re-orientation. Sham needling in such context may be as powerful as verum acupuncture. We recommend that the evaluated effects of acupuncture could be compared with those of standard treatment, also taking the individual response into consideration, before its use or non-use is established.</p>
]]></description>
<dc:creator><![CDATA[Lundeberg, T., Lund, I., Sing, A., Naslund, J.]]></dc:creator>
<dc:date>Fri, 12 Jun 2009 06:31:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep049</dc:identifier>
<dc:title><![CDATA[Is Placebo Acupuncture What It is Intended to Be?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-12</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep052v1?rss=1">
<title><![CDATA[Preventive Effects of Salacia reticulata on Obesity and Metabolic Disorders in TSOD Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep052v1?rss=1</link>
<description><![CDATA[
<p>The extracts of <I>Salacia reticulata</I> (<I>Salacia</I> extract), a plant that has been used for the treatment of early diabetes, rheumatism and gonorrhea in Ayurveda, have been shown to have an anti-obesity effect and suppress hyperglycemia. In this study, the effects of <I>Salacia</I> extract on various symptoms of metabolic disorder were investigated and compared using these TSOD mice and non-obese TSNO mice. Body weight, food intake, plasma biochemistry, visceral and subcutaneous fat (X-ray and CT), glucose tolerance, blood pressure and pain tolerance were measured, and histopathological examination of the liver was carried out. A significant dose-dependent decline in the gain in body weight, accumulation of visceral and subcutaneous fat and an improvement of abnormal glucose tolerance, hypertension and peripheral neuropathy were noticed in TSOD mice. In addition, hepatocellular swelling, fatty degeneration of hepatocytes, inflammatory cell infiltration and single-cell necrosis were observed on histopathological examination of the liver in TSOD mice. <I>Salacia</I> extract markedly improved these symptoms upon treatment. Based on the above results, it is concluded that <I>Salacia</I> extract has remarkable potential to prevent obesity and associated metabolic disorders including the development of metabolic syndrome.</p>
]]></description>
<dc:creator><![CDATA[Akase, T., Shimada, T., Harasawa, Y., Akase, T., Ikeya, Y., Nagai, E., Iizuka, S., Nakagami, G., Iizaka, S., Sanada, H., Aburada, M.]]></dc:creator>
<dc:date>Mon, 08 Jun 2009 07:08:52 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep052</dc:identifier>
<dc:title><![CDATA[Preventive Effects of Salacia reticulata on Obesity and Metabolic Disorders in TSOD Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep048v1?rss=1">
<title><![CDATA[Looking for a Person-centered Medicine: Non Conventional Medicine in the Conventional European and Italian Setting]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep048v1?rss=1</link>
<description><![CDATA[
<p>In Italy, the use of non conventional medicines (NCMs) is spreading among people as in the rest of Europe. Sales of alternative remedies are growing, and likewise the number of medical doctors (MDs) who practise NCM/complementary and alternative medicine (CAM). However, in Italy as in other countries of the European Union, at the present time the juridical/legal status of NCM/CAM is not well established, mainly due to the lack of any national law regulating NCM/CAM professional training, practice and public supply and the absence of government-promoted scientific research in this field. This is an obstacle to safeguarding the patient's interests and freedom of choice, especially now that dissatisfaction with biomedicine is inclining more and more people to look for a holistic and patient-centered form of medicine.</p>
]]></description>
<dc:creator><![CDATA[Sarsina, P. R. d., Iseppato, I.]]></dc:creator>
<dc:date>Mon, 08 Jun 2009 07:08:50 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep048</dc:identifier>
<dc:title><![CDATA[Looking for a Person-centered Medicine: Non Conventional Medicine in the Conventional European and Italian Setting]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-08</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep047v1?rss=1">
<title><![CDATA[Exploring the Evidence Base for Acupuncture in the Treatment of Meniere's Syndrome--A Systematic Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep047v1?rss=1</link>
<description><![CDATA[
<p>M&eacute;ni&egrave;re's syndrome is a long-term, progressive disease that damages the balance and hearing parts of the inner ear. To address the paucity of information on which evidence-based treatment decisions should be made, a systematic review of acupuncture for M&eacute;ni&egrave;re's syndrome was undertaken. The method used was a systematic review of English and Chinese literature, from six databases for randomized, non-randomized and observational studies. All studies were critically appraised and a narrative approach to data synthesis was adopted. Twenty-seven studies were included in this review (9 in English and 18 in Chinese languages): three randomized controlled trials, three non-randomized controlled studies and four pre-test, post-test designs. All but one of the studies was conducted in China. The studies covered body acupuncture, ear acupuncture, scalp acupuncture, fluid acupuncture point injection and moxibustion. The studies were of varying quality. The weight of evidence, across all study types, is of beneficial effect from acupuncture, for those in an acute phase or those who have had M&eacute;ni&egrave;re's syndrome for a number of years. The review reinforces the importance of searching for studies from English and Chinese literature. The transferability of the findings from China to a Western context needs confirmation. Further research is also needed to clarify questions around the appropriate frequency and number of treatment/courses of acupuncture. The weight of evidence suggests a potential benefit of acupuncture for persons with M&eacute;ni&egrave;re's disease, including those in an acute phase and reinforces the importance of searching for published studies in the Chinese language.</p>
]]></description>
<dc:creator><![CDATA[Long, A. F., Xing, M., Morgan, K., Brettle, A.]]></dc:creator>
<dc:date>Mon, 08 Jun 2009 07:08:49 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep047</dc:identifier>
<dc:title><![CDATA[Exploring the Evidence Base for Acupuncture in the Treatment of Meniere's Syndrome--A Systematic Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep042v1?rss=1">
<title><![CDATA[Bioactivity of the Murex Homeopathic Remedy and of Extracts from an Australian Muricid Mollusc Against Human Cancer Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep042v1?rss=1</link>
<description><![CDATA[
<p>Marine molluscs from the family Muricidae are the source of a homeopathic remedy <I>Murex</I>, which is used to treat a range of conditions, including cancer. The aim of this study was to evaluate the <I>in vitro</I> bioactivity of egg mass extracts of the Australian muricid <I>Dicathais orbita</I>, in comparison to the <I>Murex</I> remedy, against human carcinoma and lymphoma cells. Liquid chromatography coupled with mass spectrometry (LC-MS) was used to characterize the chemical composition of the extracts and homeopathic remedy, focusing on biologically active brominated indoles. The MTS (tetrazolium salt) colorimetric assay was used to determine effects on cell viability, while necrosis and apoptosis induction were investigated using flow cytometry (propidium iodide and Annexin-V staining respectively). Cells were treated with varying concentrations (1&ndash;0.01 mg/ml) of crude and semi-purified extracts or preparations (dilute 1 M and concentrated 4 mg/ml) from the <I>Murex</I> remedy (4 h). The <I>Murex</I> remedy showed little biological activity against the majority of cell lines tested. In contrast, the <I>D. orbita</I> egg extracts significantly decreased cell viability in the majority of carcinoma cell lines. Flow cytometry revealed these extracts induce necrosis in HT29 colorectal cancer cells, whereas apoptosis was induced in Jurkat cells. These findings highlight the biomedical potential of Muricidae extracts in the development of a natural therapy for the treatment of neoplastic tumors and lymphomas.</p>
]]></description>
<dc:creator><![CDATA[Benkendorff, K., McIver, C. M., Abbott, C. A.]]></dc:creator>
<dc:date>Tue, 02 Jun 2009 05:04:52 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep042</dc:identifier>
<dc:title><![CDATA[Bioactivity of the Murex Homeopathic Remedy and of Extracts from an Australian Muricid Mollusc Against Human Cancer Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep045v1?rss=1">
<title><![CDATA[Meta-analysis of the Related Nutritional Supplements Dimethyl Sulfoxide and Methylsulfonylmethane in the Treatment of Osteoarthritis of the Knee]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep045v1?rss=1</link>
<description><![CDATA[
<p>Dimethyl sulphoxide and methylsulfonylmethane are two related nutritional supplements used for symptomatic relief of osteoarthritis (OA). We conducted a meta-analysis to evaluate their efficacy in reducing pain associated with OA. Randomized or quasi-randomized controlled trials (RCTs), identified by systematic electronic searches, citation tracking and searches of clinical trial registries, assessing these supplements in osteoarthritis of any joint were considered for inclusion. Meta-analysis, based on difference in mean pain related outcomes between treatment and comparator groups, was carried out based on a random effect model. Seven potential trials were identified of which three RCTs, two DMSO and one MSM (total <I>N</I> = 326 patients) were eligible for inclusion. All three trials were considered high methodological quality. A significant degree of heterogeneity (<sup>2</sup> = 6.28, <I>P</I> = 0.043) was revealed. Two studies demonstrated statistically significant (but not clinically relevant) reduction in pain compared with controls; with one showing no group difference. The meta-analysis confirmed a non significant reduction of pain on visual analogue scale of 6.34 mm (SE = 3.49, 95% CI, &ndash;0.49, 13.17). The overall effect size of 1.82 was neither statistically nor clinically significant. Current evidence suggests DMSO and MSM are not clinically effective in the reduction of pain in the treatment of OA. No definitive conclusions can currently be drawn from the data due to the mixed findings and the use of inadequate dosing periods.</p>
]]></description>
<dc:creator><![CDATA[Brien, S., Prescott, P., Lewith, G.]]></dc:creator>
<dc:date>Wed, 27 May 2009 08:29:49 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep045</dc:identifier>
<dc:title><![CDATA[Meta-analysis of the Related Nutritional Supplements Dimethyl Sulfoxide and Methylsulfonylmethane in the Treatment of Osteoarthritis of the Knee]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep043v1?rss=1">
<title><![CDATA[Dejian Mind-Body Intervention on Depressive Mood of Community-Dwelling Adults: A Randomized Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep043v1?rss=1</link>
<description><![CDATA[
<p>The present study evaluated the effectiveness of a short-term mind-body intervention program on improving the depressive mood of an adult community sample. Forty adult volunteers with various degrees of depressive mood were randomly assigned to the experimental group (<I>Dejian</I> Mind-Body Intervention, DMBI) and control group (Cognitive-Behavioral Therapy, CBT). For each group, a total of four 90-min weekly sessions were conducted. Treatment-related changes were measured using the Beck Depression Inventory (BDI-II), an electroencephalographic indicator of positive affect (i.e. prefrontal activation asymmetry), and self-report ratings on physical health. Results indicated that both the DMBI and the CBT group demonstrated significant reduction in depressive mood. However, among individuals with moderate to severe depressive mood at baseline, only those in the DMBI but not the CBT group showed significant reduction in depressive mood. Besides, only the DMBI group demonstrated a significant increase in prefrontal activation asymmetry, suggesting increase in positive affect. While most psychological therapies for depressive mood normally take several months to show treatment effect, the present findings provided initial data suggesting that the DMBI was effective in improving depressive mood of community adults after 1 month of training.</p>
]]></description>
<dc:creator><![CDATA[Chan, A. S., Cheung, M.-c., Tsui, W. J., Sze, S. L., Shi, D.]]></dc:creator>
<dc:date>Wed, 27 May 2009 08:29:48 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep043</dc:identifier>
<dc:title><![CDATA[Dejian Mind-Body Intervention on Depressive Mood of Community-Dwelling Adults: A Randomized Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep036v1?rss=1">
<title><![CDATA[Homeopathic Preparations of Quartz, Sulfur and Copper Sulfate Assessed by UV-Spectroscopy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep036v1?rss=1</link>
<description><![CDATA[
<p>Homeopathic preparations are used in homeopathy and anthroposophic medicine. Although there is evidence of effectiveness in several clinical studies, including double-blinded randomized controlled trials, their nature and mode of action could not be explained with current scientific approaches yet. Several physical methods have already been applied to investigate homeopathic preparations but it is yet unclear which methods are best suited to identify characteristic physicochemical properties of homeopathic preparations. The aim of this study was to investigate homeopathic preparations with UV-spectroscopy. In a blinded, randomized, controlled experiment homeopathic preparations of copper sulfate (CuSO<SUB>4</SUB>; 11c&ndash;30c), quartz (SiO<SUB>2</SUB>; 10c&ndash;30c, i.e. centesimal dilution steps) and sulfur (S; 11<FONT FACE="arial,helvetica">x</FONT>&ndash;30<FONT FACE="arial,helvetica">x</FONT>, i.e. decimal dilution steps) and controls (one-time succussed diluent) were investigated using UV-spectroscopy and tested for contamination by inductively coupled plasma mass spectrometry (ICP-MS). The UV transmission for homeopathic preparations of CuSO<SUB>4</SUB> preparations was significantly lower than in controls. The transmission seemed to be also lower for both SiO<SUB>2</SUB> and S, but not significant. The mean effect size (95% confidence interval) was similar for the homeopathic preparations: CuSO<SUB>4</SUB> (pooled data) 0.0544% (0.0260&ndash;0.0827%), SiO<SUB>2</SUB> 0.0323% (&ndash;0.0064% to 0.0710%) and S 0.0281% (&ndash;0.0520% to 0.1082%). UV transmission values of homeopathic preparations had a significantly higher variability compared to controls. In none of the samples the concentration of any element analyzed by ICP-MS exceeded 100 ppb. Lower transmission of UV light may indicate that homeopathic preparations are less structured or more dynamic than their succussed pure solvent.</p>
]]></description>
<dc:creator><![CDATA[Wolf, U., Wolf, M., Heusser, P., Thurneysen, A., Baumgartner, S.]]></dc:creator>
<dc:date>Wed, 27 May 2009 08:29:47 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep036</dc:identifier>
<dc:title><![CDATA[Homeopathic Preparations of Quartz, Sulfur and Copper Sulfate Assessed by UV-Spectroscopy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep038v1?rss=1">
<title><![CDATA[Searching for Controlled Trials of Complementary and Alternative Medicine: a Comparison of 15 Databases]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep038v1?rss=1</link>
<description><![CDATA[
<p>This project aims to assess the utility of bibliographic databases beyond the three major ones (MEDLINE, EMBASE and Cochrane CENTRAL) for finding controlled trials of complementary and alternative medicine (CAM). Fifteen databases were searched to identify controlled clinical trials (CCTs) of CAM not also indexed in MEDLINE. Searches were conducted in May 2006 using the revised Cochrane highly sensitive search strategy (HSSS) and the PubMed CAM Subset. Yield of CAM trials per 100 records was determined, and databases were compared over a standardized period (2005). The Acudoc2 RCT, Acubriefs, Index to Chiropractic Literature (ICL) and Hom-Inform databases had the highest concentrations of non-MEDLINE records, with more than 100 non-MEDLINE records per 500. Other productive databases had ratios between 500 and 1500 records to 100 non-MEDLINE records&mdash;these were AMED, MANTIS, PsycINFO, CINAHL, Global Health and Alt HealthWatch. Five databases were found to be unproductive: AGRICOLA, CAIRSS, Datadiwan, Herb Research Foundation and IBIDS. Acudoc2 RCT yielded 100 CAM trials in the most recent 100 records screened. Acubriefs, AMED, Hom-Inform, MANTIS, PsycINFO and CINAHL had more than 25 CAM trials per 100 records screened. Global Health, ICL and Alt HealthWatch were below 25 in yield. There were 255 non-MEDLINE trials from eight databases in 2005, with only 10% indexed in more than one database. Yield varied greatly between databases; the most productive databases from both sampling methods were Acubriefs, Acudoc2 RCT, AMED and CINAHL. Low overlap between databases indicates comprehensive CAM literature searches will require multiple databases.</p>
]]></description>
<dc:creator><![CDATA[Cogo, E., Sampson, M., Ajiferuke, I., Manheimer, E., Campbell, K., Daniel, R., Moher, D.]]></dc:creator>
<dc:date>Mon, 25 May 2009 06:47:51 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep038</dc:identifier>
<dc:title><![CDATA[Searching for Controlled Trials of Complementary and Alternative Medicine: a Comparison of 15 Databases]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep016v2?rss=1">
<title><![CDATA[Aqueous Extract of Shi-Liu-Wei-Liu-Qi-Yin Induces G2/M Phase Arrest and Apoptosis in Human Bladder Carcinoma Cells via Fas and Mitochondrial Pathway]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep016v2?rss=1</link>
<description><![CDATA[
<p>Shi-Liu-Wei-Liu-Qi-Yin (SLWLQY) was traditionally used to treat cancers. However, scientific evidence of the anticancer effects still remains undefined. In this study, we aimed to clarify the possible mechanisms of SLWLQY in treating cancer. We evaluated the effects of SLWLQY on apoptosis-related experiments inducing in TSGH-8301 cells by (i) 3-(4,5-dimethylthiazol-zyl)-2,5-diphenylterazolium bromide (MTT) for cytotoxicity; (ii) cell-cycle analysis and (iii) western blot analysis of the G2/M-phase and apoptosis regulatory proteins. Human bladder carcinoma TSGH-8301 cells were transplanted into BALB/c nude mice as a tumor model for evaluating the antitumor effect of SLWLQY. Treatment of SLWLQY resulted in the G2/M phase arrest and apoptotic death in a dose-dependent manner, accompanied by a decrease in cyclin-dependent kinases (cdc2) and cyclins (cyclin B1). SLWLQY stimulated increases in the protein expression of Fas and FasL, and induced the cleavage of caspase-3, caspase-9 and caspase-8. The ratio of Bax/Bcl<SUB>2</SUB> was increased by SLWLQY treatment. SLWLQY markedly reduced tumor size in TSGH-8301 cells-xenografted tumor tissues. In the tissue specimen, SLWLQY up-regulated the expression of Fas, FasL and Bax proteins, and down-regulated Bcl<SUB>2</SUB> as well as in <I>in vitro</I> assay. Our results showed that SLWLQY reduced tumor growth, caused cell-cycle arrest and apoptosis in TSGH-8301 cells via the Fas and mitochondrial pathway.</p>
]]></description>
<dc:creator><![CDATA[Ou, T.-T., Wang, C.-J., Hung, G.-U., Wu, C.-H., Lee, H.-J.]]></dc:creator>
<dc:date>Mon, 25 May 2009 06:47:50 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep016</dc:identifier>
<dc:title><![CDATA[Aqueous Extract of Shi-Liu-Wei-Liu-Qi-Yin Induces G2/M Phase Arrest and Apoptosis in Human Bladder Carcinoma Cells via Fas and Mitochondrial Pathway]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep044v1?rss=1">
<title><![CDATA[How Much of CAM is Based on Research Evidence?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep044v1?rss=1</link>
<description><![CDATA[
<p>The aim of this article is to provide a preliminary estimate of how much CAM is evidence-based. For this purpose, I calculated the percentage of 685 treatment/condition pairings evaluated in the &lsquo;Desktop Guide to Complementary and Alternative Medicine&rsquo; which ere supported by sound data. The resulting figure was 7.4%. For a range of reasons, it might be a gross over-estimate. Further investigations into this subject are required to arrive at more representative figures.</p>
]]></description>
<dc:creator><![CDATA[Ernst, E.]]></dc:creator>
<dc:date>Thu, 21 May 2009 23:09:00 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep044</dc:identifier>
<dc:title><![CDATA[How Much of CAM is Based on Research Evidence?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-21</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep040v1?rss=1">
<title><![CDATA[Changes in Attitudes of Japanese Doctors toward Complementary and Alternative Medicine--Comparison of Surveys in 1999 and 2005 in Kyoto]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep040v1?rss=1</link>
<description><![CDATA[
<p>We surveyed the attitudes of Japanese medical doctors toward complementary and alternative medicine (CAM) in 1999. It is supposed that the situation concerning CAM has been changing recently. The aim of the present study is to survey the attitude of doctors toward CAM again, and to examine changes in attitude over the last 6 years. The attitudes of medical doctors belonging to the Kyoto Medical Association toward CAM were surveyed by a structured, self-administered questionnaire in 1999 and 2005. The results showed that the doctors familiar with the term &lsquo;CAM&rsquo;, practicing CAM therapies, and attending meetings or training courses related with CAM, increased significantly from 1999 to 2005. The doctors who possessed knowledge of CAM also increased significantly from 1999 to 2005. Almost all doctors believed in the effectiveness of Kampo (Japanese traditional herbal medicine) and acupuncture. The number of doctors who believed in the effectiveness of aromatherapy and ayurveda increased significantly in 2005, compared with 1999. In the near future, 58% of doctors desired to practice CAM therapies. In conclusion, the numbers of doctors who practice CAM therapies, possess CAM knowledge and desire to practice such therapies have increased over the last 6 years in Japan.</p>
]]></description>
<dc:creator><![CDATA[Fujiwara, K., Imanishi, J., Watanabe, S., Ozasa, K., Sakurada, K.]]></dc:creator>
<dc:date>Thu, 21 May 2009 23:08:59 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep040</dc:identifier>
<dc:title><![CDATA[Changes in Attitudes of Japanese Doctors toward Complementary and Alternative Medicine--Comparison of Surveys in 1999 and 2005 in Kyoto]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-21</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep041v1?rss=1">
<title><![CDATA[Health-Beneficial Phenolic Aldehyde in Antigonon leptopus Tea]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep041v1?rss=1</link>
<description><![CDATA[
<p>Tea prepared from the aerial parts of <I>Antigonon leptopus</I> is used as a remedy for cold and pain relief in many countries. In this study, <I>A. leptopus</I> tea, prepared from the dried aerial parts, was evaluated for lipid peroxidation (LPO) and cyclooxygenase (COX-1 and COX-2) enzyme inhibitory activities. The tea as a dried extract inhibited LPO, COX-1 and COX-2 enzymes by 78%, 38% and 89%, respectively, at 100 &micro;g/ml. Bioassay-guided fractionation of the extract yielded a selective COX-2 enzyme inhibitory phenolic aldehyde, 2,3,4-trihydroxy benzaldehyde. Also, it showed LPO inhibitory activity by 68.3% at 6.25 &micro;g/ml. Therefore, we have studied other hydroxy benzaldehydes and their methoxy analogs for LPO, COX-1 and COX-2 enzymes inhibitory activities and found that compound <b>1</b> gave the highest COX-2 enzyme inhibitory activity as indicated by a 50% inhibitory concentration (IC<SUB>50</SUB>) at 9.7 &micro;g/ml. The analogs showed only marginal LPO activity at 6.25 &micro;g/ml. The hydroxy analogs <b>6</b>, <b>7</b> and <b>9</b> showed 55%, 61% and 43% of COX-2 inhibition at 100 &micro;g/ml. However, hydroxy benzaldehydes <b>3</b> and <b>12</b> showed selective COX-1 inhibition while compounds <b>4</b> and <b>10</b> gave little or no COX-2 enzyme inhibition at 100 &micro;g/ml. At the same concentration, compounds <b>14</b>, <b>21</b> and <b>22</b> inhibited COX-1 by 83, 85 and 70%, respectively. Similarly, compounds <b>18</b>, <b>19</b> and <b>23</b> inhibited COX-2 by 68%, 72% and 70%, at 100 &micro;g/ml. This is the first report on the isolation of compound <b>1</b> from <I>A. leptopus</I> tea with selective COX-2 enzyme and LPO inhibitory activities.</p>
]]></description>
<dc:creator><![CDATA[Mulabagal, V., Alexander-Lindo, R. L., DeWitt, D. L., Nair, M. G.]]></dc:creator>
<dc:date>Tue, 19 May 2009 05:34:30 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep041</dc:identifier>
<dc:title><![CDATA[Health-Beneficial Phenolic Aldehyde in Antigonon leptopus Tea]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-19</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep035v1?rss=1">
<title><![CDATA[Cupping for Treating Pain: A Systematic Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep035v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study was to assess the evidence for or against the effectiveness of cupping as a treatment option for pain. Fourteen databases were searched. Randomized clinical trials (RCTs) testing cupping in patients with pain of any origin were considered. Trials using cupping with or without drawing blood were included, while trials comparing cupping with other treatments of unproven efficacy were excluded. Trials with cupping as concomitant treatment together with other treatments of unproven efficacy were excluded. Trials were also excluded if pain was not a central symptom of the condition. The selection of studies, data extraction and validation were performed independently by three reviewers. Seven RCTs met all the inclusion criteria. Two RCTs suggested significant pain reduction for cupping in low back pain compared with usual care (<I>P</I> &lt; 0.01) and analgesia (<I>P</I> &lt; 0.001). Another two RCTs also showed positive effects of cupping in cancer pain (<I>P</I> &lt; 0.05) and trigeminal neuralgia (<I>P</I> &lt; 0.01) compared with anticancer drugs and analgesics, respectively. Two RCTs reported favorable effects of cupping on pain in brachialgia compared with usual care (<I>P</I> = 0.03) or heat pad (<I>P</I> &lt; 0.001). The other RCT failed to show superior effects of cupping on pain in herpes zoster compared with anti-viral medication (<I>P</I> = 0.065). Currently there are few RCTs testing the effectiveness of cupping in the management of pain. Most of the existing trials are of poor quality. Therefore, more rigorous studies are required before the effectiveness of cupping for the treatment of pain can be determined.</p>
]]></description>
<dc:creator><![CDATA[Kim, J.-I., Lee, M. S., Lee, D.-H., Boddy, K., Ernst, E.]]></dc:creator>
<dc:date>Thu, 07 May 2009 07:38:39 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep035</dc:identifier>
<dc:title><![CDATA[Cupping for Treating Pain: A Systematic Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-07</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep037v1?rss=1">
<title><![CDATA[Understanding Oriental Medicine Using a Systems Approach]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep037v1?rss=1</link>
<description><![CDATA[
<p>Two international meetings, the International Physiome Symposium 2008 and the Workshop on Systems Biology (SB) and Oriental Medicine (OM), were held to discuss the most appropriate scientific tools to research OM. Participants agreed that since OM is holistic medicine it needs a systems approach such as SB. However, SB itself is still a long way from identifying the high-level organization processes in the biological system that might correlate with concepts in OM. As such, a modest goal of launching a project to examine the problems of translation and interpretation of OM concepts would be the first step.</p>
]]></description>
<dc:creator><![CDATA[Kim, J. Y., Pham, D. D.]]></dc:creator>
<dc:date>Wed, 29 Apr 2009 09:39:30 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep037</dc:identifier>
<dc:title><![CDATA[Understanding Oriental Medicine Using a Systems Approach]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-29</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep028v1?rss=1">
<title><![CDATA[The Neuroprotective Effect of Methanol Extract of Gagamjungjihwan and Fructus Euodiae on Ischemia-Induced Neuronal and Cognitive Impairment in the Rat]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep028v1?rss=1</link>
<description><![CDATA[
<p><I>Gagamjungjihwan</I> (GJ), a decoction consisting of five herbs including <I>ginseng</I>, <I>Acori Graminei Rhizoma</I>, <I>Uncariae Ramulus et Uncus</I>, <I>Polygalae Radic</I> and <I>Frustus Euodiae</I> (FE), has been widely used as herbal treatment for ischemia. In order to investigate the neuroprotective action of this novel prescription, we examined the influence of GJ and FE on learning and memory using the Morris water maze and studied their affects on the central cholinergic system in the hippocampus with neuronal and cognitive impairment. After middle cerebral artery occlusion was applied for 2 h, rats were administered GJ (200 mg kg<sup>&ndash;1</sup>, p.o.) or FE (200 mg kg<sup>&ndash;1</sup>, p.o.) daily for 2 weeks, followed by training and performance of the Morris water maze tasks. Rats with ischemic insults showed impaired learning and memory of the tasks. Pre-treatment with GJ and FE produced improvement in the escape latency to find the platform. Pre-treatments with GJ and FE also reduced the loss of cholinergic immunoreactivity in the hippocampus. The results demonstrated that GJ and FE have a protective effect against ischemia-induced neuronal and cognitive impairment. Our results suggest that GJ and FE might be useful in the treatment of vascular dementia.</p>
]]></description>
<dc:creator><![CDATA[Lee, B., Choi, E.-J., Lee, E.-J., Han, S.-M., Hahm, D.-H., Lee, H.-J., Shim, I.]]></dc:creator>
<dc:date>Fri, 24 Apr 2009 09:26:34 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep028</dc:identifier>
<dc:title><![CDATA[The Neuroprotective Effect of Methanol Extract of Gagamjungjihwan and Fructus Euodiae on Ischemia-Induced Neuronal and Cognitive Impairment in the Rat]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep033v1?rss=1">
<title><![CDATA[Antidiabetic Properties of Azardiracta indica and Bougainvillea spectabilis: In Vivo Studies in Murine Diabetes Model]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep033v1?rss=1</link>
<description><![CDATA[
<p>Diabetes mellitus is a metabolic syndrome characterized by an increase in the blood glucose level. Treatment of diabetes is complicated due to multifactorial nature of the disease. <I>Azadirachta indica Adr. Juss</I> and <I>Bougainvillea spectabilis</I> are reported to have medicinal values including antidiabetic properties. In the present study using <I>in&nbsp;vivo</I> diabetic murine model, <I>A. indica</I> and <I>B. spectabilis</I> chloroform, methanolic and aqueous extracts were investigated for the biochemical parameters important for controlling diabetes. It was found that <I>A. indica</I> chloroform extract and <I>B. spectabilis</I> aqueous, methanolic extracts showed a good oral glucose tolerance and significantly reduced the intestinal glucosidase activity. Interestingly, <I>A. indica</I> chloroform and <I>B. spectabilis</I> aqueous extracts showed significant increase in glucose-6-phosphate dehydrogenase activity and hepatic, skeletal muscle glycogen content after 21 days of treatment. In immunohistochemical analysis, we observed a regeneration of insulin-producing cells and corresponding increase in the plasma insulin and c-peptide levels with the treatment of <I>A. indica</I> chloroform and <I>B. spectabilis</I> aqueous, methanolic extracts. Analyzing the results, it is clear that <I>A. indica</I> chloroform and <I>B. spectabilis</I> aqueous extracts are good candidates for developing new neutraceuticals treatment for diabetes.</p>
]]></description>
<dc:creator><![CDATA[Bhat, M., Kothiwale, S. K., Tirmale, A. R., Bhargava, S. Y., Joshi, B. N.]]></dc:creator>
<dc:date>Thu, 23 Apr 2009 08:59:34 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep033</dc:identifier>
<dc:title><![CDATA[Antidiabetic Properties of Azardiracta indica and Bougainvillea spectabilis: In Vivo Studies in Murine Diabetes Model]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-23</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep030v1?rss=1">
<title><![CDATA[Lyprinol--is it a Useful Anti-inflammatory Agent?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep030v1?rss=1</link>
<description><![CDATA[
<p>The New Zealand green lipped mussel preparation Lyprinol is available without a prescription from a supermarket, pharmacy or Web. The Food and Drug Administration have recently warned Lyprinol USA about their extravagant anti-inflammatory claims for Lyprinol appearing on the web. These claims are put to thorough review. Lyprinol does have anti-inflammatory mechanisms, and has anti-inflammatory effects in some animal models of inflammation. Lyprinol may have benefits in dogs with arthritis. There are design problems with the clinical trials of Lyprinol in humans as an anti-inflammatory agent in osteoarthritis and rheumatoid arthritis, making it difficult to give a definite answer to how effective Lyprinol is in these conditions, but any benefit is small. Lyprinol also has a small benefit in atopic allergy. As anti-inflammatory agents, there is little to choose between Lyprinol and fish oil. No adverse effects have been reported with Lyprinol. Thus, although it is difficult to conclude whether Lyprinol does much good, it can be concluded that Lyprinol probably does no major harm.</p>
]]></description>
<dc:creator><![CDATA[Doggrell, S. A.]]></dc:creator>
<dc:date>Tue, 21 Apr 2009 09:31:58 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep030</dc:identifier>
<dc:title><![CDATA[Lyprinol--is it a Useful Anti-inflammatory Agent?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-21</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep032v1?rss=1">
<title><![CDATA[Informed Consent in Complementary and Alternative Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep032v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study was to examine complementary and alternative medicine (CAM) practitioners&rsquo; (i) attitudes toward informed consent and (ii) to assess whether standards of practice exist with respect to informed consent, and what these standards look like. The design and setting of the study constituted <b>f</b>ace-to-face qualitative interviews with 28 non-MD, community-based providers representing 11 different CAM therapeutic modalities. It was found that there is great deal of variability with respect to the informed consent process in CAM across providers and modalities. No unique profession-based patterns were identified. The content analysis yielded five major categories related to (i) general attitude towards the informed consent process, (ii) type and amount of information exchange during that process, (iii) disclosure of risks, (iv) discussions of alternatives, and (v) potential benefits. There is a widespread lack of standards with respect to the practice of informed consent across a broad range of CAM modalities. Addressing this problem requires concerted and systematic educational, ethical and judicial remedial actions. Informed consent, which is often viewed as a pervasive obligation is medicine, must be reshaped to have therapeutic value. Acknowledging current conceptions and misconception surrounding the practice of informed consent may help to bring about this change. More translational research is needed to guide this process.</p>
]]></description>
<dc:creator><![CDATA[Caspi, O., Shalom, T., Holexa, J.]]></dc:creator>
<dc:date>Fri, 17 Apr 2009 07:33:06 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep032</dc:identifier>
<dc:title><![CDATA[Informed Consent in Complementary and Alternative Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep031v1?rss=1">
<title><![CDATA[Analyzing Serum-Stimulated Prostate Cancer Cell Lines After Low-Fat, High-Fiber Diet and Exercise Intervention]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep031v1?rss=1</link>
<description><![CDATA[
<p>Serum from men undergoing a low-fat, high-fiber diet and exercise intervention has previously been shown to decrease growth and increase apoptosis in serum-stimulated, androgen-dependent LNCaP cells associated with a reduction in serum IGF-I. Here we sought to determine the underlying mechanisms for these anticancer effects. Again, the intervention slowed growth and increased apoptosis in LNCaP cells; responses that were eliminated when IGF-I was added back to the post-intervention samples. The p53 protein content was increased and NFkB activation reduced in the post serum-stimulated LNCaP cells. Similar results were observed when the IGF-I receptor was blocked in the pre-intervention serum. In androgen-independent PC-3 cells, growth was reduced while none of the other factors were changed by the intervention. We conclude that diet and exercise intervention might help prevent clinical PCa as well as aid in the treatment of PCa during the early stages of development.</p>
]]></description>
<dc:creator><![CDATA[Soliman, S., Aronson, W. J., Barnard, R. J.]]></dc:creator>
<dc:date>Fri, 17 Apr 2009 07:33:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep031</dc:identifier>
<dc:title><![CDATA[Analyzing Serum-Stimulated Prostate Cancer Cell Lines After Low-Fat, High-Fiber Diet and Exercise Intervention]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep029v1?rss=1">
<title><![CDATA[Royal Jelly Facilitates Restoration of the Cognitive Ability in Trimethyltin-Intoxicated Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep029v1?rss=1</link>
<description><![CDATA[
<p>Trimethyltin (TMT) is a toxic organotin compound that induces acute neuronal death selectively in the hippocampal dentate gyrus (DG) followed by cognition impairment; however the TMT-injured hippocampal DG itself is reported to regenerate the neuronal cell layer through rapid enhancement of neurogenesis. Neural stem/progenitor cells (NS/NPCs) are present in the adult hippocampal DG, and generate neurons that can function for the cognition ability. Therefore, we investigated whether royal jelly (RJ) stimulates the regenerating processes of the TMT-injured hippocampal DG, and found that orally administered RJ significantly increased the number of DG granule cells and simultaneously improved the cognitive impairment. Furthermore, we have already shown that RJ facilitates neurogenesis of cultured NS/NPCs. These present results, taken together with previous observations, suggest that the orally administered RJ may be a promising avenue for ameliorating neuronal function by regenerating hippocampal granule cells that function in the cognition process.</p>
]]></description>
<dc:creator><![CDATA[Hattori, N., Ohta, S., Sakamoto, T., Mishima, S., Furukawa, S.]]></dc:creator>
<dc:date>Fri, 17 Apr 2009 07:33:04 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep029</dc:identifier>
<dc:title><![CDATA[Royal Jelly Facilitates Restoration of the Cognitive Ability in Trimethyltin-Intoxicated Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep024v1?rss=1">
<title><![CDATA[Brazilian Propolis Suppresses Angiogenesis by Inducing Apoptosis in Tube-forming Endothelial Cells through Inactivation of Survival Signal ERK1/2]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep024v1?rss=1</link>
<description><![CDATA[
<p>We recently reported that propolis suppresses tumor-induced angiogenesis through tube formation inhibition and apoptosis induction in endothelial cells. However, molecular mechanisms underlying such angiogenesis suppression by propolis have not been fully elucidated. The aim of this study was to investigate the effects of ethanol extract of Brazilian propolis (EEBP) on two major survival signals, extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt, and to elucidate whether changes in these signals were actually involved in antiangiogenic effects of the propolis. Detection by western blotting revealed that EEBP suppressed phosphorylation of ERK1/2, but not that of Akt. Pharmacological inhibition by U0126 demonstrated that ERK1/2 inactivation alone was enough to inhibit tube formation and induce apoptosis. It was also shown that EEBP and U0126 similarly induced activation of caspase-3 and cleavage of poly ADP-ribose polymerase (PARP) and lamin A/C, all of which are molecular markers of apoptosis. These results indicate that inhibition of survival signal ERK1/2, and subsequent induction of apoptosis, is a critical mechanism of angiogenesis suppression by EEBP.</p>
]]></description>
<dc:creator><![CDATA[Kunimasa, K., Ahn, M.-R., Kobayashi, T., Eguchi, R., Kumazawa, S., Fujimori, Y., Nakano, T., Nakayama, T., Kaji, K., Ohta, T.]]></dc:creator>
<dc:date>Tue, 07 Apr 2009 06:16:56 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep024</dc:identifier>
<dc:title><![CDATA[Brazilian Propolis Suppresses Angiogenesis by Inducing Apoptosis in Tube-forming Endothelial Cells through Inactivation of Survival Signal ERK1/2]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep022v1?rss=1">
<title><![CDATA[Quality of Reporting of Randomized Clinical Trials in Tai Chi Interventions--A Systematic Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep022v1?rss=1</link>
<description><![CDATA[
<p><b>Objectives:</b> To evaluate the reporting quality of published randomized clinical trials (RCTs) in the Tai Chi literature following the publication of the CONSORT guidelines in 2001.</p>
<p><b>Data sources:</b> The OVID MEDLINE and PUBMED databases</p>
<p><b>Review methods:</b> To survey the general characteristics of Tai Chi RCTs in the literature, we included any report if (i) it was an original report of the trial; (ii) its design was RCT; (iii) one of the treatments being tested was Tai Chi; and (iv) it was in English. In addition, we assessed the reporting quality of RCTs that were published between 2002 and 2007, using a modified CONSORT checklist of 40 items. The adequate description of Tai Chi interventions in these trials was examined against a 10-item checklist adapted from previous reviews.</p>
<p><b>Results:</b> The search yielded 31 Tai Chi RCTs published from 2002 to 2007 and only 11 for 1992&ndash;2001. Among trials published during 2002&ndash;2007, the most adequately reported criteria were related to background, participant eligibility and interpretation of the study results. Nonetheless, the most poorly reported items were associated with randomization allocation concealment, implementation of randomization and the definitions of period of recruitment and follow-up. In addition, only 23% of RCTs provided adequate details of Tai Chi intervention used in the trials.</p>
<p><b>Conclusion:</b> The findings in this review indicated that the reporting quality of Tai Chi intervention trials is sub-optimal. Substantial improvement is required to meet the CONSORT guidelines and allow assessment of the quality of evidence. We believe that not only investigators, but also journal editors, reviewers and funding agencies need to follow the CONSORT guidelines to improve the standards of research and strengthen the evidence base for Tai Chi and for complementary and alternative medicine.</p>
]]></description>
<dc:creator><![CDATA[Li, J.-Y., Zhang, Y.-F., Smith, G. S., Xue, C.-J., Luo, Y.-N., Chen, W.-H., Skinner, C. J., Finkelstein, J.]]></dc:creator>
<dc:date>Tue, 07 Apr 2009 06:16:55 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep022</dc:identifier>
<dc:title><![CDATA[Quality of Reporting of Randomized Clinical Trials in Tai Chi Interventions--A Systematic Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-07</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep027v1?rss=1">
<title><![CDATA[Analgesic Effects and the Mechanisms of Anti-Inflammation of Hispolon in Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep027v1?rss=1</link>
<description><![CDATA[
<p>Hispolon, an active ingredient in the fungi <I>Phellinus linteus</I> was evaluated with analgesic and anti-inflammatory effects. Treatment of male ICR mice with hispolon (10 and 20 mg/kg) significantly inhibited the numbers of acetic acid-induced writhing response. Also, our result showed that hispolon (20 mg/kg) significantly inhibited the formalin-induced pain in the later phase (<I>P</I> <I>&lt;</I> 0.01). In the anti-inflammatory test, hispolon (20 mg/kg) decreased the paw edema at the fourth and fifth hour after -carrageenin (Carr) administration, and increased the activities of superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione reductase (GRx) in the liver tissue. We also demonstrated that hispolon significantly attenuated the malondialdehyde (MDA) level in the edema paw at the fifth hour after Carr injection. Hispolon (10 and 20 mg/kg) decreased the nitric oxide (NO) levels on both the edema paw and serum level at the fifth hour after Carr injection. Also, hispolon (10 and 20 mg/kg) diminished the serum TNF- at the fifth hour after Carr injection. The anti-inflammatory mechanisms of hispolon might be related to the decrease in the level of MDA in the edema paw by increasing the activities of SOD, GPx and GRx in the liver. It probably exerts anti-inflammatory effects through the suppression of TNF- and NO.</p>
]]></description>
<dc:creator><![CDATA[Chang, H.-Y., Sheu, M.-J., Yang, C.-H., Lu, T.-C., Chang, Y. S., Peng, W.-H., Huang, S.-S., Huang, G.-J.]]></dc:creator>
<dc:date>Mon, 06 Apr 2009 10:28:54 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep027</dc:identifier>
<dc:title><![CDATA[Analgesic Effects and the Mechanisms of Anti-Inflammation of Hispolon in Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-06</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep025v1?rss=1">
<title><![CDATA[San-Huang-Xie-Xin-Tang Protects Against Activated Microglia- and 6-OHDA-induced Toxicity in Neuronal SH-SY5Y Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep025v1?rss=1</link>
<description><![CDATA[
<p>San-Huang-Xie-Xin-Tang (SHXT), composed of <I>Coptidis rhizoma</I>, <I>Scutellariae radix</I> and <I>Rhei rhizoma</I>, is a traditional Chinese herbal medicine used to treat gastritis, gastric bleeding and peptic ulcers. This study investigated the neuroprotective effects of SHXT on microglia-mediated neurotoxicity using co-cultured lipopolysaccharide (LPS)-activated microglia-like BV-2 cells with neuroblastoma SH-SY5Y cells. Effects of SHXT on 6-hydroxydopamine (6-OHDA)-induced neurotoxicity were also examined in SH-SY5Y cells. Results indicated SHXT inhibited LPS-induced inflammation of BV-2 cells by downregulation of iNOS, NO, COX-2, PGE<SUB>2</SUB>, gp91<sup>phox</sup>, iROS, TNF-, IL-1&beta;, inhibition of IB degradation and upregulation of HO-1. In addition, SHXT increased cell viability and down regulated nNOS, COX-2 and gp91<sup>phox</sup> of SH-SY5Y cells co-cultured with LPS activated BV-2 cells. SHXT treatment increased cell viability and mitochondria membrane potential (MMP), decreased expression of nNOS, COX-2, gp91<sup>phox</sup> and iROS, and inhibited IB degradation in 6-OHDA-treated SH-SY5Y cells. SHXT also attenuated LPS activated BV-2 cells- and 6-OHDA-induced cell death in differentiated SH-SY5Y cells with db-cAMP. Furthermore, SHXT-inhibited nuclear translocation of p65 subunit of NF-B in LPS treated BV-2 cells and 6-OHDA treated SH-SY5Y cells. In conclusion, SHXT showed protection from activated microglia- and 6-OHDA-induced neurotoxicity by attenuating inflammation and oxidative stress.</p>
]]></description>
<dc:creator><![CDATA[Shih, Y.-T., Chen, I.-J., Wu, Y.-C., Lo, Y.-C.]]></dc:creator>
<dc:date>Wed, 01 Apr 2009 09:05:07 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep025</dc:identifier>
<dc:title><![CDATA[San-Huang-Xie-Xin-Tang Protects Against Activated Microglia- and 6-OHDA-induced Toxicity in Neuronal SH-SY5Y Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep023v1?rss=1">
<title><![CDATA[Allopathic Versus Homeopathic Strategies and the Recurrence of Prescriptions: Results from a Pharmacoeconomic Study in Italy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep023v1?rss=1</link>
<description><![CDATA[
<p>This is a pharmaeconomic study to assess the impact of different, cost-specific pharmacological strategies on the recurrence rate of prescriptions in the treatment of cold symptoms. Data were obtained from a prospective cohort study reporting individual prescriptions histories of subjects experiencing cold symptoms, obtained by a stratified random sample of 316 subjects, clustered into 139 Italian families, followed up for 40 months. Costs of homeopathic and allopathic treatments were recorded within each prescription. A Cox proportional hazards model with random effects was exploited to regress time elapsed between subsequent prescriptions over the relative difference between homeopathic- and allopathic-related costs, adjusting for age and gender and accounting for unobserved individual heterogeneity. Relative risks of event (prescription) re-occurrence have been estimated. The recurrence rate of prescriptions raise when allopathic strategies are preferred to homeopathic alternatives. No significant differences were observed between gender groups, while age was marginally significant. Inter-subjects heterogeneity was not significant.</p>
]]></description>
<dc:creator><![CDATA[Basili, A., Lagona, F., Roberti di Sarsina, P., Basili, C., Valeria Paterna, T.]]></dc:creator>
<dc:date>Wed, 01 Apr 2009 09:05:06 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep023</dc:identifier>
<dc:title><![CDATA[Allopathic Versus Homeopathic Strategies and the Recurrence of Prescriptions: Results from a Pharmacoeconomic Study in Italy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep018v1?rss=1">
<title><![CDATA[Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep018v1?rss=1</link>
<description><![CDATA[
<p>Chinese herbal medicine (CHM) has been commonly used for treating insomnia in Asian countries for centuries. The aim of this study was to conduct a large-scale pharmaco-epidemiologic study and evaluate the frequency and patterns of CHM use in treating insomnia. We obtained the traditional Chinese medicine (TCM) outpatient claims from the National Health Insurance in Taiwan for the year 2002. Patients with insomnia were identified from the diagnostic code of International Classification of Disease among claimed visiting files. Corresponding prescription files were analyzed, and an association rule was applied to evaluate the co-prescription of CHM. Results showed that there were 16 134 subjects who visited TCM clinics for insomnia in Taiwan during 2002 and received a total of 29 801 CHM prescriptions. Subjects between 40 and 49 years of age comprised the largest number of those treated (25.3%). In addition, female subjects used CHMs for insomnia more frequently than male subjects (female:male = 1.94:1). There was an average of 4.8 items prescribed in the form of either an individual Chinese herb or formula in a single CHM prescription for insomnia. Shou-wu-teng (<I>Polygonum multiflorum</I>) was the most commonly prescribed single Chinese herb, while Suan-zao-ren-tang was the most commonly prescribed Chinese herbal formula. According to the association rule, the most commonly prescribed CHM drug combination was Suan-zao-ren-tang plus Long-dan-xie-gan-tang, while the most commonly prescribed triple drug combination was Suan-zao-ren-tang, <I>Albizia julibrissin</I>, and <I>P. multiflorum</I>. Nevertheless, further clinical trials are needed to evaluate the efficacy and safety of these CHMs for treating insomnia.</p>
]]></description>
<dc:creator><![CDATA[Chen, F.-P., Jong, M.-S., Chen, Y.-C., Kung, Y.-Y., Chen, T.-J., Chen, F.-J., Hwang, S.-J.]]></dc:creator>
<dc:date>Wed, 01 Apr 2009 09:05:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep018</dc:identifier>
<dc:title><![CDATA[Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep026v1?rss=1">
<title><![CDATA[A Chinese Herbal Medicine, Tokishakuyakusan, Reduces the Worsening of Impairments and Independence After Stroke: A 1-year Randomized, Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep026v1?rss=1</link>
<description><![CDATA[
<p>In post-stroke patients, the recurrence of stroke and progression of impairments lead to a bedridden state and dementia. As for their treatments, only anti-hypertension and anti-coagulation therapies to prevent the recurrence of stroke are available. In Asia, post-stroke patients with impairments are often treated with herbal medicine. The present study evaluated the effectiveness of tokishakuyakusan (TS) in improving the impairment and independence in post-stroke patients. Thirty-one post-stroke patients (mean age = 81.4 years) were recruited and enrolled. Participants were randomly assigned to the TS group (<I>n</I>=16) or non-treatment (control) group (<I>n</I>=15) and treated for 12 months. Impairments were assessed using the Stroke Impairment Assessment Set (SIAS). Independence was evaluated using the functional independence measure (FIM). For each outcome measure, mean change was calculated every 3 months. The results were that impairments according to SIAS did not significantly change in the TS group. In contrast, SIAS significantly worsened in the control group. There was a significant difference between the two groups. In each term of SIAS, affected lower extremity scores, abdominal muscle strength, function of visuospatial perception, etc. in the TS group were better than those in the control group. Independence according to FIM did not change significantly in the TS group. In contrast, FIM significantly worsened in the control group. There was also a significant difference between the two groups. In conclusion, TS was considered to suppress the impairments of lower limbs and to exert a favorable effect on cerebral function for post-stroke patients.</p>
]]></description>
<dc:creator><![CDATA[Goto, H., Satoh, N., Hayashi, Y., Hikiami, H., Nagata, Y., Obi, R., Shimada, Y.]]></dc:creator>
<dc:date>Mon, 30 Mar 2009 06:43:14 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep026</dc:identifier>
<dc:title><![CDATA[A Chinese Herbal Medicine, Tokishakuyakusan, Reduces the Worsening of Impairments and Independence After Stroke: A 1-year Randomized, Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-30</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep021v1?rss=1">
<title><![CDATA[Gingyo-San Enhances Immunity and Potentiates Infectious Bursal Disease Vaccination]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep021v1?rss=1</link>
<description><![CDATA[
<p>The purpose of the present study was to investigate the effects of Gingyo-san (GGS), a traditional Chinese medical formula, on peripheral lymphocyte proliferation and serum antibody titers in chickens vaccinated against the infectious bursal disease (IBD) virus. Treatment groups were fed one of three doses of GGS in their diet (0.5%, 1.0% and 2.0%, w/w), and the IBD vaccine was administered at 1 and 3 weeks of age. At Weeks 8, 12 and 16, changes in serum IBD antibody titers were measured via the micro-method and T cell proliferation. In gene expression experiments, GGS-treated peripheral T lymphocytes were stimulated with concanavalin A (ConA) for 24 h. The mRNA expression of interleukin-2 (IL-2), interferon- (IFN-), interleukin-4 (IL-4) and interleukin-12 (IL-12) was determined using a semi-quantitative RT&ndash;PCR assay. The results showed that a low dose of GGS could significantly raise the antibody titers. Medium and high doses of GGS enhanced IL-2 and IFN- production. GGS altered the expression of IL-4 and IL-12 in T lymphocytes. CD4<sup>+</sup> T lymphocyte development was also skewed towards the Th1 phenotype. GGS enhanced cell-mediated immunity and augmented the effects of IBD vaccination in strengthening subsequent anti-viral responses.</p>
]]></description>
<dc:creator><![CDATA[Hung, C.-M., Yeh, C.-C., Chong, K.-Y., Chen, H.-L., Chen, J.-Y., Kao, S.-T., Yen, C.-C., Yeh, M.-H., Lin, M.-S., Chen, C.-M.]]></dc:creator>
<dc:date>Sun, 22 Mar 2009 20:47:46 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep021</dc:identifier>
<dc:title><![CDATA[Gingyo-San Enhances Immunity and Potentiates Infectious Bursal Disease Vaccination]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-22</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep020v1?rss=1">
<title><![CDATA[Inhibition of Anchorage-Independent Proliferation and G0/G1 Cell-Cycle Regulation in Human Colorectal Carcinoma Cells by 4,7-Dimethoxy-5-methyl-l,3-benzodioxole Isolated from the Fruiting Body of Antrodia camphorate]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep020v1?rss=1</link>
<description><![CDATA[
<p>In this study, 4,7-dimethoxy-5-methyl-l,3-benzodioxole (SY-1) was isolated from three different sources of dried fruiting bodies of <I>Antrodia camphorate</I> (<I>AC</I>). <I>AC</I> is a medicinal mushroom that grows on the inner heartwood wall of <I>Cinnamomum kanehirai Hay</I> (<I>Lauraceae</I>), an endemic species that is used in Chinese medicine for its anti-tumor and immunomodulatory properties. In this study, we demonstrated that SY-1 profoundly decreased the proliferation of human colon cancer cells (COLO 205) through G0/G1 cell-cycle arrest (50&ndash;150 &micro;M) and induction of apoptosis (&gt;150 &micro;M). Cell-cycle arrest induced by SY-1 was associated with a significant increase in levels of p53, p21/Cip1 and p27/Kip1, and a decrease in cyclins D1, D3 and A. In contrast, SY-1 treatment did not induce significant changes in G0/G1 phase cell-cycle regulatory proteins in normal human colonic epithelial cells (FHC). The cells were cultured in soft agar to evaluate anchorage-independent colony formation, and we found that the number of transformed colonies was significantly reduced in the SY-1-treated COLO 205 cells. These findings demonstrate for the first time that SY-1 inhibits human colon cancer cell proliferation through inhibition of cell growth and anchorage-independent colony formation in soft agar. However, the detailed mechanisms of these processes remain unclear and will require further investigation.</p>
]]></description>
<dc:creator><![CDATA[Lien, H.-M., Lin, H.-W., Wang, Y.-J., Chen, L.-C., Yang, D.-Y., Lai, Y.-Y., Ho, Y.-S.]]></dc:creator>
<dc:date>Tue, 17 Mar 2009 06:59:34 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep020</dc:identifier>
<dc:title><![CDATA[Inhibition of Anchorage-Independent Proliferation and G0/G1 Cell-Cycle Regulation in Human Colorectal Carcinoma Cells by 4,7-Dimethoxy-5-methyl-l,3-benzodioxole Isolated from the Fruiting Body of Antrodia camphorate]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep019v1?rss=1">
<title><![CDATA[Integration of Complementary and Alternative Medicine into Family Practices in Germany: Results of a National Survey]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep019v1?rss=1</link>
<description><![CDATA[
<p>More than two-thirds of patients in Germany use complementary and alternative medicine (CAM) provided either by physicians or non-medical practitioners (&lsquo;Heilpraktiker&rsquo;). There is little information about the number of family physicians (FPs) providing CAM. Given the widespread public interest in the use of CAM, this study aimed to ascertain the use of and attitude toward CAM among FPs in Germany. A postal questionnaire developed based on qualitatively derived data was sent to 3000 randomly selected FPs in Germany. A reminder letter including a postcard (containing a single question about CAM use in practice and reasons for non-particpation in the survey) was sent to all FPs who had not returned the questionnaire. Of the 3000 FPs, 1027 (34%) returned the questionnaire and 444 (15%) returned the postcard. Altogether, 886 of the 1471 responding FPs (60%) reported using CAM in their practice. A positive attitude toward CAM was indicated by 503 FPs (55%), a rather negative attitude by 127 FPs (14%). Chirotherapy, relaxation and neural therapy were rated as most beneficial CAM therapies by FPs, whereas neural therapy, phytotherapy and acupuncture were the most commonly used therapies in German family practices. This survey clearly demonstrates that CAM is highly valued by many FPs and is already making a substantial contribution to first-contact primary care in Germany. Therefore, education and research about CAM should be increased. Furthermore, with the provision of CAM by FPs, the role of non-medical CAM practitioners within the German healthcare system is to be questioned.</p>
]]></description>
<dc:creator><![CDATA[Joos, S., Musselmann, B., Szecsenyi, J.]]></dc:creator>
<dc:date>Tue, 17 Mar 2009 06:59:33 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep019</dc:identifier>
<dc:title><![CDATA[Integration of Complementary and Alternative Medicine into Family Practices in Germany: Results of a National Survey]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep014v2?rss=1">
<title><![CDATA[Brazilian Green Propolis: Effects In Vitro and In Vivo on Trypanosoma cruzi]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep014v2?rss=1</link>
<description><![CDATA[
<p>The composition of a Brazilian green propolis ethanolic extract (Et-Bra) and its effect on <I>Trypanosoma cruzi</I> trypomastigotes and other pathogenic microorganisms have already been reported. Here, we further investigated Et-Bra targets in <I>T. cruzi</I> and its effect on experimental infection of mice. The IC<SUB>50</SUB>/4 days for inhibition of amastigote proliferation was 8.5 &plusmn; 1.8 &micro;g ml<sup>&ndash;1</sup>, with no damage to the host cells. In epimastigotes Et-Bra induced alterations in reservosomes, Golgi complex and mitochondrion. These effects were confirmed by flow cytometry analysis. In trypomastigotes, Et-Bra led to the loss of plasma membrane integrity. The <I>in vitro</I> studies indicate that Et-Bra interferes in the functionality of the plasma membrane in trypomastigotes and of reservosomes and mitochondrion in epimastigotes. Acutely infected mice were treated orally with Et-Bra and the parasitemia, mortality and GPT, GOT, CK and urea levels were monitored. The extract (25&ndash;300 mg kg<sup>&ndash;1</sup> body weight/day for 10 days) reduced the parasitemia, although not at significant levels; increased the survival of the animals and did not induce any hepatic, muscular lesion or renal toxicity. Since Et-Bra was not toxic to the animals, it could be assayed in combination with other drugs. Et-Bra could be a potential metacyclogenesis blocker, considering its effect on reservosomes, which are an important energy source during parasite differentiation.</p>
]]></description>
<dc:creator><![CDATA[Salomao, K., de Souza, E. M., Henriques-Pons, A., Barbosa, H. S., de Castro, S. L.]]></dc:creator>
<dc:date>Wed, 11 Mar 2009 08:24:34 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep014</dc:identifier>
<dc:title><![CDATA[Brazilian Green Propolis: Effects In Vitro and In Vivo on Trypanosoma cruzi]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-11</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep015v1?rss=1">
<title><![CDATA[Wound Healing Activity of Topical Application Forms Based on Ayurveda]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep015v1?rss=1</link>
<description><![CDATA[
<p>The traditional Indian medicine&mdash;Ayurveda, describes various herbs, fats, oils and minerals with anti-aging as well as wound healing properties. With aging, numerous changes occur in skin, including decrease in tissue cell regeneration, decrease in collagen content, loss of skin elasticity and mechanical strength. We prepared five topical anti-aging formulations using cow ghee, flax seed oil, <I>Phyllanthus emblica</I> fruits, <I>Shorea robusta</I> resin, <I>Yashada bhasma</I> as study materials. For preliminary efficacy evaluation of the anti-aging activity we chose excision and incision wound healing animal models and studied the parameters including wound contraction, collagen content and skin breaking strength which in turn is indicative of the tissue cell regeneration capacity, collagenation capacity and mechanical strength of skin. The group treated with the formulations containing <I>Yashada bhasma</I> along with <I>Shorea robusta</I> resin and flax seed oil showed significantly better wound contraction (<I>P</I>&lt;0.01), higher collagen content (<I>P</I> &lt; 0.05) and better skin breaking strength (<I>P</I>&lt;0.01) as compared to control group; thus proposing them to be effective prospective anti-aging formulations.</p>
]]></description>
<dc:creator><![CDATA[Datta, H. S., Mitra, S. K., Patwardhan, B.]]></dc:creator>
<dc:date>Fri, 27 Feb 2009 22:19:36 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep015</dc:identifier>
<dc:title><![CDATA[Wound Healing Activity of Topical Application Forms Based on Ayurveda]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep010v1?rss=1">
<title><![CDATA[Acupuncture's Effects in Treating the Sequelae of Acute and Chronic Spinal Cord Injuries: A Review of Allopathic and Traditional Chinese Medicine Literature]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep010v1?rss=1</link>
<description><![CDATA[
<p>Each year, there are an estimated 12 000 individuals who sustain a spinal cord injury (SCI) in the United States. Improved understanding of the pathophysiology of SCI and its sequelae has over the past 50 years led to the development of medical treatments (especially urologic) that have enhanced short- and long-term survival from these injuries. The prevalence of individuals with SCI in this country is ~250 000 individuals; and beyond the incalculable personal consequences of these devastating neurologic injuries, substantial direct and indirect societal costs result from the sequelae of SCI including paralysis, sensory loss, chronic pain, decubiti and bladder and/or bowel incontinence. The purpose of this treatise is to review the allopathic and traditional Chinese medicine (TCM) literature available through MEDLINE, PubMed and eCAM search engines that discuss the potential uses of acupuncture to treat acute and chronic spinal cord injuries and their sequelae, and present the neurophysiologic mechanisms for acupuncture's beneficial effects. There is evidence that use of electroacupuncture in acute SCI may significantly improve long-term neurologic recovery from these injuries both in terms of motor, sensory and bowel/bladder function with essentially no risk. Acupuncture may even improve neurourologic function in individuals with chronic SCI, and help with management with chronic pain associated with these injuries.</p>
]]></description>
<dc:creator><![CDATA[Dorsher, P. T., McIntosh, P. M.]]></dc:creator>
<dc:date>Wed, 25 Feb 2009 04:33:54 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep010</dc:identifier>
<dc:title><![CDATA[Acupuncture's Effects in Treating the Sequelae of Acute and Chronic Spinal Cord Injuries: A Review of Allopathic and Traditional Chinese Medicine Literature]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-25</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen090v1?rss=1">
<title><![CDATA[Evidences of Protective Potentials of Microdoses of Ultra-high Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen090v1?rss=1</link>
<description><![CDATA[
<p>The present study was undertaken to examine if microdoses of ultra-high diluted arsenic trioxide (a potentized homeopathic remedy, Arsenicum Album 200C, diluted 10<sup>&ndash;400</sup> times) have hepatoprotective potentials in mice subjected to repeated injections of arsenic trioxide. Arsenic intoxicated mice were divided into: (i) those receiving Arsenicum Album-200C daily, (ii) those receiving the same dose of diluted succussed alcohol (Alc 200C) and (iii) another group receiving neither drug nor succussed alcohol. Two other control groups were also maintained: one fed normal diet only and the other receiving normal diet and Alc-200C. Toxicity biomarkers like aspartate and alanine aminotransferases, glutathione reductase, catalase, succinate dehydrogenase, superoxide dismutase and reduced glutathione contents were periodically assayed keeping the observer &lsquo;blinded&rsquo;. Additionally, electron microscopic studies and gelatin zymography for matrix metalloproteinases of liver tissues were made at day 90 and 120. Blood glucose, hemoglobin, estradiol and testosterone contents were also studied. Compared to controls, Arsenicum Album-200C fed mice showed positive modulations of all parameters studied, thereby providing evidence of protective potentials of the homeopathic drug against chronic arsenic poisoning.</p>
]]></description>
<dc:creator><![CDATA[Banerjee, P., Bhattacharyya, S. S., Pathak, S., Boujedaini, N., Belon, P., Khuda-Bukhsh, A. R.]]></dc:creator>
<dc:date>Wed, 25 Feb 2009 04:33:52 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen090</dc:identifier>
<dc:title><![CDATA[Evidences of Protective Potentials of Microdoses of Ultra-high Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep006v2?rss=1">
<title><![CDATA[WHO Standard Acupuncture Point Locations]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep006v2?rss=1</link>
<description><![CDATA[
<p><b>&lsquo;</b><I>WHO Standard Acupuncture Point Locations in the Western Pacific Region</I> (WHO Standard) was released in 2008. Initially, there were 92/361 controversial acupuncture points (acupoints). Through seven informal consultations and four task force team meetings, 86 points were agreed upon among the 92 controversial acupoints, leaving 6 remaining controversial acupoints, demanding active research in the future. This will enhance the reproducibility and validity of acupuncture studies. It will also lead to a better understanding of acupuncture mechanisms in order to optimize its clinical efficacy for a range of diseases and syndromes. This book has two parts: General Guidelines for Acupuncture Point Locations and WHO Standard Acupuncture Point Locations. First of all, familiarity with the General Guidelines for Acupuncture Point Locations in this book can help the reader to understand and use the contents of this book in depth. I would like to thank all of the participating experts and scholars for this great work, who have overcome the limits of previous acupuncture references. I also appreciate the dedicated effort and harmonious leadership of Dr Choi Seung-hoon, former Regional Adviser in Traditional Medicine of Western Pacific Office, WHO.</p>
]]></description>
<dc:creator><![CDATA[Lim, S.]]></dc:creator>
<dc:date>Tue, 24 Feb 2009 05:13:19 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep006</dc:identifier>
<dc:title><![CDATA[WHO Standard Acupuncture Point Locations]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-24</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep011v1?rss=1">
<title><![CDATA[Garlic Increases Antioxidant Levels in Diabetic and Hypertensive Rats Determined by a Modified Peroxidase Method]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep011v1?rss=1</link>
<description><![CDATA[
<p>Oxidative damage by free radicals has been implicated in the pathogenesis of vascular disease in diabetes and hypertension. In the present study, the total antioxidant status in diabetic and hypertensive rats before and after treatment with garlic (<I>Allium sativum</I>) was determined. The total serum antioxidants were measured by a modified method reported earlier by Miller and coworkers. The reproducibility of the assay was confirmed by determining standard curves for the known antioxidants: trolox (a stable analog of vitamin E), glutathione and vitamin C with interassay correlation coefficients (<I>R<sup>2</sup></I>, <I>n</I> = 10 in triplicate) of 0.9984, 0.9768 and 0.987, respectively, confirming the reliability and reproducibility of the assay. This assay was then used to determine total serum antioxidant levels of streptozotocin-induced diabetic rats and two-kidney one-clip hypertensive rats both before and after 3 weeks of treatment with an aqueous extract of garlic (500 mg/kg IP daily). The serum antioxidant levels of rats after 3 weeks of treatment were significantly higher (<I>P</I> &lt; 0.001) than the pretreatment levels in both diabetic and hypertensive rats. The increased serum antioxidant levels were paralleled by a decrease in serum glucose in the garlic-treated diabetic rats and lowered systolic blood pressure in the garlic-treated hypertensive rats. We conclude from our study that (i) total antioxidants can be measured by a simple, reproducible, reliable assay and (ii) the total antioxidant status can be significantly improved by treatment with garlic.</p>
]]></description>
<dc:creator><![CDATA[Drobiova, H., Thomson, M., Al-Qattan, K., Peltonen-Shalaby, R., Al-Amin, Z., Ali, M.]]></dc:creator>
<dc:date>Fri, 20 Feb 2009 03:13:34 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep011</dc:identifier>
<dc:title><![CDATA[Garlic Increases Antioxidant Levels in Diabetic and Hypertensive Rats Determined by a Modified Peroxidase Method]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep005v1?rss=1">
<title><![CDATA[Theories and Management of Aging: Modern and Ayurveda Perspectives]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep005v1?rss=1</link>
<description><![CDATA[
<p>Aging is a complex phenomenon, a sum total of changes that occur in a living organism with the passage of time and lead to decreasing ability to survive stress, increasing functional impairment and growing probability of death. There are many theories of aging and skin remains the largest organ of the study. Skin aging is described as a consequence of intrinsic and extrinsic factors. The most common amongst visible signs of skin aging are wrinkles and there are various therapies including antiaging cosmeceuticals, sunscreens, chemical peeling, injectable agents, such as botox, fibrel, autologous fat grafting as also few surgical procedures have been used. Ayurveda, the Indian traditional medicine, describes aging with great details. This review provides modern and Ayurvedic perspectives on theories and management of aging.</p>
]]></description>
<dc:creator><![CDATA[Datta, H. S., Mitra, S. K., Paramesh, R., Patwardhan, B.]]></dc:creator>
<dc:date>Fri, 20 Feb 2009 03:13:34 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep005</dc:identifier>
<dc:title><![CDATA[Theories and Management of Aging: Modern and Ayurveda Perspectives]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-20</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep004v1?rss=1">
<title><![CDATA[A Chinese Herbal Decoction, Dang Gui Bu Xue Tang, Prepared from Radix Astragali and Radix Angelicae sinensis, Ameliorates Insulin Resistance Induced by A High-Fructose Diet in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep004v1?rss=1</link>
<description><![CDATA[
<p>Dang Gui Bu Xue Tang (DBT), a Chinese medicinal decoction contains Radix <I>Angelicae sinensis</I> (Danggui) and Radix Astragali (Huangqi) at a ratio of 1:5, is used commonly for treating women's ailments. This study was conducted to explore the effects of this preparation on insulin resistance in rats fed with 6-week diet containing 60% fructose. Similar to the action of rosiglitazone (4 mg kg<sup>&ndash;1</sup> per day by an oral administration), repeated oral administration of DBT (2.5 g kg<sup>&ndash;1</sup> per day) for 14 days was found to significantly alleviate the hyperglycemia but made no influence on plasma lipid profiles nor weight gain in fructose chow-fed rats. Also, the higher degree of insulin resistance as measured by homeostasis model assessment of basal insulin resistance in fructose chow-fed rats was significantly decreased by repeated DBT treatment. DBT displays the characteristic of rosiglitazone by increasing the whole-body insulin sensitivity in fructose chow-fed rats after 2-week treatment, as evidenced by the marked elevation of composite whole-body insulin sensitivity index during the oral glucose tolerance test. DBT improves insulin sensitivity through increased post-receptor insulin signaling mediated by enhancements in insulin receptor substrate-1-associated phosphatidylinositol 3-kinase step and glucose transporter subtype 4 translocation in soleus muscles of animals exhibiting insulin resistance. DBT is therefore proposed as potentially useful adjuvant therapy for patients with insulin resistance and/or the patients who wish to increase insulin sensitivity.</p>
]]></description>
<dc:creator><![CDATA[Liu, I-M., Tzeng, T.-F., Liou, S.-S.]]></dc:creator>
<dc:date>Fri, 20 Feb 2009 03:13:33 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep004</dc:identifier>
<dc:title><![CDATA[A Chinese Herbal Decoction, Dang Gui Bu Xue Tang, Prepared from Radix Astragali and Radix Angelicae sinensis, Ameliorates Insulin Resistance Induced by A High-Fructose Diet in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep007v1?rss=1">
<title><![CDATA[Triterpenic Acids Present in Hawthorn Lower Plasma Cholesterol by Inhibiting Intestinal ACAT Activity in Hamsters]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep007v1?rss=1</link>
<description><![CDATA[
<p>Hawthorn (<I>Crataegus pinnatifida</I>) is an edible fruit used in traditional Chinese medicine to lower plasma lipids. This study explored lipid-lowering compounds and underlying mechanisms of action of hawthorn. Hawthorn powder extracts inhibited acylCoA:cholesterol acyltransferase (ACAT) activity in Caco-2 cells. The inhibitory activity was positively associated with triterpenic acid [i.e. oleanolic acid (OA) and ursolic acid (UA)] contents in the extracts. Cholesterol lowering effects of hawthorn and its potential additive effect in combination with plant sterol esters (PSE) were further studied in hamsters. Animals were fed a semi-synthetic diet containing 0.08% (w/w) cholesterol (control) or the same diet supplemented with (i) 0.37% hawthorn dichloromethane extract, (ii) 0.24% PSE, (iii) hawthorn dichloromethane extract (0.37%) plus PSE (0.24%) or (iv) OA/UA mixture (0.01%) for 4 weeks. Compared to the control diet, hawthorn, PSE, hawthorn plus PSE and OA/UA significantly lowered plasma non-HDL (VLDL + LDL) cholesterol concentrations by 8%, 9%, 21% and 6% and decreased hepatic cholesterol ester content by 9%, 23%, 46% and 22%, respectively. The cholesterol lowering effects of these ingredients were conversely associated with their capacities in increasing fecal neutral sterol excretion. In conclusion, OA and UA are responsible for the cholesterol lowering effect of hawthorn by inhibiting intestinal ACAT activity. In addition, hawthorn and particularly its bioactive compounds (OA and UA) enhanced the cholesterol lowering effect of plant sterols.</p>
]]></description>
<dc:creator><![CDATA[Lin, Y., Vermeer, M. A., A. Trautwein, E.]]></dc:creator>
<dc:date>Thu, 19 Feb 2009 04:33:44 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep007</dc:identifier>
<dc:title><![CDATA[Triterpenic Acids Present in Hawthorn Lower Plasma Cholesterol by Inhibiting Intestinal ACAT Activity in Hamsters]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-19</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep009v1?rss=1">
<title><![CDATA[Acupuncture at 'Zusanli' (St.36) and 'Sanyinjiao' (SP.6) Points on the Gastrointestinal Tract: A Study of the Bioavailability of 99mTc-Sodium Pertechnetate in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep009v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study is to investigate the differences of acupuncture effect between the Zusanli (St.36) and Sanyinjiao (SP.6) points on the gastrointestinal-tract (GIT) segment performed by the bioavailability of <sup>99m</sup>Tc-sodium-pertechnetate (Na<sup>99m</sup>TcO<SUB>4</SUB>) in rats. Male Wistar rats (<I>n</I> = 21) were allocated into three groups of seven each. Group 1 was treated by acupuncture bilaterally at St.36; Group 2 at SP.6; and Group 3 was untreated (control). After 10 min of needle insertion in anesthetized rats, 0.3 ml of Na<sup>99m</sup>TcO<SUB>4</SUB> (7.4 MBq) was injected via ocular-plexus. After 20 min, the exitus of animals was induced by cervical-dislocation and GIT organs isolated. However, immediately before the exitus procedure, blood was collected by cardiac-puncture for blood radio-labeling (BRL).The radioactivity uptake of the blood constituents was calculated together with the GIT organs by a well gamma counter. The percentage of injected dose per gram of tissue (%ID/g) of Na<sup>99m</sup>TcO<SUB>4</SUB> was calculated for each GIT organs, while BRL was calculated in%ID. According to the one-way ANOVA, the stomach, jejunum, ileum from the treated groups (Group 1 and Group 2) had significant differences compared to the controls (Group 3). However, between the treated groups (Group 1 and Group 2), there were significant differences (<I>P</I> &lt; 0.05) in the stomach, jejunum, ileum, cecum, transverse and rectum. In BRL analysis, Group 2 showed significant increase and decrease of the insoluble and soluble fractions of the blood cells, respectively (<I>P</I> &lt; 0.0001). The authors suggest that St.36 may have a tendency of up-regulation effect on GIT, whereas SP.6, down-regulation effect. However, further rigorous experimental studies to examine the effectiveness of acupuncture in either acupuncture points need to be carried out.</p>
]]></description>
<dc:creator><![CDATA[Senna-Fernandes, V., Franca, D. L. M., de Souza, D., Santos, K. C. M., Sousa, R. S., Manoel, C. V., Santos-Filho, S. D., Bernardo-Filho, M., Guimaraes, M. A. M.]]></dc:creator>
<dc:date>Thu, 12 Feb 2009 07:14:35 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep009</dc:identifier>
<dc:title><![CDATA[Acupuncture at 'Zusanli' (St.36) and 'Sanyinjiao' (SP.6) Points on the Gastrointestinal Tract: A Study of the Bioavailability of 99mTc-Sodium Pertechnetate in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-12</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep012v1?rss=1">
<title><![CDATA[Preventive Effect of Boiogito on Metabolic Disorders in the TSOD Mouse, a Model of Spontaneous Obese Type II Diabetes Mellitus]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep012v1?rss=1</link>
<description><![CDATA[
<p>&lsquo;Boiogito&rsquo; is a Kampo preparation which has been used since ancient times in patients with obesity of the &lsquo;asthenic constitution&rsquo; type, so-called &lsquo;watery obesity&rsquo;, and its effect has been recognized clinically. In this study, we investigated the anti-obesity effect of Boiogito in the TSOD (Tsumura Suzuki Obese Diabetes) mouse, a model of spontaneous obese type II diabetes mellitus. Boiogito showed a significant anti-obesity effect in TSOD mice by suppressing body weight gain in a dosage-dependent manner. In addition, Boiogito showed significant ameliorative effects on features of metabolic syndrome such as hyperinsulinemia, fasting hyperglycemia and abnormal lipid metabolism. Regarding lipid accumulation in TSOD mice, Boiogito showed a significant suppressive effect on accumulation of subcutaneous fat, but the effect on the visceral fat accumulation that constitutes the basis of metabolic syndrome was weak, and the suppressive effect on insulin resistance was also weak. Furthermore, Boiogito did not alleviate the abnormal glucose tolerance, the hypertension or the peripheral neuropathy characteristically developed in the TSOD mice. In contrast, in the TSNO (Tsumura Suzuki Non-Obesity) mice used as controls, Boiogito suppressed body weight gain and accumulation of subcutaneous and visceral fat. The above results suggested that Boiogito is effective as an anti-obesity drug against obesity of the &lsquo;asthenic constitution&rsquo; type in which subcutaneous fat accumulates, but cannot be expected to exert a preventive effect against various symptoms of metabolic syndrome that are based on visceral fat accumulation.</p>
]]></description>
<dc:creator><![CDATA[Shimada, T., Akase, T., Kosugi, M., Aburada, M.]]></dc:creator>
<dc:date>Tue, 10 Feb 2009 05:37:53 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep012</dc:identifier>
<dc:title><![CDATA[Preventive Effect of Boiogito on Metabolic Disorders in the TSOD Mouse, a Model of Spontaneous Obese Type II Diabetes Mellitus]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep013v1?rss=1">
<title><![CDATA[Protective Effects of Chinese Traditional Medicine Buyang Huanwu Decoction on Myocardial Injury]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep013v1?rss=1</link>
<description><![CDATA[
<p>Many clinical studies have reported that Buyang Huanwu Decoction (BYHWD) has a protective effect on ischemic heart disease (IHD). In the present study, the protective effect of BYHWD on myocardial ischemia was investigated. Different doses of BYHWD and Compound Danshen Dropping Pills (CDDP) were lavaged to rats respectively, isoproterenol (ISO) was intraperitoneally injected in to all animals to induce myocardial ischemia except the control group. Electrocardiogram (ECG) of each animal was recorded; activities of lactate dehydrogenase (LDH), creatine kinase (CK) and aspartate aminotransferase (AST) in serum were detected. As the results of ECG showed, pre-treatment with BYHWD inhibited ischemic myocardial injury, and the activities of LDH, CK and AST were lower than those in the myocardial ischemia model group, which suggests that BYHWD rescues the myocardium from ischemia status. To research the potential mechanism, the level of nitric oxide (NO), nitric oxide syntheses (NOS) and inducible nitric oxide syntheses (iNOS), the expression of iNOS and ligand of cluster of differentiation 40 (CD40L) were detected. The results revealed that BYHWD significantly decreased the level of NO, NOS and iNOS in serum. Moreover, BYHWD decreased the expression of iNOS and CD40L in myocardial tissues. These results indicate that the protective effect of BYHWD on myocardial ischemia and mechanism are associated with inhibition of iNOS and CD40L expression.</p>
]]></description>
<dc:creator><![CDATA[Yang, G., Fang, Z., Liu, Y., Zhang, H., Shi, X., Ji, Q., Lin, Q., Lin, R.]]></dc:creator>
<dc:date>Sun, 08 Feb 2009 22:26:11 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep013</dc:identifier>
<dc:title><![CDATA[Protective Effects of Chinese Traditional Medicine Buyang Huanwu Decoction on Myocardial Injury]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen089v1?rss=1">
<title><![CDATA[Winnowing the Chaff of Charlatanism from the Wheat of Science]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen089v1?rss=1</link>
<description><![CDATA[
<p>Experts and lay people alike can sometimes find it difficult to demarcate the absurd. Here I propose a set of criteria that may be helpful in achieving this in the realm of healthcare: falsifiability, plausibility and some hallmarks of pseudoscience. Applying this method is unlikely to be fool-proof but it might be a valuable aid in discriminating credible from incredible health claims.</p>
]]></description>
<dc:creator><![CDATA[Ernst, E.]]></dc:creator>
<dc:date>Fri, 06 Feb 2009 23:03:11 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen089</dc:identifier>
<dc:title><![CDATA[Winnowing the Chaff of Charlatanism from the Wheat of Science]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-06</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep003v1?rss=1">
<title><![CDATA[Antioxidant and Preventive Effects of Extract from Nymphaea candida Flower on In vitro Immunological Liver Injury of Rat Primary Hepatocyte Cultures]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep003v1?rss=1</link>
<description><![CDATA[
<p><I>Nymphaea candida</I> is traditional Uighur medicine that is commonly used to treat head pains, cough, hepatitis and hypertension in Xinjiang of China. In this article, the extract of <I>N. candida</I> was measured for antioxidant activity, using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals scavenging assay and reducing power determination, and compared with those of the positive controls of butylated hydroxytoluene (BHT) and gallic acid (GA). The active extract was further purified by liquid&ndash;liquid partition to afford four fractions, of which the ethyl acetate-soluble (EA) fraction (NCE) exhibited the strongest antioxidant capacity with IC<SUB>50</SUB> value of 12.6 &micro;g/ml for DPPH&middot;. Thirteen phenolic compounds were isolated from this fraction, and they all showed significant antioxidant activities in DPPH model system. Furthermore, NCE showed potent antioxidant capacity with IC<SUB>50</SUB> value of 59.32 &micro;g/ml, 24.48 &micro;g/ml and 86.85 &micro;g/ml, for O<SUB>2</SUB><sup>&ndash;</sup>,&middot;OH and H<SUB>2</SUB>O<SUB>2</SUB> radicals, respectively. Moreover, NCE on BCG plus LPS-induced immunological liver injury was evaluated using primary cultured rat hepatocytes. NCE produced significant hepatoprotective effects as evidenced by decreased supernatant enzyme activities (AST&mdash;aspartate transaminase, <I>P</I> &lt; 0.01; ALT&mdash;alanine transferase, <I>P</I> &lt; 0.01) and nitric oxide (NO, <I>P</I> &lt; 0.01) production. These results revealed the <I>in vitro</I> antioxidant and hepatoprotective activities of NCE against immunological liver injury. Further investigations are necessary to verify these activities <I>in vivo</I>.</p>
]]></description>
<dc:creator><![CDATA[Zhao, J., Liu, T., Ma, L., Yan, M., Gu, Z., Huang, Y., Xu, F., Zhao, Y.]]></dc:creator>
<dc:date>Thu, 05 Feb 2009 04:17:10 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep003</dc:identifier>
<dc:title><![CDATA[Antioxidant and Preventive Effects of Extract from Nymphaea candida Flower on In vitro Immunological Liver Injury of Rat Primary Hepatocyte Cultures]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-05</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep002v1?rss=1">
<title><![CDATA[Alstonine as an Antipsychotic: Effects on Brain Amines and Metabolic Changes]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep002v1?rss=1</link>
<description><![CDATA[
<p>Managing schizophrenia has never been a trivial matter. Furthermore, while classical antipsychotics induce extrapyramidal side effects and hyperprolactinaemia, atypical antipsychotics lead to diabetes, hyperlipidaemia, and weight gain. Moreover, even with newer drugs, a sizable proportion of patients do not show significant improvement. Alstonine is an indole alkaloid identified as the major component of a plant-based remedy used in Nigeria to treat the mentally ill. Alstonine presents a clear antipsychotic profile in rodents, apparently with differential effects in distinct dopaminergic pathways. The aim of this study was to complement the antipsychotic profile of alstonine, verifying its effects on brain amines in mouse frontal cortex and striatum. Additionally, we examined if alstonine induces some hormonal and metabolic changes common to antipsychotics. HPLC data reveal that alstonine increases serotonergic transmission and increases intraneuronal dopamine catabolism. In relation to possible side effects, preliminary data suggest that alstonine does not affect prolactin levels, does not induce gains in body weight, but prevents the expected fasting-induced decrease in glucose levels. Overall, this study reinforces the proposal that alstonine is a potential innovative antipsychotic, and that a comprehensive understanding of its neurochemical basis may open new avenues to developing newer antipsychotic medications.</p>
]]></description>
<dc:creator><![CDATA[Linck, V. M., Herrmann, A. P., Piato, A. L., Detanico, B. C., Figueiro, M., Florio, J., Iwu, M. M., Okunji, C. O., Leal, M. B., Elisabetsky, E.]]></dc:creator>
<dc:date>Mon, 02 Feb 2009 23:16:04 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep002</dc:identifier>
<dc:title><![CDATA[Alstonine as an Antipsychotic: Effects on Brain Amines and Metabolic Changes]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep001v1?rss=1">
<title><![CDATA[Acupuncture and Auricular Acupressure in Relieving Menopausal Hot Flashes of Bilaterally Ovariectomized Chinese Women: A Randomized Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep001v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study is to explore the effects of acupuncture and auricular acupressure in relieving menopausal hot flashes of bilaterally ovariectomized Chinese women. Between May 2006 and March 2008, 46 bilaterally ovariectomized Chinese women were randomized into an acupuncture and auricular acupressure group (<I>n</I> = 21) and a hormone replacement therapy (HRT) group (Tibolone, <I>n</I> = 25). Each patient was given a standard daily log and was required to record the frequency and severity of hot flashes and side effects of the treatment felt daily, from 1 week before the treatment started to the fourth week after the treatment ended. The serum levels of follicle stimulating hormone (FSH), LH and E<SUB>2</SUB> were detected before and after the treatment. After the treatment and the follow-up, both the severity and frequency of hot flashes in the two groups were relieved significantly when compared with pre-treatment (<I>P</I> &lt; 0.05). There was no significant difference in the severity of hot flashes between them after treatment (<I>P</I> &gt; 0.05), while after the follow-up, the severity of hot flashes in the HRT group was alleviated more. After the treatment and the follow-up, the frequency of menopausal hot flashes in the HRT group was reduced more (<I>P</I> &lt; 0.05). After treatment, the levels of FSH decreased significantly and the levels of E<SUB>2</SUB> increased significantly in both groups (<I>P</I> &lt; 0.05), and they changed more in the HRT group (<I>P</I> &lt; 0.05). Acupuncture and auricular acupressure can be used as alternative treatments to relieve menopausal hot flashes for those bilaterally ovariectomized women who are unable or unwilling to receive HRT.</p>
]]></description>
<dc:creator><![CDATA[Zhou, J., Qu, F., Sang, X., Wang, X., Nan, R.]]></dc:creator>
<dc:date>Mon, 02 Feb 2009 23:16:04 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep001</dc:identifier>
<dc:title><![CDATA[Acupuncture and Auricular Acupressure in Relieving Menopausal Hot Flashes of Bilaterally Ovariectomized Chinese Women: A Randomized Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen091v1?rss=1">
<title><![CDATA[Filtrate of Phellinus linteus Broth Culture Reduces Infarct Size Significantly in a Rat Model of Permanent Focal Cerebral Ischemia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen091v1?rss=1</link>
<description><![CDATA[
<p><I>Phellinus linteus</I>, a natural growing mushroom, has been known to exhibit anti-tumor, anti-inflammatory, anti-allergic and anti-oxidant effects. Aiming to exploit the neuroprotective effects of <I>P. linteus</I>, we evaluated its effects on infarct volume reduction in a rat model of focal cerebral ischemia. Male Sprague&ndash;Dawley rats were subjected to right middle cerebral artery occlusion. Filtrate of <I>P. linteus</I> broth culture (various doses), fractionated filtrate (based on molecular weight) or control medium was administered intraperitoneally to rats before or after ischemia induction. Rats were killed at 24 h after the stroke surgery. Cortical and caudoputaminal infarct volumes were determined separately using an image analysis program following staining with 2,3,5-triphenyltetrazolium chloride. Significant cortical infarct volume reductions were found in the pre-treatment groups (30 and 60 min before onset of cerebral ischemia) compared with the control group, showing dose dependence. Posttreatment (30 min after ischemic onset) also significantly reduced cortical infarct volume. Furthermore, the higher molecular weight (&ge;12 000) fraction of the culture filtrate was more effective compared with the lower molecular weight fraction. The present findings suggest that <I>P. linteus</I> may be a new promising approach for the treatment of focal cerebral ischemia, with the additional benefit of a wide therapeutic time window since significant infarct volume reduction is obtained by administration even after the ischemic event. Our finding that the higher molecular weight fraction of the <I>P. linteus</I> culture filtrate demonstrated more prominent effect may provide a clue to identify the neuroprotective substances and mechanisms.</p>
]]></description>
<dc:creator><![CDATA[Suzuki, S., Kawamata, T., Okada, Y., Kobayashi, T., Nakamura, T., Hori, T.]]></dc:creator>
<dc:date>Tue, 20 Jan 2009 05:36:41 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen091</dc:identifier>
<dc:title><![CDATA[Filtrate of Phellinus linteus Broth Culture Reduces Infarct Size Significantly in a Rat Model of Permanent Focal Cerebral Ischemia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen074v3?rss=1">
<title><![CDATA[A Standardized Transcutaneous Electric Acupoint Stimulation for Relieving Tobacco Urges in Dependent Smokers]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen074v3?rss=1</link>
<description><![CDATA[
<p>The efficacy of acupuncture in smoking cessation, and its effect on the urge to smoke are unclear. We evaluated the effect of a standardized protocol of transcutaneous electric acupoint stimulations (TEAS) on alleviating the urge to smoke. Ninety-eight smokers were recruited in two double-blind studies. Participants abstained from smoking for 26 h, and were randomized to receive TEAS alternating between 2 and 100 Hz at four acupoints (LI4 and PC8, PC6 and TE5) at four different intensities (10, 5, Intermittent 5 or 0 mA). The urge to smoke was assessed by the Questionnaire of Smoking Urges (QSU-Brief). In Experiment 1, the 10 mA group (<I>n</I> = 20) was compared with the 5 mA group (<I>n</I> = 20); the increase in smoking urges did not differ significantly. Considering the possibility that 5 mA may be an active intervention, in Experiment 2, a true placebo (0 mA), and a proxy of placebo [Intermittent 5 mA (i5 mA)] were compared with 10 mA TEAS. In this experiment, 10 mA (<I>n</I> = 20) TEAS showed a tendency to alleviate smoking urges compared with 0 mA (<I>n</I> = 16), and i5 mA (<I>n</I> = 19) TEAS. Only when the data of smokers with Fagerst&ouml;m Test for Nicotine Dependence score &ge;5 were analyzed that the difference between the 10 mA group and the control group (0 and i5 mA) became significant. Based on these preliminary findings, we conclude that TEAS applied on the skin may antagonize the increase in urge to smoke in abstinent-dependent smokers. It seems warranted to assess the efficacy of TEAS in smoking cessation clinical trials involving a larger population of dependent smokers.</p>
]]></description>
<dc:creator><![CDATA[Lambert, C., Berlin, I., Lee, T.-L., Hee, S. W., Tan, A. S. L., Picard, D., Han, J. S.]]></dc:creator>
<dc:date>Tue, 20 Jan 2009 05:36:41 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen074</dc:identifier>
<dc:title><![CDATA[A Standardized Transcutaneous Electric Acupoint Stimulation for Relieving Tobacco Urges in Dependent Smokers]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen088v1?rss=1">
<title><![CDATA[Forgotten Features of Head Zones and Their Relation to Diagnostically Relevant Acupuncture Points]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen088v1?rss=1</link>
<description><![CDATA[
<p>In the 1890s Sir Henry Head discovered certain areas of the skin that develop tenderness (allodynia) in the course of visceral disease. These areas were later termed &lsquo;Head zones&rsquo;. In addition, he also emphasized the existence of specific points within these zones, that he called &lsquo;maximum points&rsquo;, a finding that seems to be almost forgotten today. We hypothesized that two important groups of acupuncture points, the diagnostically relevant Mu and Shu points, spatially and functionally coincide with these maximum points to a large extent. A comparison of Head's papers with the Huang Di Neijing (Yellow Thearch's Inner Classic) and the Zhen Jiu Jia Yi Jing (Systematic Classic of Acupuncture and Moxibustion), two of the oldest still extant Chinese sources on acupuncture, revealed astonishing parallels between the two concepts regarding both point locations and functional aspects. These findings suggest that the Chinese discovery of viscerocutaneous reflexes preceded the discovery in the West by more than 2000 years. Furthermore, the fact that Chinese medicine uses Mu and Shu points not only diagnostically but also therapeutically may give us new insights into the underlying mechanisms of acupuncture.</p>
]]></description>
<dc:creator><![CDATA[Beissner, F., Henke, C., Unschuld, P. U.]]></dc:creator>
<dc:date>Mon, 12 Jan 2009 23:54:48 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen088</dc:identifier>
<dc:title><![CDATA[Forgotten Features of Head Zones and Their Relation to Diagnostically Relevant Acupuncture Points]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-12</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen086v1?rss=1">
<title><![CDATA[Jungle Honey Enhances Immune Function and Antitumor Activity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen086v1?rss=1</link>
<description><![CDATA[
<p>Jungle honey (JH) is collected from timber and blossom by wild honey bees that live in the tropical forest of Nigeria. JH is used as a traditional medicine for colds, skin inflammation and burn wounds as well as general health care. However, the effects of JH on immune functions are not clearly known. Therefore, we investigated the effects of JH on immune functions and antitumor activity in mice. Female C57BL/6 mice were injected with JH (1 mg/mouse/day, seven times intra-peritoneal). After seven injections, peritoneal cells (PC) were obtained. Antitumor activity was assessed by growth of Lewis Lung Carcinoma/2 (LL/2) cells. PC numbers were increased in JH-injected mice compared to control mice. In Dot Plot analysis by FACS, a new cell population appeared in JH-injected mice. The percent of Gr-1 surface antigen and the intensity of Gr-1 antigen expression of PC were increased in JH-injected mice. The new cell population was neutrophils. JH possessed chemotactic activity for neutrophils. Tumor incidence and weight were decreased in JH-injected mice. The ratio of reactive oxygen species (ROS) producing cells was increased in JH-injected mice. The effective component in JH was fractionized by gel filtration using HPLC and had an approximate molecular weight (MW) of 261. These results suggest that neutrophils induced by JH possess potent antitumor activity mediated by ROS and the effective immune component of JH is substrate of MW 261.</p>
]]></description>
<dc:creator><![CDATA[Fukuda, M., Kobayashi, K., Hirono, Y., Miyagawa, M., Ishida, T., Ejiogu, E. C., Sawai, M., Pinkerton, K. E., Takeuchi, M.]]></dc:creator>
<dc:date>Mon, 12 Jan 2009 23:54:48 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen086</dc:identifier>
<dc:title><![CDATA[Jungle Honey Enhances Immune Function and Antitumor Activity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-12</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen087v1?rss=1">
<title><![CDATA[Screening Antitumor Compounds Psoralen and Isopsoralen from Psoralea corylifolia L. Seeds]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen087v1?rss=1</link>
<description><![CDATA[
<p><I>Psoralea corylifolia</I> L. (Fabaceae) is a widely used medical plant in China. This study was designed to screen and identify bioactive compounds with anticancer activity from the seeds of <I>Psoralea corylifolia</I> L. One volatile fraction (fraction I) and three other fractions (fraction II, III, IV) from methanol extraction of <I>P. corylifolia</I> L. were obtained. Bioactivities of these fractions were evaluated by the cytotoxicity on KB, KBv200, K562, K562/ADM cancer cells with MTT assay. Major components in the active fraction were identified by HPLC/MS<sup>n</sup>. Fraction IV significantly inhibits the growth of cancer cells in a dose-dependent manner. The IC<SUB>50</SUB> values were 21.6, 24.4, 10.0 and 26.9, respectively. Psoralen and isopsoralen, isolated from fraction IV, were subject to bioactive assay and presented a dose-dependent anticancer activity in four cancer cell lines (KB, KBv200, K562 and K562/ADM). The IC<SUB>50</SUB> values of psoralen were 88.1, 86.6, 24.4 and 62.6, which of isopsoralen were 61.9, 49.4, 49.6 and 72.0, respectively. Apoptosis of tumor cell significantly increased after treated with psoralen and isopsoralen. Induction of apoptotic activity was confirmed by flow cytometry after staining with Annexin V/PI. These results suggested psoralen and isopsoralen contribute to anticancer effect of <I>P. corylifolia</I> L.</p>
]]></description>
<dc:creator><![CDATA[Wang, Y., Hong, C., Zhou, C., Xu, D., Qu, H.-b., Cheng, Y.]]></dc:creator>
<dc:date>Thu, 08 Jan 2009 04:35:07 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen087</dc:identifier>
<dc:title><![CDATA[Screening Antitumor Compounds Psoralen and Isopsoralen from Psoralea corylifolia L. Seeds]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen085v1?rss=1">
<title><![CDATA[A Chinese Herbal Decoction, Danggui Buxue Tang, Stimulates Proliferation, Differentiation and Gene Expression of Cultured Osteosarcoma Cells: Genomic Approach to Reveal Specific Gene Activation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen085v1?rss=1</link>
<description><![CDATA[
<p>Danggui Buxue Tang (DBT), a Chinese herbal decoction used to treat ailments in women, contains Radix Astragali (Huangqi; RA) and Radix Angelicae Sinensis (Danggui; RAS). When DBT was applied onto cultured MG-63 cells, an increase of cell proliferation and differentiation of MG-63 cell were revealed: both of these effects were significantly higher in DBT than RA or RAS extract. To search for the biological markers that are specifically regulated by DBT, DNA microarray was used to reveal the gene expression profiling of DBT in MG-63 cells as compared to that of RA- or RAS-treated cells. Amongst 883 DBT-regulated genes, 403 of them are specifically regulated by DBT treatment, including CCL-2, CCL-7, CCL-8 and galectin-9. The signaling cascade of this DBT-regulated gene expression was also elucidated in cultured MG-63 cells. The current results reveal the potential usage of this herbal decoction in treating osteoporosis and suggest the uniqueness of Chinese herbal decoction that requires a well-defined formulation. The DBT-regulated genes in the culture could serve as biological responsive markers for quality assurance of the herbal preparation.</p>
]]></description>
<dc:creator><![CDATA[Choi, R. C. Y., Gao, Q. T., Cheung, A. W. H., Zhu, J. T. T., Lau, F. T. C., Li, J., Li, W. Z. M., Chu, G. K. Y., Duan, R., Cheung, J. K. H., Ding, A. W., Zhao, K. J., Dong, T. T. X., Tsim, K. W. K.]]></dc:creator>
<dc:date>Thu, 08 Jan 2009 04:35:07 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen085</dc:identifier>
<dc:title><![CDATA[A Chinese Herbal Decoction, Danggui Buxue Tang, Stimulates Proliferation, Differentiation and Gene Expression of Cultured Osteosarcoma Cells: Genomic Approach to Reveal Specific Gene Activation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen084v1?rss=1">
<title><![CDATA[Cordycepin Induced MA-10 Mouse Leydig Tumor Cell Apoptosis through Caspase-9 Pathway]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen084v1?rss=1</link>
<description><![CDATA[
<p>In the present study, the apoptotic effect of cordycepin on MA-10 cells, a mouse Leydig tumor cell line, was investigated. Results demonstrated that the number of rounding-up cell increased by cordycepin (10 &micro;M to 5 mM for 24 h), and cells with plasma membrane blebbing could be observed by 100 &micro;M cordycepin. In viability test, MA-10 cell surviving rate significantly decreased as the dosage (10 &micro;M to 5 mM) and duration (3&ndash;24 h) of cordycepin treatment increased (<I>P</I> &lt; 0.05). Cordycepin at 100 &micro;M and 1 mM for 24 h treatment induced significant DNA fragmentation (<I>P</I> &lt; 0.05). In addition, the percentage of G1 and G2/M phase cell significantly declined by cordycepin (100 &micro;M and 1 mM) for 24 h treatment, while the percentages of subG1 phase cell increased by 100 &micro;M and/or 1 mM cordycepin in 6, 12 and 24 h treatments (<I>P</I> &lt; 0.05), respectively, which highly suggested that cordycepin induced MA-10 cell apoptosis. In mechanism study with the treatments of caspases, c-Jun NH<SUB>2</SUB> terminal kinase (JNK) or reactive oxygen species (ROS) inhibitors plus cordycepin for 24 h, only caspases inhibitor suppressed subG1 phase in MA-10 cells. Moreover, western blotting results showed that cordycepin induced caspase-9, -3 and -7 protein expressions, but not caspase-8, in time- and dose-dependent manners. In conclusion, cordycepin induced apoptosis in MA-10 mouse Leydig tumor cells through a caspase-9 and -3 and -7 dependent pathway.</p>
]]></description>
<dc:creator><![CDATA[Jen, C.-Y., Lin, C.-Y., Leu, S.-F., Huang, B.-M.]]></dc:creator>
<dc:date>Thu, 08 Jan 2009 04:35:05 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen084</dc:identifier>
<dc:title><![CDATA[Cordycepin Induced MA-10 Mouse Leydig Tumor Cell Apoptosis through Caspase-9 Pathway]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen081v1?rss=1">
<title><![CDATA[Suppressive Effect of Juzen-Taiho-To on Lung Metastasis of B16 Melanoma Cells in vivo]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen081v1?rss=1</link>
<description><![CDATA[
<p>Juzen-Taiho-To (JTT) is well known to be one of Kampo (Japanese herbal) medicine consisted of 10 component herbs and used for the supplemental therapy of cancer patients with remarkably success. However, the precise mechanisms by which JTT could favorably modify the clinical conditions of cancer patients are not well defined. The present study, therefore, was undertaken to examine the possible mechanisms of JTT on prevention of cancer metastasis using experimental mouse model. JTT was well mixed with rodent chow at concentrations of either 0.2 or 1.0%, and administered orally <I>ad libitum</I>, which was started 1 week before tumor cell injection and continue throughout the experiment. Oral administration of JTT at concentration 0.2 and 1.0% into C57BL/6 male mice significantly inhibited tumor metastasis in lungs, which was induced by the intravenous injection of 2 <FONT FACE="arial,helvetica">x</FONT> 10<sup>5</sup> B16 melanoma cell. JTT at a concentration of 1.0% also significantly suppressed lung metastasis of B16 melanoma cell from hind footpad in C57BL/6 mice. In the second part of experiments, the influence of the depression of natural killer (NK) cell, natural killer T (NKT) cell and several types of cytokines on JTT-mediated inhibition of tumor cell metastasis. Intraperitoneal injection of anti asialo-GM1 antibody against NK cells and anti NK-1.1 monoclonal antibody (mAb) to NKT cells abrogated the inhibitory action of JTT on lung metastasis of B16 melanoma cells. Although intraperitoneal administration of anti-IFN- mAb scarcely affected the inhibitory action of JTT on tumor cell metastasis, injection of amrinone, which used for IL-12 suppression, significantly decreased the ability of JTT to prevent tumor cell metastasis. These results strongly suggest that oral administration of JTT caused increase in the production of IL-12, which is responsible for the activation of both NK cell and NKT cell, in the lungs and results in inhibition of B16 melanoma cell metastasis in the lungs.</p>
]]></description>
<dc:creator><![CDATA[Matsuda, T., Maekawa, K., Asano, K., Hisamitsu, T.]]></dc:creator>
<dc:date>Thu, 08 Jan 2009 04:35:05 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen081</dc:identifier>
<dc:title><![CDATA[Suppressive Effect of Juzen-Taiho-To on Lung Metastasis of B16 Melanoma Cells in vivo]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen083v2?rss=1">
<title><![CDATA[A Milestone in Codifying the Wisdom of Traditional Oriental Medicine: TCM, Kampo, TKM, TVM--WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen083v2?rss=1</link>
<description><![CDATA[
<p>The WHO published a dictionary-type book entitled &lsquo;WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region&rsquo; which has a total of 3259 technical terms which have been commonly used in traditional Chinese (TCM), Japanese (Kampo), Korean (TKM) and Vietnamese (TVM) medicines. In this comprehensive guide, each term has the English expression, the original Chinese character and a concise English definition. The book covers 3106 terms from basic theories, diagnostics, diseases, various therapeutics including acupuncture and moxibustion and even the English wording of 153 titles which are considered the most important traditional medical classics published in these four countries. A prominent feature of the compilation is the codification format that assigns numbers in hundred decimal units for each category of the section. This type of coding system provides the flexibility for adding more terminologies in the future and is useful for constructing a database for the retrieval of various published scientific articles. Overall, the usage of these standard terminologies is highly desirable to deliver accurate meanings, and ultimately to avoid a variety of expressions for a single term in different scientific manuscripts on Oriental medicine.</p>
]]></description>
<dc:creator><![CDATA[Choi, S.-H., Chang, I.-M.]]></dc:creator>
<dc:date>Tue, 06 Jan 2009 09:36:51 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen083</dc:identifier>
<dc:title><![CDATA[A Milestone in Codifying the Wisdom of Traditional Oriental Medicine: TCM, Kampo, TKM, TVM--WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-06</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen082v1?rss=1">
<title><![CDATA[Evaluation of Oxygen Radical Absorbance Capacity in Kampo Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen082v1?rss=1</link>
<description><![CDATA[
<p>Antioxidant capacity of food has come to be shown in terms of oxygen radical absorbance capacity (ORAC) mainly on vegetables or fruit. However, the evaluation of Kampo in terms of ORAC has not yet been accomplished. It is important that such an investigation is also conducted for Kampo medicine. We measured the ORAC value of almost all the available Kampo formulas used in the Japanese National health insurance system and examined the ORAC value both for the daily prescription, and also the crude herb ingredients. The ORAC value of Kampo medicine ranged 4.65&ndash;5913 units/day. The ORAC value was high in Kampo formulas including Rhei Rhizoma, and was relatively high in Kampo formulas including anti-inflammatory herbs other than Rhei Rhizoma. The ORAC value was also high in Kampo formulas including crude herbs that have relaxation effects. The ORAC value of a crude herb would seem to not be fixed but be dependent on combination with other crude herbs from the comparison of different herbs added to the basic Kampo medicine. These results suggest variability and complexity of the antioxidant capacity of Kampo medicine within the similar range of food. On the other hand, investigation of the compound changes of various crude herbs with ORAC may lead to the elucidation of the action mechanism of Kampo medicine.</p>
]]></description>
<dc:creator><![CDATA[Nishimura, K., Osawa, T., Watanabe, K.]]></dc:creator>
<dc:date>Tue, 06 Jan 2009 02:30:05 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen082</dc:identifier>
<dc:title><![CDATA[Evaluation of Oxygen Radical Absorbance Capacity in Kampo Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-06</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen080v1?rss=1">
<title><![CDATA[Delayed Effect of Acupuncture Treatment in OA of the Knee: A Blinded, Randomized, Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen080v1?rss=1</link>
<description><![CDATA[
<p>To assess the efficacy in providing improved function and pain relief by administering 8 weeks of acupuncture as adjunctive therapy to standard care in elderly patients with OA of the knee. This randomized, controlled, blinded trial was conducted on 55 patients with OA of the knee. Forty-one patients completed the study (26 females, 15 males, mean age &plusmn; SD 71.7 &plusmn; 8.6 years). Patients were randomly divided into an intervention group that received biweekly acupuncture treatment (<I>n</I> = 28) and a control group that received sham acupuncture (<I>n</I> = 27), both in addition to standard therapy, e.g. NSAIDS, cyclooxygenase-2 inhibitors, acetaminophen, intra-articular hyaluronic acid and steroid injections. Primary outcomes measures were changes in the Knee Society Score (KSS) knee score and in KSS function and pain ratings at therapy onset, at 8 weeks (closure of study) and at 12 weeks (1 month after last treatment). Secondary outcomes were patient satisfaction and validity of sham acupuncture. There was significant improvement in all three scores in both groups after 8 and 12 weeks compared with baseline (<I>P</I>&lt;0.05). Significant differences between the intervention and control groups in the KSS knee score (<I>P</I> = 0.036) was apparent only after 12 weeks. Patient satisfaction was higher in the intervention group. Adjunctive acupuncture treatment seems to provide added improvement to standard care in elderly patients with OA of the knee. Future research should determine the optimal duration of acupuncture treatment in the context of OA.</p>
]]></description>
<dc:creator><![CDATA[Miller, E., Maimon, Y., Rosenblatt, Y., Mendler, A., Hasner, A., Barad, A., Amir, H., Dekel, S., Lev-Ari, S.]]></dc:creator>
<dc:date>Mon, 05 Jan 2009 04:23:06 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen080</dc:identifier>
<dc:title><![CDATA[Delayed Effect of Acupuncture Treatment in OA of the Knee: A Blinded, Randomized, Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-05</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen079v1?rss=1">
<title><![CDATA[Complementary and Alternative Medicine: Comparison of Current Knowledge, Attitudes and Interest among German Medical Students and Doctors]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen079v1?rss=1</link>
<description><![CDATA[
<p>Although it has been agreed that complementary and alternative medicine (CAM) should be included in the German medical curriculum, there is no consensus on which methods and how it should be taught. This study aimed to assess needs for CAM education by evaluating current knowledge, attitudes and interests of medical students, general physicians and gynecologists. Two instruments based on established and validated questionnaires were developed. One was given to seventh semester medical students and the other to office-based doctors. Data were analyzed by bivariate correlation and cross-tabulation. Altogether 550 questionnaires were distributed&mdash;280 to doctors and 270 to medical students. Completed questionnaires were returned by 80.4% of students and 78.2% of doctors. Although 73.8% (160/219) of doctors and 40% (87/217) of students had already informed themselves about CAM, neither group felt that they knew much about CAM. Doctors believed that CAM was most useful in general medicine, supportive oncology, pediatrics, dermatology and gynecology, while students believed that dermatology, general medicine, psychiatry and rheumatology offered opportunities; both recommended that CAM should be taught in these areas. Both groups believed that CAM should be included in medical education; however, they believed that CAM needed more investigation and should be taught &lsquo;critically&rsquo;. German doctors and students would like to be better informed about CAM. An approach which teaches fundamental competences to students, chooses specific content based on evidence, demographics and medical conditions and provides students with the skills they need for future learning should be adopted.</p>
]]></description>
<dc:creator><![CDATA[Munstedt, K., Harren, H., von Georgi, R., Hackethal, A.]]></dc:creator>
<dc:date>Sat, 20 Dec 2008 04:00:02 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen079</dc:identifier>
<dc:title><![CDATA[Complementary and Alternative Medicine: Comparison of Current Knowledge, Attitudes and Interest among German Medical Students and Doctors]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-12-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen066v1?rss=1">
<title><![CDATA[The Biological Safety of Stainless Steel Needles Used in Warm-needling]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen066v1?rss=1</link>
<description><![CDATA[
<p>Warm-needling (also called thermo-acupuncture) is a combination of acupuncture and moxibustion. Due to the intense heat involved, there have been concerns over the biological safety of the acuneedles used in the treatment. This paper reports two phases of a safety test. For a preliminary test, we compared the temperature change patterns of stainless steel (SS304) needles and traditional gold alloy needles, which have been increasingly replaced by the former. To verify the effects of the presence of coating materials, the main test involved three different kinds of SS304: silicone-coated, salicylic acid-coated and non-coated needles. Each group of needles was tested for pH level, heavy metals and UV absorbance spectrum along with biological tests on the cytotoxicity and hemolysis of the needle. All the tests on the extractants from the needles were negative. In the biological tests, each test result showed a significant difference from the positive control samples, while no significant difference was observed compared with the negative control samples. In the hemolysis tests, all samples satisfied the Korean Government Standards. All the results suggest that SS304 needles are biologically safe to be used in warm-needling, though they can be improved to perform as well as the gold alloy needles in terms of temperature fluctuations.</p>
]]></description>
<dc:creator><![CDATA[Lim, S., Lee, S., Yi, S.-H., Son, Y.-S., Choi, S.-m., Kim, Y.-K.]]></dc:creator>
<dc:date>Sat, 20 Dec 2008 03:59:59 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen066</dc:identifier>
<dc:title><![CDATA[The Biological Safety of Stainless Steel Needles Used in Warm-needling]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-12-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen078v1?rss=1">
<title><![CDATA[Mediation of Endogenous {beta}-Endorphin in the Plasma Glucose-lowering Action of Herbal Products Observed in Type 1-Like Diabetic Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen078v1?rss=1</link>
<description><![CDATA[
<p>Recently, there have been advances in the development of new substances effective in managing diabetic disorders. Opioid receptors couple multiple systems to result in various biological effects, although opioids are best known for analgesia. In the present review, we used our recent data to describe the advance in plasma glucose-lowering action of herbal products, especially the mediation of &beta;-endorphin in glucose homeostasis of insulin-deficient diabetes. In type 1-like streptozotocin-induced diabetic rats, we identified many products purified from herbs that show a dose-dependent plasma glucose-lowering action. Increase in &beta;-endorphin secretion from the adrenal gland may activate peripheral opioid &micro;-receptors (MOR) to enhance the expression of muscle glucose transporters and/or to reduce hepatic gluconeogenesis at the gene level, thereby leading to improved glucose utilization in peripheral tissues for amelioration of severe hyperglycemia. It has also been observed that stimulation of <SUB>1</SUB>-adrenoceptors (<SUB>1</SUB>-ARs) in the adrenal gland by some herbal products is responsible for the increase in &beta;-endorphin secretion via a phospholipase C-protein kinase dependent pathway. However, an increase in &beta;-endorphin secretion from the adrenal gland by herbal products can function via another receptor. New insights into the mediation of endogenous &beta;-endorphin activation of peripheral MOR by herbal products for regulation of glucose homeostasis without the presence of insulin have been established. Therefore, an increase in &beta;-endorphin secretion and/or direct stimulation of peripheral MOR via an insulin-independent action might serve as the potential target for development of a therapeutic agent or promising adjuvant in intensive plasma glucose control.</p>
]]></description>
<dc:creator><![CDATA[Liu, I. M., Cheng, J. T.]]></dc:creator>
<dc:date>Wed, 17 Dec 2008 22:07:19 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen078</dc:identifier>
<dc:title><![CDATA[Mediation of Endogenous {beta}-Endorphin in the Plasma Glucose-lowering Action of Herbal Products Observed in Type 1-Like Diabetic Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-12-17</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen077v1?rss=1">
<title><![CDATA[Byrsonima fagifolia Niedenzu Apolar Compounds with Antitubercular Activity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen077v1?rss=1</link>
<description><![CDATA[
<p>Bioassay-guided fractionation of the chloroform extract of <I>Byrsonima fagifolia</I> leaves led to the isolation of active antitubercular compounds alkane dotriacontane (Minimal Inhibitory Concentration&mdash;MIC, 62.5 &micro;g ml<sup>&ndash;1</sup>), triterpenoids as bassic acid (MIC = 2.5 &micro;g ml<sup>&ndash;1</sup>), -amyrin acetate (MIC = 62.5 &micro;g ml<sup>&ndash;1</sup>), a mixture of lupeol, - and &beta;-amyrin (MIC = 31.5 &micro;g ml<sup>&ndash;1</sup>) and a mixture of lupeol, and acetates of - and &beta;-amyrin (MIC = 31.5 &micro;g ml<sup>&ndash;1</sup>). The antimycobacterial activity was determined by the Microplate Alamar Blue Assay (MABA) and the structures of promising compounds were determined by spectroscopic analysis. This investigation constitutes the first report of a chemical and antitubercular study of apolar compounds from <I>B. fagifolia</I> Niedenzu (IK).</p>
]]></description>
<dc:creator><![CDATA[Higuchi, C. T., Sannomiya, M., Pavan, F. R., Leite, S. R. A., Sato, D. N., Franzblau, S. G., Sacramento, L. V. S., Vilegas, W., Leite, C. Q. F.]]></dc:creator>
<dc:date>Wed, 17 Dec 2008 04:25:14 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen077</dc:identifier>
<dc:title><![CDATA[Byrsonima fagifolia Niedenzu Apolar Compounds with Antitubercular Activity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-12-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen075v1?rss=1">
<title><![CDATA[The Knowledge, Attitudes and Usage of Complementary and Alternative Medicine of Medical Students]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen075v1?rss=1</link>
<description><![CDATA[
<p>The increasing use of CAM by patients has led to an increase in teaching about CAM in medical school in the US. In preparation for initiation of a new curriculum in Integrative Medicine at the David Geffen School of Medicine at UCLA a cross sectional survey was used to assess medical students&rsquo;: (i) familiarity, (ii) opinions, (iii) personal use and (iv) willingness to recommend specific CAM modalities, using a five point Likert scale of an established measure. A total of 263 first, second and third year medical students at UCLA completed surveys. Third year students reported less personal use of CAM and less favorable attitudes towards CAM than first year students. Since this was a cross-sectional rather than longitudinal study this may be a cohort effect. However, it may reflect the increased curricular emphasis on evidenced-based medicine, and subsequent student dependence on randomized clinical trials to influence and guide practice. This will need to be addressed in curricular efforts to incorporate Integrative Medicine.</p>
]]></description>
<dc:creator><![CDATA[DeSylvia, D., Stuber, M., Fung, C. C., Bazargan-Hejazi, S., Cooper, E.]]></dc:creator>
<dc:date>Wed, 10 Dec 2008 07:23:00 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen075</dc:identifier>
<dc:title><![CDATA[The Knowledge, Attitudes and Usage of Complementary and Alternative Medicine of Medical Students]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-12-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen070v1?rss=1">
<title><![CDATA[N-Acetylcysteine an Allium plant compound improves high-sucrose diet-induced obesity and related effects]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen070v1?rss=1</link>
<description><![CDATA[
<p>This study was designed to determine whether <I>N</I>-acetylcysteine (NAC, C<SUB>5</SUB>H<SUB>9</SUB>&ndash;NO<SUB>3</SUB>S), a compound from <I>Allium</I> species may be used as a complementary therapeutic agent, to inhibit high-sucrose induced-obesity and its effects on glucose tolerance, <I>in vivo</I> low-density lipoprotein (LDL)-oxidation and serum oxidative stress in rats. Initially, 24 male Wistar rats were divided into two groups: controls receiving standard chow (C, <I>n</I>=6) and those receiving high-sucrose diet (HS, <I>n</I> = 18). After 22 days, (HS) group was divided into three groups (<I>n</I> = 6/group); (HS-HS) continued to eat high-sucrose diet and water; (HS-N) continued to eat high-sucrose diet and received 2 mg l<sup>&ndash;1</sup>-NAC in its drinking water; (HS-CN) changing high-sucrose to standard chow and receiving 2 mg l<sup>&shy;1</sup>-NAC in its drinking water. After 22 days of the HS-group division (44 days of experimental period) body weight, body mass index and surface area were enhanced in HS-HS rats (<I>P</I> &lt; 0.001). HS-HS rats had glucose intolerance, increased serum triacylglycerol (TG), very low-density lipoprotein (VLDL), oxidized-LDL (ox-LDL) and lipid-hydroperoxide (LH) than the others (<I>P</I> &lt; 0.01). NAC in HS-N and HS-CN rats reduced the obesity markers, feed efficiency, LH and ox-LDL, as well normalized glucose response, TG and VLDL (<I>P</I> &lt; 0.01) in these groups compared with HS-HS. Total antioxidant substances, GSH/GSSG ratio and glutathione-reductase, were higher in HS-N than in HS-HS (<I>P</I> &lt; 0.01). In conclusion, NAC improved high-sucrose diet-induced obesity and its effects on glucose tolerance, lipid profile, <I>in vivo</I> LDL-oxidation and serum oxidative stress, enhancing antioxidant defences. The application of this agent may be feasible and beneficial for high-sucrose diet-induced obesity, which certainly would bring new insights on obesity-related adverse effects control.</p>
]]></description>
<dc:creator><![CDATA[Souza, G. A., Ebaid, G. X., Seiva, F. R. F., Rocha, K. H. R., Galhardi, C. M., Mani, F., Novelli, E. L. B.]]></dc:creator>
<dc:date>Tue, 11 Nov 2008 03:33:40 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen070</dc:identifier>
<dc:title><![CDATA[N-Acetylcysteine an Allium plant compound improves high-sucrose diet-induced obesity and related effects]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-11</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen068v1?rss=1">
<title><![CDATA[Carthamus Tinctorius Enhances the Antitumor Activity of Dendritic Cell Vaccines via Polarization toward Th1 Cytokines and Increase of Cytotoxic T Lymphocytes]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen068v1?rss=1</link>
<description><![CDATA[
<p><I>Carthamus tinctorius</I> (CT), also named safflower, is a traditional Chinese medicine widely used to improve blood circulation. CT also has been studied for its antitumor activity in certain cancers. To investigate the effects of CT on the dendritic cell (DC)-based vaccine in cancer treatment, cytokine secretion of mouse splenic T lymphocytes and the maturation of DCs in response to CT were analyzed. To assess the antitumor activity of CT extract on mouse CD117<sup>+</sup> (c-kit)-derived DCs pulsed with JC mammal tumor antigens, the JC tumor was challenged by the CT-treated DC vaccine <I>in vivo</I>. CT stimulated IFN- and IL-10 secretion of splenic T lymphocytes and enhanced the maturation of DCs by enhancing immunological molecule expression. When DC vaccine was pulsed with tumor antigens along with CT extract, the levels of TNF- and IL-1&beta; were dramatically increased with a dose-dependent response and more immunologic and co-stimulatory molecules were expressed on the DC surface. In addition, CT-treated tumor lysate-pulsed DC vaccine reduced the tumor weight in tumor-bearing mice by 15.3% more than tumor lysate-pulsed DC vaccine without CT treatment. CT polarized cytokine secretion toward the Th1 pathway and also increased the population of cytotoxic T lymphocytes <I>ex vivo</I>. In conclusion, CT activates DCs might promote the recognition of antigens and facilitate antigen presentation to Th1 immune responses.</p>
]]></description>
<dc:creator><![CDATA[Chang, J.-M., Hung, L.-M., Chyan, Y.-J., Cheng, C.-M., Wu, R.-Y.]]></dc:creator>
<dc:date>Tue, 11 Nov 2008 03:33:39 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen068</dc:identifier>
<dc:title><![CDATA[Carthamus Tinctorius Enhances the Antitumor Activity of Dendritic Cell Vaccines via Polarization toward Th1 Cytokines and Increase of Cytotoxic T Lymphocytes]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-11</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen072v1?rss=1">
<title><![CDATA[Mumijo Traditional Medicine: Fossil Deposits from Antarctica (Chemical Composition and Beneficial Bioactivity)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen072v1?rss=1</link>
<description><![CDATA[
<p>Mumijo is a widely used traditional medicine, especially in Russia, Altai Mountains, Mongolia, Iran Kasachstan and in Kirgistan. Mumijo preparations have been successfully used for the prevention and treatment of infectious diseases; they display immune-stimulating and antiallergic activity as well. In the present study, we investigate the chemical composition and the biomedical potential of a Mumijo(-related) product collected from the Antarctica. The yellow material originates from the snow petrels, <I>Pagodroma nivea</I>. Extensive purification and chemical analysis revealed that the fossil samples are a mixture of glycerol derivatives. <I>In vitro</I> experiments showed that the Mumijo extract caused in cortical neurons a strong neuroprotective effect against the apoptosis-inducing amyloid peptide fragment &beta;-fragment 25&ndash;35 (A&beta;25&ndash;35). In addition, the fraction rich in glycerol ethers/wax esters displayed a significant growth-promoting activity in permanent neuronal PC12 cells. It is concluded that this new Mumijo preparation has distinct and marked neuroprotective activity, very likely due to the content of glycerol ether derivatives.</p>
]]></description>
<dc:creator><![CDATA[Aiello, A., Fattorusso, E., Menna, M., Vitalone, R., Schroder, H. C., Muller, W. E. G.]]></dc:creator>
<dc:date>Fri, 07 Nov 2008 03:41:34 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen072</dc:identifier>
<dc:title><![CDATA[Mumijo Traditional Medicine: Fossil Deposits from Antarctica (Chemical Composition and Beneficial Bioactivity)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen069v1?rss=1">
<title><![CDATA[Dietary Soy Supplement on Fibromyalgia Symptoms: A Randomized, Double-blind, Placebo-controlled, Early Phase Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen069v1?rss=1</link>
<description><![CDATA[
<p>Most patients with fibromyalgia use complementary and alternative medicine (CAM). Properly designed controlled trials are necessary to assess the effectiveness of these practices. This study was a randomized, double-blind, placebo-controlled, early phase trial. Fifty patients seen at a fibromyalgia outpatient treatment program were randomly assigned to a daily soy or placebo (casein) shake. Outcome measures were scores of the Fibromyalgia Impact Questionnaire (FIQ) and the Center for Epidemiologic Studies Depression Scale (CES-D) at baseline and after 6 weeks of intervention. Analysis was with standard statistics based on the null hypothesis, and separation test for early phase CAM comparative trials. Twenty-eight patients completed the study. Use of standard statistics with intent-to-treat analysis showed that total FIQ scores decreased by 14% in the soy group (<I>P</I> = 0.02) and by 18% in the placebo group (<I>P</I>&lt;0.001). The difference in change in scores between the groups was not significant (<I>P</I> = 0.16). With the same analysis, CES-D scores decreased in the soy group by 16% (<I>P</I> = 0.004) and in the placebo group by 15% (<I>P</I> = 0.05). The change in scores was similar in the groups (<I>P</I> = 0.83). Results of statistical analysis using the separation test and intent-to-treat analysis revealed no benefit of soy compared with placebo. Shakes that contain soy and shakes that contain casein, when combined with a multidisciplinary fibromyalgia treatment program, provide a decrease in fibromyalgia symptoms. Separation between the effects of soy and casein (control) shakes did not favor the intervention. Therefore, large&ndash;sample studies using soy for patients with fibromyalgia are probably not indicated.</p>
]]></description>
<dc:creator><![CDATA[Wahner-Roedler, D. L., Thompson, J. M., Luedtke, C. A., King, S. M., Cha, S. S., Elkin, P. L., Bruce, B. K., Townsend, C. O., Bergeson, J. R., Eickhoff, A. L., Loehrer, L. L., Sood, A., Bauer, B. A.]]></dc:creator>
<dc:date>Thu, 06 Nov 2008 03:33:22 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen069</dc:identifier>
<dc:title><![CDATA[Dietary Soy Supplement on Fibromyalgia Symptoms: A Randomized, Double-blind, Placebo-controlled, Early Phase Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-06</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen034v2?rss=1">
<title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture Part 3: A Short Review of Animal Experiments]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen034v2?rss=1</link>
<description><![CDATA[
<p>High-tech acupuncture research has been performed for 10 years at the Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine at the Medical University of Graz. This article as a part of a series comprises animal experiments in the field of needle and laser acupuncture. The investigations presented in this article were performed in pigs, dogs and sheep. In all studies sedative stimulation effects of the acupoint Yintang are described using different measurement parameters (EEG-bispectral index, EEG spectral edge frequency and metabolic parameters).</p>
]]></description>
<dc:creator><![CDATA[Litscher, G.]]></dc:creator>
<dc:date>Wed, 05 Nov 2008 23:39:02 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen034</dc:identifier>
<dc:title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture Part 3: A Short Review of Animal Experiments]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-05</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen071v1?rss=1">
<title><![CDATA[Sustainable Traditional Medicine: Taking the Inspirations from Ancient Veterinary Science]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen071v1?rss=1</link>
<description><![CDATA[
<p>Rapid reduction in natural resources as a consequence to the expanded urbanization, global warming and reduced natural habitat posed a considerable threat to the sustainability of traditional medicine. Being completely dependent upon natural resources like herbs, minerals and animal products, traditional medicine would possibly rank first in order of extinction of heritage if an alternative way is not considered well in time. In reference to the use of animal products, Ayurveda presents some unique examples where animals are used without causing harm to them and so without posing a threat to their existence. In the current context, when natural resources are facing a threat to their existence, a revisit to these ideas may give us a new insight to refine our look at natural resources used in traditional medicine.</p>
]]></description>
<dc:creator><![CDATA[Rastogi, S., Kaphle, K.]]></dc:creator>
<dc:date>Sun, 02 Nov 2008 21:00:41 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen071</dc:identifier>
<dc:title><![CDATA[Sustainable Traditional Medicine: Taking the Inspirations from Ancient Veterinary Science]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-02</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen067v1?rss=1">
<title><![CDATA[Weight Loss in Animals and Humans Treated with 'Weighlevel', a Combination of Four Medicinal Plants Used In Traditional Arabic and Islamic Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen067v1?rss=1</link>
<description><![CDATA[
<p>Weighlevel, a mixture of extract of four plants used in traditional Arabic and Islamic medicine as well as in European herbal medicine, was prepared and assessed for its safety and efficacy in weight loss. Leaves of <I>Alchemilla vulgaris</I>, <I>Olea europaea</I> and <I>Mentha longifolia</I> L., as well as seeds of <I>Cuminum cyminum</I>, were used. Cultured human fibroblasts treated with Weighlevel did not exhibit any sign of toxicity as evidenced by lactate dehydrogenase release. These results were confirmed in experimental studies on rats where an LD<SUB>50</SUB> of 15.3 g kg<sup>&ndash;1</sup> was observed. Significant antioxidant properties were seen at very low concentrations of Weighlevel (10 &micro;g ml<sup>&ndash;1</sup>) as measured by the lipid peroxidation method. Progressive and significant weight loss was observed in chickens given this mixture weekly for 4 weeks compared with controls. Furthermore, a 3-fold increase in the thermogenesis was seen in rat interscapular brown adipose tissue following exposure to different concentrations of Weighlevel extract as determined by measurement of increased oxygen consumption. In addition, a clinical study was carried out among 80 human volunteers with a body mass index (BMI) of 30.67 &plusmn; 2.14 kg m<sup>&ndash;</sup><sup>2</sup>. All 80 subjects were asked to continue their usual diet but to eat only three main meals daily and to take one Weighlevel tablet 30 min before each meal. Fourteen subjects were excluded for not following the protocol, and 66 subjects were all evaluated for efficacy and tolerability of Weighlevel monthly for 3 months. Weighlevel was well tolerated by all subjects, and no side effects were reported. A progressive and significant weight loss was seen in these subjects during the whole study period. Higher levels of weight loss were seen in people with BMI of 25&ndash;30 kg m<sup>&ndash;</sup><sup>2</sup> (overweight) compared to people with BMI &gt;30 kg m<sup>&ndash;</sup><sup>2</sup> (obese). The BMI was reduced after 3 months from 28.5 &plusmn; 1.2 and 32.1 &plusmn; 1.8 kg m<sup>&ndash;</sup><sup>2</sup> to 24.5 &plusmn; 1.4 and 27.5 &plusmn; 2.2 kg m<sup>&ndash;</sup><sup>2</sup> in overweight and obese group, respectively. Results indicate safety, tolerability and efficacy of Weighlevel.</p>
]]></description>
<dc:creator><![CDATA[Said, O., Saad, B., Fulder, S., Khalil, K., Kassis, E.]]></dc:creator>
<dc:date>Fri, 24 Oct 2008 02:56:19 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen067</dc:identifier>
<dc:title><![CDATA[Weight Loss in Animals and Humans Treated with 'Weighlevel', a Combination of Four Medicinal Plants Used In Traditional Arabic and Islamic Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-10-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen062v1?rss=1">
<title><![CDATA[Inhibition of cell growth and cellular protein, DNA and RNA synthesis in human hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq of traditional Uighur medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen062v1?rss=1</link>
<description><![CDATA[
<p>Abnormal Savda Munziq (ASMq) is a traditional Uighur medicinal herbal preparation, commonly used for the treatment and prevention of cancer. We tested the effects of ethanol extract of ASMq on cultured human hepatoma cells (HepG2) to explore the mechanism of its putative anticancer properties, using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) bromide, neutral red and lactate dehydrogenase (LDH) leakage assays, testing the incorporation of <sup>3</sup>[H]-leucine and <sup>3</sup>[H]-nucleosides into protein, DNA and RNA, and quantifying the formation of malondialdehyde&ndash;thiobarbituric acid (MDA) adducts. ASMq ethanol extract significantly inhibited the growth of HepG2 and cell viability, increased the leakage of LDH after 48 h or 72 h treatment, in a concentration- and time-dependent manner (<I>P</I> &lt; 0.05). Cellular protein, DNA and RNA synthesis were inhibited in a concentration- and time-dependent manner (<I>P</I> &lt; 0.05). No significant MDA release in culture medium and no lipid peroxidation in cells were observed. The results suggest that the cytotoxic effects of ASMq ethanol extract might be related to inhibition of cancer cell growth, alteration of cell membrane integrity and inhibition of cellular protein, DNA and RNA synthesis.</p>
]]></description>
<dc:creator><![CDATA[Upur, H., Yusup, A., Baudrimont, I., Umar, A., Berke, B., Yimit, D., Lapham, J. C., Creppy, E. E., Moore, N.]]></dc:creator>
<dc:date>Wed, 15 Oct 2008 02:39:00 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen062</dc:identifier>
<dc:title><![CDATA[Inhibition of cell growth and cellular protein, DNA and RNA synthesis in human hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq of traditional Uighur medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-10-15</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen063v1?rss=1">
<title><![CDATA[Aqueous Extract of Black Maca (Lepidium meyenii) on Memory Impairment Induced by Ovariectomy in Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen063v1?rss=1</link>
<description><![CDATA[
<p>The present study aims to test two different doses of aqueous extract of black maca on learning and memory in ovariectomized (OVX) mice and their relation with malonalehyde (MDA), acetylcholinesterase (Ache) and monoamine oxidase (MAO) brain levels. Female mice were divided into five groups: (i) naive (control), (ii) sham, (iii) OVX mice and OVX mice treated with (iv) 0.50 g kg<sup>&ndash;1</sup> and (v) 2.00 g kg<sup>&ndash;1</sup> black maca. Mice were orally treated with distilled water or black maca during 35 days starting 7 days after surgery. Memory and learning were assessed using the water Morris maze (from day 23&ndash;27) and the step-down avoidance test (days 34 and 35). At the end of each treatment, mice were sacrificed by decapitation and brains were dissected out for MDA, Ache and MAO determinations. Black maca (0.5 and 2.0 g/kg) increased step-down latency when compared to OVX control mice. Black maca decreased MDA and Ache levels in OVX mice; whereas, no differences were observed in MAO levels. Finally, black maca improved experimental memory impairment induced by ovariectomy, due in part, by its antioxidant and Ache inhibitory activities.</p>
]]></description>
<dc:creator><![CDATA[Rubio, J., Qiong, W., Liu, X., Jiang, Z., Dang, H., Chen, S.-L., Gonzales, G. F.]]></dc:creator>
<dc:date>Thu, 09 Oct 2008 02:14:10 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen063</dc:identifier>
<dc:title><![CDATA[Aqueous Extract of Black Maca (Lepidium meyenii) on Memory Impairment Induced by Ovariectomy in Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-10-09</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen065v1?rss=1">
<title><![CDATA[An International Comparison of Attitudes Toward Traditional and Modern Medicine in a Chinese and an American Clinic Setting]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen065v1?rss=1</link>
<description><![CDATA[
<p>Introduction: International comparative research on traditional medicine (TM) offers a useful method for examining differences in patient characteristics and can provide insight into: (i) more universal characteristics which may cross cultures and international borders; (ii) unique characteristics influenced by regional/national factors; and (iii) cultural values of immigrant populations. To explore these issues TM patients from the United States and China were compared. Methods: Data collection took place at two TM college clinics. A convenience sample of 128 patients in China and 127 patients in the United States completed a 28-item questionnaire. Results: There was a marked similarity between the two patient groups in terms of the biological characteristics of age and gender. Musculoskeletal issues were the most common presenting complaints in the United States; while, in China TM was used for a more diverse array of conditions. The majority of patients in both countries had initially used allopathic medicine (AM); significantly, more of the United States respondents stopped allopathic treatment after beginning traditional treatment. In comparing the two countries, patients in China were significantly more satisfied with AM and American patients significantly more satisfied with TM. In comparing the two medicines, the patient samples in both countries were significantly more satisfied with TM than AM. Discussion: Although treatment often originated with allopathic providers, many patients sought alternatives presumably to find the best solution to their problems. This tendency toward self-assignment suggests that a pluralistic healthcare system may provide the greatest satisfaction resulting from personal choice and improved outcomes.</p>
]]></description>
<dc:creator><![CDATA[Burke, A., Kuo, T., Harvey, R., Wang, J.]]></dc:creator>
<dc:date>Tue, 07 Oct 2008 21:30:17 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen065</dc:identifier>
<dc:title><![CDATA[An International Comparison of Attitudes Toward Traditional and Modern Medicine in a Chinese and an American Clinic Setting]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-10-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen064v1?rss=1">
<title><![CDATA[Electroacupuncture Delays Hypertension Development through Enhancing NO/NOS Activity in Spontaneously Hypertensive Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen064v1?rss=1</link>
<description><![CDATA[
<p>Using spontaneously hypertensive rats (SHR), this study investigated whether electroacupuncture (EA) could reduce early stage hypertension by examining nitric oxide (NO) levels in plasma and nitric oxide synthase (NOS) levels in the mesenteric resistance artery. EA was applied to the acupuncture point Governor Vessel 20 (GV20) or to a non-acupuncture point in the tail twice weekly for 3 weeks under anesthesia. In conscious SHR and normotensive Wistar Kyoto (WKY) rats, blood pressure was determined the day after EA treatment by the tail-cuff method. We measured plasma NO concentration, and evaluated endothelial NO syntheses (eNOS) and neuronal NOS (nNOS) protein expression in the mesenteric artery. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were lower after 3 weeks of GV20 treatment than EA at non-acupuncture point and no treatment control in SHR. nNOS expression by EA was significantly different between both WKY and no treatment SHR control, and EA at GV20 in SHR. eNOS expression was significantly high in EA at GV 20 compared with no treatment control. In conclusion, EA could attenuate the blood pressure elevation of SHR, along with enhancing NO/NOS activity in the mesenteric artery in SHR.</p>
]]></description>
<dc:creator><![CDATA[Hwang, H. S., Kim, Y. S., Ryu, Y. H., Lee, J. E., Lee, Y. S., Yang, E. J., Lee, M. S., Choi, S.-M.]]></dc:creator>
<dc:date>Tue, 07 Oct 2008 21:30:16 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen064</dc:identifier>
<dc:title><![CDATA[Electroacupuncture Delays Hypertension Development through Enhancing NO/NOS Activity in Spontaneously Hypertensive Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-10-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen061v1?rss=1">
<title><![CDATA[The Influence of Acupressure at Extra 1 Acupuncture Point on the Spectral Entropy of the EEG and the LF/HF Ratio of Heart Rate Variability]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen061v1?rss=1</link>
<description><![CDATA[
<p>Acupressure applied on the Extra 1 acupuncture point results in sedation, thereby reducing bispectral index (BIS) values. Mental status and hypnotic agents influence the autonomic nervous system. We hypothesized that acupressure at the Extra 1 point would induce sedation and change sympatho&ndash;parasympathetic nerve balance. We investigated the effect of acupressure at the Extra 1 point on the EEG spectral entropy values and heart rate variability (HRV). Forty-eight volunteers (24 males and 24 females) were randomly assigned to the control or Extra 1 group. The control group received acupressure at a sham point and the Extra 1 group received acupressure at the Extra 1 point. Acupressure was applied for 5 min. The record of the EEG spectral entropy values and HRV started 5 min before acupressure and stopped 5 min after acupressure. Acupressure significantly reduced the EEG spectral entropy values in both groups, but the values of the Extra 1 group were significantly smaller than those of the control group (<I>P</I> &lt; 0.01). Acupressure significantly decreased the LF/HF ratio of HRV in both groups (<I>P</I> &lt; 0.05). When divided upon gender, although acupressure tended to decrease the LF/HF ratio, the ratio significantly decreased during and after acupressure only in females of the Extra 1 group (<I>P</I> &lt; 0.05). We concluded that acupressure on the Extra 1 point significantly reduced the EEG spectral entropy in both the genders, but affected the LF/HF ratio of HRV only in females.</p>
]]></description>
<dc:creator><![CDATA[Arai, Y.-C. P, Ushida, T., Matsubara, T., Shimo, K., Ito, H., Sato, Y., Wakao, Y., Komatsu, T.]]></dc:creator>
<dc:date>Tue, 30 Sep 2008 03:07:42 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen061</dc:identifier>
<dc:title><![CDATA[The Influence of Acupressure at Extra 1 Acupuncture Point on the Spectral Entropy of the EEG and the LF/HF Ratio of Heart Rate Variability]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-30</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen060v1?rss=1">
<title><![CDATA[A Chinese Herbal Preparation Containing Radix Salviae Miltiorrhizae, Radix Notoginseng and Borneolum Syntheticum Reduces Circulating Adhesion Molecules]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen060v1?rss=1</link>
<description><![CDATA[
<p>Circulating adhesion molecules (CAMs), surface proteins expressed in the vascular endothelium, have emerged as risk factors for cardiovascular disease (CVD). CAMs are involved in intercellular communication that are believed to play a role in atherosclerosis. A Chinese medicine, the &lsquo;Dantonic Pill&rsquo; (DP) (also known as the &lsquo;Cardiotonic Pill&rsquo;), containing three Chinese herbal material medica, Radix Salviae Miltiorrhizae, Radix Notoginseng and Borneolum Syntheticum, has been used in China for the prevention and management of CVD. Previous laboratory and animal studies have suggested that this preparation reduces both atherogenesis and adhesion molecule expression. A parallel double blind randomized placebo-controlled study was conducted to assess the effects of the DP on three species of CAM [intercellular cell adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 and endothelial cell selectin (E-selectin)] in participants with mild&ndash;moderate hypercholesterolemia. Secondary endpoints included biochemical and hematological variables and clinical effects. Forty participants were randomized to either treatment or control for 12 weeks. Treatment with DP was associated with a statistically significant decrease in ICAM-1 (9% decrease, <I>P</I> = 0.03) and E-Selectin (15% decrease, <I>P</I> = 0.004). There was no significant change in renal function tests, liver function tests, glucose, lipids or C-reactive protein levels and clinical adverse effects did not differ between the active and the control groups. There were no relevant changes in participants receiving placebo. These results suggest that this herbal medicine may contribute to the development of a novel approach to cardiovascular risk reduction.</p>
]]></description>
<dc:creator><![CDATA[O'Brien, K. A., Ling, S., Abbas, E., Dai, A., Zhang, J., Wang, W. C., Bensoussan, A., Luo, R., Guo, Z.-X., Komesaroff, P. A.]]></dc:creator>
<dc:date>Sat, 27 Sep 2008 05:24:41 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen060</dc:identifier>
<dc:title><![CDATA[A Chinese Herbal Preparation Containing Radix Salviae Miltiorrhizae, Radix Notoginseng and Borneolum Syntheticum Reduces Circulating Adhesion Molecules]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen058v1?rss=1">
<title><![CDATA[Spirulina in Clinical Practice: Evidence-Based Human Applications]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen058v1?rss=1</link>
<description><![CDATA[
<p><I>Spirulina</I> or <I>Arthrospira</I> is a blue-green alga that became famous after it was successfully used by NASA as a dietary supplement for astronauts on space missions. It has the ability to modulate immune functions and exhibits anti-inflammatory properties by inhibiting the release of histamine by mast cells. Multiple studies investigating the efficacy and the potential clinical applications of <I>Spirulina</I> in treating several diseases have been performed and a few randomized controlled trials and systematic reviews suggest that this alga may improve several symptoms and may even have an anticancer, antiviral and antiallergic effects. Current and potential clinical applications, issues of safety, indications, side-effects and levels of evidence are addressed in this review. Areas of ongoing and future research are also discussed.</p>
]]></description>
<dc:creator><![CDATA[Karkos, P. D., Leong, S. C., Karkos, C. D., Sivaji, N., Assimakopoulos, D. A.]]></dc:creator>
<dc:date>Sun, 14 Sep 2008 22:48:45 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen058</dc:identifier>
<dc:title><![CDATA[Spirulina in Clinical Practice: Evidence-Based Human Applications]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-14</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen056v1?rss=1">
<title><![CDATA[Hypericum triquetrifolium--Derived Factors Downregulate the Production Levels of LPS-Induced Nitric Oxide and Tumor Necrosis Factor-{alpha} in THP-1 Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen056v1?rss=1</link>
<description><![CDATA[
<p>Based on knowledge from traditional Arab herbal medicine, this <I>in vitro</I> study aims to examine the anti-inflammatory mechanism of <I>Hypericum triquetrifolium</I> by measuring the expression and release of pro-inflammatory cytokines, tumor necrosis factor- (TNF-) and interleukine-6 (IL-6), and inducible nitric oxide synthase (iNOS) in human monocytic cells, THP-1. The effects were assessed by measuring the levels of secretory proteins and mRNA of TNF- and IL-6, the levels of nitric oxide (NO) secretion and the expression of iNOS in THP-1 cells. Cells were treated with 5 &micro;g lipopolysaccharide/ml (LPS) in the presence and absence of increasing concentrations of extracts from the aerial parts of <I>H. triquetrifolium</I>. During the entire experimental period, we used extract concentrations (up to 250 &micro;g ml<sup>&ndash;1</sup>) that had no cytotoxic effects, as measured with MTT and LDH assays. <I>Hypericum triquetrifolium</I> extracts remarkably suppressed the LPS-induced NO release, significantly attenuated the LPS-induced transcription of iNOS and inhibited in a dose-dependent manner the expression and release of TNF-. No significant effects were observed on the release of IL-6. Taken together, these results suggest that <I>H. triquetrifolium</I> probably exerts anti-inflammatory effects through the suppression of TNF- and iNOS expressions.</p>
]]></description>
<dc:creator><![CDATA[Saad, B., AbouAtta, B. S., Basha, W., Hmade, A., Kmail, A., Khasib, S., Said, O.]]></dc:creator>
<dc:date>Sun, 14 Sep 2008 22:48:44 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen056</dc:identifier>
<dc:title><![CDATA[Hypericum triquetrifolium--Derived Factors Downregulate the Production Levels of LPS-Induced Nitric Oxide and Tumor Necrosis Factor-{alpha} in THP-1 Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-14</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen059v1?rss=1">
<title><![CDATA[Science Across Borders: 5th Annual Natural Health Product Research Conference--March 26-29, 2008, Toronto, Canada]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen059v1?rss=1</link>
<description><![CDATA[
<p>Canada is experiencing a growing interest in the use of alternative therapies and products particularly natural health products (NHP). In 1997, Canadians spent around C$ 2 billion on NHP. In an attempt to catch with this popularity of NHP use, Canadian researchers and administrators from academia, industry and government jointly established the Natural Health Product Research Society of Canada (NHPRS). Since its formation, NHPRS has been organizing an annual meeting which brings together world renowned researchers and experts in the area of NHP research. For 2008, the annual NHPRS meeting took place in Toronto from the 26th to 29th of March with a focus on &lsquo;Science Across Borders: Global Natural Health Products Research&rsquo;. The scientific program was spread into three days of plenary lectures and oral presentations. The different sessions containing these talks were on: ethnobotany around the world; chemical analysis of NHP; product standards and quality control; ethnomedicine; novel analytical approaches; systemic research, nutrisciences and molecular medicine; and drug development from NHP. The meeting proved to be a great success in terms of the speakers that were invited and based on the data that was presented which highlighted recent research taking place in the field of NHP not only in Canada but from many parts of the world.</p>
]]></description>
<dc:creator><![CDATA[Ghayur, M. N.]]></dc:creator>
<dc:date>Thu, 04 Sep 2008 02:57:28 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen059</dc:identifier>
<dc:title><![CDATA[Science Across Borders: 5th Annual Natural Health Product Research Conference--March 26-29, 2008, Toronto, Canada]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-04</prism:publicationDate>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen057v1?rss=1">
<title><![CDATA[An Extract of Antrodia camphorata Mycelia Attenuates the Progression of Nephritis in Systemic Lupus Erythematosus-Prone NZB/W F1 Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen057v1?rss=1</link>
<description><![CDATA[
<p><I>Antrodia camphorata</I> is used in folk medicine for the treatment of inflammation syndromes and liver-related diseases in Taiwan. The goal of this study was to evaluate the efficacy of the mycelial extract of <I>A. camphorata</I> (ACE) for the treatment of systemic lupus erythematosus (SLE) in SLE-prone NZB/W F1 mice. After antibodies against double-stranded DNA appeared in NZB/W mice, the mice were orally administered varying dosages of ACE (100, 200 and 400 mg kg<sup>&ndash;1</sup>) for 5 consecutive days per week for 12 weeks via gavage. To assess the efficacy of ACE, we measured SLE-associated biochemical and histopathological biomarkers levels of blood urine nitrogen (BUN), blood creatinine, urine protein and urine creatinine and thickness of the kidney glomerular basement membrane by staining with periodic acid&ndash;Schiff. Antroquinonol, an active component of ACE, was investigated for anti-inflammation activity in lipopolysaccharide-induced RAW 267.4 cells.ACE at 400 mg kg<sup>&ndash;1</sup> significantly suppressed urine protein and serum BUN levels and decreased the thickness of the kidney glomerular basement membrane. Antroquinonol significantly inhibited the production of tumor necrosis factor- and interleukin-1&beta; by 75 and 78%, respectively. In conclusion, ACE reduced urine protein and creatinine levels and suppressed the thickening of the kidney glomerular basement membrane, suggesting that ACE protects the kidney from immunological damage resulting from autoimmune disease.</p>
]]></description>
<dc:creator><![CDATA[Chang, J.-M., Lee, Y.-R., Hung, L.-M., Liu, S.-Y., Kuo, M.-T., Wen, W.-C., Chen, P.]]></dc:creator>
<dc:date>Tue, 02 Sep 2008 06:35:35 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen057</dc:identifier>
<dc:title><![CDATA[An Extract of Antrodia camphorata Mycelia Attenuates the Progression of Nephritis in Systemic Lupus Erythematosus-Prone NZB/W F1 Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen052v1?rss=1">
<title><![CDATA[Comparative Analysis of Viperidae Venoms Antibacterial Profile: a Short Communication for Proteomics]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen052v1?rss=1</link>
<description><![CDATA[
<p>Bacterial infections involving multidrug-resistant strains are one of the ten leading causes of death and an important health problem in need for new antibacterial sources and agents. Herein, we tested and compared four snake venoms (<I>Agkistrodon rhodostoma, Bothrops jararaca, B. atrox and Lachesis muta</I>) against 10 Gram-positive and Gram-negative drug-resistant clinical bacteria strains to identify them as new sources of potential antibacterial molecules. Our data revealed that, as efficient as some antibiotics currently on the market [minimal inhibitory concentration (MIC) = 1&ndash;32 &micro;g ml<sup>&ndash;1</sup>], <I>A. rhodostoma</I> and <I>B. atrox</I> venoms were active against <I>Staphylococcus epidermidis</I> and <I>Enterococcus faecalis</I> (MIC = 4.5 &micro;g ml<sup>&ndash;1</sup>), while <I>B. jararaca</I> inhibited <I>S. aureus</I> growth (MIC = 13 &micro;g ml<sup>&ndash;1</sup>). As genomic and proteomic technologies are improving and developing rapidly, our results suggested that <I>A. rhodostoma, B. atrox</I> and <I>B. jararaca</I> venoms and glands are feasible sources for searching antimicrobial prototypes for future design new antibiotics against drug-resistant clinical bacteria. They also point to an additional perspective to fully identify the pharmacological potential of these venoms by using different techniques.</p>
]]></description>
<dc:creator><![CDATA[Ferreira, B. L., Santos, D. O., Santos, A. L. d., Rodrigues, C. R., de Freitas, C. C., Cabral, L. M., Castro, H. C.]]></dc:creator>
<dc:date>Tue, 02 Sep 2008 06:35:32 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen052</dc:identifier>
<dc:title><![CDATA[Comparative Analysis of Viperidae Venoms Antibacterial Profile: a Short Communication for Proteomics]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen055v1?rss=1">
<title><![CDATA[Ethical Considerations for Acupuncture and Chinese Herbal Medicine Clinical Trials: A Cross-cultural Perspective]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen055v1?rss=1</link>
<description><![CDATA[
<p>Many ethical concerns revolve around the four basic principles of research: merit and integrity, respect for human beings, weighting of risk&ndash;benefit and justice. These principles form the basis for any discussion concerning human research ethics and are applicable to all areas of research including acupuncture and Chinese herbal medicine. World Health Organisation document, <I>Guidelines for Clinical Research on Acupuncture</I>, states that &lsquo;consideration should be given to the different value systems that are involved in human rights such as social, cultural and historical issues&rsquo; and that &lsquo;further studies should be conducted in relation to ethical issues involved in clinical research on acupuncture&rsquo;. In addition to outlining the four basic principles, this paper will also examine the effect of Asian culture on Western human research ethics and how this may impact upon issues such as informed consent and weighting of risk&ndash;benefit.</p>
]]></description>
<dc:creator><![CDATA[Zaslawski, C.]]></dc:creator>
<dc:date>Thu, 21 Aug 2008 01:48:58 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen055</dc:identifier>
<dc:title><![CDATA[Ethical Considerations for Acupuncture and Chinese Herbal Medicine Clinical Trials: A Cross-cultural Perspective]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-08-21</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen051v2?rss=1">
<title><![CDATA[Geffen Faculty Highlight Concerns Linking CAIM and Conventional Researchers at UCLA Symposium]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen051v2?rss=1</link>
<description><![CDATA[
<p>David Geffen School of Medicine faculty, representing a wide range of disciplines, engaged speakers nationally known for their expertise on complementary, alternative and integrative medicine (CAIM) and its investigation at a January, 2008 symposium on the campus of the University of California, Los Angeles. The forum was created to educate the UCLA Institutional Review Board (IRB), and lively participation by School of Medicine faculty helped bring IRB members up to speed on controversies surrounding CAIM research. The symposium demonstrated that academics who are neither proponents nor detractors of CAIM can facilitate cross talk between opposing camps, elucidating questions important to its evaluation by those charged with protecting research subjects. It also brought attention to the universality of quandaries facing CAIM investigators and to the ingenuity with which they have addressed many of them.</p>
]]></description>
<dc:creator><![CDATA[Logue, E. H.]]></dc:creator>
<dc:date>Wed, 13 Aug 2008 03:19:58 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen051</dc:identifier>
<dc:title><![CDATA[Geffen Faculty Highlight Concerns Linking CAIM and Conventional Researchers at UCLA Symposium]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-08-13</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen053v1?rss=1">
<title><![CDATA[An Antioxidant Phytotherapy to Rescue Neuronal Oxidative Stress]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen053v1?rss=1</link>
<description><![CDATA[
<p>Oxidative stress is involved in the pathogenesis of ischemic neuronal injury. A Chinese herbal formula composed of <I>Poria cocos</I> (Chinese name: <I>Fu Ling</I>), <I>Atractylodes macrocephala</I> (Chinese name: <I>Bai Zhu</I>) and <I>Angelica sinensis</I> (Chinese names: <I>Danggui, Dong quai, Donggui</I>; Korean name: <I>Danggwi</I>) (FBD), has been proved to be beneficial in the treatment of cerebral ischemia/reperfusion (I/R).This study was carried out to evaluate the protective effect of FBD against neuronal oxidative stress <I>in vivo</I> and <I>in vitro</I>. Rat I/R were established by middle cerebral artery occlusion (MCAO) for 1 h, followed by 24 h reperfusion. MCAO led to significant depletion in superoxide dismutase and glutathione and rise in lipid peroxidation (LPO) and nitric oxide in brain. The neurological deficit and brain infarction were also significantly elevated by MCAO as compared with sham-operated group. All the brain oxidative stress and damage were significantly attenuated by 7 days pretreatment with the aqueous extract of FBD (250 mg kg<sup>&ndash;1</sup>, p.o.). Moreover, cerebrospinal fluid sampled from FBD-pretreated rats protected PC12 cells against oxidative insult induced by 0.2 mM hydrogen peroxide, in a concentration and time-dependent manner (IC<SUB>50</SUB> 10.6%, ET<SUB>50</SUB> 1.2 h). However, aqueous extract of FBD just slightly scavenged superoxide anion radical generated in xanthine&ndash;xanthine oxidase system (IC<SUB>50</SUB> 2.4 mg ml<sup>&ndash;1</sup>) and hydroxyl radical generated in Fenton reaction system (IC<SUB>50</SUB> 3.6 mg ml<sup>&ndash;1</sup>). In conclusion, FBD was a distinct antioxidant phytotherapy to rescue neuronal oxidative stress, through blocking LPO, restoring endogenous antioxidant system, but not scavenging free radicals.</p>
]]></description>
<dc:creator><![CDATA[Lin, Z., Zhu, D., Yan, Y., Yu, B., Wang, Q., Shen, P., Ruan, K.]]></dc:creator>
<dc:date>Thu, 07 Aug 2008 23:10:51 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen053</dc:identifier>
<dc:title><![CDATA[An Antioxidant Phytotherapy to Rescue Neuronal Oxidative Stress]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-08-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen050v1?rss=1">
<title><![CDATA[Addition of Fructooligosaccharides and Dried Plum to Soy-based Diets Reverses Bone Loss in the Ovariectomized Rat]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen050v1?rss=1</link>
<description><![CDATA[
<p>Dietary bioactive components that play a role in improving skeletal health have received considerable attention in complementary and alternative medicine practices as a result of their increased efficacy to combat chronic diseases. The objectives of this study were to evaluate the additive or synergistic effects of dried plum and fructooligosaccharides (FOS) and to determine whether dried plum and FOS or their combination in a soy protein-based diet can restore bone mass in ovarian hormone deficient rats. For this purpose, 72 3-month-old female Sprague-Dawley rats were divided into six groups (<I>n</I> = 12) and either ovariectomized (Ovx, five groups) or sham-operated (sham, one group). The rats were maintained on a semipurified standard diet for 45 days after surgery to establish bone loss. Thereafter, the rats were placed on one of the following dietary treatments for 60 days: casein-based diet (Sham and Ovx), soy-based diet (Ovx+soy) or soy-based diet with dried plum (Ovx+soy+plum), FOS (Ovx+soy+FOS) and combination of dried plum and FOS (Ovx+soy+plum+FOS). Soy protein in combination with the test compounds significantly improved whole-body bone mineral density (BMD). All test compounds in combination with soy protein significantly increased femoral BMD but the combination of soy protein, dried plum and FOS had the most pronounced effect in increasing lumbar BMD. Similarly, all of the test compounds increased ultimate load, indicating improved biomechanical properties. The positive effects of these test compounds on bone may be due to their ability to modulate bone resorption and formation, as shown by suppressed urinary deoxypyridinoline excretion and enhanced alkaline phosphatase activity.</p>
]]></description>
<dc:creator><![CDATA[Johnson, C. D., Lucas, E. A., Hooshmand, S., Campbell, S., Akhter, M. P., Arjmandi, B. H.]]></dc:creator>
<dc:date>Wed, 30 Jul 2008 23:10:13 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen050</dc:identifier>
<dc:title><![CDATA[Addition of Fructooligosaccharides and Dried Plum to Soy-based Diets Reverses Bone Loss in the Ovariectomized Rat]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-30</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen047v1?rss=1">
<title><![CDATA[Cranberry and Grape Seed Extracts Inhibit the Proliferative Phenotype of Oral Squamous Cell Carcinomas]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen047v1?rss=1</link>
<description><![CDATA[
<p>Proanthocyanidins, compounds highly concentrated in dietary fruits, such as cranberries and grapes, demonstrate significant cancer prevention potential against many types of cancer. The objective of this study was to evaluate cranberry and grape seed extracts to quantitate and compare their anti-proliferative effects on the most common type of oral cancer, oral squamous cell carcinoma. Using two well-characterized oral squamous cell carcinoma cell lines, CAL27 and SCC25, assays were performed to evaluate the effects of cranberry and grape seed extract on phenotypic behaviors of these oral cancers. The proliferation of both oral cancer cell lines was significantly inhibited by the administration of cranberry and grape seed extracts, in a dose-dependent manner. In addition, key regulators of apoptosis, caspase-2 and caspase-8, were concomitantly up-regulated by these treatments. However, cranberry and grape seed extracts elicited differential effects on cell adhesion, cell morphology, and cell cycle regulatory pathways. This study represents one of the first comparative investigations of cranberry and grape seed extracts and their anti-proliferative effects on oral cancers. Previous findings using purified proanthocyanidin from grape seed extract demonstrated more prominent growth inhibition, as well as apoptosis-inducing, properties on CAL27 cells. These observations provide evidence that cranberry and grape seed extracts not only inhibit oral cancer proliferation but also that the mechanism of this inhibition may function by triggering key apoptotic regulators in these cell lines. This information will be of benefit to researchers interested in elucidating which dietary components are central to mechanisms involved in the mediation of oral carcinogenesis and progression.</p>
]]></description>
<dc:creator><![CDATA[Chatelain, K., Phippen, S., McCabe, J., Teeters, C. A., O'Malley, S., Kingsley, K.]]></dc:creator>
<dc:date>Wed, 23 Jul 2008 00:15:01 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen047</dc:identifier>
<dc:title><![CDATA[Cranberry and Grape Seed Extracts Inhibit the Proliferative Phenotype of Oral Squamous Cell Carcinomas]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-23</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen037v2?rss=1">
<title><![CDATA[Public Status and Prevalence of Acupuncture in Japan]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen037v2?rss=1</link>
<description><![CDATA[
<p>Acupuncture originated in China and is widespread throughout Asia. It is expected that a higher utilization of this remedy exists in these countries compared to Western countries. We conducted annual nationwide surveys from 2003 through 2006 on the utilization of acupuncture in Japan. Face-to-face interviews were conducted with 2000 individuals randomly chosen from the resident database. Annual utilization percentages, based on the number of respondents, from 2003 to 2006 were 6.5%, 4.8%, 6.4%, and 6.7%, respectively, while lifetime experiences determined in each surveys were estimated as 26.7, 19.4, 24.4 and 25.4, respectively. Respondents who had utilized acupuncture and/or moxibustion tended to be older than those who had no experience. Acupuncture was mainly used for musculoskeletal symptoms, and a detailed breakdown of the musculoskeletal symptoms identified in the 2005 survey showed 50.9% for low back pain, 35.9% for shoulder stiffness and 12.0% for knee pain. Reasons given for continuing therapy included the effective amelioration of symptoms, comfort of the procedure and low number of side-effects, while those who decided against continuing cited no improvement of symptoms, cost and lack of time for treatment. In conclusion, annual utilization of acupuncture and/or moxibustion was estimated at more than 6%, and the percentage of those with a lifetime experience was ~25%, thus demonstrating the relatively higher utilization of the remedy in Japan over utilization in western countries. Application of the treatment for musculoskeletal problems and utilization by the older population were specific standouts of the use of acupuncture and/or moxibustion in Japan.</p>
]]></description>
<dc:creator><![CDATA[Ishizaki, N., Yano, T., Kawakita, K.]]></dc:creator>
<dc:date>Sat, 19 Jul 2008 04:00:01 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen037</dc:identifier>
<dc:title><![CDATA[Public Status and Prevalence of Acupuncture in Japan]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-19</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem182v3?rss=1">
<title><![CDATA[Group Music Intervention Reduces Aggression and Improves Self-esteem in Children with Highly Aggressive Behavior: A Pilot Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem182v3?rss=1</link>
<description><![CDATA[
<p>We investigated the effects of group music intervention on aggression and self-esteem in children with highly aggressive behavior. Forty-eight children were allocated to either a music intervention group or an untreated control group. The music intervention group received 50 min of music intervention twice weekly for 15 consecutive weeks. The outcome measures were Child Behavior Checklist Aggression Problems Scale (Parents), Child Aggression Assessment Inventory (Teachers) and Rosenberg Self-esteem Scale. After 15 weeks, the music intervention group showed significant reduction of aggression and improvement of self-esteem compared with the control group. All outcome measures were significantly lower in the music intervention group than prior to treatment, while there was no change in the control group. These findings suggest that music can reduce aggressive behavior and improve self-esteem in children with highly aggressive behavior. Music intervention is an easily accessible therapy for children and as such may be an effective intervention for aggressive behavior. Further more, objective and replicable measures are required from a randomized controlled trial with a larger sample size and active comparable control.</p>
]]></description>
<dc:creator><![CDATA[Choi, A.-N., Lee, M. S., Lee, J.-S.]]></dc:creator>
<dc:date>Thu, 17 Jul 2008 03:24:12 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem182</dc:identifier>
<dc:title><![CDATA[Group Music Intervention Reduces Aggression and Improves Self-esteem in Children with Highly Aggressive Behavior: A Pilot Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen045v1?rss=1">
<title><![CDATA[Antidepressant-like Effect of l-perillaldehyde in Stress-induced Depression-like Model Mice through Regulation of the Olfactory Nervous System]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen045v1?rss=1</link>
<description><![CDATA[
<p>Perillae Herba (a leaf of <I>Perilla frutescens</I>) has been prescribed as one of the component herbs in certain Kampo (Japanese herbal) medicines that are used clinically for the improvement of depressive mood. <I>l</I>-Perillaldehyde (PAH) is a major component in the essential oil containing in Perillae Herba, but its antidepressant-like effect has not been reported. To clarify the antidepressant-like effect of PAH, the inhaled effect of PAH on stress-induced depression-like model mice prepared by subjection to a combination of forced swimming and chronic mild stresses was investigated. The degree of the depression-like state was measured by the animal's duration of immobility using a forced swimming test. Inhalation of PAH (0.0965 and 0.965 mg/mouse/day, 9 days) significantly shortened the duration of immobility of the depression-like model mice and did not affect locomotor activity. However, another odor substance, cinnamaldehyde containing in Cinnamomi Cortex, exhibited no reduction in the immobility. The reduction in the immobility induced by the inhalation of PAH was prevented on anosmia-induced mice prepared by intranasal irrigation with zinc sulfate. These results suggest that the inhalation of PAH shows antidepressant-like activity through the olfactory nervous function.</p>
]]></description>
<dc:creator><![CDATA[Ito, N., Nagai, T., Oikawa, T., Yamada, H., Hanawa, T.]]></dc:creator>
<dc:date>Wed, 16 Jul 2008 04:56:07 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen045</dc:identifier>
<dc:title><![CDATA[Antidepressant-like Effect of l-perillaldehyde in Stress-induced Depression-like Model Mice through Regulation of the Olfactory Nervous System]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen049v1?rss=1">
<title><![CDATA[Assessment of the Mutagenic Activity of Extracts of Brazilian Propolis in Topical Pharmaceutical Formulations on Mammalian Cells In Vitro and In Vivo]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen049v1?rss=1</link>
<description><![CDATA[
<p>Propolis possesses various biological activities such as antibacterial, antifungal, anti-inflammatory, anesthetic and antioxidant properties. A topically applied product based on Brazilian green propolis was developed for the treatment of burns. For such substance to be used more safely in future clinical applications, the present study evaluated the mutagenic potential of topical formulations supplemented with green propolis extract (1.2, 2.4 and 3.6%) based on the analysis of chromosomal aberrations and of micronuclei. In the <I>in vitro</I> studies, 3-h pulse (G<SUB>1</SUB> phase of the cell cycle) and continuous (20 h) treatments were performed. In the <I>in vivo</I> assessment, the animals were injured on the back and then submitted to acute (24 h), subacute (7 days) and subchronic (30 days) treatments consisting of daily dermal applications of gels containing different concentrations of propolis. Similar frequencies of chromosomal aberrations were observed for cultures submitted to 3-h pulse and continuous treatment with gels containing different propolis concentrations and cultures not submitted to any treatment. However, in the continuous treatment cultures treated with the 3.6% propolis gel presented significantly lower mitotic indices than the negative control. No statistically significant differences in the frequencies of micronuclei were observed between animals treated with gels containing different concentrations of propolis and the negative control for the three treatment times. Under the present conditions, topical formulations containing different concentrations of green propolis used for the treatment of burns showed no mutagenic effect in either test system, but 3.6% propolis gel was found to be cytotoxic in the <I>in vitro</I> test.</p>
]]></description>
<dc:creator><![CDATA[Senedese, J. M., Rodrigues, A. R., Furtado, M. A., Faustino, V. D., Berretta, A. A., Marchetti, J. M., Tavares, D. C.]]></dc:creator>
<dc:date>Wed, 09 Jul 2008 23:58:02 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen049</dc:identifier>
<dc:title><![CDATA[Assessment of the Mutagenic Activity of Extracts of Brazilian Propolis in Topical Pharmaceutical Formulations on Mammalian Cells In Vitro and In Vivo]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-09</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen044v1?rss=1">
<title><![CDATA[GP Participation and Recruitment of Patients to RCTs: Lessons from Trials of Acupuncture and Exercise for Low Back Pain in Primary Care]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen044v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study was to identify factors associated with general practitioner (GP) participation and the recruitment of people to trials in primary care, based on data from two trials of interventions for treating chronic low back pain. The study was based on data from two randomized controlled trials (RCTs), one involving exercise, the other acupuncture, and subsequent reporting by GPs in a postal questionnaire. The exercise trial achieved 62% recruitment whereas the acupuncture trial achieved 100% recruitment. In both trials GPs most efficient at referring patients were those with a special interest in the subject area, and those known personally to the research team. A follow-up GP questionnaire found that both trials had maintained a high profile with over 80% of GPs, and successful recruitment strategies included project reminder letters, updates and personal contacts. Achieving target recruitment of patients in the acupuncture trial was aided by the deliberate application of lessons learned in the exercise trial, in particular the need to keep initial study entry criteria broad, with subsequent filtering undertaken by the study researcher. In addition the use of effective methods of maintaining the trial profile, the involvement of a GP advisor, the decision to maximize the recruitment of GPs early in the trial and the direct recruitment of interested individual GPs. The successful recruitment of patients to trials in primary care requires careful planning and continuous monitoring from the outset. Prior to starting recruitment, it is useful to identify previous trials in a similar environment in order to learn from their experience and optimize patient recruitment.</p>
]]></description>
<dc:creator><![CDATA[Bell-Syer, S. E. M., Thorpe, L. N., Thomas, K., MacPherson, H.]]></dc:creator>
<dc:date>Tue, 08 Jul 2008 23:21:59 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen044</dc:identifier>
<dc:title><![CDATA[GP Participation and Recruitment of Patients to RCTs: Lessons from Trials of Acupuncture and Exercise for Low Back Pain in Primary Care]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem179v2?rss=1">
<title><![CDATA[Body Acupuncture for Nicotine Withdrawal Symptoms: A Randomized Placebo-controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem179v2?rss=1</link>
<description><![CDATA[
<p>This study evaluated whether improvements in nicotine withdrawal symptoms (NWS), depression and anxiety are greater for body acupuncture than for sham acupuncture. Smoking volunteers from the public were randomized to receive six sessions of either real or sham acupuncture for 2 weeks. The primary outcome measure was NWS measured by the Minnesota Nicotine Withdrawal Score, and the secondary measures were scores on the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI). Eighty volunteers were randomized into real acupuncture (<I>n</I> = 38) and sham acupuncture (<I>n</I> = 42) groups, of which 46 subjects (22 and 24 in the real and sham acupuncture groups, respectively) completed the treatment and the 2-week follow-up. An intention-to-treat analysis revealed that the NWS did not differ significantly between the real and sham acupuncture groups immediately after the treatment (12.2 &plusmn; 9.7 and 12.8 &plusmn; 7.7, respectively; mean &plusmn; SD) and at the 2-week follow-up (11.7 &plusmn; 10.2 and 12.6 &plusmn; 7.8). Both groups also showed similar improvements in BDI and BAI scores. These results indicate that the real acupuncture treatment tested in this trial was no more effective than sham acupuncture at reducing NWS, depression and anxiety for smoking cessation.</p>
]]></description>
<dc:creator><![CDATA[Hyun, M.-K., Lee, M. S., Kang, K., Choi, S.-M.]]></dc:creator>
<dc:date>Fri, 04 Jul 2008 23:11:23 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem179</dc:identifier>
<dc:title><![CDATA[Body Acupuncture for Nicotine Withdrawal Symptoms: A Randomized Placebo-controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-04</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen048v1?rss=1">
<title><![CDATA[Potential Benefits on Impairment of Endothelial Function after a High-fat Meal of 4 weeks of Flavonoid Supplementation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen048v1?rss=1</link>
<description><![CDATA[
<p>Studies with foods high in flavonoids have demonstrated improvement in endothelial function. We investigated whether 4 weeks of flavonoid supplementation would prevent an adverse impact on endothelial function of a high-fat meal. Endothelial function was measured by reactive hyperemia peripheral arterial tonometry (RH-PAT). The RH-PAT index was measured both before and 3 h after a high-fat meal, in 23 healthy volunteers. Subjects were randomized in a double-blind, cross-over design to 4 weeks of daily supplementation with OPC-3&reg;, or a matching placebo. RH-PAT index before and after the high-fat meal was measured at the beginning and end of each 4-week treatment phase. The high-fat meal caused a decline in endothelial function at baseline in the placebo (&ndash;10.71%, <I>P</I> = 0.006) and flavonoid [&ndash;9.97% (<I>P</I> = 0.077)] groups, and there was no difference in decline between arms (<I>P</I> = 0.906). The high-fat meal produced a decline after 4 weeks of placebo [&ndash;12.37% (<I>P</I> = 0.005)], but no decline after 4 weeks of flavonoid supplement [&ndash;3.16% (<I>P</I> = 0.663)], and the difference between the two responses was highly significant (<I>P</I> &lt; 0.0001). Within-group comparisons revealed no difference in endothelial function decline in the placebo arm between baseline and 4 weeks [&ndash;10.71% versus &ndash;12.37% (<I>P</I> = 0.758)]. In the flavonoid supplement arm, the difference in endothelial function decline between baseline and 4 weeks was &ndash;9.97% versus &ndash;3.16%, but did not reach statistical significance (<I>P</I> = 0.451). These results suggest that the flavonoid supplement used in this study mitigates the impairment of endothelial function caused by a high-fat meal. Whether certain subpopulations derive greater or lesser benefit remains unclear.</p>
]]></description>
<dc:creator><![CDATA[Barringer, T. A., Hatcher, L., Sasser, H. C.]]></dc:creator>
<dc:date>Thu, 03 Jul 2008 04:57:55 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen048</dc:identifier>
<dc:title><![CDATA[Potential Benefits on Impairment of Endothelial Function after a High-fat Meal of 4 weeks of Flavonoid Supplementation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-03</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen040v1?rss=1">
<title><![CDATA[Antidiabetic Indian Plants: a Good Source of Potent Amylase Inhibitors]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen040v1?rss=1</link>
<description><![CDATA[
<p>Diabetes is known as a multifactorial disease. The treatment of diabetes (Type II) is complicated due to the inherent patho-physiological factors related to this disease. One of the complications of diabetes is post-prandial hyperglycemia (PPHG). Glucosidase inhibitors, particularly -amylase inhibitors are a class of compounds that helps in managing PPHG. Six ethno-botanically known plants having antidiabetic property namely, <I>Azadirachta indica</I> Adr. Juss.; <I>Murraya koenigii</I> (L.) Sprengel; <I>Ocimum tenuflorum</I> (L.) (syn: <I>Sanctum</I>); <I>Syzygium cumini</I> (L.) Skeels (syn: <I>Eugenia jambolana</I>); <I>Linum usitatissimum</I> (L.) and <I>Bougainvillea spectabilis</I> were tested for their ability to inhibit glucosidase activity. The chloroform, methanol and aqueous extracts were prepared sequentially from either leaves or seeds of these plants. It was observed that the chloroform extract of <I>O. tenuflorum; B. spectabilis; M. koenigii</I> and <I>S. cumini</I> have significant -amylase inhibitory property. Plants extracts were further tested against murine pancreatic, liver and small intestinal crude enzyme preparations for glucosidase inhibitory activity. The three extracts of <I>O. tenuflorum</I> and chloroform extract of <I>M. koenigi</I> showed good inhibition of murine pancreatic and intestinal glucosidases as compared with acarbose, a known glucosidase inhibitor.</p>
]]></description>
<dc:creator><![CDATA[Bhat, M., Zinjarde, S. S., Bhargava, S. Y., Kumar, A. R., Joshi, B. N.]]></dc:creator>
<dc:date>Fri, 27 Jun 2008 02:18:26 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen040</dc:identifier>
<dc:title><![CDATA[Antidiabetic Indian Plants: a Good Source of Potent Amylase Inhibitors]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-06-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen036v1?rss=1">
<title><![CDATA[Therapeutic Potential of Plants as Anti-microbials for Drug Discovery]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen036v1?rss=1</link>
<description><![CDATA[
<p>The uses of traditional medicinal plants for primary health care have steadily increased worldwide in recent years. Scientists are in search of new phytochemicals that could be developed as useful anti-microbials for treatment of infectious diseases. Currently, out of 80% of pharmaceuticals derived from plants, very few are now being used as anti-microbials. Plants are rich in a wide variety of secondary metabolites that have found anti-microbial properties. This review highlights the current status of traditional medicine, its contribution to modern medicine, recent trends in the evaluation of anti-microbials with a special emphasis upon some tribal medicine, <I>in vitro</I> and <I>in vivo</I> experimental design for screening, and therapeutic efficacy in safety and human clinical trails for commercial outlet. Many of these commercially available compounds are crude preparations administered without performing human clinical trials. Recent methods are useful to standardize the extraction for scientific investigation of new phytochemicals and anti-microbials of traditionally used plants. It is concluded that once the local ethnomedical preparations 